data_1wh9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wh9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.9 t80 . . . . . 0 CA--C 1.527 0.061 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -57.94 -31.72 67.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -42.33 58.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.407 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -62.73 -46.41 88.21 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.144 0.577 . . . . 0.0 110.807 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.75 -38.82 90.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.651 0.781 . . . . 0.0 110.166 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.45 -42.18 83.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.352 0.524 . . . . 0.0 111.14 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.95 -46.26 78.6 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.588 0.755 . . . . 0.0 110.876 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.57 -61.59 2.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.001 0.92 . . . . 0.0 109.439 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.51 -32.23 72.26 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.737 1.215 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.3 m -54.56 -45.42 73.48 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.885 0.766 . . . . 0.0 110.497 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -49.97 65.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.689 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -55.88 -35.53 66.6 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.104 0.561 . . . . 0.0 112.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -121.15 24.77 9.93 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.09 1.356 . . . . 0.0 110.524 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.03 -63.04 1.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.42 1.488 . . . . 0.0 110.595 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.23 -24.94 51.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.905 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.7 -35.54 72.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.341 0.973 . . . . 0.0 111.418 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.68 35.73 0.83 Allowed Glycine 0 C--N 1.338 0.65 0 O-C-N 123.553 0.533 . . . . 0.0 113.018 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -59.38 167.46 1.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.174 0.987 . . . . 0.0 112.509 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -44.88 0.16 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.406 1.482 . . . . 0.0 110.042 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.32 -169.53 42.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.77 156.34 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.39 158.96 22.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.576 1.951 . . . . 0.0 107.857 163.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.02 150.07 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -132.88 156.79 46.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 163.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.52 124.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 p -120.41 176.83 1.64 Allowed Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -167.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.12 8.07 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.509 1.473 . . . . 0.0 112.591 167.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -125.78 -45.08 1.77 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.376 0.989 . . . . 0.0 110.637 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -161.73 173.22 14.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.92 1.236 . . . . 0.0 110.865 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.6 m -88.94 149.47 23.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 160.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.2 138.41 52.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.176 1.79 . . . . 0.0 106.613 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -132.16 120.7 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.41 95.03 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.26 153.24 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -118.8 108.14 14.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.827 2.451 . . . . 0.0 105.972 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.93 157.93 45.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.556 0.693 . . . . 0.0 112.29 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.8 p -64.08 -34.24 77.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.549 1.14 . . . . 0.0 111.018 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -134.88 82.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.479 1.512 . . . . 0.0 109.821 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 p -53.4 -35.37 60.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.732 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -60.79 -36.57 79.35 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.448 1.477 . . . . 0.0 112.456 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -67.03 -45.28 77.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.814 0.733 . . . . 0.0 109.066 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -30.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.049 0.939 . . . . 0.0 111.105 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.21 -40.22 52.72 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.524 -0.735 . . . . 0.0 110.519 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.3 179.7 47.06 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.501 1.048 . . . . 0.0 111.487 -171.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -57.06 114.93 2.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.545 0.738 . . . . 0.0 109.447 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 mttp 39.46 46.82 1.47 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.181 1.792 . . . . 0.0 112.464 -174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.88 9.54 77.43 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.118 -0.824 . . . . 0.0 113.751 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -43.86 -62.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.253 1.526 . . . . 0.0 112.738 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.02 -40.77 78.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.368 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.04 -41.27 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.306 0.957 . . . . 0.0 111.186 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -52.61 64.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.972 -1.08 . . . . 0.0 109.649 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -58.54 -47.06 85.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.795 0.725 . . . . 0.0 111.732 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 40.0 mt -62.0 -30.24 70.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.715 0.806 . . . . 0.0 110.898 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -61.17 -51.7 67.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.436 1.016 . . . . 0.0 109.413 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.71 78.79 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.857 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 11.4 p -59.87 -46.17 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.722 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 t -60.45 -45.69 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 120.234 1.379 . . . . 0.0 110.152 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -51.9 -44.25 63.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.785 1.234 . . . . 0.0 110.426 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -70.75 -50.78 32.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.2 1.0 . . . . 0.0 110.139 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -44.87 90.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.282 1.433 . . . . 0.0 111.016 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -103.57 -13.67 16.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.81 1.244 . . . . 0.0 111.503 -171.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 20.36 54.91 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 121.324 -0.86 . . . . 0.0 113.943 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -62.32 138.38 96.23 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.063 0.932 . . . . 0.0 112.456 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.96 141.6 49.03 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.275 1.983 . . . . 0.0 110.24 165.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.47 147.35 39.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.735 0.814 . . . . 0.0 110.03 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.97 -7.44 7.57 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.435 -0.791 . . . . 0.0 113.197 -169.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.0 m -122.02 7.21 9.78 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.138 1.775 . . . . 0.0 111.201 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.07 136.84 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 156.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 140.77 51.88 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.54 126.67 50.92 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.205 1.402 . . . . 0.0 107.629 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -129.89 168.23 16.95 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.847 2.459 . . . . 0.0 109.22 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.62 122.07 17.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.37 155.28 18.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -101.23 149.49 23.95 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 122.517 1.151 . . . . 0.0 108.134 178.479 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 t80 . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.31 -36.19 60.99 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 118.547 -0.739 . . . . 0.0 112.177 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.37 -51.52 51.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.951 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.91 -46.0 74.82 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.427 1.091 . . . . 0.0 109.932 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.21 -43.26 82.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.737 0.815 . . . . 0.0 110.625 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -64.12 -47.19 80.93 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.324 0.65 . . . . 0.0 109.942 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.73 -44.29 85.89 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.186 1.394 . . . . 0.0 111.739 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -56.54 -60.07 4.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.5 -38.89 78.61 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.476 1.11 . . . . 0.0 112.487 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -51.91 -37.05 51.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.552 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -90.79 -39.01 12.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.293 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.09 -25.46 65.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 113.071 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.38 22.6 12.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.2 1.8 . . . . 0.0 110.758 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.23 64.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.872 1.269 . . . . 0.0 111.683 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.77 -26.65 59.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.673 0.215 . . . . 0.0 111.071 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 -34.99 79.41 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.639 0.775 . . . . 0.0 112.12 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.57 33.63 2.23 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.49 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -51.67 157.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.862 0.865 . . . . 0.0 112.478 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -128.96 -57.06 1.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.472 1.509 . . . . 0.0 108.96 169.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.12 -166.45 32.9 Favored Glycine 0 C--O 1.227 -0.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.23 154.56 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -124.27 152.17 43.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 165.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.75 137.28 54.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -115.3 152.28 33.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.99 96.23 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 -171.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -120.69 163.89 26.45 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 123.768 0.827 . . . . 0.0 108.914 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.85 13.7 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.84 2.36 . . . . 0.0 112.011 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 p -120.64 -45.52 2.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.33 1.452 . . . . 0.0 110.324 -163.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -162.05 173.22 14.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.95 2.1 . . . . 0.0 106.989 162.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -75.71 147.37 39.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 158.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.77 129.7 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -126.9 132.51 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.99 100.53 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.55 131.75 33.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt -106.92 114.63 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.643 1.977 . . . . 0.0 106.22 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.81 169.63 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.801 0.441 . . . . 0.0 110.081 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -68.61 -46.45 69.27 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.408 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -115.8 89.6 3.14 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 127.519 2.328 . . . . 0.0 107.605 -164.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -45.27 66.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 111.324 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -65.76 -19.43 65.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -74.35 -49.06 24.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.67 -39.29 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.998 1.319 . . . . 0.0 110.844 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.16 -40.73 90.76 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.599 -0.688 . . . . 0.0 110.858 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 -175.29 40.0 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.54 113.67 2.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.889 1.275 . . . . 0.0 110.467 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.1 pttt 46.25 30.07 0.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.635 1.174 . . . . 0.0 113.867 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.62 5.74 59.97 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.992 0.806 . . . . 0.0 114.374 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -45.72 -55.91 5.91 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 112.855 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -72.27 -46.48 55.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.25 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.0 tt -59.08 -35.93 59.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.848 1.658 . . . . 0.0 111.134 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.94 -36.67 72.71 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 120.699 -1.251 . . . . 0.0 112.559 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.91 -49.27 71.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.265 0.484 . . . . 0.0 109.997 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 83.1 mt -59.87 -29.09 68.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.937 1.295 . . . . 0.0 110.507 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -63.32 -56.67 14.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.815 . . . . 0.0 109.067 169.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.6 88.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.863 1.265 . . . . 0.0 112.097 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 7.4 p -62.88 -52.4 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.115 -1.422 . . . . 0.0 108.101 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.81 -46.38 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.187 1.358 . . . . 0.0 109.976 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.99 -44.89 64.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 0.0 109.517 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -83.89 -37.51 22.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.707 0.685 . . . . 0.0 112.646 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.98 -55.3 32.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.528 1.131 . . . . 0.0 109.088 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 97.2 m-85 -93.8 -11.18 31.85 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.486 1.114 . . . . 0.0 110.51 -169.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.98 23.11 59.96 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.424 1.011 . . . . 0.0 111.811 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.65 139.98 97.71 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 118.263 1.031 . . . . 0.0 111.508 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.17 130.74 35.54 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.934 2.423 . . . . 0.0 109.449 165.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.07 122.67 15.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.433 0.693 . . . . 0.0 109.301 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.58 -12.47 56.03 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.985 0.802 . . . . 0.0 114.368 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -89.2 15.18 9.31 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.779 1.232 . . . . 0.0 111.582 165.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.57 156.4 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 159.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 145.31 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 170.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 113.16 19.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -112.36 164.67 12.98 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.064 2.145 . . . . 0.0 108.609 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.84 114.37 10.39 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.43 153.68 20.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.088 0.946 . . . . 0.0 109.194 172.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -83.28 148.3 27.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.323 -0.558 0 C-N-CA 123.794 0.837 . . . . 0.0 109.339 172.625 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.227 -0.101 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.55 -38.52 74.89 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.544 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.83 65.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.782 0.719 . . . . 0.0 111.759 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -58.13 -48.73 79.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.911 0.778 . . . . 0.0 109.48 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.62 -41.86 92.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.344 1.457 . . . . 0.0 111.39 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.02 -50.16 73.59 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 123.764 0.826 . . . . 0.0 109.51 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.72 -42.68 97.88 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.11 -52.12 65.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.681 0.793 . . . . 0.0 109.419 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.18 -38.66 85.77 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.242 1.017 . . . . 0.0 111.787 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -54.6 -42.53 71.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.907 0.883 . . . . 0.0 109.9 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.51 -61.44 1.89 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.369 0.668 . . . . 0.0 110.061 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -21.97 64.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -170.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -122.65 21.58 10.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.138 1.775 . . . . 0.0 111.104 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.56 -55.07 17.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.309 1.044 . . . . 0.0 112.228 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -71.11 -16.08 62.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.554 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.48 -16.1 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.544 1.066 . . . . 0.0 113.39 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.73 40.26 6.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.58 158.85 4.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.834 -0.804 . . . . 0.0 110.89 170.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -147.35 -29.86 0.34 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.115 0.966 . . . . 0.0 112.564 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.64 -167.02 40.04 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.74 149.27 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.43 119.48 28.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -82.67 135.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -109.39 120.58 42.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.37 121.92 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 157.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -120.29 164.75 20.95 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.29 2.85 5.77 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.678 2.252 . . . . 0.0 111.877 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -112.82 -41.75 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -161.83 173.37 14.67 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.077 1.351 . . . . 0.0 109.965 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.4 m -74.79 146.38 42.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 154.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -127.45 143.55 51.18 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.435 2.294 . . . . 0.0 105.114 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -132.46 117.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.84 95.98 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.49 125.42 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.36 113.97 25.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.274 1.83 . . . . 0.0 106.299 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.42 171.07 14.57 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 109.209 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -81.87 -17.99 45.38 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.388 -1.445 . . . . 0.0 112.886 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -133.05 61.65 1.67 Allowed 'General case' 0 CA--C 1.523 -0.066 0 C-N-CA 124.74 1.216 . . . . 0.0 110.214 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -48.86 -41.69 34.05 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.894 0.877 . . . . 0.0 112.112 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.2 83.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.625 0.37 . . . . 0.0 111.431 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -72.27 -43.48 64.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.302 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.37 -31.58 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 110.976 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.96 -32.37 70.58 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.069 -1.019 . . . . 0.0 111.767 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.9 169.74 7.57 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.224 1.392 . . . . 0.0 111.665 -166.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.19 125.68 24.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.519 1.528 . . . . 0.0 108.679 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt 42.63 43.63 3.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.153 1.781 . . . . 0.0 111.767 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.0 66.57 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.886 -0.952 . . . . 0.0 114.948 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -52.93 -51.46 61.25 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.753 1.776 . . . . 0.0 111.175 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -34.65 62.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.881 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -65.82 -36.71 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.194 1.361 . . . . 0.0 111.24 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -65.15 -41.16 94.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 120.756 -1.215 . . . . 0.0 111.42 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -56.68 -60.11 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.057 0.943 . . . . 0.0 109.017 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.8 mt -57.27 -35.9 70.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.349 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -55.58 -52.38 63.93 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.594 1.088 . . . . 0.0 109.933 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.91 85.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.688 0.676 . . . . 0.0 111.294 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -64.13 -46.3 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 117.633 -1.175 . . . . 0.0 109.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.92 -46.29 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 120.568 1.531 . . . . 0.0 109.365 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -53.55 -39.91 65.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.085 0.554 . . . . 0.0 110.922 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -85.22 -36.65 20.82 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 118.964 0.802 . . . . 0.0 111.459 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -45.42 94.09 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.807 0.843 . . . . 0.0 109.16 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.77 -2.77 21.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.905 1.282 . . . . 0.0 112.69 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.27 35.57 63.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.687 1.137 . . . . 0.0 113.573 172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.13 133.7 68.51 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 118.371 1.086 . . . . 0.0 111.453 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.41 138.96 87.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.121 2.548 . . . . 0.0 111.185 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 111.07 9.84 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.169 0.987 . . . . 0.0 110.16 -173.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.76 -2.18 55.65 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.277 -0.735 . . . . 0.0 112.694 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 m -109.66 6.5 23.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.519 1.128 . . . . 0.0 112.081 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.68 163.71 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.749 1.219 . . . . 0.0 107.836 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.66 157.26 43.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.37 1.468 . . . . 0.0 107.43 159.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.39 135.49 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.07 165.25 19.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.016 1.726 . . . . 0.0 108.241 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.77 111.16 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -116.53 154.15 30.93 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.045 1.338 . . . . 0.0 109.009 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -110.69 135.36 51.41 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.633 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 C--O 1.239 0.527 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 119.496 -0.288 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -54.68 -47.36 73.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.411 -0.805 . . . . 0.0 109.768 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.89 -53.44 50.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.464 1.105 . . . . 0.0 111.917 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.83 -45.77 59.69 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.202 0.601 . . . . 0.0 110.439 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp -69.23 -41.04 77.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.746 1.219 . . . . 0.0 110.868 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -50.37 74.25 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.983 1.313 . . . . 0.0 108.758 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -66.38 -31.99 73.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.506 1.922 . . . . 0.0 112.127 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.97 -62.6 1.35 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.592 1.157 . . . . 0.0 108.533 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -55.8 -29.6 59.98 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.383 1.473 . . . . 0.0 112.389 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -51.51 -45.16 62.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.233 1.013 . . . . 0.0 111.856 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -74.27 -58.27 3.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -30.44 15.04 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 125.9 1.68 . . . . 0.0 113.402 -169.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.52 22.34 5.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.843 1.257 . . . . 0.0 111.566 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.629 0.771 . . . . 0.0 110.054 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.1 -26.09 68.06 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.572 1.149 . . . . 0.0 110.446 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.75 -25.79 65.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.52 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.51 25.59 4.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.43 -1.205 . . . . 0.0 114.077 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -54.41 148.95 10.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.709 1.604 . . . . 0.0 113.646 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m -128.46 -41.51 1.53 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 112.453 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.16 -166.36 39.59 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 156.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.46 138.73 50.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 160.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.95 124.52 65.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.29 121.98 46.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.86 95.87 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 p -78.38 166.04 45.79 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.18 -2.55 12.7 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.225 1.283 . . . . 0.0 112.921 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 p -103.73 -51.05 3.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.595 1.089 . . . . 0.0 109.606 -166.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -157.44 162.97 38.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.758 2.023 . . . . 0.0 107.757 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.1 m -73.11 139.69 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -110.49 144.01 39.95 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.4 mt -135.31 123.41 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.5 101.54 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.5 mt -68.15 123.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 mt -96.5 118.3 32.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.69 -177.92 6.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.689 0.756 . . . . 0.0 111.504 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 p -86.49 -25.36 25.18 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -129.67 78.46 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.68 1.192 . . . . 0.0 107.96 -165.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -40.7 72.81 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.247 1.019 . . . . 0.0 111.346 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -69.51 -22.08 63.62 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.691 -0.631 . . . . 0.0 111.63 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -72.76 -46.43 53.44 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.43 -36.55 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.146 1.378 . . . . 0.0 111.678 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -65.39 -42.67 92.38 Favored 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 120.916 -1.115 . . . . 0.0 109.34 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -179.57 29.42 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-O 122.976 1.32 . . . . 0.0 110.673 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.51 116.81 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.895 2.078 . . . . 0.0 109.156 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt 52.68 8.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.776 2.03 . . . . 0.0 115.305 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 18.72 11.24 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 120.695 1.588 . . . . 0.0 113.493 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -60.77 -57.26 13.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.489 2.145 . . . . 0.0 112.437 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -67.44 -33.61 75.5 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.916 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.6 -44.02 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.151 0.887 . . . . 0.0 110.456 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -69.13 -38.88 79.06 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.113 -0.992 . . . . 0.0 111.228 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.65 -49.12 76.42 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.759 0.709 . . . . 0.0 109.402 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.0 mt -59.69 -29.09 67.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.647 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 m -60.77 -56.82 16.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.596 1.089 . . . . 0.0 108.922 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.67 73.04 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.763 1.225 . . . . 0.0 111.978 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 14.3 p -59.17 -51.9 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.539 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.83 -43.88 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.656 1.571 . . . . 0.0 109.778 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -53.05 -44.04 67.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.603 0.761 . . . . 0.0 110.846 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -72.71 -52.75 13.92 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.902 0.774 . . . . 0.0 110.875 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.84 -24.17 21.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.667 1.987 . . . . 0.0 112.589 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.97 -3.37 5.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.488 1.115 . . . . 0.0 112.961 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.83 7.78 85.26 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.754 1.169 . . . . 0.0 114.924 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -61.22 143.62 92.35 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.389 1.595 . . . . 0.0 111.948 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.44 163.67 23.05 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.472 2.115 . . . . 0.0 110.447 162.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -68.83 141.39 55.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 164.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.44 -40.65 2.42 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.681 1.134 . . . . 0.0 113.661 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.7 m -67.47 -4.78 12.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.943 1.372 . . . . 0.0 112.922 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.91 141.38 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 163.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.96 130.2 48.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.33 137.89 39.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -130.47 167.49 18.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 127.612 2.365 . . . . 0.0 109.209 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.31 120.19 14.41 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.142 1.777 . . . . 0.0 108.915 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -119.14 148.56 42.94 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.717 1.207 . . . . 0.0 110.502 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -74.7 147.73 41.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.403 0.62 . . . . 0.0 109.839 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.428 0 C-N-CA 125.904 1.682 . . . . 0.0 107.982 172.097 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.6 t80 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.22 -35.58 73.88 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -49.79 14.08 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.178 0.991 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.22 -47.78 65.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.445 0.641 . . . . 0.0 109.801 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.856 -0.527 . . . . 0.0 110.824 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.04 -57.5 12.8 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.821 1.248 . . . . 0.0 110.007 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.03 -34.8 78.5 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 118.754 0.706 . . . . 0.0 111.855 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.7 -64.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.687 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.18 80.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.574 1.55 . . . . 0.0 111.717 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.6 m -49.88 -37.38 30.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.616 1.166 . . . . 0.0 110.935 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.79 -16.63 28.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.61 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.68 -16.47 28.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.428 1.091 . . . . 0.0 112.457 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -136.97 36.63 2.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.38 1.472 . . . . 0.0 112.008 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.89 -61.23 2.51 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.051 -1.031 . . . . 0.0 111.774 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.75 -15.86 60.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.801 0.84 . . . . 0.0 112.081 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.12 -15.14 62.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.067 1.347 . . . . 0.0 112.774 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.88 32.75 28.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.167 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -52.96 144.57 14.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.519 0.66 . . . . 0.0 111.213 168.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.1 m -126.58 -47.78 1.55 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.395 1.478 . . . . 0.0 110.428 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.87 -162.94 29.68 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.55 158.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 121.083 -1.245 . . . . 0.0 107.969 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -128.36 157.69 40.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.652 1.981 . . . . 0.0 109.277 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.07 134.65 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.508 1.123 . . . . 0.0 111.231 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -121.45 161.85 21.48 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.673 1.189 . . . . 0.0 110.124 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.76 133.71 65.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.993 1.717 . . . . 0.0 106.493 164.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -122.37 170.53 7.75 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.325 1.45 . . . . 0.0 109.095 167.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.44 4.82 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.593 2.196 . . . . 0.0 112.651 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.3 p -108.22 -54.9 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.443 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.01 169.28 24.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.592 1.087 . . . . 0.0 111.689 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.4 m -68.0 151.91 46.35 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -135.39 135.08 40.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.9 124.15 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.68 107.42 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.47 1.108 . . . . 0.0 108.582 -166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.17 142.93 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.65 115.55 30.35 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 163.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.58 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.988 0.813 . . . . 0.0 110.546 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -78.64 -49.02 13.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.656 -1.278 . . . . 0.0 111.283 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -99.71 74.28 1.85 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -51.89 -35.35 44.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.691 -0.631 . . . . 0.0 112.659 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -77.09 -18.61 57.88 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.297 1.408 . . . . 0.0 113.067 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -65.12 -59.94 3.56 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 162.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -53.58 -43.83 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.287 1.035 . . . . 0.0 111.751 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.21 -41.32 77.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.48 -0.762 . . . . 0.0 110.816 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.84 178.76 34.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.465 0.481 . . . . 0.0 112.111 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.85 119.15 7.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.62 0.768 . . . . 0.0 110.204 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.87 32.16 5.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.753 1.621 . . . . 0.0 112.356 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.77 58.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.013 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -51.65 -63.43 1.14 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.164 1.482 . . . . 0.0 113.024 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -39.63 94.71 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.732 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.73 -43.53 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.265 1.393 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -68.3 -38.27 81.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.03 -1.044 . . . . 0.0 111.476 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.15 -51.77 66.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 16.9 mt -62.71 -26.47 68.69 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.277 -1.344 . . . . 0.0 111.752 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -60.82 -50.45 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.117 1.326 . . . . 0.0 108.408 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.26 85.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.689 0.796 . . . . 0.0 112.286 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.9 p -68.45 -39.07 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.336 -1.316 . . . . 0.0 110.142 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.32 -43.6 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 121.532 1.969 . . . . 0.0 109.961 173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -54.64 -40.36 68.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.927 0.891 . . . . 0.0 111.073 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -67.62 -65.53 0.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.494 1.043 . . . . 0.0 108.849 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -38.89 69.0 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.28 2.232 . . . . 0.0 111.754 -167.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.64 -4.4 17.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.623 1.169 . . . . 0.0 111.185 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.26 51.38 57.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.638 1.108 . . . . 0.0 110.908 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -79.12 153.8 77.25 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.638 0.375 . . . . 0.0 110.577 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -72.42 117.03 4.94 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.703 2.268 . . . . 0.0 108.319 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -57.37 143.42 40.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 110.075 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.77 -46.43 3.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.948 1.261 . . . . 0.0 111.085 -168.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m -83.56 17.28 2.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.366 1.466 . . . . 0.0 114.279 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.45 136.07 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.81 135.07 47.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 128.156 2.582 . . . . 0.0 108.155 174.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.3 134.55 52.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.37 177.29 6.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.245 2.218 . . . . 0.0 108.838 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 158.84 43.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.93 153.24 46.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.759 2.424 . . . . 0.0 106.353 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -95.5 135.97 36.48 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.24 0.602 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.478 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.711 0.291 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.94 -38.1 81.45 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.909 -169.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 -55.01 31.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.241 0.616 . . . . 0.0 110.622 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.49 -42.85 78.98 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.315 0.507 . . . . 0.0 111.578 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.5 tp -71.37 -38.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.548 0.339 . . . . 0.0 110.636 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -59.93 -51.53 69.28 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.057 0.943 . . . . 0.0 108.634 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.19 -37.8 81.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 112.371 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.15 -57.01 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.188 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.05 -30.35 71.43 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.686 1.195 . . . . 0.0 111.939 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.9 m -49.67 -40.22 39.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.185 1.394 . . . . 0.0 111.118 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -91.18 -45.87 8.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.448 0.699 . . . . 0.0 110.424 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -55.98 -30.39 61.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.409 0.684 . . . . 0.0 112.613 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.8 mt -125.53 22.45 7.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.015 1.326 . . . . 0.0 110.703 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.18 -63.48 1.14 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.014 0.925 . . . . 0.0 110.222 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.05 -15.51 61.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.521 0.329 . . . . 0.0 111.836 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -35.65 74.94 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.74 28.41 1.42 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.907 -0.94 . . . . 0.0 113.818 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -53.29 153.63 3.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.526 1.163 . . . . 0.0 112.628 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 m -142.42 -34.35 0.45 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.972 1.309 . . . . 0.0 112.405 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.77 -169.57 42.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.064 0.847 . . . . 0.0 111.075 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.4 149.75 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.76 159.67 34.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.867 1.267 . . . . 0.0 108.287 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.1 127.81 18.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.673 1.189 . . . . 0.0 110.904 -163.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -126.03 161.95 26.39 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.796 1.238 . . . . 0.0 108.675 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.46 115.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 35' ' ' THR . 51.1 p -92.17 172.44 6.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 123.813 0.845 . . . . 0.0 108.773 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 51.8 Cg_endo -70.94 20.67 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.936 2.424 . . . . 0.0 112.124 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.416 ' H ' ' C ' ' A' ' 33' ' ' THR . 37.9 p -128.07 -44.93 1.42 Allowed 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 120.842 -1.161 . . . . 0.0 111.421 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.11 172.71 15.41 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.182 0.901 . . . . 0.0 111.122 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 m -71.51 157.43 38.03 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 159.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.81 128.42 34.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.168 1.787 . . . . 0.0 107.195 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.0 mt -117.04 124.09 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.92 104.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.25 133.31 32.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.71 117.03 33.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.047 . . . . 0.0 106.756 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.54 167.49 23.57 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -31.47 65.82 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.909 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -132.35 81.33 1.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.1 p -52.58 -43.73 65.46 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.772 -0.58 . . . . 0.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.45 -30.11 62.47 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.325 1.45 . . . . 0.0 112.734 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -70.14 -52.2 25.46 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.618 0.645 . . . . 0.0 109.478 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.94 -34.19 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.83 1.252 . . . . 0.0 111.073 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -68.86 -35.19 76.62 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.474 -0.766 . . . . 0.0 111.3 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.65 -179.31 26.57 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.835 0.731 . . . . 0.0 111.745 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -54.1 109.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.937 1.695 . . . . 0.0 109.683 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt 46.58 43.34 12.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.783 1.233 . . . . 0.0 111.966 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 11.5 71.67 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.731 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -40.89 -64.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.895 1.678 . . . . 0.0 111.903 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.26 -47.08 68.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.499 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.22 -41.78 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.01 1.277 . . . . 0.0 110.371 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.3 -45.48 80.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.008 0.923 . . . . 0.0 111.463 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.64 -55.14 38.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.173 0.589 . . . . 0.0 109.819 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.77 -33.13 69.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.579 1.551 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.2 m -55.13 -50.49 69.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.686 1.13 . . . . 0.0 109.28 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.65 96.31 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.556 0.617 . . . . 0.0 111.963 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.6 t -58.62 -54.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 t -59.1 -41.31 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.883 2.073 . . . . 0.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -61.47 -22.15 64.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.361 0.982 . . . . 0.0 112.321 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.82 -50.73 5.22 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.503 -0.748 . . . . 0.0 110.859 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.92 62.03 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.231 1.412 . . . . 0.0 110.294 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.73 7.98 28.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.189 1.796 . . . . 0.0 111.041 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.96 23.13 37.48 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 125.352 1.453 . . . . 0.0 114.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -56.6 147.39 51.06 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.349 1.075 . . . . 0.0 111.583 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.2 128.87 30.31 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.627 2.218 . . . . 0.0 110.6 166.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 153.22 28.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 168.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.7 -44.43 0.63 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.837 2.161 . . . . 0.0 114.098 -164.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -91.08 18.24 7.05 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.77 1.628 . . . . 0.0 115.152 -166.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.45 139.89 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.55 150.67 50.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.282 0.492 . . . . 0.0 110.592 163.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.2 126.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -122.42 173.54 7.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.36 1.464 . . . . 0.0 109.807 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.32 109.75 5.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.461 1.105 . . . . 0.0 108.345 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -104.06 142.27 34.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -76.35 149.76 36.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.083 0.953 . . . . 0.0 112.477 168.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 45.9 t80 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -61.97 -36.22 80.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -171.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 -60.24 3.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.949 1.299 . . . . 0.0 109.625 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -55.39 -40.66 71.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.084 0.554 . . . . 0.0 111.363 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.426 HD21 ' CZ ' ' A' ' 8' ' ' PHE . 13.0 tp -69.3 -41.37 76.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.325 0.65 . . . . 0.0 111.031 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.81 -54.45 47.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.226 0.466 . . . . 0.0 109.84 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -57.3 -35.09 69.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.779 0.432 . . . . 0.0 112.145 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -67.22 -58.1 5.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.487 1.115 . . . . 0.0 110.872 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.7 -33.27 73.71 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.43 1.492 . . . . 0.0 111.861 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -47.97 -38.64 17.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.301 1.44 . . . . 0.0 111.321 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -89.09 -40.1 13.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.817 0.735 . . . . 0.0 111.437 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.66 -20.69 63.7 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.5 mt -133.02 24.64 4.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.791 1.636 . . . . 0.0 110.856 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.92 -56.32 20.87 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.88 1.272 . . . . 0.0 111.453 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -61.49 -45.28 94.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.574 1.15 . . . . 0.0 110.47 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.98 -31.28 72.44 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.913 0.885 . . . . 0.0 112.835 -163.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.61 41.05 1.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 119.338 -0.701 . . . . 0.0 113.775 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -49.93 154.85 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.612 0.765 . . . . 0.0 111.33 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.25 -45.43 0.77 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.534 1.534 . . . . 0.0 109.525 172.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.99 -164.89 34.6 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.47 151.64 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 121.457 -1.026 . . . . 0.0 108.646 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -121.99 151.48 40.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.835 0.826 . . . . 0.0 109.27 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.6 p -125.43 148.75 29.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.251 1.42 . . . . 0.0 108.395 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -132.79 153.48 51.2 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.1 t -98.37 135.75 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 155.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.89 166.08 16.82 Favored Pre-proline 0 C--O 1.243 0.717 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.02 0.91 6.5 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.651 2.234 . . . . 0.0 111.899 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -113.42 -47.33 3.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.486 1.039 . . . . 0.0 111.648 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -162.21 172.97 14.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.062 0.847 . . . . 0.0 110.332 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.7 m -68.96 150.28 47.89 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -124.98 143.65 50.78 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -129.72 122.71 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 99.43 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.97 132.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.63 108.5 20.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.349 1.859 . . . . 0.0 106.38 164.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 172.26 13.02 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 p -83.33 -37.49 23.32 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.873 -0.517 . . . . 0.0 111.43 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -117.11 64.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.634 -1.291 . . . . 0.0 108.035 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -43.83 -48.62 8.27 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.54 2.336 . . . . 0.0 113.169 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.15 -34.2 71.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.136 0.88 . . . . 0.0 111.859 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.58 -32.29 36.58 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.205 -0.934 . . . . 0.0 111.212 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.26 -42.35 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.875 0.87 . . . . 0.0 109.453 169.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 mt -61.26 -44.52 97.11 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.89 45.52 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 124.634 1.111 . . . . 0.0 110.684 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -57.3 114.91 2.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.733 1.213 . . . . 0.0 110.513 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 55.24 32.98 19.66 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.166 0.987 . . . . 0.0 110.897 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.34 22.57 77.35 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.873 -0.959 . . . . 0.0 112.837 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -52.87 63.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.89 1.845 . . . . 0.0 111.636 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -43.91 91.36 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 116.759 -1.591 . . . . 0.0 109.533 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.8 -40.97 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.212 1.369 . . . . 0.0 110.991 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.47 -44.53 82.44 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.914 1.234 . . . . 0.0 112.765 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -54.52 45.96 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.123 0.874 . . . . 0.0 108.799 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 57.0 mt -60.12 -27.31 66.93 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.379 1.472 . . . . 0.0 112.491 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.7 m -62.84 -59.53 4.73 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.661 1.119 . . . . 0.0 109.579 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.4 89.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.177 0.991 . . . . 0.0 111.262 -171.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 14.7 p -57.62 -50.43 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.758 -1.115 . . . . 0.0 108.686 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.81 -49.48 83.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 124.644 1.178 . . . . 0.0 109.495 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -49.56 -46.38 48.75 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.538 1.135 . . . . 0.0 110.623 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -73.06 -53.56 10.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -55.52 14.09 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 111.122 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.99 2.11 55.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.767 2.027 . . . . 0.0 112.429 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.43 51.11 44.71 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.47 149.99 86.76 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 117.496 0.648 . . . . 0.0 109.433 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.52 124.66 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.697 1.598 . . . . 0.0 109.155 161.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.55 153.62 27.08 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.76 -14.44 3.52 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.598 0.618 . . . . 0.0 113.446 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.8 m -133.04 28.81 4.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.765 1.283 . . . . 0.0 112.236 -161.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.94 145.71 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.091 1.356 . . . . 0.0 107.803 159.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -128.29 148.34 50.65 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.118 1.367 . . . . 0.0 109.266 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.35 137.7 51.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.89 1.276 . . . . 0.0 109.02 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -134.5 168.13 19.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.858 2.463 . . . . 0.0 109.551 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 109.86 6.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.452 1.901 . . . . 0.0 109.018 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -104.13 156.27 18.02 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.616 1.166 . . . . 0.0 109.122 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.69 145.6 27.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.661 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.24 0.595 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 168.332 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -61.2 -34.02 74.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.464 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.98 -59.06 4.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.505 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -55.03 -38.57 68.13 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 118.787 0.721 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.06 -43.81 77.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.456 0.702 . . . . 0.0 110.612 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.15 -43.68 98.3 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 123.97 0.908 . . . . 0.0 109.932 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.17 -25.41 63.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.799 1.24 . . . . 0.0 112.57 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 19' ' ' GLU . 37.0 t80 -72.64 -64.66 0.91 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.393 1.477 . . . . 0.0 108.647 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.92 -43.7 60.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.297 2.239 . . . . 0.0 111.883 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -52.77 -34.04 51.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.071 0.851 . . . . 0.0 111.411 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -91.01 -41.25 11.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.35 -0.834 . . . . 0.0 110.103 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 15' ' ' PHE . 6.6 mm-40 -56.97 -42.92 81.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.749 1.22 . . . . 0.0 112.724 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -115.68 26.63 9.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.514 1.526 . . . . 0.0 109.731 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.38 61.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.125 1.37 . . . . 0.0 111.905 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -79.68 -14.56 58.68 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.262 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.99 -23.04 17.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -159.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 35.85 3.76 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 119.072 0.851 . . . . 0.0 112.687 -168.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.74 162.49 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.185 0.993 . . . . 0.0 109.361 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 m -136.73 -60.84 0.69 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.67 -167.85 29.9 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.91 155.16 17.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -125.67 164.12 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.011 0.91 . . . . 0.0 109.141 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.26 139.58 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.102 1.761 . . . . 0.0 107.357 -170.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -132.82 138.62 47.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 106.96 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.2 t -136.16 116.53 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 36.5 p -120.9 176.69 1.75 Allowed Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.56 0.744 . . . . 0.0 110.361 -164.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 61.3 Cg_endo -73.12 3.75 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 121.727 1.618 . . . . 0.0 112.452 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.9 p -113.44 -52.1 2.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.268 1.395 . . . . 0.0 111.145 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -160.61 174.71 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.364 1.465 . . . . 0.0 111.198 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -82.04 151.59 27.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.505 -0.747 . . . . 0.0 109.062 163.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.14 142.79 34.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.594 1.958 . . . . 0.0 108.018 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.2 mt -141.13 126.03 18.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.4 105.07 15.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -173.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -70.43 130.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.87 115.76 28.73 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.6 169.87 16.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.047 0.84 . . . . 0.0 111.015 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.8 p -70.5 -31.81 69.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.257 -0.902 . . . . 0.0 111.7 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -134.32 85.39 2.19 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 p -53.36 -38.56 63.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.106 0.962 . . . . 0.0 111.454 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -57.97 -44.31 87.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.616 1.167 . . . . 0.0 111.984 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -68.83 -40.62 79.36 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.046 0.538 . . . . 0.0 109.578 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -46.59 93.77 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 C-N-CA 122.978 0.511 . . . . 0.0 109.683 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.53 -36.22 70.94 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.994 -1.066 . . . . 0.0 111.086 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 179.88 50.98 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 109.52 0.5 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.032 1.333 . . . . 0.0 109.277 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 mttm 40.22 46.16 1.87 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.439 1.496 . . . . 0.0 112.765 -173.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.99 9.3 82.72 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.17 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -46.08 78.43 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.57 2.185 . . . . 0.0 113.008 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -45.21 90.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.626 1.103 . . . . 0.0 110.678 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tt -67.55 -34.99 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.456 1.026 . . . . 0.0 111.111 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -57.36 -50.96 71.29 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.575 -0.703 . . . . 0.0 109.889 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -61.07 2.53 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.346 1.058 . . . . 0.0 109.705 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.0 mt -57.74 -34.97 70.08 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.525 -174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 m -57.64 -48.08 80.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.437 1.017 . . . . 0.0 109.484 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.77 -42.76 73.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.059 0.944 . . . . 0.0 112.005 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.3 p -66.75 -45.75 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.647 1.112 . . . . 0.0 109.736 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -55.67 -45.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.084 1.311 . . . . 0.0 109.511 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.71 -46.42 67.35 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.123 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -71.9 -50.66 27.3 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.075 0.852 . . . . 0.0 111.666 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -39.79 86.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.415 1.086 . . . . 0.0 110.787 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.72 3.77 24.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 111.737 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.91 26.75 71.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.072 0.844 . . . . 0.0 112.823 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -67.77 145.51 98.05 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 118.35 1.075 . . . . 0.0 109.595 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.22 165.66 16.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.795 2.33 . . . . 0.0 110.737 160.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -88.38 147.98 24.47 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.98 -45.99 2.59 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.403 1.478 . . . . 0.0 112.454 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 m -72.04 8.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.257 1.823 . . . . 0.0 112.501 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.87 126.0 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 162.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 146.61 38.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -120.55 140.71 51.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -132.93 165.32 24.94 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.47 1.908 . . . . 0.0 108.569 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.59 109.08 5.59 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -111.38 155.01 23.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.554 1.541 . . . . 0.0 110.371 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.97 141.01 29.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.517 0.675 . . . . 0.0 112.348 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 C--O 1.241 0.613 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.112 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 t80 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -62.11 -29.65 70.47 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.426 -1.273 . . . . 0.0 110.625 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.02 4.46 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.5 1.5 . . . . 0.0 110.387 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.53 -45.16 73.33 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.915 0.486 . . . . 0.0 110.555 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.83 -43.3 84.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.671 0.388 . . . . 0.0 110.455 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -57.26 -51.52 69.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 109.447 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.18 -52.94 62.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.404 0.682 . . . . 0.0 111.028 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -53.27 -48.52 68.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.412 1.085 . . . . 0.0 111.145 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.41 -38.68 81.48 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.58 1.552 . . . . 0.0 111.615 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -51.71 -47.29 64.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -66.97 -47.17 72.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 111.821 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.66 -12.83 60.86 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.999 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.17 15.45 8.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 113.499 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.53 27.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.324 1.05 . . . . 0.0 112.064 -172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -87.81 -26.86 22.62 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.53 -34.74 76.04 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.738 0.699 . . . . 0.0 110.31 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 65.25 0.53 Allowed Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -67.84 174.2 3.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.915 1.34 . . . . 0.0 110.266 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -164.4 -23.99 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.06 1.344 . . . . 0.0 112.046 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.15 -161.78 29.82 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -161.3 155.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -125.94 160.22 30.56 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 108.631 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.91 135.4 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 126.053 1.741 . . . . 0.0 108.287 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -132.62 122.74 25.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.13 92.76 2.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 43.7 p -84.07 176.83 3.39 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.702 1.601 . . . . 0.0 109.433 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 85.6 Cg_endo -76.38 6.08 4.23 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.052 1.835 . . . . 0.0 113.21 165.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -116.6 -57.97 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.68 1.582 . . . . 0.0 112.169 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -161.67 149.58 15.0 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.056 1.342 . . . . 0.0 108.055 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -70.93 138.64 50.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -110.42 137.37 48.22 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.97 122.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.87 103.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.01 145.51 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -115.22 112.04 21.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.47 165.75 26.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.399 0.679 . . . . 0.0 111.522 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.9 p -85.59 -21.55 28.44 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.866 -1.146 . . . . 0.0 113.503 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -131.64 59.17 1.7 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.853 0.751 . . . . 0.0 109.28 -166.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -56.8 -37.37 71.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -63.8 -37.08 86.03 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 120.101 1.319 . . . . 0.0 110.072 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.6 -49.28 78.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.861 1.264 . . . . 0.0 109.014 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.29 -44.83 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.751 2.02 . . . . 0.0 110.904 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.04 -39.12 93.8 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.365 -0.834 . . . . 0.0 110.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 -179.27 48.85 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 122.278 0.932 . . . . 0.0 112.008 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.23 109.1 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.357 2.263 . . . . 0.0 110.937 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt 43.43 50.65 6.16 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.67 1.588 . . . . 0.0 110.673 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 37.67 69.2 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.866 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -67.38 0.42 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.042 1.421 . . . . 0.0 112.351 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -36.74 84.75 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.361 -172.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.78 -44.88 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 119.129 0.877 . . . . 0.0 111.964 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -63.11 -49.5 74.19 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.996 -1.065 . . . . 0.0 110.949 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -51.58 66.31 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.164 0.585 . . . . 0.0 110.046 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 88.8 mt -67.95 -30.16 69.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.613 -1.185 . . . . 0.0 112.096 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.0 m -56.99 -37.28 71.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.736 1.153 . . . . 0.0 110.32 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.51 17.4 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.845 1.202 . . . . 0.0 111.337 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 60' ' ' LEU 0.261 2.0 p -61.46 -42.47 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.124 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.36 -47.72 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 121.249 1.84 . . . . 0.0 109.814 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -53.43 -37.34 62.47 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.26 0.482 . . . . 0.0 111.845 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 -38.93 18.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.209 0.913 . . . . 0.0 111.138 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.53 -36.78 83.66 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.838 1.255 . . . . 0.0 110.505 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 94.1 m-85 -114.66 -21.33 10.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 112.74 -168.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.03 50.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.052 1.311 . . . . 0.0 114.442 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -53.29 145.65 25.35 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.169 1.484 . . . . 0.0 113.355 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -68.84 156.69 64.59 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.786 2.99 . . . . 0.0 111.578 163.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -71.95 139.98 48.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.72 -21.17 1.27 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.897 -1.502 . . . . 0.0 115.026 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m -80.9 -8.69 59.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 120.048 1.924 . . . . 0.0 112.703 168.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.63 126.81 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 139.54 48.59 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 163.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.32 134.45 54.88 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -132.72 171.76 13.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.747 2.019 . . . . 0.0 109.262 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.91 148.96 52.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 167.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.87 52.09 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.659 1.584 . . . . 0.0 107.517 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -82.96 151.23 25.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.74 178.63 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.5 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -57.35 -43.19 83.27 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.34 -55.39 24.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 117.477 -1.249 . . . . 0.0 108.517 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -47.77 -41.36 23.11 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.496 1.118 . . . . 0.0 111.062 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.27 -45.95 21.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.298 1.439 . . . . 0.0 111.687 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -58.29 -53.84 53.77 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.283 1.033 . . . . 0.0 110.009 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.16 -43.98 96.78 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.855 0.862 . . . . 0.0 111.039 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -48.02 -61.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.59 1.556 . . . . 0.0 110.254 168.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.77 -35.68 78.83 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.566 0.746 . . . . 0.0 112.105 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.5 m -60.75 -29.1 69.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.403 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -90.58 -30.23 17.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.674 1.19 . . . . 0.0 112.59 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.32 -22.33 52.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.49 23.88 3.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.281 1.032 . . . . 0.0 111.755 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.42 34.38 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.953 1.301 . . . . 0.0 112.187 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -71.56 -31.77 67.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.491 0.716 . . . . 0.0 110.503 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.93 -44.2 94.49 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.176 0.99 . . . . 0.0 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.47 28.37 0.52 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.801 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.34 148.53 41.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.367 1.584 . . . . 0.0 112.226 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 -30.5 1.32 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.519 1.128 . . . . 0.0 113.054 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.89 -170.46 43.42 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 120.11 1.323 . . . . 0.0 110.806 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.06 152.25 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -126.68 108.89 11.49 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.831 1.253 . . . . 0.0 107.911 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.5 146.53 6.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.467 1.507 . . . . 0.0 108.44 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -131.9 150.28 52.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.87 1.268 . . . . 0.0 107.755 167.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.41 121.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -120.81 176.75 1.71 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.517 1.527 . . . . 0.0 109.423 -165.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.47 4.02 6.99 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.183 1.922 . . . . 0.0 113.833 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -121.48 -58.53 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.095 1.316 . . . . 0.0 111.907 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -161.57 138.19 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.664 1.586 . . . . 0.0 110.315 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 m -58.5 143.92 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.74 146.42 39.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 172.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.74 117.4 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.28 113.45 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.76 117.81 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.761 1.224 . . . . 0.0 108.86 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 mt -89.72 110.49 21.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.256 1.822 . . . . 0.0 108.49 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 168.17 20.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.345 0.658 . . . . 0.0 110.865 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -66.73 -35.97 81.35 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.927 -1.108 . . . . 0.0 111.299 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -120.61 79.23 1.46 Allowed 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.555 0.742 . . . . 0.0 109.555 -165.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.59 -48.52 14.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.628 1.571 . . . . 0.0 111.365 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -65.46 -27.41 68.49 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.258 -0.901 . . . . 0.0 112.258 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -70.59 -44.05 68.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.893 1.224 . . . . 0.0 108.938 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.29 -35.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.491 1.116 . . . . 0.0 110.592 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.3 -44.53 71.58 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.662 -1.273 . . . . 0.0 108.871 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.45 45.01 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.5 1.048 . . . . 0.0 111.919 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.72 123.76 14.29 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.247 1.019 . . . . 0.0 108.46 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt 46.79 39.67 7.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.865 0.866 . . . . 0.0 111.959 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.77 30.16 72.65 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.98 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -67.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.398 2.099 . . . . 0.0 112.815 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -37.41 87.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.68 -169.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 tt -57.64 -56.93 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.948 0.794 . . . . 0.0 109.757 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -56.31 -43.57 79.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.224 1.409 . . . . 0.0 112.34 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -58.71 7.46 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.37 -25.05 66.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.855 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.6 m -57.79 -55.1 39.29 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.378 1.444 . . . . 0.0 109.724 167.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.63 89.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.455 0.702 . . . . 0.0 111.203 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.1 t -53.78 -59.12 2.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 t -61.26 -39.78 83.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.059 0.944 . . . . 0.0 111.016 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.44 -37.7 70.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.733 0.697 . . . . 0.0 111.067 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.69 -55.27 4.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.734 0.697 . . . . 0.0 109.995 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -39.41 60.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.368 1.867 . . . . 0.0 111.898 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.49 -1.29 13.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.1 1.36 . . . . 0.0 111.546 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.18 78.91 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 120.85 -1.156 . . . . 0.0 114.702 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.31 147.67 75.1 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.819 1.31 . . . . 0.0 112.648 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.53 141.29 79.73 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.747 2.965 . . . . 0.0 111.979 168.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -66.41 141.42 57.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.83 -16.76 6.41 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.214 -0.77 . . . . 0.0 114.294 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -121.48 9.95 10.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 112.916 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.01 155.28 26.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 159.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -139.33 156.44 47.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.753 1.221 . . . . 0.0 108.433 164.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -131.71 134.83 46.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -132.47 160.98 34.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.433 1.893 . . . . 0.0 108.386 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 142.11 46.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.616 0.767 . . . . 0.0 108.961 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -141.7 153.81 44.91 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 108.769 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.66 146.86 27.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 122.38 1.086 . . . . 0.0 108.188 175.077 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.5 t80 . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -53.22 -41.95 65.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.312 1.045 . . . . 0.0 112.009 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.78 25.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.78 1.232 . . . . 0.0 109.588 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.7 -40.33 62.86 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.446 0.566 . . . . 0.0 111.448 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 tp -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.972 1.309 . . . . 0.0 110.826 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -63.0 -43.71 98.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.185 0.594 . . . . 0.0 110.335 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.28 -30.7 71.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.452 1.101 . . . . 0.0 112.853 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -67.51 -63.97 0.95 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.5 mt -56.45 -33.14 65.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.605 1.162 . . . . 0.0 111.96 -168.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -46.2 -46.53 17.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.162 0.985 . . . . 0.0 111.783 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.48 -56.69 4.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.69 -26.51 45.33 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 113.521 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.62 18.9 9.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.774 1.229 . . . . 0.0 111.359 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.94 -64.31 0.87 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.908 0.883 . . . . 0.0 111.023 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.85 -22.12 62.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.474 -0.766 . . . . 0.0 111.309 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.7 -24.29 67.53 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.545 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.06 25.29 3.05 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.459 1.027 . . . . 0.0 114.763 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -63.65 165.2 8.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 112.42 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.97 -52.93 0.22 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.729 1.212 . . . . 0.0 110.46 171.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.09 -172.02 38.3 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 118.927 0.785 . . . . 0.0 111.429 -171.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.46 134.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.53 161.91 13.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 164.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.14 144.91 23.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -120.1 160.47 22.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.39 115.71 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 p -121.01 176.85 1.68 Allowed Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -169.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.84 12.17 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.281 1.988 . . . . 0.0 111.448 166.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.9 p -127.7 -50.04 1.37 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 0.0 112.579 -170.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -162.6 173.6 13.72 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.142 1.777 . . . . 0.0 110.156 -169.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.1 m -98.23 149.17 22.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -125.32 142.57 51.42 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.764 2.026 . . . . 0.0 105.757 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -129.0 125.93 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -123.73 97.56 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -76.87 125.95 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.4 108.09 20.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.064 2.146 . . . . 0.0 107.131 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.95 168.09 20.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.852 1.31 . . . . 0.0 110.354 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 p -79.12 -26.84 42.85 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.955 -1.091 . . . . 0.0 111.769 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -129.01 79.93 1.94 Allowed 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.76 1.624 . . . . 0.0 107.904 -167.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 p -48.98 -39.2 25.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.334 1.053 . . . . 0.0 111.334 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.89 -39.95 95.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.215 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -59.87 -48.82 80.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.742 1.155 . . . . 0.0 109.183 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.06 -43.65 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.908 1.283 . . . . 0.0 110.786 -174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.84 -36.67 84.12 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.643 -0.66 . . . . 0.0 109.878 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.57 175.68 41.18 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.058 1.313 . . . . 0.0 110.554 -167.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 55' ' ' ARG . 4.2 tt0 -55.5 128.18 33.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 167.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp 50.33 38.86 18.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.649 0.779 . . . . 0.0 112.839 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.84 10.01 67.01 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.795 0.712 . . . . 0.0 113.907 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 52' ' ' GLU . 17.0 mtm180 -52.31 -53.34 45.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 113.244 -175.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.88 74.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 116.176 -1.868 . . . . 0.0 109.954 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -60.73 -38.05 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 121.562 1.983 . . . . 0.0 111.224 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -52.73 64.31 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.304 -0.873 . . . . 0.0 110.854 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -28.12 63.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.434 1.094 . . . . 0.0 112.108 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.6 mt -80.03 -24.82 40.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.139 1.376 . . . . 0.0 110.467 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -66.28 -55.38 16.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.19 70.35 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.457 1.103 . . . . 0.0 111.965 -174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 p -58.65 -47.91 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.702 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.36 -39.83 82.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-N 119.649 1.113 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -53.84 -44.94 70.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.799 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.83 -58.45 3.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.819 0.736 . . . . 0.0 109.659 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -45.77 54.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.549 1.54 . . . . 0.0 111.848 -168.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.12 -1.8 25.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.46 47.62 89.67 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 125.244 1.402 . . . . 0.0 112.177 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -80.05 145.62 61.46 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.202 1.001 . . . . 0.0 111.32 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.49 137.52 51.06 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.484 2.123 . . . . 0.0 109.713 166.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.36 143.04 58.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.353 1.061 . . . . 0.0 109.512 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 -6.49 6.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.397 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -117.05 8.37 13.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.128 1.771 . . . . 0.0 112.17 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -113.71 140.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 154.19 51.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 168.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -121.65 136.45 54.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -125.17 163.21 22.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.885 1.674 . . . . 0.0 107.461 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.68 109.12 9.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.163 0.585 . . . . 0.0 109.796 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -119.88 145.8 46.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.439 0.638 . . . . 0.0 110.385 -168.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.75 140.16 36.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 -167.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.141 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.5 t80 . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -54.3 -29.43 47.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.19 1.396 . . . . 0.0 113.499 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -58.12 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.395 2.278 . . . . 0.0 111.007 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -56.05 -40.63 73.81 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.633 1.106 . . . . 0.0 111.2 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.11 -36.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 110.593 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.19 -51.5 67.55 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.585 0.754 . . . . 0.0 109.587 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.34 -27.46 67.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.148 0.979 . . . . 0.0 111.864 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.05 -63.37 1.09 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.429 1.092 . . . . 0.0 109.104 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.05 -31.55 71.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.49 1.116 . . . . 0.0 112.234 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.4 m -55.91 -35.68 66.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.102 1.361 . . . . 0.0 111.157 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -90.54 -44.64 9.43 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.932 -0.48 . . . . 0.0 110.112 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.86 -42.25 93.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.953 0.342 . . . . 0.0 111.902 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.56 20.64 16.42 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.032 1.733 . . . . 0.0 110.554 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.52 -58.87 4.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.398 1.479 . . . . 0.0 110.141 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 -19.74 55.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.632 0.773 . . . . 0.0 111.995 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -71.09 -32.58 69.24 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.282 0.633 . . . . 0.0 110.386 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.07 47.02 1.11 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.399 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HH ' ' HB ' ' A' ' 28' ' ' VAL . 67.2 t80 -57.72 171.24 0.49 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.698 1.599 . . . . 0.0 112.967 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.77 -42.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.812 1.645 . . . . 0.0 111.479 170.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.2 -170.29 43.33 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.419 ' HB ' ' HH ' ' A' ' 25' ' ' TYR . 7.4 p -152.79 153.99 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -119.94 158.0 27.62 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.437 1.495 . . . . 0.0 109.055 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.41 129.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.34 1.056 . . . . 0.0 110.265 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -125.81 122.93 37.59 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.247 1.019 . . . . 0.0 108.93 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.26 130.09 38.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 163.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -121.76 170.66 7.28 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.612 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.08 19.37 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.906 2.404 . . . . 0.0 112.809 165.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 p -127.25 -58.1 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -154.44 173.44 16.25 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.285 1.834 . . . . 0.0 109.494 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.2 m -86.54 148.54 25.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 162.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.94 131.69 33.38 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.678 1.591 . . . . 0.0 106.881 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.81 123.65 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.62 1.568 . . . . 0.0 107.799 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.7 112.51 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -73.09 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -99.94 118.09 35.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.079 165.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.62 167.05 25.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.301 0.5 . . . . 0.0 111.258 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -67.13 -45.56 76.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.874 0.47 . . . . 0.0 110.798 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -122.93 82.43 1.99 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.045 1.738 . . . . 0.0 108.144 -167.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 p -46.58 -42.92 16.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.457 1.103 . . . . 0.0 110.552 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -45.15 74.25 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.644 1.111 . . . . 0.0 112.339 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -68.59 -42.26 78.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.71 -31.44 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.062 1.745 . . . . 0.0 110.837 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -76.77 -42.32 41.37 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.29 1.036 . . . . 0.0 110.185 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.19 176.12 27.02 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.165 0.888 . . . . 0.0 111.294 -171.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.88 116.91 4.09 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.366 0.666 . . . . 0.0 110.484 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.1 mttt 42.31 44.63 3.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.238 1.415 . . . . 0.0 111.648 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.5 73.77 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.506 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.29 -56.67 11.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.558 1.679 . . . . 0.0 112.658 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.27 -48.41 81.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.273 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -60.44 -44.47 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.077 0.853 . . . . 0.0 109.879 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -38.19 82.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.362 0.983 . . . . 0.0 112.891 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -62.18 1.85 Allowed 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.01 -24.88 68.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.009 -1.472 . . . . 0.0 111.767 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.0 m -55.55 -51.87 65.63 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 120.683 1.583 . . . . 0.0 108.946 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.24 82.69 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.833 0.742 . . . . 0.0 110.669 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.44 -50.01 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 118.691 0.678 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.86 -51.23 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.372 1.469 . . . . 0.0 109.871 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -54.76 -28.35 47.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -93.48 -44.93 8.0 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.364 0.983 . . . . 0.0 110.213 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -39.52 69.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.01 1.324 . . . . 0.0 111.188 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.07 5.99 15.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.69 1.196 . . . . 0.0 111.417 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.78 41.62 66.86 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.896 2.189 . . . . 0.0 114.576 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -81.9 145.51 53.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.576 1.188 . . . . 0.0 111.488 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.49 153.8 73.06 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.109 1.873 . . . . 0.0 110.888 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.21 122.56 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.759 1.224 . . . . 0.0 109.359 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 -14.76 4.95 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.318 0.961 . . . . 0.0 114.467 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -74.74 -6.88 51.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.192 0.997 . . . . 0.0 111.522 161.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.18 149.46 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 162.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -137.29 149.68 47.25 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 165.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.96 122.64 46.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -118.3 165.62 13.62 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 127.71 2.404 . . . . 0.0 108.997 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.68 113.52 7.88 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.191 1.396 . . . . 0.0 109.202 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.04 154.93 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.86 1.664 . . . . 0.0 109.18 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -90.9 156.12 18.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 C--O 1.237 0.439 0 CA-C-O 122.227 1.013 . . . . 0.0 109.665 -179.819 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 t80 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 29' ' ' GLU . 79.5 tttt -57.47 -31.9 66.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.778 -0.629 . . . . 0.0 111.247 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -39.8 47.39 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.234 0.925 . . . . 0.0 111.766 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.29 -43.85 96.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.358 0.981 . . . . 0.0 109.365 171.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.58 -39.22 93.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.392 0.677 . . . . 0.0 110.54 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.18 -56.33 22.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.161 1.384 . . . . 0.0 109.772 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.2 -28.43 68.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.35 -64.76 0.79 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.567 1.147 . . . . 0.0 109.006 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.28 -37.28 74.7 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 112.646 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.5 m -51.14 -48.32 61.85 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.817 0.847 . . . . 0.0 110.367 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -75.45 -42.22 53.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.134 -0.46 . . . . 0.0 109.919 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -31.57 72.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.836 0.744 . . . . 0.0 111.881 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.7 mt -119.01 15.84 13.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.314 -165.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.83 -63.1 0.92 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.033 1.333 . . . . 0.0 112.331 -173.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -15.46 59.56 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -71.66 -12.1 61.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.678 1.126 . . . . 0.0 111.06 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.5 47.73 4.21 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.699 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -56.96 166.32 1.04 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.933 1.349 . . . . 0.0 110.519 168.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -156.76 -37.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.792 2.037 . . . . 0.0 109.958 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.23 -169.32 42.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 124.21 0.909 . . . . 0.0 110.853 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.69 154.13 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -116.55 162.57 17.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.659 1.984 . . . . 0.0 110.124 164.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.36 137.47 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.853 1.261 . . . . 0.0 108.342 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -127.61 127.48 43.9 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.5 91.78 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 p -90.36 169.64 11.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.35 4.04 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.832 2.355 . . . . 0.0 112.922 169.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 p -113.34 -54.89 2.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.354 0.979 . . . . 0.0 110.922 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -155.47 157.82 37.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.61 1.564 . . . . 0.0 108.614 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 m -68.22 139.33 56.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 161.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.33 139.97 44.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.94 124.65 65.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.93 93.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -172.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.16 122.25 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 mt -98.39 73.02 2.11 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.633 1.173 . . . . 0.0 109.446 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.7 160.41 15.73 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.423 1.465 . . . . 0.0 111.352 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -72.32 -25.1 61.43 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.676 -1.265 . . . . 0.0 111.527 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -131.81 72.17 1.49 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.541 1.136 . . . . 0.0 108.733 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -56.74 -40.25 75.43 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.45 -0.781 . . . . 0.0 111.808 -174.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -53.33 -39.31 63.99 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.811 1.244 . . . . 0.0 112.634 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.01 -45.34 67.44 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.442 0.697 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.4 -39.73 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.396 0.678 . . . . 0.0 109.302 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.6 -39.09 93.49 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.289 -0.882 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 172.79 28.44 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -165.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -54.87 126.25 23.52 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.706 -0.879 . . . . 0.0 109.67 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.279 58.9 pttt 39.96 42.3 1.05 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.206 1.802 . . . . 0.0 113.507 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.75 20.99 77.62 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.489 -0.757 . . . . 0.0 113.27 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -44.56 -67.26 0.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.407 1.483 . . . . 0.0 111.689 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -32.87 67.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.637 -169.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 tt -61.86 -40.89 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.144 1.338 . . . . 0.0 111.655 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.32 -45.31 88.46 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.027 1.285 . . . . 0.0 110.625 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.25 -48.02 79.91 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.01 0.524 . . . . 0.0 110.518 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 10.5 mt -63.93 -36.13 82.95 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 117.975 -1.012 . . . . 0.0 111.524 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.2 m -59.6 -48.99 79.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 120.425 1.466 . . . . 0.0 109.364 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.15 79.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 8.0 p -60.66 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.515 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -58.36 -41.75 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.697 1.589 . . . . 0.0 109.54 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -32.79 63.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.063 0.545 . . . . 0.0 111.915 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -96.83 -19.51 18.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.788 2.035 . . . . 0.0 112.842 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -20.63 27.12 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.286 -1.509 . . . . 0.0 110.231 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.69 1.34 4.93 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.665 1.186 . . . . 0.0 112.05 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.77 10.03 66.84 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.574 1.079 . . . . 0.0 114.299 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -57.32 151.98 34.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.915 0.857 . . . . 0.0 111.982 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.66 174.24 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.988 3.792 . . . . 0.0 109.561 166.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 153.99 22.07 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.72 -46.25 0.55 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.41 1.957 . . . . 0.0 112.569 -166.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.1 m -77.86 8.64 4.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.549 1.94 . . . . 0.0 113.194 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.82 131.41 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 160.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -122.08 148.84 44.37 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.356 1.062 . . . . 0.0 108.251 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.81 145.14 42.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.42 162.75 31.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.811 2.044 . . . . 0.0 107.317 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.1 145.35 43.11 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -139.96 141.43 36.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 139.68 36.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.239 0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.706 177.224 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.2 -29.13 68.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.769 0.828 . . . . 0.0 111.879 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.44 -63.66 1.01 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 109.08 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.67 -45.6 19.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.911 1.285 . . . . 0.0 111.581 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.7 tp -74.41 -35.81 63.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.219 0.608 . . . . 0.0 111.771 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -66.96 -45.01 79.07 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 109.69 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.59 -55.63 20.94 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.949 0.9 . . . . 0.0 110.147 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.5 -63.53 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.755 1.622 . . . . 0.0 110.033 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.9 mt -59.78 -30.96 69.24 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.814 0.846 . . . . 0.0 113.197 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -55.58 -36.14 66.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.245 0.618 . . . . 0.0 111.237 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -88.35 -52.37 5.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.8 -20.41 49.84 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.59 25.54 4.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.344 1.458 . . . . 0.0 112.015 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.5 -63.17 1.07 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.091 1.757 . . . . 0.0 111.92 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -73.07 -29.83 63.25 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 122.037 -0.414 . . . . 0.0 110.6 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -64.73 -29.87 70.86 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.4 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.24 34.35 0.89 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-O 118.824 -0.986 . . . . 0.0 114.325 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -57.02 171.43 0.36 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.109 1.764 . . . . 0.0 113.705 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -141.29 -60.77 0.48 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.432 1.493 . . . . 0.0 109.215 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.12 41.89 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.53 145.5 16.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.251 -1.146 . . . . 0.0 108.8 -170.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.06 150.83 26.11 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.439 1.496 . . . . 0.0 107.857 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.38 143.29 41.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.125 1.77 . . . . 0.0 107.011 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -133.65 153.31 51.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.8 t -140.1 118.84 11.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 p -119.68 170.53 6.7 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.82 8.65 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.961 1.774 . . . . 0.0 112.589 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 p -121.9 -56.31 1.85 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.769 1.168 . . . . 0.0 110.204 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -140.44 170.62 15.45 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.188 0.904 . . . . 0.0 111.589 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 m -87.21 151.07 23.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.75 134.36 45.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -126.0 120.85 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.19 99.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -69.38 139.7 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt -108.96 112.11 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 171.13 15.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 110.422 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 p -84.26 -28.98 26.83 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.15 -0.969 . . . . 0.0 112.525 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -131.46 73.11 1.52 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -167.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -54.0 -27.81 34.04 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.435 1.094 . . . . 0.0 112.878 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -57.46 -44.39 84.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.828 0.851 . . . . 0.0 111.098 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.92 -38.91 79.84 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.437 1.095 . . . . 0.0 111.538 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.4 -39.09 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.704 0.802 . . . . 0.0 110.062 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -74.98 -43.66 52.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.69 -172.03 33.0 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -59.66 106.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.798 1.639 . . . . 0.0 110.831 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt 42.69 47.73 4.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.513 1.525 . . . . 0.0 111.202 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.3 11.16 81.12 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.749 -2.139 . . . . 0.0 114.026 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -45.51 -60.13 2.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.244 2.522 . . . . 0.0 112.058 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -50.54 73.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.473 1.033 . . . . 0.0 109.327 -174.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -65.22 -34.33 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.974 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -64.67 -61.09 2.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.694 1.198 . . . . 0.0 110.085 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -50.21 -50.9 48.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 125.709 1.604 . . . . 0.0 111.235 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.1 -21.29 64.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.002 -1.475 . . . . 0.0 112.197 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -56.88 -46.18 82.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 121.53 1.968 . . . . 0.0 108.382 167.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.02 76.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.692 0.678 . . . . 0.0 111.528 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.57 -54.39 35.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.22 -47.37 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 124.611 1.164 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.458 HE22 ' HG2' ' A' ' 72' ' ' GLU . 1.6 mt-30 -53.94 -42.11 68.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.535 0.607 . . . . 0.0 110.876 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -80.74 -50.69 9.55 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 109.409 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -46.84 68.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.414 1.086 . . . . 0.0 110.682 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.19 -14.4 22.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.76 0.824 . . . . 0.0 112.267 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.89 51.86 13.61 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.18 154.25 49.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.097 0.959 . . . . 0.0 110.117 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 167.21 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.3 2.666 . . . . 0.0 111.485 159.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.458 ' HG2' HE22 ' A' ' 65' ' ' GLN . 50.9 mt-10 -77.77 161.45 27.68 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 163.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.84 -1.52 4.5 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.93 1.252 . . . . 0.0 114.586 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -132.33 14.73 4.58 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.474 1.51 . . . . 0.0 111.823 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.9 125.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 165.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.75 146.58 43.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.47 134.06 55.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -130.5 165.71 22.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.647 2.379 . . . . 0.0 108.645 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.62 6.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.268 1.027 . . . . 0.0 108.654 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 152.82 21.37 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.494 1.518 . . . . 0.0 108.045 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -97.0 143.78 27.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.323 -0.583 0 C-N-CA 123.785 0.834 . . . . 0.0 108.759 178.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 t80 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.861 0.362 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -61.6 -36.94 82.13 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.051 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.03 -53.88 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.456 1.502 . . . . 0.0 111.379 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -57.94 -43.73 86.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.383 0.538 . . . . 0.0 110.598 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.51 -42.42 92.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.904 0.481 . . . . 0.0 110.219 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.95 -50.45 73.36 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 123.871 0.868 . . . . 0.0 109.991 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -59.49 -37.95 79.6 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -59.52 -60.42 3.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.461 1.028 . . . . 0.0 110.228 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 mt -59.05 -35.48 73.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.649 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 m -53.43 -31.2 44.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.921 1.289 . . . . 0.0 112.709 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -90.51 -54.09 4.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.992 0.814 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.87 -39.96 63.04 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.619 0.767 . . . . 0.0 111.518 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -106.94 18.89 21.23 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.737 1.215 . . . . 0.0 112.295 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.08 -50.09 73.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.266 -0.896 . . . . 0.0 112.746 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.49 -15.09 58.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.74 0.7 . . . . 0.0 111.479 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.24 -41.3 70.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 109.532 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.77 45.46 0.47 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 119.111 -0.827 . . . . 0.0 114.861 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.56 167.16 2.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.422 1.111 . . . . 0.0 112.277 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -158.96 -27.06 0.07 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.62 -169.74 40.8 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.59 149.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.74 158.51 21.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.722 1.249 . . . . 0.0 109.045 161.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.43 125.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -167.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -133.07 125.53 29.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.012 1.325 . . . . 0.0 108.291 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -116.47 127.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 47.5 p -121.66 174.98 2.74 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 124.797 1.239 . . . . 0.0 109.276 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 49.2 Cg_endo -69.64 3.72 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.942 1.761 . . . . 0.0 113.513 167.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.8 p -113.3 -59.75 1.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.923 1.238 . . . . 0.0 110.511 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -158.75 157.2 31.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.663 1.574 . . . . 0.0 112.933 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.0 m -62.97 147.57 50.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.235 1.014 . . . . 0.0 108.668 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.79 134.93 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.242 2.217 . . . . 0.0 107.381 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -124.94 123.12 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.37 94.01 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.49 139.74 20.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt -107.2 115.3 29.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 127.989 2.516 . . . . 0.0 105.922 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.73 175.83 10.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.758 0.708 . . . . 0.0 112.847 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.32 -21.65 21.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.333 -1.479 . . . . 0.0 114.22 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -137.09 70.9 1.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.476 1.11 . . . . 0.0 108.828 -162.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -57.54 -33.63 68.3 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.527 -0.733 . . . . 0.0 112.109 -173.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -60.16 -36.94 78.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.654 1.116 . . . . 0.0 112.416 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -71.83 -43.68 65.15 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.175 0.99 . . . . 0.0 109.273 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.5 t -57.79 -50.62 77.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 125.898 1.679 . . . . 0.0 108.835 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.63 -31.45 72.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.679 0.792 . . . . 0.0 111.342 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.64 178.84 44.05 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -169.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.86 125.51 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 51.87 21.96 1.61 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.9 63.07 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.672 1.124 . . . . 0.0 113.985 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -55.14 -54.76 39.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 112.56 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -39.08 85.26 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.625 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 tt -63.03 -38.36 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 120.331 1.423 . . . . 0.0 110.97 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -41.21 97.39 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.614 -1.304 . . . . 0.0 111.85 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.89 -58.53 7.59 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.463 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 61.7 mt -55.44 -40.88 72.11 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.878 1.671 . . . . 0.0 111.961 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.3 m -55.21 -50.87 68.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.261 1.392 . . . . 0.0 111.266 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.38 84.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.049 0.84 . . . . 0.0 112.174 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 3.7 p -61.75 -49.73 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.801 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.77 -47.35 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 119.696 1.135 . . . . 0.0 110.337 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -54.17 -47.02 72.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.75 . . . . 0.0 110.607 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -73.78 -41.77 61.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.073 0.851 . . . . 0.0 110.085 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -51.61 63.7 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 109.845 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.59 1.89 46.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.264 1.426 . . . . 0.0 111.28 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 18.73 75.48 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.885 1.231 . . . . 0.0 114.072 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -63.18 149.47 90.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 118.545 1.173 . . . . 0.0 112.028 -174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.44 132.73 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.862 2.374 . . . . 0.0 110.102 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 74' ' ' SER . 4.2 tm-20 -57.51 141.83 46.37 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.223 1.009 . . . . 0.0 110.939 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 -12.78 1.06 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.195 1.379 . . . . 0.0 113.454 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 72' ' ' GLU . 45.9 m -115.27 14.59 16.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.909 1.684 . . . . 0.0 111.333 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.84 144.34 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.741 1.617 . . . . 0.0 107.134 154.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.97 151.62 49.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.37 1.468 . . . . 0.0 108.911 172.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -124.7 128.62 49.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -112.29 168.74 9.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.057 2.143 . . . . 0.0 107.339 175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 108.72 6.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -104.85 166.32 10.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.558 1.143 . . . . 0.0 109.166 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -112.98 143.21 44.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.944 -0.473 . . . . 0.0 110.823 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.24 0.595 0 C-N-CA 124.201 1.0 . . . . 0.0 111.345 171.635 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.7 t80 . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -59.66 -33.75 71.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.287 -1.339 . . . . 0.0 111.345 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.21 13.44 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.471 -1.252 . . . . 0.0 110.038 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.14 -46.77 65.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.483 1.038 . . . . 0.0 109.888 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.52 -40.86 96.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.008 0.923 . . . . 0.0 111.087 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -62.36 -51.75 66.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.798 1.239 . . . . 0.0 109.695 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.32 -27.18 65.15 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 111.29 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.05 -63.26 1.1 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.848 1.659 . . . . 0.0 108.973 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.31 -35.77 72.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.244 1.018 . . . . 0.0 112.093 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.7 m -50.53 -43.35 55.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.338 0.655 . . . . 0.0 111.148 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -42.75 18.03 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.143 0.429 . . . . 0.0 110.215 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -21.74 61.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.975 -172.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.07 30.81 6.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.14 2.176 . . . . 0.0 110.43 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.91 82.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.57 -8.2 58.42 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.983 0.81 . . . . 0.0 111.4 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -16.98 58.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.005 0.922 . . . . 0.0 113.14 -169.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.37 47.8 7.21 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 118.722 -1.704 . . . . 0.0 109.576 -163.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -64.0 142.26 58.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.2 -28.68 3.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.117 0.967 . . . . 0.0 112.209 -174.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.02 -168.83 35.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -153.4 145.82 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -118.29 165.38 13.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.816 1.646 . . . . 0.0 108.442 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 141.53 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.649 1.179 . . . . 0.0 107.872 -171.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -125.32 167.41 14.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.239 1.018 . . . . 0.0 110.269 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.72 118.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 p -121.69 170.73 7.14 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.719 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.37 15.66 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 165.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.9 p -127.24 -52.19 1.4 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.125 1.33 . . . . 0.0 111.577 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -154.64 160.91 41.72 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.285 1.034 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.0 m -72.01 151.79 42.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.81 133.15 31.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.39 123.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 125.873 1.669 . . . . 0.0 106.775 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.17 95.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.56 133.16 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.557 1.143 . . . . 0.0 108.496 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.18 114.51 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.91 175.46 10.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.013 0.525 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -99.76 -49.3 4.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.11 1.323 . . . . 0.0 111.912 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -90.6 61.48 4.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.667 2.387 . . . . 0.0 108.957 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 p -56.07 -28.56 58.1 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.53 -1.356 . . . . 0.0 113.48 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -57.7 -37.96 74.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.384 1.074 . . . . 0.0 113.62 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.88 -46.65 74.27 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.864 0.866 . . . . 0.0 108.905 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.09 -39.21 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.429 1.092 . . . . 0.0 110.108 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.14 -44.62 83.65 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.699 -0.626 . . . . 0.0 110.7 174.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.77 175.92 47.02 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 124.795 1.188 . . . . 0.0 112.151 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -55.44 116.66 2.99 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.355 1.062 . . . . 0.0 109.814 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 53.78 23.44 3.76 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.661 0.784 . . . . 0.0 112.729 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.67 59.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.403 -0.811 . . . . 0.0 112.549 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -59.29 -57.8 11.43 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.052 1.426 . . . . 0.0 110.246 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.06 -41.36 98.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.287 -169.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.4 tp -57.88 -42.83 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 120.091 1.314 . . . . 0.0 111.256 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -70.17 -42.11 72.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 110.794 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -56.32 23.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.1 mt -62.26 -24.26 67.16 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.885 1.274 . . . . 0.0 112.587 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -61.16 -48.76 80.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.348 1.431 . . . . 0.0 109.659 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.98 -40.18 95.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.293 0.497 . . . . 0.0 110.997 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.0 -53.26 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -63.55 -43.69 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 124.995 1.318 . . . . 0.0 110.241 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -54.48 -37.31 65.11 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.358 0.663 . . . . 0.0 110.568 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -73.9 -58.13 3.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.005 0.82 . . . . 0.0 110.081 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -57.38 -30.05 64.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.996 1.318 . . . . 0.0 112.379 -170.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 98.1 m-85 -121.59 2.24 10.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.416 1.486 . . . . 0.0 111.774 -171.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.98 22.9 65.27 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.037 0.835 . . . . 0.0 114.156 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -63.66 146.24 96.89 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.2 0.6 . . . . 0.0 111.267 -172.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.52 129.38 27.81 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.542 2.161 . . . . 0.0 110.581 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.65 143.53 46.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.73 61.11 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.873 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -136.61 21.48 3.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.156 1.478 . . . . 0.0 113.113 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.07 138.8 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 154.94 42.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.899 0.88 . . . . 0.0 110.567 165.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -132.94 114.08 13.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.36 2.264 . . . . 0.0 107.551 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.81 176.29 5.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.623 1.169 . . . . 0.0 110.524 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.18 114.76 8.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.594 0.633 . . . . 0.0 109.635 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -114.56 141.41 47.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.982 2.113 . . . . 0.0 109.598 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.8 156.22 19.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 C--O 1.235 0.303 0 C-N-CA 125.192 1.397 . . . . 0.0 110.493 176.266 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.46 0.072 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -70.89 -13.26 61.96 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.471 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.46 -50.55 7.66 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.977 1.262 . . . . 0.0 109.999 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.51 -46.75 80.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.866 0.757 . . . . 0.0 111.687 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.7 -33.99 75.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.787 1.235 . . . . 0.0 110.931 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -66.59 -51.14 59.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 109.94 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.6 -52.41 59.9 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.122 0.969 . . . . 0.0 110.557 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -52.22 -60.16 3.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.163 1.385 . . . . 0.0 110.498 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.0 mt -62.66 -36.74 83.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -51.79 -47.34 64.27 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.732 0.813 . . . . 0.0 109.237 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -76.68 -41.1 46.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.862 0.465 . . . . 0.0 110.117 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -17.88 62.15 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.718 -1.134 . . . . 0.0 113.677 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -130.54 24.48 5.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.14 1.776 . . . . 0.0 112.631 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.24 66.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.15 -36.21 83.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.803 0.811 . . . . 0.0 109.127 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -38.87 86.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.508 1.123 . . . . 0.0 110.651 -168.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.52 37.88 0.88 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 119.96 1.255 . . . . 0.0 114.386 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.79 165.74 2.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.319 1.047 . . . . 0.0 112.923 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 m -159.03 -31.02 0.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.41 -171.72 43.74 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.51 137.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.86 158.8 15.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.64 117.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 124.767 1.227 . . . . 0.0 107.872 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.85 122.05 46.63 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.7 131.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 161.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.9 p -120.51 166.53 15.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.47 -12.68 36.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.329 1.353 . . . . 0.0 111.511 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.79 -50.59 5.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.307 1.443 . . . . 0.0 110.266 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 76' ' ' GLU . 5.6 ptp180 -162.08 173.7 14.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.386 1.448 . . . . 0.0 111.496 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.15 152.99 39.72 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.933 -1.104 . . . . 0.0 108.084 162.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -135.05 138.78 44.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.475 2.31 . . . . 0.0 105.108 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.9 mt -129.18 124.17 59.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.86 98.01 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.24 127.27 29.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.0 mt -97.1 110.06 22.69 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.171 1.388 . . . . 0.0 107.544 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.13 170.43 19.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.443 0.697 . . . . 0.0 109.48 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.29 -48.67 15.17 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.31 -1.493 . . . . 0.0 112.505 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -94.97 69.49 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.828 1.651 . . . . 0.0 108.795 -165.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -52.75 -34.85 54.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.21 -47.15 85.71 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 120.918 -1.114 . . . . 0.0 111.939 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.65 -43.78 97.93 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.02 -51.79 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 126.414 1.885 . . . . 0.0 109.461 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.4 -32.46 68.65 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 121.879 -0.513 . . . . 0.0 110.204 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 179.07 46.57 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.97 107.28 0.28 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.247 1.419 . . . . 0.0 110.508 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 48.25 50.53 16.25 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.023 0.916 . . . . 0.0 112.173 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.96 58.98 9.82 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -93.57 -68.39 0.8 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.301 1.04 . . . . 0.0 110.565 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -61.82 -38.15 87.09 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.356 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tp -55.64 -43.04 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.269 0.94 . . . . 0.0 111.355 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -72.5 -36.24 68.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.783 -1.198 . . . . 0.0 111.097 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -56.93 15.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.26 -22.73 64.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.552 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.5 m -58.15 -57.41 12.96 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 120.494 1.497 . . . . 0.0 109.054 166.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -27.53 69.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.278 0.944 . . . . 0.0 112.237 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.11 -63.45 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.61 -43.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.329 1.851 . . . . 0.0 110.86 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -53.91 -45.32 71.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.154 0.982 . . . . 0.0 110.784 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -71.68 -57.92 3.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 109.631 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -47.36 27.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.526 1.93 . . . . 0.0 111.918 -173.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.04 -7.57 22.21 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.336 1.454 . . . . 0.0 111.411 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.15 44.68 95.35 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.053 0.835 . . . . 0.0 111.198 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -69.73 141.59 90.29 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 117.55 0.675 . . . . 0.0 109.619 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.15 128.03 27.18 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 108.38 -1.431 . . . . 0.0 108.38 161.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.72 99.94 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.425 1.49 . . . . 0.0 111.643 -175.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.98 -8.75 33.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.532 1.539 . . . . 0.0 112.028 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 m -85.18 21.72 1.62 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.621 1.21 . . . . 0.0 111.111 162.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 154.73 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.59 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HG3' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.93 150.95 33.79 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.886 2.075 . . . . 0.0 107.335 174.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -123.86 131.28 53.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.532 1.133 . . . . 0.0 108.862 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -126.16 161.53 27.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.54 2.336 . . . . 0.0 109.314 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.36 109.21 9.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.366 1.066 . . . . 0.0 108.821 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 158.09 16.59 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.155 1.382 . . . . 0.0 108.46 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -83.28 152.22 25.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.63 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.104 160.695 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 63.3 t80 . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.62 -31.02 69.11 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.764 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.0 -59.0 5.42 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.766 1.166 . . . . 0.0 110.705 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.78 -45.01 82.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.4 tp -66.42 -39.29 88.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.681 0.613 . . . . 0.0 110.513 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.28 -53.0 62.37 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.019 0.827 . . . . 0.0 108.959 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 -30.44 71.47 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.3 0.5 . . . . 0.0 111.569 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -65.78 -52.1 53.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.308 1.443 . . . . 0.0 110.215 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.86 -32.73 72.61 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.577 1.151 . . . . 0.0 112.161 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -50.98 -49.75 59.6 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.229 1.012 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -61.5 -57.69 11.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.735 1.214 . . . . 0.0 110.285 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.21 -14.34 62.92 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -134.48 18.94 3.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.969 0.908 . . . . 0.0 112.157 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -58.15 7.92 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 110.937 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.41 -27.6 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.646 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -15.89 62.77 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.0 1.32 . . . . 0.0 112.158 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.89 42.03 6.14 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.523 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HH ' ' HB ' ' A' ' 28' ' ' VAL . 57.2 t80 -53.21 167.3 0.19 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.806 1.242 . . . . 0.0 111.616 167.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 m -153.93 -43.21 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.731 1.212 . . . . 0.0 110.928 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.23 34.43 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.43 ' HB ' ' HH ' ' A' ' 25' ' ' TYR . 2.5 p -149.86 159.39 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 121.456 -1.026 . . . . 0.0 108.33 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -127.84 164.3 22.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.242 1.017 . . . . 0.0 109.475 158.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.13 148.52 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 127.147 2.179 . . . . 0.0 108.701 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -122.85 129.61 51.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.97 116.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 154.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.1 p -120.74 165.09 19.69 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 165.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.8 -12.85 29.13 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.376 2.051 . . . . 0.0 111.959 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 p -96.37 -47.08 6.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.206 0.912 . . . . 0.0 109.77 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.3 169.59 20.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.81 1.644 . . . . 0.0 108.789 164.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.9 m -72.87 145.13 47.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 162.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.68 140.65 52.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 171.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.38 120.05 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.13 111.71 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.71 132.35 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.5 105.29 17.41 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 163.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.22 166.62 22.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -71.3 -35.88 71.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.796 -0.565 . . . . 0.0 111.259 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -127.29 74.89 1.54 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.178 0.899 . . . . 0.0 110.84 -163.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 p -50.61 -40.54 53.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -58.19 -34.69 70.64 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -77.57 -37.33 50.84 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.26 -37.36 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 118.528 0.604 . . . . 0.0 110.03 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.76 -41.95 97.91 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.151 -0.968 . . . . 0.0 109.164 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.06 179.59 43.68 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.53 115.97 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.969 0.907 . . . . 0.0 109.934 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt 51.33 32.68 8.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.422 1.489 . . . . 0.0 111.633 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 33.7 37.42 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.033 -1.426 . . . . 0.0 112.727 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -65.61 0.64 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.732 1.766 . . . . 0.0 112.274 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -60.59 -42.12 96.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -167.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.27 -42.21 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 123.888 0.743 . . . . 0.0 110.425 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -46.84 83.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.258 1.39 . . . . 0.0 111.303 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -59.88 4.32 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.64 -25.16 66.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 117.303 -1.332 . . . . 0.0 112.185 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -56.23 -52.58 63.93 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 120.324 1.42 . . . . 0.0 108.673 169.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.11 79.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.494 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.28 -60.09 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.81 -44.46 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 127.258 2.223 . . . . 0.0 110.624 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.24 -45.9 76.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.933 0.893 . . . . 0.0 110.467 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -70.17 -50.78 36.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.547 1.067 . . . . 0.0 111.488 170.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -29.24 49.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.796 1.638 . . . . 0.0 112.566 -172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.71 4.22 7.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.324 1.45 . . . . 0.0 112.133 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.54 79.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.405 1.003 . . . . 0.0 114.625 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -70.25 142.0 89.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.137 . . . . 0.0 112.366 -172.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.74 121.51 8.58 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.496 2.797 . . . . 0.0 110.921 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.94 146.44 26.8 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.593 1.557 . . . . 0.0 110.256 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.42 -22.71 3.09 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 120.87 -1.144 . . . . 0.0 112.462 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.7 m -109.85 10.35 24.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.457 2.303 . . . . 0.0 110.862 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.86 140.22 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 162.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.18 154.76 46.45 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 124.002 0.921 . . . . 0.0 109.083 166.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -119.84 138.7 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -132.83 168.24 18.74 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.942 1.697 . . . . 0.0 109.949 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.79 108.58 9.97 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.168 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.71 147.44 28.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 111.14 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -81.83 150.98 27.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.238 0.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -63.63 -12.15 31.11 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.317 -0.849 . . . . 0.0 113.159 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.49 1.14 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 121.165 1.802 . . . . 0.0 108.854 166.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -50.32 -45.41 54.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.48 1.512 . . . . 0.0 111.443 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.22 -40.76 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.839 0.456 . . . . 0.0 110.472 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -64.0 -48.13 77.58 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.12 -48.55 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.046 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -53.36 -56.53 15.99 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.091 0.859 . . . . 0.0 110.597 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.2 -37.41 85.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 111.16 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.8 m -53.84 -47.91 70.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.905 0.882 . . . . 0.0 110.618 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -58.37 5.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.01 0.924 . . . . 0.0 109.813 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.01 -27.62 63.69 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.23 18.03 12.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.837 1.655 . . . . 0.0 111.92 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.96 -35.82 47.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.268 1.027 . . . . 0.0 113.361 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -90.82 -19.59 23.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.906 0.775 . . . . 0.0 112.665 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.74 -26.34 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.593 1.157 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 50.58 2.81 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -169.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -57.43 168.42 0.8 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 110.417 166.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -154.24 -43.44 0.09 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 110.184 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.53 -165.9 33.86 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.7 157.47 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -124.96 138.45 54.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 108.212 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.61 116.48 35.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.207 1.803 . . . . 0.0 108.842 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -113.96 122.0 45.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -107.71 111.92 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 p -120.46 167.02 13.66 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.35 22.89 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.878 2.385 . . . . 0.0 111.445 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -127.61 -53.03 1.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.397 -1.439 . . . . 0.0 110.937 -168.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -162.09 171.71 17.06 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.459 2.304 . . . . 0.0 107.56 160.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -87.62 138.05 31.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.75 151.64 27.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.74 122.36 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 mt -123.57 108.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 mt -71.01 122.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.83 110.53 20.57 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.59 168.08 21.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 111.321 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -78.43 -26.37 46.29 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 120.458 -1.401 . . . . 0.0 112.854 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -128.89 67.02 1.41 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.964 0.906 . . . . 0.0 110.562 -164.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -45.32 26.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.697 1.999 . . . . 0.0 113.42 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -70.78 -28.61 64.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.223 -0.923 . . . . 0.0 111.744 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.59 -42.26 64.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 0.56 . . . . 0.0 109.689 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.76 -47.44 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.1 mt -61.82 -38.66 88.99 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.441 -0.787 . . . . 0.0 111.024 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.0 174.05 29.67 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.52 117.21 3.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.273 1.029 . . . . 0.0 109.488 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 47.62 41.11 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.507 1.123 . . . . 0.0 112.925 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.93 13.74 83.34 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.114 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -48.61 -60.16 2.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.132 1.466 . . . . 0.0 113.046 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -43.25 99.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 117.025 -1.465 . . . . 0.0 110.363 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 tt -61.06 -39.02 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 120.185 1.357 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -63.51 -47.7 80.6 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 120.747 -1.221 . . . . 0.0 112.361 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.25 -58.88 6.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.257 1.023 . . . . 0.0 109.303 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.84 -26.23 67.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.624 -173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.4 m -58.32 -47.58 83.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.06 1.3 . . . . 0.0 109.803 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.84 88.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.624 1.102 . . . . 0.0 111.796 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.98 -58.82 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.283 -0.885 . . . . 0.0 108.64 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.2 t -52.12 -45.72 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 126.378 1.871 . . . . 0.0 110.197 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -52.6 -49.29 65.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.534 0.733 . . . . 0.0 110.732 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.87 32.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.734 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -40.92 65.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.011 0.823 . . . . 0.0 111.965 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.15 8.24 27.93 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.055 1.742 . . . . 0.0 111.227 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 33.21 63.38 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.495 1.521 . . . . 0.0 113.695 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -72.32 151.41 92.08 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.782 0.833 . . . . 0.0 112.291 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.0 119.67 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.393 2.062 . . . . 0.0 109.241 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.09 137.16 56.16 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.758 0.823 . . . . 0.0 109.034 166.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.35 56.05 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.75 1.643 . . . . 0.0 113.152 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.3 m -133.51 17.7 3.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.076 1.438 . . . . 0.0 112.993 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.53 139.58 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 151.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -128.49 145.11 51.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.63 140.96 48.39 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -131.6 167.73 18.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 128.136 2.574 . . . . 0.0 108.871 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.33 119.47 15.54 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -121.49 171.78 8.55 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.375 1.47 . . . . 0.0 111.886 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -115.25 131.55 56.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.569 -164.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -173.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.7 t80 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.243 0.068 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -52.59 -38.23 59.67 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.698 0.799 . . . . 0.0 110.757 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.26 -49.65 40.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.117 -0.944 . . . . 0.0 112.241 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -55.95 -46.95 78.41 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.516 1.053 . . . . 0.0 109.787 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.4 -39.78 94.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.694 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -61.26 -51.78 67.51 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.003 0.921 . . . . 0.0 109.792 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -59.66 -40.08 86.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.928 0.785 . . . . 0.0 111.579 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.02 -57.92 10.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.934 0.893 . . . . 0.0 109.315 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -61.26 -38.39 86.53 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.856 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -53.61 -31.14 45.89 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.484 1.493 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.86 -47.69 7.46 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 110.526 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -60.63 -33.76 73.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.791 0.723 . . . . 0.0 112.41 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -113.55 23.58 13.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.293 2.237 . . . . 0.0 110.37 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.87 -59.69 4.04 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.593 1.157 . . . . 0.0 110.143 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.03 -39.94 79.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.695 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -43.51 92.66 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.699 1.6 . . . . 0.0 112.21 -164.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.63 48.73 0.78 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.868 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HH ' ' HB ' ' A' ' 28' ' ' VAL . 69.1 t80 -65.51 169.79 5.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.163 1.385 . . . . 0.0 111.095 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -157.16 -26.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.14 -169.54 36.75 Favored Glycine 0 C--O 1.227 -0.311 0 O-C-N 121.632 -0.667 . . . . 0.0 111.689 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.43 ' HB ' ' HH ' ' A' ' 25' ' ' TYR . 4.9 p -155.59 142.52 11.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.21 158.37 16.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.335 1.054 . . . . 0.0 109.506 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.79 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.093 1.357 . . . . 0.0 107.471 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.7 129.07 57.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 p -121.83 177.06 1.67 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.634 1.574 . . . . 0.0 110.407 -172.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.75 0.0 10.36 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 121.424 1.416 . . . . 0.0 113.182 165.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -119.64 -53.14 2.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.766 1.621 . . . . 0.0 112.971 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -153.73 161.38 42.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.649 1.18 . . . . 0.0 110.66 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.1 m -71.63 148.06 46.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.08 130.99 53.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.336 1.854 . . . . 0.0 106.769 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.9 mt -124.03 121.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.94 97.14 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -69.61 141.74 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -115.39 120.8 40.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 127.923 2.489 . . . . 0.0 107.76 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.91 169.71 22.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.101 1.361 . . . . 0.0 109.643 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -80.41 -35.43 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.406 -0.809 . . . . 0.0 112.342 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -125.55 83.47 2.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.306 1.442 . . . . 0.0 108.32 -165.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -49.92 -45.15 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.049 1.34 . . . . 0.0 112.387 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -56.85 -38.47 72.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.49 -43.73 80.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.485 1.039 . . . . 0.0 109.877 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.05 -42.32 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.079 0.552 . . . . 0.0 109.768 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.15 -30.78 71.73 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.979 -1.076 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.16 -174.38 9.42 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.06 111.6 1.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 110.228 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp 56.41 3.13 0.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.251 1.82 . . . . 0.0 115.14 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.72 -2.14 9.35 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 120.422 1.464 . . . . 0.0 114.112 -169.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -44.06 -57.44 3.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.057 1.929 . . . . 0.0 113.941 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.87 -45.02 79.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.122 0.874 . . . . 0.0 110.621 -173.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.29 -34.33 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.374 0.988 . . . . 0.0 109.827 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -71.84 -37.42 70.28 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 113.753 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.28 -55.27 16.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.469 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.2 mt -56.09 -36.1 67.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.136 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -49.32 -52.56 27.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.18 0.9 . . . . 0.0 110.729 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.61 -44.63 56.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.2 1.0 . . . . 0.0 111.36 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -60.28 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 t -54.85 -46.49 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 120.417 1.462 . . . . 0.0 110.614 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -49.95 -42.51 48.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.272 1.029 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -83.77 -41.06 18.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.002 0.921 . . . . 0.0 111.709 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -29.64 70.88 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.98 0.912 . . . . 0.0 111.474 -173.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.3 -8.76 11.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.983 0.913 . . . . 0.0 110.464 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.5 51.07 45.12 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -78.18 150.4 77.39 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.011 0.524 . . . . 0.0 110.018 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.54 119.51 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.773 1.649 . . . . 0.0 109.712 162.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.86 145.59 15.81 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.93 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.601 -1.111 . . . . 0.0 114.296 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -134.46 40.16 3.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.462 2.131 . . . . 0.0 111.882 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.2 139.57 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 164.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 138.34 50.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.092 1.357 . . . . 0.0 108.729 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.44 129.23 47.44 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -117.04 160.3 21.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.421 1.488 . . . . 0.0 109.554 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.67 109.36 10.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 108.463 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.12 156.48 17.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.376 1.47 . . . . 0.0 108.475 173.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -107.06 148.83 28.27 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.633 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -154.32 157.43 38.62 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.312 -1.11 . . . . 0.0 110.649 -172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.3 t -74.67 150.72 39.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.599 1.16 . . . . 0.0 110.721 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.73 -161.81 31.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.1 m -55.36 143.88 27.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.369 0.668 . . . . 0.0 110.011 164.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m 174.35 -8.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.919 1.688 . . . . 0.0 114.6 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.97 -91.23 0.7 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.705 1.139 . . . . 0.0 112.041 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -45.42 -49.82 12.97 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 126.437 1.895 . . . . 0.0 112.659 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -57.94 -31.72 67.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -42.33 58.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.407 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -62.73 -46.41 88.21 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.144 0.577 . . . . 0.0 110.807 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.75 -38.82 90.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.651 0.781 . . . . 0.0 110.166 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.45 -42.18 83.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.352 0.524 . . . . 0.0 111.14 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.95 -46.26 78.6 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.588 0.755 . . . . 0.0 110.876 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.57 -61.59 2.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.001 0.92 . . . . 0.0 109.439 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.51 -32.23 72.26 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.737 1.215 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.3 m -54.56 -45.42 73.48 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.885 0.766 . . . . 0.0 110.497 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -49.97 65.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.689 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -55.88 -35.53 66.6 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.104 0.561 . . . . 0.0 112.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -121.15 24.77 9.93 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.09 1.356 . . . . 0.0 110.524 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.03 -63.04 1.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.42 1.488 . . . . 0.0 110.595 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.23 -24.94 51.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.905 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.7 -35.54 72.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.341 0.973 . . . . 0.0 111.418 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.68 35.73 0.83 Allowed Glycine 0 C--N 1.338 0.65 0 O-C-N 123.553 0.533 . . . . 0.0 113.018 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -59.38 167.46 1.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.174 0.987 . . . . 0.0 112.509 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -44.88 0.16 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.406 1.482 . . . . 0.0 110.042 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.32 -169.53 42.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.77 156.34 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.39 158.96 22.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.576 1.951 . . . . 0.0 107.857 163.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.02 150.07 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -132.88 156.79 46.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 163.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.52 124.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 p -120.41 176.83 1.64 Allowed Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -167.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.12 8.07 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.509 1.473 . . . . 0.0 112.591 167.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -125.78 -45.08 1.77 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.376 0.989 . . . . 0.0 110.637 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -161.73 173.22 14.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.92 1.236 . . . . 0.0 110.865 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.6 m -88.94 149.47 23.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 160.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.2 138.41 52.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.176 1.79 . . . . 0.0 106.613 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -132.16 120.7 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.41 95.03 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.26 153.24 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -118.8 108.14 14.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.827 2.451 . . . . 0.0 105.972 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.93 157.93 45.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.556 0.693 . . . . 0.0 112.29 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.8 p -64.08 -34.24 77.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.549 1.14 . . . . 0.0 111.018 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -134.88 82.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.479 1.512 . . . . 0.0 109.821 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 p -53.4 -35.37 60.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.732 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -60.79 -36.57 79.35 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.448 1.477 . . . . 0.0 112.456 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -67.03 -45.28 77.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.814 0.733 . . . . 0.0 109.066 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -30.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.049 0.939 . . . . 0.0 111.105 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.21 -40.22 52.72 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.524 -0.735 . . . . 0.0 110.519 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.3 179.7 47.06 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.501 1.048 . . . . 0.0 111.487 -171.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -57.06 114.93 2.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.545 0.738 . . . . 0.0 109.447 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 mttp 39.46 46.82 1.47 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.181 1.792 . . . . 0.0 112.464 -174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.88 9.54 77.43 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.118 -0.824 . . . . 0.0 113.751 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -43.86 -62.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.253 1.526 . . . . 0.0 112.738 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.02 -40.77 78.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.368 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.04 -41.27 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.306 0.957 . . . . 0.0 111.186 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -52.61 64.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.972 -1.08 . . . . 0.0 109.649 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -58.54 -47.06 85.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.795 0.725 . . . . 0.0 111.732 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 40.0 mt -62.0 -30.24 70.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.715 0.806 . . . . 0.0 110.898 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -61.17 -51.7 67.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.436 1.016 . . . . 0.0 109.413 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.71 78.79 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.857 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 11.4 p -59.87 -46.17 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.722 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 t -60.45 -45.69 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 120.234 1.379 . . . . 0.0 110.152 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -51.9 -44.25 63.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.785 1.234 . . . . 0.0 110.426 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -70.75 -50.78 32.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.2 1.0 . . . . 0.0 110.139 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -44.87 90.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.282 1.433 . . . . 0.0 111.016 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -103.57 -13.67 16.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.81 1.244 . . . . 0.0 111.503 -171.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 20.36 54.91 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 121.324 -0.86 . . . . 0.0 113.943 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -62.32 138.38 96.23 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.063 0.932 . . . . 0.0 112.456 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.96 141.6 49.03 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.275 1.983 . . . . 0.0 110.24 165.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.47 147.35 39.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.735 0.814 . . . . 0.0 110.03 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.97 -7.44 7.57 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.435 -0.791 . . . . 0.0 113.197 -169.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.0 m -122.02 7.21 9.78 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.138 1.775 . . . . 0.0 111.201 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.07 136.84 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 156.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 140.77 51.88 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.54 126.67 50.92 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.205 1.402 . . . . 0.0 107.629 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -129.89 168.23 16.95 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.847 2.459 . . . . 0.0 109.22 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.62 122.07 17.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.37 155.28 18.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -101.23 149.49 23.95 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.79 144.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 122.517 1.151 . . . . 0.0 108.134 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.57 139.46 5.53 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.488 1.515 . . . . 0.0 108.804 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.4 t -70.2 148.15 48.96 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -65.94 155.3 36.93 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.26 -174.79 23.32 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m 60.12 173.13 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.616 1.967 . . . . 0.0 113.507 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -101.13 178.74 28.25 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.158 0.885 . . . . 0.0 111.63 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.11 -69.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.488 2.125 . . . . 0.0 107.98 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -142.92 -32.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.21 1.804 . . . . 0.0 109.561 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m 70.78 6.73 5.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.019 1.328 . . . . 0.0 112.626 -174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 C-N-CA 128.227 2.822 . . . . 0.0 107.245 171.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.277 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t 38.82 83.27 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.181 2.592 . . . . 0.0 113.271 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -145.04 177.18 8.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.68 125.85 1.78 Allowed Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 105.682 -2.967 . . . . 0.0 105.682 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.4 m 30.32 74.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.438 2.295 . . . . 0.0 112.668 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -163.15 142.2 8.5 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.155 1.382 . . . . 0.0 107.404 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.37 94.04 1.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -32.85 -51.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.515 3.126 . . . . 0.0 114.085 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.31 -36.19 60.99 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 118.547 -0.739 . . . . 0.0 112.177 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.37 -51.52 51.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.951 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.91 -46.0 74.82 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.427 1.091 . . . . 0.0 109.932 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.21 -43.26 82.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.737 0.815 . . . . 0.0 110.625 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -64.12 -47.19 80.93 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.324 0.65 . . . . 0.0 109.942 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.73 -44.29 85.89 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.186 1.394 . . . . 0.0 111.739 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -56.54 -60.07 4.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.5 -38.89 78.61 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.476 1.11 . . . . 0.0 112.487 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -51.91 -37.05 51.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.552 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -90.79 -39.01 12.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.293 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.09 -25.46 65.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 113.071 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.38 22.6 12.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.2 1.8 . . . . 0.0 110.758 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.23 64.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.872 1.269 . . . . 0.0 111.683 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.77 -26.65 59.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.673 0.215 . . . . 0.0 111.071 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 -34.99 79.41 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.639 0.775 . . . . 0.0 112.12 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.57 33.63 2.23 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.49 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -51.67 157.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.862 0.865 . . . . 0.0 112.478 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -128.96 -57.06 1.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.472 1.509 . . . . 0.0 108.96 169.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.12 -166.45 32.9 Favored Glycine 0 C--O 1.227 -0.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.23 154.56 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -124.27 152.17 43.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 165.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.75 137.28 54.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -115.3 152.28 33.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.99 96.23 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 -171.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -120.69 163.89 26.45 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 123.768 0.827 . . . . 0.0 108.914 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.85 13.7 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.84 2.36 . . . . 0.0 112.011 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 p -120.64 -45.52 2.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.33 1.452 . . . . 0.0 110.324 -163.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -162.05 173.22 14.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.95 2.1 . . . . 0.0 106.989 162.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -75.71 147.37 39.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 158.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.77 129.7 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -126.9 132.51 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.99 100.53 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.55 131.75 33.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt -106.92 114.63 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.643 1.977 . . . . 0.0 106.22 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.81 169.63 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.801 0.441 . . . . 0.0 110.081 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -68.61 -46.45 69.27 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.408 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -115.8 89.6 3.14 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 127.519 2.328 . . . . 0.0 107.605 -164.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -45.27 66.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 111.324 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -65.76 -19.43 65.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -74.35 -49.06 24.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.67 -39.29 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.998 1.319 . . . . 0.0 110.844 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.16 -40.73 90.76 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.599 -0.688 . . . . 0.0 110.858 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 -175.29 40.0 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.54 113.67 2.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.889 1.275 . . . . 0.0 110.467 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.1 pttt 46.25 30.07 0.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.635 1.174 . . . . 0.0 113.867 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.62 5.74 59.97 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.992 0.806 . . . . 0.0 114.374 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -45.72 -55.91 5.91 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 112.855 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -72.27 -46.48 55.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.25 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.0 tt -59.08 -35.93 59.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.848 1.658 . . . . 0.0 111.134 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.94 -36.67 72.71 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 120.699 -1.251 . . . . 0.0 112.559 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.91 -49.27 71.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.265 0.484 . . . . 0.0 109.997 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 83.1 mt -59.87 -29.09 68.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.937 1.295 . . . . 0.0 110.507 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -63.32 -56.67 14.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.815 . . . . 0.0 109.067 169.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.6 88.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.863 1.265 . . . . 0.0 112.097 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 7.4 p -62.88 -52.4 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.115 -1.422 . . . . 0.0 108.101 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.81 -46.38 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.187 1.358 . . . . 0.0 109.976 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.99 -44.89 64.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 0.0 109.517 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -83.89 -37.51 22.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.707 0.685 . . . . 0.0 112.646 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.98 -55.3 32.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.528 1.131 . . . . 0.0 109.088 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 97.2 m-85 -93.8 -11.18 31.85 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.486 1.114 . . . . 0.0 110.51 -169.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.98 23.11 59.96 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.424 1.011 . . . . 0.0 111.811 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.65 139.98 97.71 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 118.263 1.031 . . . . 0.0 111.508 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.17 130.74 35.54 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.934 2.423 . . . . 0.0 109.449 165.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.07 122.67 15.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.433 0.693 . . . . 0.0 109.301 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.58 -12.47 56.03 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.985 0.802 . . . . 0.0 114.368 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -89.2 15.18 9.31 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.779 1.232 . . . . 0.0 111.582 165.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.57 156.4 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 159.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 145.31 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 170.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 113.16 19.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -112.36 164.67 12.98 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.064 2.145 . . . . 0.0 108.609 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.84 114.37 10.39 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.43 153.68 20.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.088 0.946 . . . . 0.0 109.194 172.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -83.28 148.3 27.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -85.09 146.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.794 0.837 . . . . 0.0 109.339 172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 83.81 84.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 129.765 3.226 . . . . 0.0 109.71 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 p -76.03 95.2 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.712 1.605 . . . . 0.0 110.289 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -130.38 141.23 50.56 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.499 -1.375 . . . . 0.0 107.612 163.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.67 -107.33 0.33 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 51.42 74.98 0.22 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.039 1.336 . . . . 0.0 110.103 -169.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.06 95.09 0.6 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 107.29 -2.324 . . . . 0.0 107.29 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.76 -23.5 19.18 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 CA-C-N 119.882 1.841 . . . . 0.0 112.934 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 m 39.95 81.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.265 1.826 . . . . 0.0 112.303 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.1 m 58.67 89.32 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 159.317 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 m -125.45 104.59 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.631 1.572 . . . . 0.0 108.802 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 t -146.97 97.49 2.9 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.551 1.94 . . . . 0.0 106.338 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.86 -39.0 3.0 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.682 1.134 . . . . 0.0 111.934 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.0 m -81.93 142.85 32.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.619 1.709 . . . . 0.0 108.852 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.1 m -141.48 164.94 28.87 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.885 1.274 . . . . 0.0 108.043 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.68 -152.13 48.76 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -46.86 -49.88 19.5 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 125.682 1.593 . . . . 0.0 112.004 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.55 -38.52 74.89 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.544 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.83 65.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.782 0.719 . . . . 0.0 111.759 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -58.13 -48.73 79.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.911 0.778 . . . . 0.0 109.48 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.62 -41.86 92.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.344 1.457 . . . . 0.0 111.39 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.02 -50.16 73.59 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 123.764 0.826 . . . . 0.0 109.51 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.72 -42.68 97.88 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.11 -52.12 65.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.681 0.793 . . . . 0.0 109.419 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.18 -38.66 85.77 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.242 1.017 . . . . 0.0 111.787 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -54.6 -42.53 71.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.907 0.883 . . . . 0.0 109.9 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.51 -61.44 1.89 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.369 0.668 . . . . 0.0 110.061 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -21.97 64.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -170.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -122.65 21.58 10.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.138 1.775 . . . . 0.0 111.104 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.56 -55.07 17.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.309 1.044 . . . . 0.0 112.228 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -71.11 -16.08 62.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.554 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.48 -16.1 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.544 1.066 . . . . 0.0 113.39 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.73 40.26 6.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.58 158.85 4.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.834 -0.804 . . . . 0.0 110.89 170.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -147.35 -29.86 0.34 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.115 0.966 . . . . 0.0 112.564 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.64 -167.02 40.04 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.74 149.27 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.43 119.48 28.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -82.67 135.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -109.39 120.58 42.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.37 121.92 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 157.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -120.29 164.75 20.95 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.29 2.85 5.77 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.678 2.252 . . . . 0.0 111.877 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -112.82 -41.75 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -161.83 173.37 14.67 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.077 1.351 . . . . 0.0 109.965 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.4 m -74.79 146.38 42.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 154.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -127.45 143.55 51.18 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.435 2.294 . . . . 0.0 105.114 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -132.46 117.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.84 95.98 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.49 125.42 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.36 113.97 25.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.274 1.83 . . . . 0.0 106.299 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.42 171.07 14.57 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 109.209 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -81.87 -17.99 45.38 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.388 -1.445 . . . . 0.0 112.886 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -133.05 61.65 1.67 Allowed 'General case' 0 CA--C 1.523 -0.066 0 C-N-CA 124.74 1.216 . . . . 0.0 110.214 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -48.86 -41.69 34.05 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.894 0.877 . . . . 0.0 112.112 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.2 83.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.625 0.37 . . . . 0.0 111.431 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -72.27 -43.48 64.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.302 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.37 -31.58 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 110.976 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.96 -32.37 70.58 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.069 -1.019 . . . . 0.0 111.767 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.9 169.74 7.57 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.224 1.392 . . . . 0.0 111.665 -166.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.19 125.68 24.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.519 1.528 . . . . 0.0 108.679 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt 42.63 43.63 3.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.153 1.781 . . . . 0.0 111.767 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.0 66.57 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.886 -0.952 . . . . 0.0 114.948 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -52.93 -51.46 61.25 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.753 1.776 . . . . 0.0 111.175 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -34.65 62.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.881 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -65.82 -36.71 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.194 1.361 . . . . 0.0 111.24 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -65.15 -41.16 94.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 120.756 -1.215 . . . . 0.0 111.42 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -56.68 -60.11 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.057 0.943 . . . . 0.0 109.017 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.8 mt -57.27 -35.9 70.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.349 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -55.58 -52.38 63.93 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.594 1.088 . . . . 0.0 109.933 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.91 85.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.688 0.676 . . . . 0.0 111.294 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -64.13 -46.3 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 117.633 -1.175 . . . . 0.0 109.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.92 -46.29 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 120.568 1.531 . . . . 0.0 109.365 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -53.55 -39.91 65.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.085 0.554 . . . . 0.0 110.922 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -85.22 -36.65 20.82 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 118.964 0.802 . . . . 0.0 111.459 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -45.42 94.09 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.807 0.843 . . . . 0.0 109.16 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.77 -2.77 21.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.905 1.282 . . . . 0.0 112.69 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.27 35.57 63.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.687 1.137 . . . . 0.0 113.573 172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.13 133.7 68.51 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 118.371 1.086 . . . . 0.0 111.453 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.41 138.96 87.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.121 2.548 . . . . 0.0 111.185 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 111.07 9.84 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.169 0.987 . . . . 0.0 110.16 -173.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.76 -2.18 55.65 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.277 -0.735 . . . . 0.0 112.694 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 m -109.66 6.5 23.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.519 1.128 . . . . 0.0 112.081 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.68 163.71 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.749 1.219 . . . . 0.0 107.836 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.66 157.26 43.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.37 1.468 . . . . 0.0 107.43 159.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.39 135.49 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.07 165.25 19.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.016 1.726 . . . . 0.0 108.241 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.77 111.16 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -116.53 154.15 30.93 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.045 1.338 . . . . 0.0 109.009 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -110.69 135.36 51.41 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.633 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.84 130.4 36.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.2 92.48 0.41 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 t -63.29 142.65 58.31 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.962 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -174.27 142.54 0.81 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.657 1.983 . . . . 0.0 107.985 162.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.27 95.04 0.17 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -150.44 152.94 35.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.916 1.358 . . . . 0.0 112.077 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.14 97.82 0.17 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.52 168.31 25.08 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 120.069 1.934 . . . . 0.0 109.444 165.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -140.49 152.58 45.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 162.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.36 -3.92 2.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.97 2.108 . . . . 0.0 112.082 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.526 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 176.229 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.385 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -137.05 125.22 23.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.887 2.075 . . . . 0.0 106.097 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.98 140.58 1.58 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.16 148.66 2.45 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 -172.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.11 25.47 5.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 112.942 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -88.92 121.88 31.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.181 0.992 . . . . 0.0 113.491 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.4 -161.97 41.45 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 124.635 1.112 . . . . 0.0 112.908 158.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -50.59 -48.9 57.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.779 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -54.68 -47.36 73.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.411 -0.805 . . . . 0.0 109.768 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.89 -53.44 50.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.464 1.105 . . . . 0.0 111.917 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.83 -45.77 59.69 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.202 0.601 . . . . 0.0 110.439 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp -69.23 -41.04 77.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.746 1.219 . . . . 0.0 110.868 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -50.37 74.25 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.983 1.313 . . . . 0.0 108.758 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -66.38 -31.99 73.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.506 1.922 . . . . 0.0 112.127 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.97 -62.6 1.35 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.592 1.157 . . . . 0.0 108.533 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -55.8 -29.6 59.98 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.383 1.473 . . . . 0.0 112.389 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -51.51 -45.16 62.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.233 1.013 . . . . 0.0 111.856 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -74.27 -58.27 3.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -30.44 15.04 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 125.9 1.68 . . . . 0.0 113.402 -169.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.52 22.34 5.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.843 1.257 . . . . 0.0 111.566 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.629 0.771 . . . . 0.0 110.054 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.1 -26.09 68.06 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.572 1.149 . . . . 0.0 110.446 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.75 -25.79 65.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.52 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.51 25.59 4.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.43 -1.205 . . . . 0.0 114.077 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -54.41 148.95 10.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.709 1.604 . . . . 0.0 113.646 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m -128.46 -41.51 1.53 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 112.453 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.16 -166.36 39.59 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 156.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.46 138.73 50.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 160.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.95 124.52 65.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.29 121.98 46.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.86 95.87 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 p -78.38 166.04 45.79 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.18 -2.55 12.7 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.225 1.283 . . . . 0.0 112.921 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 p -103.73 -51.05 3.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.595 1.089 . . . . 0.0 109.606 -166.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -157.44 162.97 38.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.758 2.023 . . . . 0.0 107.757 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.1 m -73.11 139.69 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -110.49 144.01 39.95 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.4 mt -135.31 123.41 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.5 101.54 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.5 mt -68.15 123.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 mt -96.5 118.3 32.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.69 -177.92 6.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.689 0.756 . . . . 0.0 111.504 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 p -86.49 -25.36 25.18 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -129.67 78.46 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.68 1.192 . . . . 0.0 107.96 -165.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -40.7 72.81 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.247 1.019 . . . . 0.0 111.346 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -69.51 -22.08 63.62 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.691 -0.631 . . . . 0.0 111.63 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -72.76 -46.43 53.44 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.43 -36.55 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.146 1.378 . . . . 0.0 111.678 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -65.39 -42.67 92.38 Favored 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 120.916 -1.115 . . . . 0.0 109.34 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -179.57 29.42 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-O 122.976 1.32 . . . . 0.0 110.673 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.51 116.81 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.895 2.078 . . . . 0.0 109.156 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt 52.68 8.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.776 2.03 . . . . 0.0 115.305 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 18.72 11.24 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 120.695 1.588 . . . . 0.0 113.493 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -60.77 -57.26 13.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.489 2.145 . . . . 0.0 112.437 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -67.44 -33.61 75.5 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.916 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.6 -44.02 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.151 0.887 . . . . 0.0 110.456 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -69.13 -38.88 79.06 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.113 -0.992 . . . . 0.0 111.228 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.65 -49.12 76.42 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.759 0.709 . . . . 0.0 109.402 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.0 mt -59.69 -29.09 67.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.647 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 m -60.77 -56.82 16.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.596 1.089 . . . . 0.0 108.922 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.67 73.04 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.763 1.225 . . . . 0.0 111.978 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 14.3 p -59.17 -51.9 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.539 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.83 -43.88 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.656 1.571 . . . . 0.0 109.778 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -53.05 -44.04 67.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.603 0.761 . . . . 0.0 110.846 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -72.71 -52.75 13.92 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.902 0.774 . . . . 0.0 110.875 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.84 -24.17 21.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.667 1.987 . . . . 0.0 112.589 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.97 -3.37 5.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.488 1.115 . . . . 0.0 112.961 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.83 7.78 85.26 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.754 1.169 . . . . 0.0 114.924 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -61.22 143.62 92.35 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.389 1.595 . . . . 0.0 111.948 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.44 163.67 23.05 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.472 2.115 . . . . 0.0 110.447 162.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -68.83 141.39 55.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 164.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.44 -40.65 2.42 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.681 1.134 . . . . 0.0 113.661 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.7 m -67.47 -4.78 12.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.943 1.372 . . . . 0.0 112.922 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.91 141.38 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 163.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.96 130.2 48.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.33 137.89 39.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -130.47 167.49 18.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 127.612 2.365 . . . . 0.0 109.209 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.31 120.19 14.41 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.142 1.777 . . . . 0.0 108.915 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -119.14 148.56 42.94 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.717 1.207 . . . . 0.0 110.502 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -74.7 147.73 41.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.403 0.62 . . . . 0.0 109.839 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.94 159.65 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.904 1.682 . . . . 0.0 107.982 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.7 167.88 12.97 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.844 1.257 . . . . 0.0 111.587 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 85' ' ' ARG . 2.6 m 59.58 -177.47 0.09 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.352 1.061 . . . . 0.0 110.282 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' H ' HG23 ' A' ' 84' ' ' THR . 25.0 ttm180 42.73 67.25 0.64 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.685 1.994 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.68 97.82 1.98 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -104.83 -70.07 0.79 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.761 0.825 . . . . 0.0 109.138 170.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.74 169.87 28.92 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.0 122.72 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.984 2.456 . . . . 0.0 107.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.2 m -135.3 90.46 2.62 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.67 156.84 32.46 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.974 0.91 . . . . 0.0 109.402 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.568 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.827 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -57.24 136.49 56.49 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.481 1.112 . . . . 0.0 109.949 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.57 144.78 50.86 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.97 151.62 19.88 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.008 0.813 . . . . 0.0 111.629 -167.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 m -68.49 106.93 2.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.091 0.956 . . . . 0.0 110.031 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -69.18 163.19 25.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.441 0.296 . . . . 0.0 110.772 162.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.16 -87.23 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 126.277 1.894 . . . . 0.0 110.934 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -33.04 -51.54 0.32 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.13 2.972 . . . . 0.0 113.784 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.22 -35.58 73.88 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -49.79 14.08 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.178 0.991 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.22 -47.78 65.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.445 0.641 . . . . 0.0 109.801 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.856 -0.527 . . . . 0.0 110.824 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.04 -57.5 12.8 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.821 1.248 . . . . 0.0 110.007 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.03 -34.8 78.5 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 118.754 0.706 . . . . 0.0 111.855 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.7 -64.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.687 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.18 80.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.574 1.55 . . . . 0.0 111.717 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.6 m -49.88 -37.38 30.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.616 1.166 . . . . 0.0 110.935 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.79 -16.63 28.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.61 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.68 -16.47 28.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.428 1.091 . . . . 0.0 112.457 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -136.97 36.63 2.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.38 1.472 . . . . 0.0 112.008 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.89 -61.23 2.51 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.051 -1.031 . . . . 0.0 111.774 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.75 -15.86 60.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.801 0.84 . . . . 0.0 112.081 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.12 -15.14 62.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.067 1.347 . . . . 0.0 112.774 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.88 32.75 28.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.167 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -52.96 144.57 14.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.519 0.66 . . . . 0.0 111.213 168.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.1 m -126.58 -47.78 1.55 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.395 1.478 . . . . 0.0 110.428 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.87 -162.94 29.68 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.55 158.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 121.083 -1.245 . . . . 0.0 107.969 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -128.36 157.69 40.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.652 1.981 . . . . 0.0 109.277 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.07 134.65 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.508 1.123 . . . . 0.0 111.231 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -121.45 161.85 21.48 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.673 1.189 . . . . 0.0 110.124 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.76 133.71 65.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.993 1.717 . . . . 0.0 106.493 164.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -122.37 170.53 7.75 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.325 1.45 . . . . 0.0 109.095 167.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.44 4.82 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.593 2.196 . . . . 0.0 112.651 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.3 p -108.22 -54.9 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.443 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.01 169.28 24.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.592 1.087 . . . . 0.0 111.689 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.4 m -68.0 151.91 46.35 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -135.39 135.08 40.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.9 124.15 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.68 107.42 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.47 1.108 . . . . 0.0 108.582 -166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.17 142.93 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.65 115.55 30.35 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 163.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.58 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.988 0.813 . . . . 0.0 110.546 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -78.64 -49.02 13.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.656 -1.278 . . . . 0.0 111.283 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -99.71 74.28 1.85 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -51.89 -35.35 44.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.691 -0.631 . . . . 0.0 112.659 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -77.09 -18.61 57.88 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.297 1.408 . . . . 0.0 113.067 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -65.12 -59.94 3.56 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 162.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -53.58 -43.83 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.287 1.035 . . . . 0.0 111.751 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.21 -41.32 77.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.48 -0.762 . . . . 0.0 110.816 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.84 178.76 34.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.465 0.481 . . . . 0.0 112.111 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.85 119.15 7.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.62 0.768 . . . . 0.0 110.204 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.87 32.16 5.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.753 1.621 . . . . 0.0 112.356 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.77 58.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.013 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -51.65 -63.43 1.14 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.164 1.482 . . . . 0.0 113.024 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -39.63 94.71 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.732 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.73 -43.53 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.265 1.393 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -68.3 -38.27 81.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.03 -1.044 . . . . 0.0 111.476 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.15 -51.77 66.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 16.9 mt -62.71 -26.47 68.69 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.277 -1.344 . . . . 0.0 111.752 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -60.82 -50.45 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.117 1.326 . . . . 0.0 108.408 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.26 85.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.689 0.796 . . . . 0.0 112.286 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.9 p -68.45 -39.07 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.336 -1.316 . . . . 0.0 110.142 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.32 -43.6 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 121.532 1.969 . . . . 0.0 109.961 173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -54.64 -40.36 68.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.927 0.891 . . . . 0.0 111.073 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -67.62 -65.53 0.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.494 1.043 . . . . 0.0 108.849 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -38.89 69.0 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.28 2.232 . . . . 0.0 111.754 -167.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.64 -4.4 17.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.623 1.169 . . . . 0.0 111.185 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.26 51.38 57.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.638 1.108 . . . . 0.0 110.908 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -79.12 153.8 77.25 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.638 0.375 . . . . 0.0 110.577 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -72.42 117.03 4.94 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.703 2.268 . . . . 0.0 108.319 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -57.37 143.42 40.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 110.075 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.77 -46.43 3.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.948 1.261 . . . . 0.0 111.085 -168.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m -83.56 17.28 2.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.366 1.466 . . . . 0.0 114.279 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.45 136.07 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.81 135.07 47.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 128.156 2.582 . . . . 0.0 108.155 174.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.3 134.55 52.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.37 177.29 6.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.245 2.218 . . . . 0.0 108.838 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 158.84 43.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.93 153.24 46.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.759 2.424 . . . . 0.0 106.353 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -95.5 135.97 36.48 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.76 144.11 11.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -168.85 -168.67 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.41 1.484 . . . . 0.0 107.984 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -17.13 6.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 113.0 2.03 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 124.273 1.029 . . . . 0.0 109.514 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.51 150.26 44.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 142.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.8 m -128.58 168.37 15.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.856 2.462 . . . . 0.0 108.177 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.23 -153.92 7.22 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 118.855 0.752 . . . . 0.0 114.213 -160.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.36 96.08 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.731 2.954 . . . . 0.0 110.202 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.7 t -94.58 -66.33 0.92 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.561 1.944 . . . . 0.0 107.344 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m 55.87 -175.87 0.05 OUTLIER 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.894 0.878 . . . . 0.0 110.569 -151.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 179.057 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.556 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -62.79 -28.26 69.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.692 -166.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m 38.67 55.69 1.92 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.52 1.928 . . . . 0.0 111.862 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.25 -173.58 36.34 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.546 -165.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.6 m 69.83 100.62 0.06 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.694 1.997 . . . . 0.0 108.593 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -42.35 136.24 2.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.887 2.475 . . . . 0.0 109.792 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.31 -170.69 38.82 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -166.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -55.56 -53.23 59.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.244 0.618 . . . . 0.0 110.805 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.94 -38.1 81.45 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.909 -169.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 -55.01 31.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.241 0.616 . . . . 0.0 110.622 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.49 -42.85 78.98 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.315 0.507 . . . . 0.0 111.578 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.5 tp -71.37 -38.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.548 0.339 . . . . 0.0 110.636 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -59.93 -51.53 69.28 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.057 0.943 . . . . 0.0 108.634 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.19 -37.8 81.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 112.371 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.15 -57.01 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.188 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.05 -30.35 71.43 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.686 1.195 . . . . 0.0 111.939 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.9 m -49.67 -40.22 39.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.185 1.394 . . . . 0.0 111.118 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -91.18 -45.87 8.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.448 0.699 . . . . 0.0 110.424 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -55.98 -30.39 61.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.409 0.684 . . . . 0.0 112.613 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.8 mt -125.53 22.45 7.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.015 1.326 . . . . 0.0 110.703 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.18 -63.48 1.14 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.014 0.925 . . . . 0.0 110.222 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.05 -15.51 61.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.521 0.329 . . . . 0.0 111.836 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -35.65 74.94 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.74 28.41 1.42 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.907 -0.94 . . . . 0.0 113.818 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -53.29 153.63 3.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.526 1.163 . . . . 0.0 112.628 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 m -142.42 -34.35 0.45 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.972 1.309 . . . . 0.0 112.405 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.77 -169.57 42.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.064 0.847 . . . . 0.0 111.075 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.4 149.75 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.76 159.67 34.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.867 1.267 . . . . 0.0 108.287 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.1 127.81 18.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.673 1.189 . . . . 0.0 110.904 -163.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -126.03 161.95 26.39 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.796 1.238 . . . . 0.0 108.675 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.46 115.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 35' ' ' THR . 51.1 p -92.17 172.44 6.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 123.813 0.845 . . . . 0.0 108.773 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 51.8 Cg_endo -70.94 20.67 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.936 2.424 . . . . 0.0 112.124 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.416 ' H ' ' C ' ' A' ' 33' ' ' THR . 37.9 p -128.07 -44.93 1.42 Allowed 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 120.842 -1.161 . . . . 0.0 111.421 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.11 172.71 15.41 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.182 0.901 . . . . 0.0 111.122 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 m -71.51 157.43 38.03 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 159.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.81 128.42 34.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.168 1.787 . . . . 0.0 107.195 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.0 mt -117.04 124.09 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.92 104.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.25 133.31 32.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.71 117.03 33.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.047 . . . . 0.0 106.756 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.54 167.49 23.57 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -31.47 65.82 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.909 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -132.35 81.33 1.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.1 p -52.58 -43.73 65.46 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.772 -0.58 . . . . 0.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.45 -30.11 62.47 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.325 1.45 . . . . 0.0 112.734 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -70.14 -52.2 25.46 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.618 0.645 . . . . 0.0 109.478 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.94 -34.19 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.83 1.252 . . . . 0.0 111.073 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -68.86 -35.19 76.62 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.474 -0.766 . . . . 0.0 111.3 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.65 -179.31 26.57 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.835 0.731 . . . . 0.0 111.745 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -54.1 109.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.937 1.695 . . . . 0.0 109.683 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt 46.58 43.34 12.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.783 1.233 . . . . 0.0 111.966 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 11.5 71.67 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.731 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -40.89 -64.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.895 1.678 . . . . 0.0 111.903 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.26 -47.08 68.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.499 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.22 -41.78 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.01 1.277 . . . . 0.0 110.371 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.3 -45.48 80.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.008 0.923 . . . . 0.0 111.463 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.64 -55.14 38.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.173 0.589 . . . . 0.0 109.819 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.77 -33.13 69.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.579 1.551 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.2 m -55.13 -50.49 69.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.686 1.13 . . . . 0.0 109.28 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.65 96.31 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.556 0.617 . . . . 0.0 111.963 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.6 t -58.62 -54.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 t -59.1 -41.31 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.883 2.073 . . . . 0.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -61.47 -22.15 64.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.361 0.982 . . . . 0.0 112.321 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.82 -50.73 5.22 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.503 -0.748 . . . . 0.0 110.859 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.92 62.03 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.231 1.412 . . . . 0.0 110.294 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.73 7.98 28.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.189 1.796 . . . . 0.0 111.041 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.96 23.13 37.48 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 125.352 1.453 . . . . 0.0 114.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -56.6 147.39 51.06 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.349 1.075 . . . . 0.0 111.583 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.2 128.87 30.31 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.627 2.218 . . . . 0.0 110.6 166.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 153.22 28.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 168.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.7 -44.43 0.63 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.837 2.161 . . . . 0.0 114.098 -164.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -91.08 18.24 7.05 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.77 1.628 . . . . 0.0 115.152 -166.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.45 139.89 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.55 150.67 50.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.282 0.492 . . . . 0.0 110.592 163.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.2 126.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -122.42 173.54 7.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.36 1.464 . . . . 0.0 109.807 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.32 109.75 5.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.461 1.105 . . . . 0.0 108.345 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -104.06 142.27 34.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -76.35 149.76 36.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 t -70.61 -10.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.083 0.953 . . . . 0.0 112.477 168.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 54.89 -131.42 1.95 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.282 1.433 . . . . 0.0 110.943 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -129.88 46.05 2.71 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.106 1.321 . . . . 0.0 109.555 -170.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 154.68 6.33 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.47 -0.769 . . . . 0.0 111.373 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.94 77.76 1.13 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.501 1.048 . . . . 0.0 110.999 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m 56.81 174.53 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.539 1.535 . . . . 0.0 113.218 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 133.58 179.47 16.4 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.11 142.59 38.4 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.177 2.584 . . . . 0.0 111.026 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m 59.91 169.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.127 2.571 . . . . 0.0 113.792 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.9 m -141.2 172.61 12.44 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.647 1.579 . . . . 0.0 109.83 -171.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.808 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 166.754 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 m -117.71 -60.05 1.85 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.949 0.874 . . . . 0.0 108.693 164.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t 64.92 -71.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.134 1.774 . . . . 0.0 109.818 -170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.41 164.65 22.38 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.031 2.729 . . . . 0.0 107.5 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -154.3 140.96 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.031 1.332 . . . . 0.0 108.12 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -62.0 153.71 28.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.508 1.147 . . . . 0.0 108.893 167.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.89 161.05 30.39 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 106.031 -2.828 . . . . 0.0 106.031 -173.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 45.9 t80 -51.64 -46.06 63.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -61.97 -36.22 80.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -171.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 -60.24 3.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.949 1.299 . . . . 0.0 109.625 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -55.39 -40.66 71.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.084 0.554 . . . . 0.0 111.363 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.426 HD21 ' CZ ' ' A' ' 8' ' ' PHE . 13.0 tp -69.3 -41.37 76.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.325 0.65 . . . . 0.0 111.031 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.81 -54.45 47.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.226 0.466 . . . . 0.0 109.84 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -57.3 -35.09 69.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.779 0.432 . . . . 0.0 112.145 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -67.22 -58.1 5.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.487 1.115 . . . . 0.0 110.872 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.7 -33.27 73.71 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.43 1.492 . . . . 0.0 111.861 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -47.97 -38.64 17.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.301 1.44 . . . . 0.0 111.321 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -89.09 -40.1 13.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.817 0.735 . . . . 0.0 111.437 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.66 -20.69 63.7 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.5 mt -133.02 24.64 4.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.791 1.636 . . . . 0.0 110.856 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.92 -56.32 20.87 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.88 1.272 . . . . 0.0 111.453 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -61.49 -45.28 94.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.574 1.15 . . . . 0.0 110.47 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.98 -31.28 72.44 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.913 0.885 . . . . 0.0 112.835 -163.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.61 41.05 1.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 119.338 -0.701 . . . . 0.0 113.775 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -49.93 154.85 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.612 0.765 . . . . 0.0 111.33 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.25 -45.43 0.77 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.534 1.534 . . . . 0.0 109.525 172.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.99 -164.89 34.6 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.47 151.64 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 121.457 -1.026 . . . . 0.0 108.646 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -121.99 151.48 40.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.835 0.826 . . . . 0.0 109.27 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.6 p -125.43 148.75 29.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.251 1.42 . . . . 0.0 108.395 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -132.79 153.48 51.2 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.1 t -98.37 135.75 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 155.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.89 166.08 16.82 Favored Pre-proline 0 C--O 1.243 0.717 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.02 0.91 6.5 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.651 2.234 . . . . 0.0 111.899 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -113.42 -47.33 3.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.486 1.039 . . . . 0.0 111.648 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -162.21 172.97 14.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.062 0.847 . . . . 0.0 110.332 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.7 m -68.96 150.28 47.89 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -124.98 143.65 50.78 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -129.72 122.71 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 99.43 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.97 132.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.63 108.5 20.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.349 1.859 . . . . 0.0 106.38 164.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 172.26 13.02 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 p -83.33 -37.49 23.32 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.873 -0.517 . . . . 0.0 111.43 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -117.11 64.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.634 -1.291 . . . . 0.0 108.035 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -43.83 -48.62 8.27 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.54 2.336 . . . . 0.0 113.169 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.15 -34.2 71.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.136 0.88 . . . . 0.0 111.859 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.58 -32.29 36.58 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.205 -0.934 . . . . 0.0 111.212 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.26 -42.35 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.875 0.87 . . . . 0.0 109.453 169.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 mt -61.26 -44.52 97.11 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.89 45.52 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 124.634 1.111 . . . . 0.0 110.684 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -57.3 114.91 2.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.733 1.213 . . . . 0.0 110.513 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 55.24 32.98 19.66 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.166 0.987 . . . . 0.0 110.897 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.34 22.57 77.35 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.873 -0.959 . . . . 0.0 112.837 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -52.87 63.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.89 1.845 . . . . 0.0 111.636 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -43.91 91.36 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 116.759 -1.591 . . . . 0.0 109.533 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.8 -40.97 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.212 1.369 . . . . 0.0 110.991 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.47 -44.53 82.44 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.914 1.234 . . . . 0.0 112.765 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -54.52 45.96 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.123 0.874 . . . . 0.0 108.799 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 57.0 mt -60.12 -27.31 66.93 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.379 1.472 . . . . 0.0 112.491 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.7 m -62.84 -59.53 4.73 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.661 1.119 . . . . 0.0 109.579 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.4 89.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.177 0.991 . . . . 0.0 111.262 -171.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 14.7 p -57.62 -50.43 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.758 -1.115 . . . . 0.0 108.686 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.81 -49.48 83.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 124.644 1.178 . . . . 0.0 109.495 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -49.56 -46.38 48.75 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.538 1.135 . . . . 0.0 110.623 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -73.06 -53.56 10.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -55.52 14.09 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 111.122 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.99 2.11 55.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.767 2.027 . . . . 0.0 112.429 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.43 51.11 44.71 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.47 149.99 86.76 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 117.496 0.648 . . . . 0.0 109.433 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.52 124.66 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.697 1.598 . . . . 0.0 109.155 161.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.55 153.62 27.08 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.76 -14.44 3.52 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.598 0.618 . . . . 0.0 113.446 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.8 m -133.04 28.81 4.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.765 1.283 . . . . 0.0 112.236 -161.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.94 145.71 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.091 1.356 . . . . 0.0 107.803 159.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -128.29 148.34 50.65 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.118 1.367 . . . . 0.0 109.266 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.35 137.7 51.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.89 1.276 . . . . 0.0 109.02 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -134.5 168.13 19.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.858 2.463 . . . . 0.0 109.551 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 109.86 6.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.452 1.901 . . . . 0.0 109.018 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -104.13 156.27 18.02 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.616 1.166 . . . . 0.0 109.122 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.69 145.6 27.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.661 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.07 156.51 7.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.26 -170.75 0.76 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.182 1.393 . . . . 0.0 108.824 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.8 -23.63 0.85 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 165.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -164.97 161.66 20.07 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.983 1.265 . . . . 0.0 108.668 161.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.15 164.66 25.84 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.515 1.531 . . . . 0.0 109.571 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 t -160.24 145.51 14.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.96 80.91 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.84 141.98 24.89 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.788 1.659 . . . . 0.0 110.42 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m 87.29 161.47 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.793 2.837 . . . . 0.0 110.61 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 p -143.87 95.11 2.68 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.208 0 N-CA-C 104.852 -3.299 . . . . 0.0 104.852 -179.514 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.786 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -85.16 156.9 20.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 166.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m -153.89 170.12 21.79 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.494 1.118 . . . . 0.0 109.292 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.27 109.61 0.29 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 t -70.82 -61.16 1.87 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -143.81 85.14 1.81 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 118.543 0.611 . . . . 0.0 111.51 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.84 135.98 7.3 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -52.44 -53.91 39.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.211 0.505 . . . . 0.0 110.56 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -61.2 -34.02 74.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.464 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.98 -59.06 4.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.505 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -55.03 -38.57 68.13 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 118.787 0.721 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.06 -43.81 77.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.456 0.702 . . . . 0.0 110.612 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.15 -43.68 98.3 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 123.97 0.908 . . . . 0.0 109.932 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.17 -25.41 63.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.799 1.24 . . . . 0.0 112.57 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 19' ' ' GLU . 37.0 t80 -72.64 -64.66 0.91 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.393 1.477 . . . . 0.0 108.647 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.92 -43.7 60.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.297 2.239 . . . . 0.0 111.883 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -52.77 -34.04 51.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.071 0.851 . . . . 0.0 111.411 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -91.01 -41.25 11.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.35 -0.834 . . . . 0.0 110.103 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 15' ' ' PHE . 6.6 mm-40 -56.97 -42.92 81.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.749 1.22 . . . . 0.0 112.724 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -115.68 26.63 9.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.514 1.526 . . . . 0.0 109.731 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.38 61.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.125 1.37 . . . . 0.0 111.905 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -79.68 -14.56 58.68 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.262 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.99 -23.04 17.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -159.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 35.85 3.76 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 119.072 0.851 . . . . 0.0 112.687 -168.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.74 162.49 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.185 0.993 . . . . 0.0 109.361 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 m -136.73 -60.84 0.69 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.67 -167.85 29.9 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.91 155.16 17.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -125.67 164.12 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.011 0.91 . . . . 0.0 109.141 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.26 139.58 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.102 1.761 . . . . 0.0 107.357 -170.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -132.82 138.62 47.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 106.96 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.2 t -136.16 116.53 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 36.5 p -120.9 176.69 1.75 Allowed Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.56 0.744 . . . . 0.0 110.361 -164.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 61.3 Cg_endo -73.12 3.75 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 121.727 1.618 . . . . 0.0 112.452 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.9 p -113.44 -52.1 2.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.268 1.395 . . . . 0.0 111.145 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -160.61 174.71 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.364 1.465 . . . . 0.0 111.198 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -82.04 151.59 27.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.505 -0.747 . . . . 0.0 109.062 163.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.14 142.79 34.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.594 1.958 . . . . 0.0 108.018 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.2 mt -141.13 126.03 18.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.4 105.07 15.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -173.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -70.43 130.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.87 115.76 28.73 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.6 169.87 16.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.047 0.84 . . . . 0.0 111.015 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.8 p -70.5 -31.81 69.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.257 -0.902 . . . . 0.0 111.7 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -134.32 85.39 2.19 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 p -53.36 -38.56 63.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.106 0.962 . . . . 0.0 111.454 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -57.97 -44.31 87.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.616 1.167 . . . . 0.0 111.984 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -68.83 -40.62 79.36 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.046 0.538 . . . . 0.0 109.578 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -46.59 93.77 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 C-N-CA 122.978 0.511 . . . . 0.0 109.683 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.53 -36.22 70.94 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.994 -1.066 . . . . 0.0 111.086 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 179.88 50.98 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 109.52 0.5 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.032 1.333 . . . . 0.0 109.277 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 mttm 40.22 46.16 1.87 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.439 1.496 . . . . 0.0 112.765 -173.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.99 9.3 82.72 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.17 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -46.08 78.43 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.57 2.185 . . . . 0.0 113.008 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -45.21 90.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.626 1.103 . . . . 0.0 110.678 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tt -67.55 -34.99 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.456 1.026 . . . . 0.0 111.111 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -57.36 -50.96 71.29 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.575 -0.703 . . . . 0.0 109.889 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -61.07 2.53 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.346 1.058 . . . . 0.0 109.705 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.0 mt -57.74 -34.97 70.08 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.525 -174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 m -57.64 -48.08 80.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.437 1.017 . . . . 0.0 109.484 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.77 -42.76 73.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.059 0.944 . . . . 0.0 112.005 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.3 p -66.75 -45.75 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.647 1.112 . . . . 0.0 109.736 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -55.67 -45.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.084 1.311 . . . . 0.0 109.511 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.71 -46.42 67.35 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.123 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -71.9 -50.66 27.3 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.075 0.852 . . . . 0.0 111.666 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -39.79 86.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.415 1.086 . . . . 0.0 110.787 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.72 3.77 24.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 111.737 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.91 26.75 71.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.072 0.844 . . . . 0.0 112.823 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -67.77 145.51 98.05 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 118.35 1.075 . . . . 0.0 109.595 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.22 165.66 16.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.795 2.33 . . . . 0.0 110.737 160.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -88.38 147.98 24.47 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.98 -45.99 2.59 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.403 1.478 . . . . 0.0 112.454 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 m -72.04 8.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.257 1.823 . . . . 0.0 112.501 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.87 126.0 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 162.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 146.61 38.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -120.55 140.71 51.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -132.93 165.32 24.94 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.47 1.908 . . . . 0.0 108.569 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.59 109.08 5.59 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -111.38 155.01 23.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.554 1.541 . . . . 0.0 110.371 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.97 141.01 29.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.517 0.675 . . . . 0.0 112.348 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.43 154.45 8.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 52.3 38.69 25.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.09 1.756 . . . . 0.0 112.099 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.8 m -64.76 136.47 56.96 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.652 1.181 . . . . 0.0 108.941 169.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -159.05 29.98 0.21 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.679 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.13 -123.81 7.97 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 125.78 1.657 . . . . 0.0 109.565 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 39.76 30.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.411 1.084 . . . . 0.0 113.734 169.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -108.63 85.19 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.321 -1.266 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.13 97.66 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.321 2.681 . . . . 0.0 108.579 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -132.64 119.98 21.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -143.2 98.63 3.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.601 1.56 . . . . 0.0 106.859 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 105.323 -3.111 . . . . 0.0 105.323 -154.498 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.474 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.35 77.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.995 1.718 . . . . 0.0 110.407 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -74.72 174.31 9.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.839 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.35 -110.26 0.65 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.804 1.669 . . . . 0.0 112.685 170.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.7 m -124.9 140.12 53.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.393 1.477 . . . . 0.0 108.39 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 t -152.73 147.38 26.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.84 164.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.29 147.79 18.69 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 125.411 1.481 . . . . 0.0 111.405 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -53.58 -49.32 67.98 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.12 1.368 . . . . 0.0 109.8 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -62.11 -29.65 70.47 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.426 -1.273 . . . . 0.0 110.625 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.02 4.46 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.5 1.5 . . . . 0.0 110.387 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.53 -45.16 73.33 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.915 0.486 . . . . 0.0 110.555 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.83 -43.3 84.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.671 0.388 . . . . 0.0 110.455 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -57.26 -51.52 69.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 109.447 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.18 -52.94 62.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.404 0.682 . . . . 0.0 111.028 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -53.27 -48.52 68.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.412 1.085 . . . . 0.0 111.145 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.41 -38.68 81.48 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.58 1.552 . . . . 0.0 111.615 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -51.71 -47.29 64.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -66.97 -47.17 72.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 111.821 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.66 -12.83 60.86 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.999 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.17 15.45 8.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 113.499 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.53 27.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.324 1.05 . . . . 0.0 112.064 -172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -87.81 -26.86 22.62 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.53 -34.74 76.04 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.738 0.699 . . . . 0.0 110.31 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 65.25 0.53 Allowed Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -67.84 174.2 3.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.915 1.34 . . . . 0.0 110.266 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -164.4 -23.99 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.06 1.344 . . . . 0.0 112.046 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.15 -161.78 29.82 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -161.3 155.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -125.94 160.22 30.56 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 108.631 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.91 135.4 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 126.053 1.741 . . . . 0.0 108.287 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -132.62 122.74 25.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.13 92.76 2.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 43.7 p -84.07 176.83 3.39 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.702 1.601 . . . . 0.0 109.433 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 85.6 Cg_endo -76.38 6.08 4.23 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.052 1.835 . . . . 0.0 113.21 165.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -116.6 -57.97 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.68 1.582 . . . . 0.0 112.169 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -161.67 149.58 15.0 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.056 1.342 . . . . 0.0 108.055 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -70.93 138.64 50.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -110.42 137.37 48.22 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.97 122.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.87 103.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.01 145.51 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -115.22 112.04 21.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.47 165.75 26.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.399 0.679 . . . . 0.0 111.522 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.9 p -85.59 -21.55 28.44 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.866 -1.146 . . . . 0.0 113.503 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -131.64 59.17 1.7 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.853 0.751 . . . . 0.0 109.28 -166.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -56.8 -37.37 71.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -63.8 -37.08 86.03 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 120.101 1.319 . . . . 0.0 110.072 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.6 -49.28 78.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.861 1.264 . . . . 0.0 109.014 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.29 -44.83 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.751 2.02 . . . . 0.0 110.904 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.04 -39.12 93.8 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.365 -0.834 . . . . 0.0 110.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 -179.27 48.85 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 122.278 0.932 . . . . 0.0 112.008 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.23 109.1 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.357 2.263 . . . . 0.0 110.937 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt 43.43 50.65 6.16 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.67 1.588 . . . . 0.0 110.673 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 37.67 69.2 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.866 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -67.38 0.42 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.042 1.421 . . . . 0.0 112.351 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -36.74 84.75 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.361 -172.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.78 -44.88 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 119.129 0.877 . . . . 0.0 111.964 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -63.11 -49.5 74.19 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.996 -1.065 . . . . 0.0 110.949 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -51.58 66.31 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.164 0.585 . . . . 0.0 110.046 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 88.8 mt -67.95 -30.16 69.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.613 -1.185 . . . . 0.0 112.096 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.0 m -56.99 -37.28 71.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.736 1.153 . . . . 0.0 110.32 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.51 17.4 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.845 1.202 . . . . 0.0 111.337 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 60' ' ' LEU 0.261 2.0 p -61.46 -42.47 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.124 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.36 -47.72 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 121.249 1.84 . . . . 0.0 109.814 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -53.43 -37.34 62.47 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.26 0.482 . . . . 0.0 111.845 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 -38.93 18.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.209 0.913 . . . . 0.0 111.138 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.53 -36.78 83.66 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.838 1.255 . . . . 0.0 110.505 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 94.1 m-85 -114.66 -21.33 10.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 112.74 -168.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.03 50.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.052 1.311 . . . . 0.0 114.442 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -53.29 145.65 25.35 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.169 1.484 . . . . 0.0 113.355 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -68.84 156.69 64.59 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.786 2.99 . . . . 0.0 111.578 163.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -71.95 139.98 48.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.72 -21.17 1.27 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.897 -1.502 . . . . 0.0 115.026 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m -80.9 -8.69 59.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 120.048 1.924 . . . . 0.0 112.703 168.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.63 126.81 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 139.54 48.59 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 163.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.32 134.45 54.88 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -132.72 171.76 13.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.747 2.019 . . . . 0.0 109.262 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.91 148.96 52.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 167.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.87 52.09 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.659 1.584 . . . . 0.0 107.517 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -82.96 151.23 25.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.21 162.39 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.74 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 166.47 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 130.646 3.578 . . . . 0.0 107.372 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p -53.51 -46.97 70.27 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.12 2.168 . . . . 0.0 112.996 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ttm105 -144.92 -82.21 0.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 156.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.79 -176.7 16.19 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.983 1.278 . . . . 0.0 110.182 -170.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m 68.58 128.03 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.423 3.089 . . . . 0.0 115.277 167.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.15 131.6 50.11 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.79 -43.57 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 CA-C-N 119.921 1.861 . . . . 0.0 112.878 -165.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 m -60.99 107.06 0.66 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -149.88 -9.9 0.29 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.502 0.721 . . . . 0.0 112.692 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.983 1.754 . . . . 0.0 109.087 174.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.983 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 t 56.7 44.18 24.08 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.996 1.719 . . . . 0.0 112.554 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 p -100.91 145.61 28.4 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.364 -0.835 . . . . 0.0 110.441 169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.23 -134.18 6.71 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 106.101 -2.8 . . . . 0.0 106.101 160.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -49.64 114.94 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.036 1.335 . . . . 0.0 110.087 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 m -67.47 179.62 1.27 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.921 -0.487 . . . . 0.0 109.912 168.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.13 -108.11 0.76 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -40.14 -42.13 1.4 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.875 2.47 . . . . 0.0 113.443 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -57.35 -43.19 83.27 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.34 -55.39 24.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 117.477 -1.249 . . . . 0.0 108.517 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -47.77 -41.36 23.11 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.496 1.118 . . . . 0.0 111.062 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.27 -45.95 21.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.298 1.439 . . . . 0.0 111.687 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -58.29 -53.84 53.77 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.283 1.033 . . . . 0.0 110.009 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.16 -43.98 96.78 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.855 0.862 . . . . 0.0 111.039 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -48.02 -61.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.59 1.556 . . . . 0.0 110.254 168.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.77 -35.68 78.83 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.566 0.746 . . . . 0.0 112.105 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.5 m -60.75 -29.1 69.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.403 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -90.58 -30.23 17.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.674 1.19 . . . . 0.0 112.59 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.32 -22.33 52.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.49 23.88 3.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.281 1.032 . . . . 0.0 111.755 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.42 34.38 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.953 1.301 . . . . 0.0 112.187 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -71.56 -31.77 67.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.491 0.716 . . . . 0.0 110.503 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.93 -44.2 94.49 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.176 0.99 . . . . 0.0 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.47 28.37 0.52 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.801 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.34 148.53 41.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.367 1.584 . . . . 0.0 112.226 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 -30.5 1.32 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.519 1.128 . . . . 0.0 113.054 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.89 -170.46 43.42 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 120.11 1.323 . . . . 0.0 110.806 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.06 152.25 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -126.68 108.89 11.49 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.831 1.253 . . . . 0.0 107.911 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.5 146.53 6.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.467 1.507 . . . . 0.0 108.44 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -131.9 150.28 52.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.87 1.268 . . . . 0.0 107.755 167.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.41 121.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -120.81 176.75 1.71 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.517 1.527 . . . . 0.0 109.423 -165.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.47 4.02 6.99 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.183 1.922 . . . . 0.0 113.833 165.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -121.48 -58.53 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.095 1.316 . . . . 0.0 111.907 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -161.57 138.19 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.664 1.586 . . . . 0.0 110.315 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 m -58.5 143.92 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.74 146.42 39.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 172.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.74 117.4 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.28 113.45 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.76 117.81 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.761 1.224 . . . . 0.0 108.86 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 mt -89.72 110.49 21.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.256 1.822 . . . . 0.0 108.49 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 168.17 20.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.345 0.658 . . . . 0.0 110.865 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -66.73 -35.97 81.35 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.927 -1.108 . . . . 0.0 111.299 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -120.61 79.23 1.46 Allowed 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.555 0.742 . . . . 0.0 109.555 -165.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.59 -48.52 14.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.628 1.571 . . . . 0.0 111.365 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -65.46 -27.41 68.49 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.258 -0.901 . . . . 0.0 112.258 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -70.59 -44.05 68.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.893 1.224 . . . . 0.0 108.938 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.29 -35.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.491 1.116 . . . . 0.0 110.592 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.3 -44.53 71.58 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.662 -1.273 . . . . 0.0 108.871 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.45 45.01 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.5 1.048 . . . . 0.0 111.919 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.72 123.76 14.29 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.247 1.019 . . . . 0.0 108.46 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt 46.79 39.67 7.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.865 0.866 . . . . 0.0 111.959 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.77 30.16 72.65 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.98 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -67.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.398 2.099 . . . . 0.0 112.815 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -37.41 87.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.68 -169.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 tt -57.64 -56.93 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.948 0.794 . . . . 0.0 109.757 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -56.31 -43.57 79.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.224 1.409 . . . . 0.0 112.34 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -58.71 7.46 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.37 -25.05 66.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.855 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.6 m -57.79 -55.1 39.29 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.378 1.444 . . . . 0.0 109.724 167.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.63 89.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.455 0.702 . . . . 0.0 111.203 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.1 t -53.78 -59.12 2.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 t -61.26 -39.78 83.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.059 0.944 . . . . 0.0 111.016 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.44 -37.7 70.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.733 0.697 . . . . 0.0 111.067 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.69 -55.27 4.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.734 0.697 . . . . 0.0 109.995 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -39.41 60.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.368 1.867 . . . . 0.0 111.898 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.49 -1.29 13.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.1 1.36 . . . . 0.0 111.546 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.18 78.91 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 120.85 -1.156 . . . . 0.0 114.702 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.31 147.67 75.1 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.819 1.31 . . . . 0.0 112.648 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.53 141.29 79.73 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.747 2.965 . . . . 0.0 111.979 168.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -66.41 141.42 57.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.83 -16.76 6.41 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.214 -0.77 . . . . 0.0 114.294 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -121.48 9.95 10.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 112.916 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.01 155.28 26.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 159.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -139.33 156.44 47.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.753 1.221 . . . . 0.0 108.433 164.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -131.71 134.83 46.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -132.47 160.98 34.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.433 1.893 . . . . 0.0 108.386 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 142.11 46.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.616 0.767 . . . . 0.0 108.961 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -141.7 153.81 44.91 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 108.769 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.66 146.86 27.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.87 151.05 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 122.38 1.086 . . . . 0.0 108.188 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.58 166.96 31.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.028 2.131 . . . . 0.0 107.086 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 m -70.78 119.39 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -125.49 -103.68 0.36 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.928 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.57 -176.7 24.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.785 1.175 . . . . 0.0 110.511 -171.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -57.54 -55.3 36.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.702 0.801 . . . . 0.0 112.149 -162.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 45.9 70.82 0.58 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.094 -1.948 . . . . 0.0 111.558 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.49 75.03 0.28 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 125.248 3.965 . . . . 0.0 113.09 -172.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 134.03 54.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.642 1.577 . . . . 0.0 108.334 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.9 m -156.37 167.25 31.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.672 1.189 . . . . 0.0 110.259 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.68 0 N-CA-C 105.877 -2.889 . . . . 0.0 105.877 -164.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.9 m -72.8 74.27 1.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.989 1.894 . . . . 0.0 107.759 161.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -164.47 162.6 22.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 130.289 3.436 . . . . 0.0 105.204 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.29 77.69 1.35 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.6 m 61.09 96.47 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.582 1.553 . . . . 0.0 112.478 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -56.68 160.77 3.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.967 . . . . 0.0 108.646 154.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.63 -139.39 14.48 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.385 -2.286 . . . . 0.0 107.385 -157.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -36.79 -54.25 0.91 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.839 1.656 . . . . 0.0 113.983 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -53.22 -41.95 65.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.312 1.045 . . . . 0.0 112.009 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.78 25.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.78 1.232 . . . . 0.0 109.588 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.7 -40.33 62.86 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.446 0.566 . . . . 0.0 111.448 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 tp -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.972 1.309 . . . . 0.0 110.826 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -63.0 -43.71 98.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.185 0.594 . . . . 0.0 110.335 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.28 -30.7 71.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.452 1.101 . . . . 0.0 112.853 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -67.51 -63.97 0.95 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.5 mt -56.45 -33.14 65.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.605 1.162 . . . . 0.0 111.96 -168.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -46.2 -46.53 17.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.162 0.985 . . . . 0.0 111.783 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.48 -56.69 4.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.69 -26.51 45.33 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 113.521 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.62 18.9 9.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.774 1.229 . . . . 0.0 111.359 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.94 -64.31 0.87 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.908 0.883 . . . . 0.0 111.023 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.85 -22.12 62.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.474 -0.766 . . . . 0.0 111.309 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.7 -24.29 67.53 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.545 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.06 25.29 3.05 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.459 1.027 . . . . 0.0 114.763 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -63.65 165.2 8.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 112.42 -168.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.97 -52.93 0.22 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.729 1.212 . . . . 0.0 110.46 171.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.09 -172.02 38.3 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 118.927 0.785 . . . . 0.0 111.429 -171.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.46 134.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.53 161.91 13.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 164.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.14 144.91 23.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -120.1 160.47 22.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.39 115.71 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 p -121.01 176.85 1.68 Allowed Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -169.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.84 12.17 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.281 1.988 . . . . 0.0 111.448 166.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.9 p -127.7 -50.04 1.37 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 0.0 112.579 -170.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -162.6 173.6 13.72 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.142 1.777 . . . . 0.0 110.156 -169.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.1 m -98.23 149.17 22.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -125.32 142.57 51.42 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.764 2.026 . . . . 0.0 105.757 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -129.0 125.93 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -123.73 97.56 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -76.87 125.95 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.4 108.09 20.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.064 2.146 . . . . 0.0 107.131 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.95 168.09 20.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.852 1.31 . . . . 0.0 110.354 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 p -79.12 -26.84 42.85 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.955 -1.091 . . . . 0.0 111.769 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -129.01 79.93 1.94 Allowed 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.76 1.624 . . . . 0.0 107.904 -167.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 p -48.98 -39.2 25.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.334 1.053 . . . . 0.0 111.334 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.89 -39.95 95.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.215 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -59.87 -48.82 80.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.742 1.155 . . . . 0.0 109.183 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.06 -43.65 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.908 1.283 . . . . 0.0 110.786 -174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.84 -36.67 84.12 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.643 -0.66 . . . . 0.0 109.878 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.57 175.68 41.18 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.058 1.313 . . . . 0.0 110.554 -167.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 55' ' ' ARG . 4.2 tt0 -55.5 128.18 33.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 167.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp 50.33 38.86 18.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.649 0.779 . . . . 0.0 112.839 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.84 10.01 67.01 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.795 0.712 . . . . 0.0 113.907 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 52' ' ' GLU . 17.0 mtm180 -52.31 -53.34 45.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 113.244 -175.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.88 74.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 116.176 -1.868 . . . . 0.0 109.954 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -60.73 -38.05 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 121.562 1.983 . . . . 0.0 111.224 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -52.73 64.31 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.304 -0.873 . . . . 0.0 110.854 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -28.12 63.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.434 1.094 . . . . 0.0 112.108 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.6 mt -80.03 -24.82 40.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.139 1.376 . . . . 0.0 110.467 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -66.28 -55.38 16.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.19 70.35 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.457 1.103 . . . . 0.0 111.965 -174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 p -58.65 -47.91 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.702 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.36 -39.83 82.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-N 119.649 1.113 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -53.84 -44.94 70.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.799 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.83 -58.45 3.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.819 0.736 . . . . 0.0 109.659 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -45.77 54.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.549 1.54 . . . . 0.0 111.848 -168.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.12 -1.8 25.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.46 47.62 89.67 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 125.244 1.402 . . . . 0.0 112.177 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -80.05 145.62 61.46 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.202 1.001 . . . . 0.0 111.32 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.49 137.52 51.06 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.484 2.123 . . . . 0.0 109.713 166.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.36 143.04 58.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.353 1.061 . . . . 0.0 109.512 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 -6.49 6.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.397 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -117.05 8.37 13.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.128 1.771 . . . . 0.0 112.17 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -113.71 140.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 154.19 51.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 168.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -121.65 136.45 54.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -125.17 163.21 22.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.885 1.674 . . . . 0.0 107.461 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.68 109.12 9.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.163 0.585 . . . . 0.0 109.796 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -119.88 145.8 46.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.439 0.638 . . . . 0.0 110.385 -168.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.75 140.16 36.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 -167.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.0 160.08 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -140.05 98.48 3.46 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.487 -1.383 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 m -66.23 -65.36 0.69 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.067 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -114.57 154.51 28.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.555 1.525 . . . . 0.0 109.775 -175.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' H ' ' HD3' ' A' ' 85' ' ' ARG . . . -169.16 -133.54 1.6 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.029 2.252 . . . . 0.0 108.753 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.0 m 60.11 89.97 0.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.094 2.158 . . . . 0.0 111.24 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.28 172.3 44.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 123.48 0.562 . . . . 0.0 112.827 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.78 67.85 8.48 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.868 3.712 . . . . 0.0 112.346 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 t -61.86 115.41 4.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 162.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.8 m -146.84 118.0 7.79 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.607 1.563 . . . . 0.0 109.578 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 117.514 -1.715 . . . . 0.0 111.451 171.533 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m 40.69 61.58 1.62 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.602 1.561 . . . . 0.0 111.51 -176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -57.33 148.5 22.74 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.2 -121.72 3.49 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -60.19 118.23 6.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.916 1.287 . . . . 0.0 109.181 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -90.22 113.63 25.47 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.368 1.867 . . . . 0.0 108.13 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.84 143.39 14.59 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -32.31 -46.88 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.334 3.453 . . . . 0.0 114.841 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -54.3 -29.43 47.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.19 1.396 . . . . 0.0 113.499 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -58.12 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.395 2.278 . . . . 0.0 111.007 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -56.05 -40.63 73.81 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.633 1.106 . . . . 0.0 111.2 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.11 -36.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 110.593 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.19 -51.5 67.55 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.585 0.754 . . . . 0.0 109.587 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.34 -27.46 67.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.148 0.979 . . . . 0.0 111.864 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.05 -63.37 1.09 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.429 1.092 . . . . 0.0 109.104 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.05 -31.55 71.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.49 1.116 . . . . 0.0 112.234 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.4 m -55.91 -35.68 66.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.102 1.361 . . . . 0.0 111.157 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -90.54 -44.64 9.43 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.932 -0.48 . . . . 0.0 110.112 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.86 -42.25 93.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.953 0.342 . . . . 0.0 111.902 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.56 20.64 16.42 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.032 1.733 . . . . 0.0 110.554 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.52 -58.87 4.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.398 1.479 . . . . 0.0 110.141 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 -19.74 55.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.632 0.773 . . . . 0.0 111.995 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -71.09 -32.58 69.24 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.282 0.633 . . . . 0.0 110.386 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.07 47.02 1.11 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.399 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HH ' ' HB ' ' A' ' 28' ' ' VAL . 67.2 t80 -57.72 171.24 0.49 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.698 1.599 . . . . 0.0 112.967 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.77 -42.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.812 1.645 . . . . 0.0 111.479 170.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.2 -170.29 43.33 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.419 ' HB ' ' HH ' ' A' ' 25' ' ' TYR . 7.4 p -152.79 153.99 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -119.94 158.0 27.62 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.437 1.495 . . . . 0.0 109.055 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.41 129.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.34 1.056 . . . . 0.0 110.265 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -125.81 122.93 37.59 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.247 1.019 . . . . 0.0 108.93 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.26 130.09 38.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 163.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -121.76 170.66 7.28 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.612 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.08 19.37 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.906 2.404 . . . . 0.0 112.809 165.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 p -127.25 -58.1 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -154.44 173.44 16.25 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.285 1.834 . . . . 0.0 109.494 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.2 m -86.54 148.54 25.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 162.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.94 131.69 33.38 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.678 1.591 . . . . 0.0 106.881 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.81 123.65 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.62 1.568 . . . . 0.0 107.799 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.7 112.51 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -73.09 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -99.94 118.09 35.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.079 165.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.62 167.05 25.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.301 0.5 . . . . 0.0 111.258 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -67.13 -45.56 76.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.874 0.47 . . . . 0.0 110.798 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -122.93 82.43 1.99 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.045 1.738 . . . . 0.0 108.144 -167.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 p -46.58 -42.92 16.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.457 1.103 . . . . 0.0 110.552 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -45.15 74.25 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.644 1.111 . . . . 0.0 112.339 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -68.59 -42.26 78.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.71 -31.44 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.062 1.745 . . . . 0.0 110.837 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -76.77 -42.32 41.37 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.29 1.036 . . . . 0.0 110.185 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.19 176.12 27.02 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.165 0.888 . . . . 0.0 111.294 -171.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.88 116.91 4.09 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.366 0.666 . . . . 0.0 110.484 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.1 mttt 42.31 44.63 3.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.238 1.415 . . . . 0.0 111.648 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.5 73.77 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.506 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.29 -56.67 11.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.558 1.679 . . . . 0.0 112.658 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.27 -48.41 81.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.273 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -60.44 -44.47 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.077 0.853 . . . . 0.0 109.879 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -38.19 82.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.362 0.983 . . . . 0.0 112.891 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -62.18 1.85 Allowed 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.01 -24.88 68.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.009 -1.472 . . . . 0.0 111.767 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.0 m -55.55 -51.87 65.63 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 120.683 1.583 . . . . 0.0 108.946 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.24 82.69 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.833 0.742 . . . . 0.0 110.669 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.44 -50.01 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 118.691 0.678 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.86 -51.23 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.372 1.469 . . . . 0.0 109.871 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -54.76 -28.35 47.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -93.48 -44.93 8.0 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.364 0.983 . . . . 0.0 110.213 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -39.52 69.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.01 1.324 . . . . 0.0 111.188 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.07 5.99 15.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.69 1.196 . . . . 0.0 111.417 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.78 41.62 66.86 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.896 2.189 . . . . 0.0 114.576 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -81.9 145.51 53.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.576 1.188 . . . . 0.0 111.488 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.49 153.8 73.06 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.109 1.873 . . . . 0.0 110.888 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.21 122.56 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.759 1.224 . . . . 0.0 109.359 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 -14.76 4.95 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.318 0.961 . . . . 0.0 114.467 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -74.74 -6.88 51.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.192 0.997 . . . . 0.0 111.522 161.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.18 149.46 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 162.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -137.29 149.68 47.25 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 165.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.96 122.64 46.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -118.3 165.62 13.62 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 127.71 2.404 . . . . 0.0 108.997 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.68 113.52 7.88 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.191 1.396 . . . . 0.0 109.202 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.04 154.93 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.86 1.664 . . . . 0.0 109.18 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -90.9 156.12 18.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -85.43 150.21 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 122.227 1.013 . . . . 0.0 109.665 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.92 35.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.479 1.912 . . . . 0.0 108.583 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.6 t -81.47 164.87 21.71 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 108.642 168.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.4 mtt-85 -102.79 143.62 32.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 156.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.04 106.39 0.19 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 105.984 -2.847 . . . . 0.0 105.984 170.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 m -64.45 160.13 19.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.857 0.863 . . . . 0.0 110.091 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.05 111.07 0.5 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.37 -34.09 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 120.48 2.14 . . . . 0.0 111.034 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.0 m 51.05 83.13 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.916 1.686 . . . . 0.0 112.033 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.85 -172.95 0.12 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.214 2.206 . . . . 0.0 109.518 -164.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.481 0 C-N-CA 127.749 2.595 . . . . 0.0 106.826 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -134.57 160.88 36.69 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.746 1.219 . . . . 0.0 108.706 168.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -152.49 156.14 38.84 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 107.766 155.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.71 -170.61 31.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -156.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 m -71.67 -86.1 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.358 1.079 . . . . 0.0 108.248 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.2 m -80.05 175.75 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 156.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.22 113.49 3.86 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -53.15 -53.88 43.93 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.863 0.831 . . . . 0.0 110.249 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 29' ' ' GLU . 79.5 tttt -57.47 -31.9 66.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.778 -0.629 . . . . 0.0 111.247 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -39.8 47.39 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.234 0.925 . . . . 0.0 111.766 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.29 -43.85 96.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.358 0.981 . . . . 0.0 109.365 171.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.58 -39.22 93.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.392 0.677 . . . . 0.0 110.54 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.18 -56.33 22.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.161 1.384 . . . . 0.0 109.772 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.2 -28.43 68.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.35 -64.76 0.79 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.567 1.147 . . . . 0.0 109.006 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.28 -37.28 74.7 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 112.646 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.5 m -51.14 -48.32 61.85 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.817 0.847 . . . . 0.0 110.367 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -75.45 -42.22 53.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.134 -0.46 . . . . 0.0 109.919 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -31.57 72.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.836 0.744 . . . . 0.0 111.881 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.7 mt -119.01 15.84 13.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.314 -165.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.83 -63.1 0.92 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.033 1.333 . . . . 0.0 112.331 -173.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -15.46 59.56 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -71.66 -12.1 61.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.678 1.126 . . . . 0.0 111.06 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.5 47.73 4.21 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.699 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -56.96 166.32 1.04 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.933 1.349 . . . . 0.0 110.519 168.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -156.76 -37.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.792 2.037 . . . . 0.0 109.958 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.23 -169.32 42.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 124.21 0.909 . . . . 0.0 110.853 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.69 154.13 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -116.55 162.57 17.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.659 1.984 . . . . 0.0 110.124 164.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.36 137.47 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.853 1.261 . . . . 0.0 108.342 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -127.61 127.48 43.9 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.5 91.78 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 p -90.36 169.64 11.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.35 4.04 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.832 2.355 . . . . 0.0 112.922 169.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 p -113.34 -54.89 2.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.354 0.979 . . . . 0.0 110.922 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -155.47 157.82 37.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.61 1.564 . . . . 0.0 108.614 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 m -68.22 139.33 56.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 161.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.33 139.97 44.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.94 124.65 65.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.93 93.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -172.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.16 122.25 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 mt -98.39 73.02 2.11 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.633 1.173 . . . . 0.0 109.446 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.7 160.41 15.73 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.423 1.465 . . . . 0.0 111.352 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -72.32 -25.1 61.43 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.676 -1.265 . . . . 0.0 111.527 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -131.81 72.17 1.49 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.541 1.136 . . . . 0.0 108.733 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -56.74 -40.25 75.43 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.45 -0.781 . . . . 0.0 111.808 -174.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -53.33 -39.31 63.99 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.811 1.244 . . . . 0.0 112.634 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.01 -45.34 67.44 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.442 0.697 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.4 -39.73 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.396 0.678 . . . . 0.0 109.302 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.6 -39.09 93.49 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.289 -0.882 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 172.79 28.44 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -165.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -54.87 126.25 23.52 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.706 -0.879 . . . . 0.0 109.67 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.279 58.9 pttt 39.96 42.3 1.05 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.206 1.802 . . . . 0.0 113.507 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.75 20.99 77.62 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.489 -0.757 . . . . 0.0 113.27 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -44.56 -67.26 0.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.407 1.483 . . . . 0.0 111.689 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -32.87 67.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.637 -169.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 tt -61.86 -40.89 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.144 1.338 . . . . 0.0 111.655 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.32 -45.31 88.46 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.027 1.285 . . . . 0.0 110.625 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.25 -48.02 79.91 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.01 0.524 . . . . 0.0 110.518 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 10.5 mt -63.93 -36.13 82.95 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 117.975 -1.012 . . . . 0.0 111.524 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.2 m -59.6 -48.99 79.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 120.425 1.466 . . . . 0.0 109.364 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.15 79.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 8.0 p -60.66 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.515 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -58.36 -41.75 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.697 1.589 . . . . 0.0 109.54 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -32.79 63.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.063 0.545 . . . . 0.0 111.915 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -96.83 -19.51 18.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.788 2.035 . . . . 0.0 112.842 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -20.63 27.12 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.286 -1.509 . . . . 0.0 110.231 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.69 1.34 4.93 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.665 1.186 . . . . 0.0 112.05 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.77 10.03 66.84 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.574 1.079 . . . . 0.0 114.299 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -57.32 151.98 34.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.915 0.857 . . . . 0.0 111.982 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.66 174.24 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.988 3.792 . . . . 0.0 109.561 166.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 153.99 22.07 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.72 -46.25 0.55 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.41 1.957 . . . . 0.0 112.569 -166.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.1 m -77.86 8.64 4.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.549 1.94 . . . . 0.0 113.194 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.82 131.41 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 160.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -122.08 148.84 44.37 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.356 1.062 . . . . 0.0 108.251 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.81 145.14 42.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.42 162.75 31.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.811 2.044 . . . . 0.0 107.317 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.1 145.35 43.11 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -139.96 141.43 36.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 139.68 36.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.2 160.32 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.706 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.97 -64.89 0.19 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 128.869 2.868 . . . . 0.0 113.168 164.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -67.83 162.87 23.1 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 161.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -140.38 175.26 9.74 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.884 -0.51 . . . . 0.0 110.464 -171.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.63 75.1 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 126.031 1.777 . . . . 0.0 109.657 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -61.57 -166.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.917 0.887 . . . . 0.0 109.365 154.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.84 78.71 1.03 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.74 154.51 74.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.84 1.693 . . . . 0.0 109.916 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.04 150.28 20.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 167.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 m -170.34 144.86 2.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.48 2.712 . . . . 0.0 105.613 163.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.713 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 175.592 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.523 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -147.2 -58.8 0.27 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.111 0.956 . . . . 0.0 110.544 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.88 144.31 50.71 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.756 1.162 . . . . 0.0 111.196 173.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.63 148.19 39.81 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 156.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.83 159.46 39.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -75.85 120.82 21.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.191 0.596 . . . . 0.0 111.188 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.03 146.42 4.45 Favored Glycine 0 C--O 1.223 -0.539 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.423 152.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -33.47 -51.19 0.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.293 2.637 . . . . 0.0 115.882 -170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.2 -29.13 68.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.769 0.828 . . . . 0.0 111.879 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.44 -63.66 1.01 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 109.08 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.67 -45.6 19.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.911 1.285 . . . . 0.0 111.581 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.7 tp -74.41 -35.81 63.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.219 0.608 . . . . 0.0 111.771 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -66.96 -45.01 79.07 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 109.69 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.59 -55.63 20.94 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.949 0.9 . . . . 0.0 110.147 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.5 -63.53 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.755 1.622 . . . . 0.0 110.033 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.9 mt -59.78 -30.96 69.24 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.814 0.846 . . . . 0.0 113.197 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -55.58 -36.14 66.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.245 0.618 . . . . 0.0 111.237 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -88.35 -52.37 5.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.8 -20.41 49.84 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.59 25.54 4.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.344 1.458 . . . . 0.0 112.015 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.5 -63.17 1.07 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.091 1.757 . . . . 0.0 111.92 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -73.07 -29.83 63.25 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 122.037 -0.414 . . . . 0.0 110.6 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -64.73 -29.87 70.86 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.4 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.24 34.35 0.89 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-O 118.824 -0.986 . . . . 0.0 114.325 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -57.02 171.43 0.36 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.109 1.764 . . . . 0.0 113.705 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -141.29 -60.77 0.48 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.432 1.493 . . . . 0.0 109.215 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.12 41.89 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.53 145.5 16.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.251 -1.146 . . . . 0.0 108.8 -170.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.06 150.83 26.11 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.439 1.496 . . . . 0.0 107.857 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.38 143.29 41.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.125 1.77 . . . . 0.0 107.011 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -133.65 153.31 51.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.8 t -140.1 118.84 11.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.5 p -119.68 170.53 6.7 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.82 8.65 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.961 1.774 . . . . 0.0 112.589 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 p -121.9 -56.31 1.85 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.769 1.168 . . . . 0.0 110.204 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -140.44 170.62 15.45 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.188 0.904 . . . . 0.0 111.589 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 m -87.21 151.07 23.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.75 134.36 45.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -126.0 120.85 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.19 99.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -69.38 139.7 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt -108.96 112.11 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 171.13 15.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 110.422 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 p -84.26 -28.98 26.83 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.15 -0.969 . . . . 0.0 112.525 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -131.46 73.11 1.52 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -167.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -54.0 -27.81 34.04 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.435 1.094 . . . . 0.0 112.878 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -57.46 -44.39 84.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.828 0.851 . . . . 0.0 111.098 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.92 -38.91 79.84 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.437 1.095 . . . . 0.0 111.538 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.4 -39.09 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.704 0.802 . . . . 0.0 110.062 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -74.98 -43.66 52.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.69 -172.03 33.0 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -59.66 106.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.798 1.639 . . . . 0.0 110.831 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt 42.69 47.73 4.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.513 1.525 . . . . 0.0 111.202 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.3 11.16 81.12 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.749 -2.139 . . . . 0.0 114.026 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -45.51 -60.13 2.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.244 2.522 . . . . 0.0 112.058 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -50.54 73.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.473 1.033 . . . . 0.0 109.327 -174.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -65.22 -34.33 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.974 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -64.67 -61.09 2.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.694 1.198 . . . . 0.0 110.085 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -50.21 -50.9 48.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 125.709 1.604 . . . . 0.0 111.235 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.1 -21.29 64.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.002 -1.475 . . . . 0.0 112.197 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -56.88 -46.18 82.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 121.53 1.968 . . . . 0.0 108.382 167.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.02 76.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.692 0.678 . . . . 0.0 111.528 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.57 -54.39 35.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.22 -47.37 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 124.611 1.164 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.458 HE22 ' HG2' ' A' ' 72' ' ' GLU . 1.6 mt-30 -53.94 -42.11 68.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.535 0.607 . . . . 0.0 110.876 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -80.74 -50.69 9.55 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 109.409 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -46.84 68.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.414 1.086 . . . . 0.0 110.682 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.19 -14.4 22.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.76 0.824 . . . . 0.0 112.267 -172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.89 51.86 13.61 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.18 154.25 49.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.097 0.959 . . . . 0.0 110.117 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 167.21 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.3 2.666 . . . . 0.0 111.485 159.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.458 ' HG2' HE22 ' A' ' 65' ' ' GLN . 50.9 mt-10 -77.77 161.45 27.68 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 163.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.84 -1.52 4.5 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.93 1.252 . . . . 0.0 114.586 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -132.33 14.73 4.58 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.474 1.51 . . . . 0.0 111.823 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.9 125.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 165.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.75 146.58 43.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.47 134.06 55.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -130.5 165.71 22.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.647 2.379 . . . . 0.0 108.645 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.62 6.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.268 1.027 . . . . 0.0 108.654 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 152.82 21.37 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.494 1.518 . . . . 0.0 108.045 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -97.0 143.78 27.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -86.16 145.35 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 123.785 0.834 . . . . 0.0 108.759 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.43 171.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.554 2.342 . . . . 0.0 107.576 167.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.4 p -141.11 124.15 16.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -151.63 136.87 17.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.4 77.43 0.25 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 p -173.91 115.55 0.22 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.72 121.25 6.66 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 108.319 -1.913 . . . . 0.0 108.319 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.01 169.8 21.39 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.367 2.045 . . . . 0.0 110.076 170.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 p -117.92 -167.16 1.29 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.978 2.111 . . . . 0.0 107.149 163.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -144.21 158.81 43.52 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 159.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 -163.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -63.2 140.96 58.93 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.905 1.353 . . . . 0.0 108.364 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 p -153.1 70.65 0.88 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.655 0.741 . . . . 0.0 109.58 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.98 -157.72 7.93 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.973 1.273 . . . . 0.0 110.961 169.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 m 123.58 -159.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 133.049 4.54 . . . . 0.0 106.861 -168.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -51.28 161.04 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.097 0.951 . . . . 0.0 112.725 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 132.94 7.74 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -173.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -54.24 -47.72 71.9 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.404 -0.468 . . . . 0.0 111.298 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -61.6 -36.94 82.13 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.051 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.03 -53.88 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.456 1.502 . . . . 0.0 111.379 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -57.94 -43.73 86.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.383 0.538 . . . . 0.0 110.598 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.51 -42.42 92.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.904 0.481 . . . . 0.0 110.219 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.95 -50.45 73.36 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 123.871 0.868 . . . . 0.0 109.991 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -59.49 -37.95 79.6 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -59.52 -60.42 3.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.461 1.028 . . . . 0.0 110.228 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 mt -59.05 -35.48 73.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.649 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 m -53.43 -31.2 44.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.921 1.289 . . . . 0.0 112.709 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -90.51 -54.09 4.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.992 0.814 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.87 -39.96 63.04 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.619 0.767 . . . . 0.0 111.518 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -106.94 18.89 21.23 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.737 1.215 . . . . 0.0 112.295 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.08 -50.09 73.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.266 -0.896 . . . . 0.0 112.746 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.49 -15.09 58.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.74 0.7 . . . . 0.0 111.479 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.24 -41.3 70.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 109.532 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.77 45.46 0.47 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 119.111 -0.827 . . . . 0.0 114.861 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.56 167.16 2.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.422 1.111 . . . . 0.0 112.277 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -158.96 -27.06 0.07 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.62 -169.74 40.8 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.59 149.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.74 158.51 21.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.722 1.249 . . . . 0.0 109.045 161.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.43 125.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -167.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -133.07 125.53 29.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.012 1.325 . . . . 0.0 108.291 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -116.47 127.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 47.5 p -121.66 174.98 2.74 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 124.797 1.239 . . . . 0.0 109.276 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 49.2 Cg_endo -69.64 3.72 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.942 1.761 . . . . 0.0 113.513 167.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.8 p -113.3 -59.75 1.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.923 1.238 . . . . 0.0 110.511 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -158.75 157.2 31.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.663 1.574 . . . . 0.0 112.933 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.0 m -62.97 147.57 50.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.235 1.014 . . . . 0.0 108.668 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.79 134.93 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.242 2.217 . . . . 0.0 107.381 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -124.94 123.12 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.37 94.01 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.49 139.74 20.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt -107.2 115.3 29.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 127.989 2.516 . . . . 0.0 105.922 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.73 175.83 10.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.758 0.708 . . . . 0.0 112.847 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.32 -21.65 21.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.333 -1.479 . . . . 0.0 114.22 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -137.09 70.9 1.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.476 1.11 . . . . 0.0 108.828 -162.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -57.54 -33.63 68.3 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.527 -0.733 . . . . 0.0 112.109 -173.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -60.16 -36.94 78.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.654 1.116 . . . . 0.0 112.416 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -71.83 -43.68 65.15 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.175 0.99 . . . . 0.0 109.273 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.5 t -57.79 -50.62 77.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 125.898 1.679 . . . . 0.0 108.835 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.63 -31.45 72.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.679 0.792 . . . . 0.0 111.342 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.64 178.84 44.05 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -169.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.86 125.51 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 51.87 21.96 1.61 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.9 63.07 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.672 1.124 . . . . 0.0 113.985 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -55.14 -54.76 39.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 112.56 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -39.08 85.26 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.625 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 tt -63.03 -38.36 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 120.331 1.423 . . . . 0.0 110.97 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -41.21 97.39 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.614 -1.304 . . . . 0.0 111.85 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.89 -58.53 7.59 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 61.7 mt -55.44 -40.88 72.11 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.878 1.671 . . . . 0.0 111.961 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.3 m -55.21 -50.87 68.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.261 1.392 . . . . 0.0 111.266 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.38 84.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.049 0.84 . . . . 0.0 112.174 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 3.7 p -61.75 -49.73 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.801 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.77 -47.35 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 119.696 1.135 . . . . 0.0 110.337 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -54.17 -47.02 72.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.75 . . . . 0.0 110.607 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -73.78 -41.77 61.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.073 0.851 . . . . 0.0 110.085 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -51.61 63.7 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 109.845 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.59 1.89 46.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.264 1.426 . . . . 0.0 111.28 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 18.73 75.48 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.885 1.231 . . . . 0.0 114.072 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -63.18 149.47 90.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 118.545 1.173 . . . . 0.0 112.028 -174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.44 132.73 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.862 2.374 . . . . 0.0 110.102 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 74' ' ' SER . 4.2 tm-20 -57.51 141.83 46.37 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.223 1.009 . . . . 0.0 110.939 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 -12.78 1.06 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.195 1.379 . . . . 0.0 113.454 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 72' ' ' GLU . 45.9 m -115.27 14.59 16.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.909 1.684 . . . . 0.0 111.333 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.84 144.34 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.741 1.617 . . . . 0.0 107.134 154.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.97 151.62 49.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.37 1.468 . . . . 0.0 108.911 172.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -124.7 128.62 49.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -112.29 168.74 9.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.057 2.143 . . . . 0.0 107.339 175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 108.72 6.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -104.85 166.32 10.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.558 1.143 . . . . 0.0 109.166 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -112.98 143.21 44.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.944 -0.473 . . . . 0.0 110.823 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.09 162.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.201 1.0 . . . . 0.0 111.345 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.79 -3.94 0.84 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.782 2.033 . . . . 0.0 115.277 163.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.7 m 16.67 75.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 131.459 3.903 . . . . 0.0 113.61 167.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 157.44 40.81 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.652 -0.655 . . . . 0.0 109.816 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.6 164.04 14.03 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -172.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.74 114.57 10.62 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.36 164.26 54.62 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.87 -0.406 . . . . 0.0 112.462 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.16 123.67 14.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 124.055 3.17 . . . . 0.0 111.755 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.2 t -137.5 47.34 2.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.695 1.198 . . . . 0.0 108.521 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 t 79.81 129.96 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.254 2.222 . . . . 0.0 106.73 -159.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 105.124 -3.19 . . . . 0.0 105.124 -158.562 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t 90.82 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 128.386 2.674 . . . . 0.0 107.801 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -69.96 108.53 4.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.56 9.03 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.11 1.338 . . . . 0.0 113.043 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.1 m -142.46 157.66 44.52 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.154 1.382 . . . . 0.0 109.023 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.0 m -170.2 171.01 7.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.609 2.364 . . . . 0.0 107.831 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.78 -142.58 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 166.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -38.11 -48.95 1.28 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.342 1.457 . . . . 0.0 112.935 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -59.66 -33.75 71.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.287 -1.339 . . . . 0.0 111.345 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.21 13.44 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.471 -1.252 . . . . 0.0 110.038 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.14 -46.77 65.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.483 1.038 . . . . 0.0 109.888 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.52 -40.86 96.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.008 0.923 . . . . 0.0 111.087 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -62.36 -51.75 66.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.798 1.239 . . . . 0.0 109.695 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.32 -27.18 65.15 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 111.29 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.05 -63.26 1.1 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.848 1.659 . . . . 0.0 108.973 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.31 -35.77 72.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.244 1.018 . . . . 0.0 112.093 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.7 m -50.53 -43.35 55.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.338 0.655 . . . . 0.0 111.148 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -42.75 18.03 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.143 0.429 . . . . 0.0 110.215 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -21.74 61.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.975 -172.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.07 30.81 6.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.14 2.176 . . . . 0.0 110.43 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.91 82.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.57 -8.2 58.42 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.983 0.81 . . . . 0.0 111.4 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -16.98 58.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.005 0.922 . . . . 0.0 113.14 -169.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.37 47.8 7.21 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 118.722 -1.704 . . . . 0.0 109.576 -163.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -64.0 142.26 58.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.2 -28.68 3.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.117 0.967 . . . . 0.0 112.209 -174.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.02 -168.83 35.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -153.4 145.82 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -118.29 165.38 13.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.816 1.646 . . . . 0.0 108.442 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 141.53 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.649 1.179 . . . . 0.0 107.872 -171.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -125.32 167.41 14.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.239 1.018 . . . . 0.0 110.269 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.72 118.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 p -121.69 170.73 7.14 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.719 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.37 15.66 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 165.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.9 p -127.24 -52.19 1.4 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.125 1.33 . . . . 0.0 111.577 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -154.64 160.91 41.72 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.285 1.034 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.0 m -72.01 151.79 42.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.81 133.15 31.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.39 123.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 125.873 1.669 . . . . 0.0 106.775 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.17 95.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.56 133.16 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.557 1.143 . . . . 0.0 108.496 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.18 114.51 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.91 175.46 10.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.013 0.525 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -99.76 -49.3 4.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.11 1.323 . . . . 0.0 111.912 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -90.6 61.48 4.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.667 2.387 . . . . 0.0 108.957 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 p -56.07 -28.56 58.1 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.53 -1.356 . . . . 0.0 113.48 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -57.7 -37.96 74.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.384 1.074 . . . . 0.0 113.62 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.88 -46.65 74.27 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.864 0.866 . . . . 0.0 108.905 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.09 -39.21 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.429 1.092 . . . . 0.0 110.108 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.14 -44.62 83.65 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.699 -0.626 . . . . 0.0 110.7 174.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.77 175.92 47.02 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 124.795 1.188 . . . . 0.0 112.151 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -55.44 116.66 2.99 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.355 1.062 . . . . 0.0 109.814 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 53.78 23.44 3.76 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.661 0.784 . . . . 0.0 112.729 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.67 59.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.403 -0.811 . . . . 0.0 112.549 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -59.29 -57.8 11.43 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.052 1.426 . . . . 0.0 110.246 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.06 -41.36 98.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.287 -169.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.4 tp -57.88 -42.83 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 120.091 1.314 . . . . 0.0 111.256 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -70.17 -42.11 72.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 110.794 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -56.32 23.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.1 mt -62.26 -24.26 67.16 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.885 1.274 . . . . 0.0 112.587 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -61.16 -48.76 80.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.348 1.431 . . . . 0.0 109.659 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.98 -40.18 95.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.293 0.497 . . . . 0.0 110.997 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.0 -53.26 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -63.55 -43.69 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 124.995 1.318 . . . . 0.0 110.241 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -54.48 -37.31 65.11 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.358 0.663 . . . . 0.0 110.568 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -73.9 -58.13 3.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.005 0.82 . . . . 0.0 110.081 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -57.38 -30.05 64.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.996 1.318 . . . . 0.0 112.379 -170.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 98.1 m-85 -121.59 2.24 10.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.416 1.486 . . . . 0.0 111.774 -171.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.98 22.9 65.27 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.037 0.835 . . . . 0.0 114.156 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -63.66 146.24 96.89 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.2 0.6 . . . . 0.0 111.267 -172.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.52 129.38 27.81 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.542 2.161 . . . . 0.0 110.581 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.65 143.53 46.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.73 61.11 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.873 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -136.61 21.48 3.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.156 1.478 . . . . 0.0 113.113 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.07 138.8 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 154.94 42.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.899 0.88 . . . . 0.0 110.567 165.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -132.94 114.08 13.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.36 2.264 . . . . 0.0 107.551 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.81 176.29 5.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.623 1.169 . . . . 0.0 110.524 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.18 114.76 8.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.594 0.633 . . . . 0.0 109.635 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -114.56 141.41 47.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.982 2.113 . . . . 0.0 109.598 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.8 156.22 19.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.43 158.43 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 125.192 1.397 . . . . 0.0 110.493 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.37 -47.83 0.66 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.938 2.895 . . . . 0.0 114.3 169.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 m 62.74 169.65 0.13 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.517 1.927 . . . . 0.0 112.325 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -153.35 174.74 13.95 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 119.662 -1.899 . . . . 0.0 110.365 167.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.43 -90.79 1.58 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 t 65.2 -173.79 0.18 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.906 0.882 . . . . 0.0 110.242 -161.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.71 101.01 0.43 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 117.671 -1.627 . . . . 0.0 109.242 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.5 163.83 37.46 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 120.27 2.035 . . . . 0.0 110.664 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 71.04 170.61 0.32 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.359 2.663 . . . . 0.0 113.679 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.2 m -161.77 85.66 0.63 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.258 1.823 . . . . 0.0 108.893 -177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 N-CA-C 103.547 -3.821 . . . . 0.0 103.547 -160.082 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -177.77 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 129.607 3.163 . . . . 0.0 109.847 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -136.88 166.64 23.15 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.04 -1.037 . . . . 0.0 109.009 157.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.5 -170.95 44.11 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 p -63.49 167.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 112.162 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 m -74.89 151.94 38.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 154.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.35 171.46 12.69 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.249 -0.907 . . . . 0.0 112.604 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -52.58 -50.74 62.4 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.229 1.012 . . . . 0.0 111.834 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -70.89 -13.26 61.96 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.471 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.46 -50.55 7.66 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.977 1.262 . . . . 0.0 109.999 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.51 -46.75 80.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.866 0.757 . . . . 0.0 111.687 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.7 -33.99 75.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.787 1.235 . . . . 0.0 110.931 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -66.59 -51.14 59.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 109.94 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.6 -52.41 59.9 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.122 0.969 . . . . 0.0 110.557 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -52.22 -60.16 3.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.163 1.385 . . . . 0.0 110.498 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.0 mt -62.66 -36.74 83.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -51.79 -47.34 64.27 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.732 0.813 . . . . 0.0 109.237 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -76.68 -41.1 46.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.862 0.465 . . . . 0.0 110.117 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -17.88 62.15 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.718 -1.134 . . . . 0.0 113.677 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -130.54 24.48 5.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.14 1.776 . . . . 0.0 112.631 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.24 66.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.15 -36.21 83.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.803 0.811 . . . . 0.0 109.127 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -38.87 86.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.508 1.123 . . . . 0.0 110.651 -168.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.52 37.88 0.88 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 119.96 1.255 . . . . 0.0 114.386 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.79 165.74 2.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.319 1.047 . . . . 0.0 112.923 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 m -159.03 -31.02 0.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.41 -171.72 43.74 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.51 137.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.86 158.8 15.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.64 117.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 124.767 1.227 . . . . 0.0 107.872 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.85 122.05 46.63 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.7 131.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 161.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.9 p -120.51 166.53 15.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.47 -12.68 36.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.329 1.353 . . . . 0.0 111.511 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.79 -50.59 5.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.307 1.443 . . . . 0.0 110.266 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 76' ' ' GLU . 5.6 ptp180 -162.08 173.7 14.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.386 1.448 . . . . 0.0 111.496 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.15 152.99 39.72 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.933 -1.104 . . . . 0.0 108.084 162.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -135.05 138.78 44.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.475 2.31 . . . . 0.0 105.108 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.9 mt -129.18 124.17 59.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.86 98.01 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.24 127.27 29.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.0 mt -97.1 110.06 22.69 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.171 1.388 . . . . 0.0 107.544 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.13 170.43 19.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.443 0.697 . . . . 0.0 109.48 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.29 -48.67 15.17 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.31 -1.493 . . . . 0.0 112.505 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -94.97 69.49 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.828 1.651 . . . . 0.0 108.795 -165.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -52.75 -34.85 54.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.21 -47.15 85.71 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 120.918 -1.114 . . . . 0.0 111.939 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.65 -43.78 97.93 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.02 -51.79 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 126.414 1.885 . . . . 0.0 109.461 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.4 -32.46 68.65 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 121.879 -0.513 . . . . 0.0 110.204 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 179.07 46.57 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.97 107.28 0.28 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.247 1.419 . . . . 0.0 110.508 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 48.25 50.53 16.25 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.023 0.916 . . . . 0.0 112.173 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.96 58.98 9.82 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -93.57 -68.39 0.8 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.301 1.04 . . . . 0.0 110.565 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -61.82 -38.15 87.09 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.356 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tp -55.64 -43.04 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.269 0.94 . . . . 0.0 111.355 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -72.5 -36.24 68.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.783 -1.198 . . . . 0.0 111.097 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -56.93 15.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.26 -22.73 64.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.552 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.5 m -58.15 -57.41 12.96 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 120.494 1.497 . . . . 0.0 109.054 166.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -27.53 69.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.278 0.944 . . . . 0.0 112.237 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.11 -63.45 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.61 -43.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.329 1.851 . . . . 0.0 110.86 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -53.91 -45.32 71.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.154 0.982 . . . . 0.0 110.784 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -71.68 -57.92 3.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 109.631 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -47.36 27.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.526 1.93 . . . . 0.0 111.918 -173.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.04 -7.57 22.21 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.336 1.454 . . . . 0.0 111.411 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.15 44.68 95.35 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.053 0.835 . . . . 0.0 111.198 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -69.73 141.59 90.29 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 117.55 0.675 . . . . 0.0 109.619 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.15 128.03 27.18 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 108.38 -1.431 . . . . 0.0 108.38 161.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.72 99.94 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.425 1.49 . . . . 0.0 111.643 -175.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.98 -8.75 33.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.532 1.539 . . . . 0.0 112.028 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 m -85.18 21.72 1.62 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.621 1.21 . . . . 0.0 111.111 162.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 154.73 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.59 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HG3' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.93 150.95 33.79 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.886 2.075 . . . . 0.0 107.335 174.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -123.86 131.28 53.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.532 1.133 . . . . 0.0 108.862 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -126.16 161.53 27.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.54 2.336 . . . . 0.0 109.314 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.36 109.21 9.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.366 1.066 . . . . 0.0 108.821 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 158.09 16.59 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.155 1.382 . . . . 0.0 108.46 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -83.28 152.22 25.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.63 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.1 177.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.104 160.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 140.36 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 131.518 3.927 . . . . 0.0 108.351 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.272 18.3 p 58.38 -148.21 0.48 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.717 1.607 . . . . 0.0 111.739 168.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -161.76 -60.77 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.517 1.508 . . . . 0.0 111.327 155.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.9 -98.31 2.12 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.899 1.238 . . . . 0.0 110.012 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -132.96 -103.4 0.25 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 156.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.4 170.96 12.85 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -161.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.76 152.98 53.52 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.634 2.223 . . . . 0.0 111.165 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.1 m -100.26 -12.13 19.78 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 111.962 161.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 m -154.57 165.09 37.59 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.123 1.369 . . . . 0.0 108.352 167.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.55 0 C-N-CA 127.795 2.617 . . . . 0.0 106.964 178.647 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -148.41 92.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.433 -1.039 . . . . 0.0 109.298 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 m -148.17 81.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.77 100.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 O-C-N 121.497 -0.752 . . . . 0.0 111.953 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -126.17 -98.65 0.4 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 136.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -108.9 154.9 21.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.497 0.719 . . . . 0.0 110.167 -163.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.34 153.5 6.39 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 126.276 1.893 . . . . 0.0 108.622 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 63.3 t80 -48.96 -50.47 35.45 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -168.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.62 -31.02 69.11 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.764 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.0 -59.0 5.42 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.766 1.166 . . . . 0.0 110.705 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.78 -45.01 82.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.4 tp -66.42 -39.29 88.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.681 0.613 . . . . 0.0 110.513 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.28 -53.0 62.37 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.019 0.827 . . . . 0.0 108.959 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 -30.44 71.47 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.3 0.5 . . . . 0.0 111.569 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -65.78 -52.1 53.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.308 1.443 . . . . 0.0 110.215 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.86 -32.73 72.61 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.577 1.151 . . . . 0.0 112.161 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -50.98 -49.75 59.6 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.229 1.012 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -61.5 -57.69 11.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.735 1.214 . . . . 0.0 110.285 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.21 -14.34 62.92 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -134.48 18.94 3.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.969 0.908 . . . . 0.0 112.157 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -58.15 7.92 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 110.937 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.41 -27.6 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.646 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -15.89 62.77 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.0 1.32 . . . . 0.0 112.158 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.89 42.03 6.14 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.523 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HH ' ' HB ' ' A' ' 28' ' ' VAL . 57.2 t80 -53.21 167.3 0.19 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.806 1.242 . . . . 0.0 111.616 167.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 m -153.93 -43.21 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.731 1.212 . . . . 0.0 110.928 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.23 34.43 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.43 ' HB ' ' HH ' ' A' ' 25' ' ' TYR . 2.5 p -149.86 159.39 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 121.456 -1.026 . . . . 0.0 108.33 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -127.84 164.3 22.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.242 1.017 . . . . 0.0 109.475 158.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.13 148.52 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 127.147 2.179 . . . . 0.0 108.701 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -122.85 129.61 51.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.97 116.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 154.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.1 p -120.74 165.09 19.69 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 165.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.8 -12.85 29.13 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.376 2.051 . . . . 0.0 111.959 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 p -96.37 -47.08 6.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.206 0.912 . . . . 0.0 109.77 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.3 169.59 20.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.81 1.644 . . . . 0.0 108.789 164.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.9 m -72.87 145.13 47.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 162.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.68 140.65 52.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 171.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.38 120.05 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.13 111.71 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.71 132.35 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.5 105.29 17.41 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 163.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.22 166.62 22.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -71.3 -35.88 71.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.796 -0.565 . . . . 0.0 111.259 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -127.29 74.89 1.54 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.178 0.899 . . . . 0.0 110.84 -163.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 p -50.61 -40.54 53.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -58.19 -34.69 70.64 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -77.57 -37.33 50.84 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.26 -37.36 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 118.528 0.604 . . . . 0.0 110.03 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.76 -41.95 97.91 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.151 -0.968 . . . . 0.0 109.164 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.06 179.59 43.68 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.53 115.97 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.969 0.907 . . . . 0.0 109.934 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt 51.33 32.68 8.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.422 1.489 . . . . 0.0 111.633 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 33.7 37.42 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.033 -1.426 . . . . 0.0 112.727 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -65.61 0.64 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.732 1.766 . . . . 0.0 112.274 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -60.59 -42.12 96.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -167.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.27 -42.21 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 123.888 0.743 . . . . 0.0 110.425 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -46.84 83.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.258 1.39 . . . . 0.0 111.303 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -59.88 4.32 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.64 -25.16 66.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 117.303 -1.332 . . . . 0.0 112.185 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -56.23 -52.58 63.93 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 120.324 1.42 . . . . 0.0 108.673 169.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.11 79.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.494 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.28 -60.09 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.81 -44.46 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 127.258 2.223 . . . . 0.0 110.624 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.24 -45.9 76.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.933 0.893 . . . . 0.0 110.467 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -70.17 -50.78 36.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.547 1.067 . . . . 0.0 111.488 170.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -29.24 49.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.796 1.638 . . . . 0.0 112.566 -172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.71 4.22 7.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.324 1.45 . . . . 0.0 112.133 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.54 79.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.405 1.003 . . . . 0.0 114.625 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -70.25 142.0 89.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.137 . . . . 0.0 112.366 -172.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.74 121.51 8.58 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.496 2.797 . . . . 0.0 110.921 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.94 146.44 26.8 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.593 1.557 . . . . 0.0 110.256 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.42 -22.71 3.09 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 120.87 -1.144 . . . . 0.0 112.462 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.7 m -109.85 10.35 24.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.457 2.303 . . . . 0.0 110.862 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.86 140.22 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 162.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.18 154.76 46.45 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 124.002 0.921 . . . . 0.0 109.083 166.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -119.84 138.7 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -132.83 168.24 18.74 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.942 1.697 . . . . 0.0 109.949 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.79 108.58 9.97 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.168 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.71 147.44 28.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 111.14 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -81.83 150.98 27.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.8 157.07 6.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.21 113.5 3.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.425 1.49 . . . . 0.0 107.092 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -75.82 -85.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -144.84 80.43 1.62 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.759 2.023 . . . . 0.0 105.64 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.09 112.25 0.49 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m 60.68 174.96 0.1 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.829 1.651 . . . . 0.0 112.705 -167.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.41 149.04 5.71 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.91 142.39 75.25 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 CA-C-N 119.14 1.47 . . . . 0.0 110.221 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -144.32 -13.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.4 1.08 . . . . 0.0 112.106 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 p -135.43 100.19 4.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.138 0.975 . . . . 0.0 108.507 163.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 -175.611 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -169.77 163.32 9.83 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.269 2.227 . . . . 0.0 107.514 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -71.85 -23.71 61.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -170.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.46 -164.61 12.4 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -161.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m 73.06 107.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.719 2.408 . . . . 0.0 115.007 168.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m 49.31 78.62 0.09 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.664 2.386 . . . . 0.0 112.944 162.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.03 151.39 16.65 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.0 -49.67 76.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -63.63 -12.15 31.11 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.317 -0.849 . . . . 0.0 113.159 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.49 1.14 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 121.165 1.802 . . . . 0.0 108.854 166.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -50.32 -45.41 54.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.48 1.512 . . . . 0.0 111.443 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.22 -40.76 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.839 0.456 . . . . 0.0 110.472 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -64.0 -48.13 77.58 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.12 -48.55 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.046 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -53.36 -56.53 15.99 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.091 0.859 . . . . 0.0 110.597 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.2 -37.41 85.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 111.16 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.8 m -53.84 -47.91 70.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.905 0.882 . . . . 0.0 110.618 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -58.37 5.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.01 0.924 . . . . 0.0 109.813 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.01 -27.62 63.69 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.23 18.03 12.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.837 1.655 . . . . 0.0 111.92 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.96 -35.82 47.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.268 1.027 . . . . 0.0 113.361 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -90.82 -19.59 23.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.906 0.775 . . . . 0.0 112.665 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.74 -26.34 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.593 1.157 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 50.58 2.81 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -169.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -57.43 168.42 0.8 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 110.417 166.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -154.24 -43.44 0.09 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 110.184 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.53 -165.9 33.86 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.7 157.47 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -124.96 138.45 54.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 108.212 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.61 116.48 35.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.207 1.803 . . . . 0.0 108.842 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -113.96 122.0 45.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -107.71 111.92 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 p -120.46 167.02 13.66 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.35 22.89 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.878 2.385 . . . . 0.0 111.445 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -127.61 -53.03 1.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.397 -1.439 . . . . 0.0 110.937 -168.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -162.09 171.71 17.06 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.459 2.304 . . . . 0.0 107.56 160.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -87.62 138.05 31.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.75 151.64 27.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.74 122.36 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 mt -123.57 108.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 mt -71.01 122.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.83 110.53 20.57 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.59 168.08 21.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 111.321 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -78.43 -26.37 46.29 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 120.458 -1.401 . . . . 0.0 112.854 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -128.89 67.02 1.41 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.964 0.906 . . . . 0.0 110.562 -164.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -45.32 26.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.697 1.999 . . . . 0.0 113.42 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -70.78 -28.61 64.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.223 -0.923 . . . . 0.0 111.744 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.59 -42.26 64.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 0.56 . . . . 0.0 109.689 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.76 -47.44 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.1 mt -61.82 -38.66 88.99 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.441 -0.787 . . . . 0.0 111.024 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.0 174.05 29.67 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.52 117.21 3.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.273 1.029 . . . . 0.0 109.488 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 47.62 41.11 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.507 1.123 . . . . 0.0 112.925 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.93 13.74 83.34 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.114 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -48.61 -60.16 2.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.132 1.466 . . . . 0.0 113.046 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -43.25 99.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 117.025 -1.465 . . . . 0.0 110.363 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 tt -61.06 -39.02 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 120.185 1.357 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -63.51 -47.7 80.6 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 120.747 -1.221 . . . . 0.0 112.361 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.25 -58.88 6.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.257 1.023 . . . . 0.0 109.303 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.84 -26.23 67.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.624 -173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.4 m -58.32 -47.58 83.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.06 1.3 . . . . 0.0 109.803 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.84 88.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.624 1.102 . . . . 0.0 111.796 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.98 -58.82 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.283 -0.885 . . . . 0.0 108.64 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.2 t -52.12 -45.72 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 126.378 1.871 . . . . 0.0 110.197 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -52.6 -49.29 65.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.534 0.733 . . . . 0.0 110.732 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.87 32.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.734 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -40.92 65.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.011 0.823 . . . . 0.0 111.965 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.15 8.24 27.93 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.055 1.742 . . . . 0.0 111.227 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 33.21 63.38 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.495 1.521 . . . . 0.0 113.695 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -72.32 151.41 92.08 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.782 0.833 . . . . 0.0 112.291 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.0 119.67 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.393 2.062 . . . . 0.0 109.241 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.09 137.16 56.16 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.758 0.823 . . . . 0.0 109.034 166.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.35 56.05 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.75 1.643 . . . . 0.0 113.152 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.3 m -133.51 17.7 3.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.076 1.438 . . . . 0.0 112.993 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.53 139.58 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 151.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -128.49 145.11 51.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.63 140.96 48.39 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -131.6 167.73 18.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 128.136 2.574 . . . . 0.0 108.871 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.33 119.47 15.54 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -121.49 171.78 8.55 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.375 1.47 . . . . 0.0 111.886 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -115.25 131.55 56.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.569 -164.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.24 148.08 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 74.16 99.76 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.424 2.289 . . . . 0.0 110.653 -175.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.2 m -63.8 120.75 12.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.467 2.307 . . . . 0.0 108.546 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 -23.12 0.12 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.105 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.78 -149.63 5.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.305 0.955 . . . . 0.0 112.113 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 m -146.22 -177.39 5.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.144 1.778 . . . . 0.0 108.562 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.5 171.38 16.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 162.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.34 159.15 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.109 2.54 . . . . 0.0 110.863 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 p -157.25 -20.99 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.681 1.192 . . . . 0.0 112.282 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -156.88 95.73 1.55 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 N-CA-C 106.924 -2.47 . . . . 0.0 106.924 176.031 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -160.99 166.28 28.52 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 117.987 0.893 . . . . 0.0 108.992 163.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 p -163.68 177.85 8.39 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.304 1.442 . . . . 0.0 108.433 159.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.7 159.67 26.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 168.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.4 m -106.42 -63.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.968 1.307 . . . . 0.0 109.195 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -145.82 -44.39 0.21 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.99 0.916 . . . . 0.0 110.768 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.43 -66.68 0.23 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -61.61 -56.81 15.82 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.372 1.069 . . . . 0.0 111.153 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -52.59 -38.23 59.67 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.698 0.799 . . . . 0.0 110.757 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.26 -49.65 40.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.117 -0.944 . . . . 0.0 112.241 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -55.95 -46.95 78.41 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.516 1.053 . . . . 0.0 109.787 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.4 -39.78 94.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.694 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -61.26 -51.78 67.51 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.003 0.921 . . . . 0.0 109.792 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -59.66 -40.08 86.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.928 0.785 . . . . 0.0 111.579 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.02 -57.92 10.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.934 0.893 . . . . 0.0 109.315 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -61.26 -38.39 86.53 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.856 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -53.61 -31.14 45.89 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.484 1.493 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.86 -47.69 7.46 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 110.526 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -60.63 -33.76 73.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.791 0.723 . . . . 0.0 112.41 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -113.55 23.58 13.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.293 2.237 . . . . 0.0 110.37 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.87 -59.69 4.04 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.593 1.157 . . . . 0.0 110.143 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.03 -39.94 79.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.695 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -43.51 92.66 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.699 1.6 . . . . 0.0 112.21 -164.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.63 48.73 0.78 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.868 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HH ' ' HB ' ' A' ' 28' ' ' VAL . 69.1 t80 -65.51 169.79 5.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.163 1.385 . . . . 0.0 111.095 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -157.16 -26.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.14 -169.54 36.75 Favored Glycine 0 C--O 1.227 -0.311 0 O-C-N 121.632 -0.667 . . . . 0.0 111.689 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.43 ' HB ' ' HH ' ' A' ' 25' ' ' TYR . 4.9 p -155.59 142.52 11.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.21 158.37 16.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.335 1.054 . . . . 0.0 109.506 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.79 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.093 1.357 . . . . 0.0 107.471 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.7 129.07 57.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.8 p -121.83 177.06 1.67 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.634 1.574 . . . . 0.0 110.407 -172.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.75 0.0 10.36 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 121.424 1.416 . . . . 0.0 113.182 165.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -119.64 -53.14 2.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.766 1.621 . . . . 0.0 112.971 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -153.73 161.38 42.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.649 1.18 . . . . 0.0 110.66 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.1 m -71.63 148.06 46.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.08 130.99 53.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.336 1.854 . . . . 0.0 106.769 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.9 mt -124.03 121.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.94 97.14 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -69.61 141.74 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -115.39 120.8 40.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 127.923 2.489 . . . . 0.0 107.76 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.91 169.71 22.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.101 1.361 . . . . 0.0 109.643 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -80.41 -35.43 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.406 -0.809 . . . . 0.0 112.342 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -125.55 83.47 2.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.306 1.442 . . . . 0.0 108.32 -165.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -49.92 -45.15 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.049 1.34 . . . . 0.0 112.387 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -56.85 -38.47 72.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.49 -43.73 80.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.485 1.039 . . . . 0.0 109.877 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.05 -42.32 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.079 0.552 . . . . 0.0 109.768 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.15 -30.78 71.73 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.979 -1.076 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.16 -174.38 9.42 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.06 111.6 1.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 110.228 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp 56.41 3.13 0.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.251 1.82 . . . . 0.0 115.14 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.72 -2.14 9.35 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 120.422 1.464 . . . . 0.0 114.112 -169.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -44.06 -57.44 3.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.057 1.929 . . . . 0.0 113.941 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.87 -45.02 79.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.122 0.874 . . . . 0.0 110.621 -173.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.29 -34.33 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.374 0.988 . . . . 0.0 109.827 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -71.84 -37.42 70.28 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 113.753 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.28 -55.27 16.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.469 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.2 mt -56.09 -36.1 67.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.136 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -49.32 -52.56 27.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.18 0.9 . . . . 0.0 110.729 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.61 -44.63 56.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.2 1.0 . . . . 0.0 111.36 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -60.28 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 t -54.85 -46.49 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 120.417 1.462 . . . . 0.0 110.614 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -49.95 -42.51 48.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.272 1.029 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -83.77 -41.06 18.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.002 0.921 . . . . 0.0 111.709 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -29.64 70.88 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.98 0.912 . . . . 0.0 111.474 -173.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.3 -8.76 11.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.983 0.913 . . . . 0.0 110.464 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.5 51.07 45.12 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -78.18 150.4 77.39 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.011 0.524 . . . . 0.0 110.018 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.54 119.51 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.773 1.649 . . . . 0.0 109.712 162.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.86 145.59 15.81 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.93 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.601 -1.111 . . . . 0.0 114.296 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -134.46 40.16 3.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.462 2.131 . . . . 0.0 111.882 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.2 139.57 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 164.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 138.34 50.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.092 1.357 . . . . 0.0 108.729 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.44 129.23 47.44 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -117.04 160.3 21.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.421 1.488 . . . . 0.0 109.554 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.67 109.36 10.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 108.463 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.12 156.48 17.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.376 1.47 . . . . 0.0 108.475 173.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -107.06 148.83 28.27 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -100.1 146.54 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.63 -44.85 0.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.09 1.756 . . . . 0.0 111.773 -171.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.2 p 32.67 64.8 0.25 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.865 2.866 . . . . 0.0 113.87 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.07 83.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.816 1.246 . . . . 0.0 109.979 -174.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.91 73.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.0 p -154.53 176.36 12.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.408 0.604 . . . . 0.0 111.144 168.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.95 79.44 0.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.92 170.5 17.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.616 2.211 . . . . 0.0 111.209 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.0 t -141.37 170.35 15.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.213 1.405 . . . . 0.0 108.683 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.1 m -137.36 -78.56 0.39 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.972 1.709 . . . . 0.0 107.751 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -149.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.421 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 44.9 t80 . . . . . 0 CA--C 1.527 0.061 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -57.94 -31.72 67.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -42.33 58.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.407 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -62.73 -46.41 88.21 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.144 0.577 . . . . 0.0 110.807 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.6 tp -65.75 -38.82 90.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.651 0.781 . . . . 0.0 110.166 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.45 -42.18 83.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.352 0.524 . . . . 0.0 111.14 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.95 -46.26 78.6 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.588 0.755 . . . . 0.0 110.876 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.57 -61.59 2.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.001 0.92 . . . . 0.0 109.439 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.51 -32.23 72.26 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.737 1.215 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.3 m -54.56 -45.42 73.48 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.885 0.766 . . . . 0.0 110.497 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -49.97 65.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.689 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -55.88 -35.53 66.6 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.104 0.561 . . . . 0.0 112.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -121.15 24.77 9.93 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.09 1.356 . . . . 0.0 110.524 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.03 -63.04 1.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.42 1.488 . . . . 0.0 110.595 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.23 -24.94 51.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.905 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.7 -35.54 72.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.341 0.973 . . . . 0.0 111.418 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.68 35.73 0.83 Allowed Glycine 0 C--N 1.338 0.65 0 O-C-N 123.553 0.533 . . . . 0.0 113.018 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 41' ' ' ILE . 29.9 t80 -59.38 167.46 1.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.174 0.987 . . . . 0.0 112.509 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -44.88 0.16 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.406 1.482 . . . . 0.0 110.042 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.32 -169.53 42.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.77 156.34 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.39 158.96 22.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.576 1.951 . . . . 0.0 107.857 163.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.02 150.07 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -132.88 156.79 46.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 163.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.52 124.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.0 p -120.41 176.83 1.64 Allowed Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -167.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 67.6 Cg_endo -72.12 8.07 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.509 1.473 . . . . 0.0 112.591 167.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -125.78 -45.08 1.77 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.376 0.989 . . . . 0.0 110.637 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -161.73 173.22 14.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.92 1.236 . . . . 0.0 110.865 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.6 m -88.94 149.47 23.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 160.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.2 138.41 52.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.176 1.79 . . . . 0.0 106.613 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -132.16 120.7 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.41 95.03 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.484 HG23 ' CE1' ' A' ' 25' ' ' TYR . 2.5 mp -64.26 153.24 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -118.8 108.14 14.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.827 2.451 . . . . 0.0 105.972 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.93 157.93 45.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.556 0.693 . . . . 0.0 112.29 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.8 p -64.08 -34.24 77.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.549 1.14 . . . . 0.0 111.018 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -134.88 82.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.479 1.512 . . . . 0.0 109.821 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 p -53.4 -35.37 60.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.732 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -60.79 -36.57 79.35 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.448 1.477 . . . . 0.0 112.456 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.03 -45.28 77.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.814 0.733 . . . . 0.0 109.066 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -30.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.049 0.939 . . . . 0.0 111.105 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.21 -40.22 52.72 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.524 -0.735 . . . . 0.0 110.519 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.3 179.7 47.06 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.501 1.048 . . . . 0.0 111.487 -171.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -57.06 114.93 2.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.545 0.738 . . . . 0.0 109.447 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 mttp 39.46 46.82 1.47 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.181 1.792 . . . . 0.0 112.464 -174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.88 9.54 77.43 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.118 -0.824 . . . . 0.0 113.751 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -43.86 -62.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.253 1.526 . . . . 0.0 112.738 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.02 -40.77 78.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.368 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.04 -41.27 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.306 0.957 . . . . 0.0 111.186 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -52.61 64.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.972 -1.08 . . . . 0.0 109.649 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -58.54 -47.06 85.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.795 0.725 . . . . 0.0 111.732 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 63' ' ' VAL . 40.0 mt -62.0 -30.24 70.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.715 0.806 . . . . 0.0 110.898 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -61.17 -51.7 67.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.436 1.016 . . . . 0.0 109.413 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.71 78.79 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.857 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 60' ' ' LEU . 11.4 p -59.87 -46.17 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.722 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 t -60.45 -45.69 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 120.234 1.379 . . . . 0.0 110.152 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -51.9 -44.25 63.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.785 1.234 . . . . 0.0 110.426 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -70.75 -50.78 32.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.2 1.0 . . . . 0.0 110.139 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -44.87 90.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.282 1.433 . . . . 0.0 111.016 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -103.57 -13.67 16.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.81 1.244 . . . . 0.0 111.503 -171.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 20.36 54.91 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 121.324 -0.86 . . . . 0.0 113.943 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -62.32 138.38 96.23 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.063 0.932 . . . . 0.0 112.456 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.96 141.6 49.03 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.275 1.983 . . . . 0.0 110.24 165.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.47 147.35 39.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.735 0.814 . . . . 0.0 110.03 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.97 -7.44 7.57 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.435 -0.791 . . . . 0.0 113.197 -169.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.0 m -122.02 7.21 9.78 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.138 1.775 . . . . 0.0 111.201 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.07 136.84 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 156.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -127.65 140.77 51.88 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.54 126.67 50.92 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.205 1.402 . . . . 0.0 107.629 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 63.5 m-85 -129.89 168.23 16.95 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.847 2.459 . . . . 0.0 109.22 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.62 122.07 17.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.37 155.28 18.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -101.23 149.49 23.95 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 122.517 1.151 . . . . 0.0 108.134 178.479 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 t80 . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.31 -36.19 60.99 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 118.547 -0.739 . . . . 0.0 112.177 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.37 -51.52 51.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.951 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.91 -46.0 74.82 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.427 1.091 . . . . 0.0 109.932 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.21 -43.26 82.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.737 0.815 . . . . 0.0 110.625 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -64.12 -47.19 80.93 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.324 0.65 . . . . 0.0 109.942 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.73 -44.29 85.89 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.186 1.394 . . . . 0.0 111.739 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -56.54 -60.07 4.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.5 -38.89 78.61 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.476 1.11 . . . . 0.0 112.487 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -51.91 -37.05 51.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.552 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -90.79 -39.01 12.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.293 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.09 -25.46 65.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 113.071 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.38 22.6 12.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.2 1.8 . . . . 0.0 110.758 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.23 64.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.872 1.269 . . . . 0.0 111.683 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.77 -26.65 59.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.673 0.215 . . . . 0.0 111.071 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 -34.99 79.41 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.639 0.775 . . . . 0.0 112.12 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.57 33.63 2.23 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.49 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HE1' HG23 ' A' ' 41' ' ' ILE . 38.5 t80 -51.67 157.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.862 0.865 . . . . 0.0 112.478 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.436 ' CB ' HG21 ' A' ' 82' ' ' VAL . 22.9 m -128.96 -57.06 1.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.472 1.509 . . . . 0.0 108.96 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.12 -166.45 32.9 Favored Glycine 0 C--O 1.227 -0.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.23 154.56 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -124.27 152.17 43.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 165.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.75 137.28 54.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -115.3 152.28 33.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.99 96.23 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 -171.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -120.69 163.89 26.45 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 123.768 0.827 . . . . 0.0 108.914 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.85 13.7 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.84 2.36 . . . . 0.0 112.011 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 p -120.64 -45.52 2.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.33 1.452 . . . . 0.0 110.324 -163.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -162.05 173.22 14.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.95 2.1 . . . . 0.0 106.989 162.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -75.71 147.37 39.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 158.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.77 129.7 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -126.9 132.51 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.99 100.53 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' A' ' 25' ' ' TYR . 59.8 mt -69.55 131.75 33.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 82' ' ' VAL . 51.0 mt -106.92 114.63 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.643 1.977 . . . . 0.0 106.22 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.81 169.63 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.801 0.441 . . . . 0.0 110.081 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -68.61 -46.45 69.27 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.408 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -115.8 89.6 3.14 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 127.519 2.328 . . . . 0.0 107.605 -164.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -45.27 66.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 111.324 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -65.76 -19.43 65.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -74.35 -49.06 24.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.67 -39.29 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.998 1.319 . . . . 0.0 110.844 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.16 -40.73 90.76 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.599 -0.688 . . . . 0.0 110.858 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 -175.29 40.0 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.54 113.67 2.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.889 1.275 . . . . 0.0 110.467 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.1 pttt 46.25 30.07 0.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.635 1.174 . . . . 0.0 113.867 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.62 5.74 59.97 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.992 0.806 . . . . 0.0 114.374 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -45.72 -55.91 5.91 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 112.855 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -72.27 -46.48 55.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.25 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.0 tt -59.08 -35.93 59.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.848 1.658 . . . . 0.0 111.134 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.94 -36.67 72.71 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 120.699 -1.251 . . . . 0.0 112.559 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.91 -49.27 71.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.265 0.484 . . . . 0.0 109.997 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 63' ' ' VAL . 83.1 mt -59.87 -29.09 68.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.937 1.295 . . . . 0.0 110.507 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -63.32 -56.67 14.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.815 . . . . 0.0 109.067 169.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.6 88.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.863 1.265 . . . . 0.0 112.097 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 60' ' ' LEU . 7.4 p -62.88 -52.4 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.115 -1.422 . . . . 0.0 108.101 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.81 -46.38 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.187 1.358 . . . . 0.0 109.976 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.99 -44.89 64.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 0.0 109.517 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -83.89 -37.51 22.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.707 0.685 . . . . 0.0 112.646 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.98 -55.3 32.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.528 1.131 . . . . 0.0 109.088 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 97.2 m-85 -93.8 -11.18 31.85 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.486 1.114 . . . . 0.0 110.51 -169.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.98 23.11 59.96 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.424 1.011 . . . . 0.0 111.811 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.65 139.98 97.71 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 118.263 1.031 . . . . 0.0 111.508 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.17 130.74 35.54 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.934 2.423 . . . . 0.0 109.449 165.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.07 122.67 15.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.433 0.693 . . . . 0.0 109.301 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.58 -12.47 56.03 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.985 0.802 . . . . 0.0 114.368 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -89.2 15.18 9.31 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.779 1.232 . . . . 0.0 111.582 165.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.57 156.4 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 159.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 145.31 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 170.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 113.16 19.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -112.36 164.67 12.98 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.064 2.145 . . . . 0.0 108.609 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.84 114.37 10.39 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.43 153.68 20.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.088 0.946 . . . . 0.0 109.194 172.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -83.28 148.3 27.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 26' ' ' SER . 91.5 t . . . . . 0 C--N 1.323 -0.558 0 C-N-CA 123.794 0.837 . . . . 0.0 109.339 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.227 -0.101 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.55 -38.52 74.89 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.544 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.83 65.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.782 0.719 . . . . 0.0 111.759 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -58.13 -48.73 79.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.911 0.778 . . . . 0.0 109.48 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.62 -41.86 92.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.344 1.457 . . . . 0.0 111.39 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.02 -50.16 73.59 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 123.764 0.826 . . . . 0.0 109.51 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.72 -42.68 97.88 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.11 -52.12 65.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.681 0.793 . . . . 0.0 109.419 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.18 -38.66 85.77 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.242 1.017 . . . . 0.0 111.787 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -54.6 -42.53 71.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.907 0.883 . . . . 0.0 109.9 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.51 -61.44 1.89 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.369 0.668 . . . . 0.0 110.061 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -21.97 64.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -170.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -122.65 21.58 10.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.138 1.775 . . . . 0.0 111.104 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.56 -55.07 17.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.309 1.044 . . . . 0.0 112.228 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -71.11 -16.08 62.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.554 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.48 -16.1 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.544 1.066 . . . . 0.0 113.39 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.73 40.26 6.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.58 158.85 4.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.834 -0.804 . . . . 0.0 110.89 170.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -147.35 -29.86 0.34 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.115 0.966 . . . . 0.0 112.564 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.64 -167.02 40.04 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.74 149.27 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.43 119.48 28.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -82.67 135.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -109.39 120.58 42.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.37 121.92 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 157.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 p -120.29 164.75 20.95 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 92.9 Cg_endo -74.29 2.85 5.77 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.678 2.252 . . . . 0.0 111.877 173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -112.82 -41.75 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -161.83 173.37 14.67 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.077 1.351 . . . . 0.0 109.965 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.4 m -74.79 146.38 42.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 154.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -127.45 143.55 51.18 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.435 2.294 . . . . 0.0 105.114 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -132.46 117.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.84 95.98 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.49 125.42 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.36 113.97 25.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.274 1.83 . . . . 0.0 106.299 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.42 171.07 14.57 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 109.209 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -81.87 -17.99 45.38 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.388 -1.445 . . . . 0.0 112.886 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -133.05 61.65 1.67 Allowed 'General case' 0 CA--C 1.523 -0.066 0 C-N-CA 124.74 1.216 . . . . 0.0 110.214 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -48.86 -41.69 34.05 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.894 0.877 . . . . 0.0 112.112 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.2 83.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.625 0.37 . . . . 0.0 111.431 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -72.27 -43.48 64.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.302 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.37 -31.58 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 110.976 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.96 -32.37 70.58 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.069 -1.019 . . . . 0.0 111.767 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.9 169.74 7.57 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.224 1.392 . . . . 0.0 111.665 -166.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.19 125.68 24.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.519 1.528 . . . . 0.0 108.679 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt 42.63 43.63 3.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.153 1.781 . . . . 0.0 111.767 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.0 66.57 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.886 -0.952 . . . . 0.0 114.948 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -52.93 -51.46 61.25 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.753 1.776 . . . . 0.0 111.175 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -34.65 62.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.881 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -65.82 -36.71 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.194 1.361 . . . . 0.0 111.24 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -65.15 -41.16 94.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 120.756 -1.215 . . . . 0.0 111.42 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -56.68 -60.11 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.057 0.943 . . . . 0.0 109.017 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.8 mt -57.27 -35.9 70.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.349 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -55.58 -52.38 63.93 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.594 1.088 . . . . 0.0 109.933 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.91 85.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.688 0.676 . . . . 0.0 111.294 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -64.13 -46.3 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 117.633 -1.175 . . . . 0.0 109.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.92 -46.29 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 120.568 1.531 . . . . 0.0 109.365 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -53.55 -39.91 65.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.085 0.554 . . . . 0.0 110.922 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -85.22 -36.65 20.82 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 118.964 0.802 . . . . 0.0 111.459 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.65 -45.42 94.09 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.807 0.843 . . . . 0.0 109.16 178.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 96.6 m-85 -106.77 -2.77 21.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.905 1.282 . . . . 0.0 112.69 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.27 35.57 63.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.687 1.137 . . . . 0.0 113.573 172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.13 133.7 68.51 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 118.371 1.086 . . . . 0.0 111.453 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.41 138.96 87.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.121 2.548 . . . . 0.0 111.185 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 111.07 9.84 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.169 0.987 . . . . 0.0 110.16 -173.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.76 -2.18 55.65 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.277 -0.735 . . . . 0.0 112.694 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 m -109.66 6.5 23.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.519 1.128 . . . . 0.0 112.081 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.68 163.71 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.749 1.219 . . . . 0.0 107.836 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.66 157.26 43.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.37 1.468 . . . . 0.0 107.43 159.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.39 135.49 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.07 165.25 19.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.016 1.726 . . . . 0.0 108.241 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.77 111.16 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -116.53 154.15 30.93 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.045 1.338 . . . . 0.0 109.009 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -110.69 135.36 51.41 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.633 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 C--O 1.239 0.527 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.562 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.496 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 35.6 t80 . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 119.496 -0.288 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -54.68 -47.36 73.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.411 -0.805 . . . . 0.0 109.768 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.89 -53.44 50.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.464 1.105 . . . . 0.0 111.917 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.83 -45.77 59.69 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.202 0.601 . . . . 0.0 110.439 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.9 tp -69.23 -41.04 77.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.746 1.219 . . . . 0.0 110.868 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -50.37 74.25 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.983 1.313 . . . . 0.0 108.758 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -66.38 -31.99 73.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.506 1.922 . . . . 0.0 112.127 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.97 -62.6 1.35 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.592 1.157 . . . . 0.0 108.533 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -55.8 -29.6 59.98 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.383 1.473 . . . . 0.0 112.389 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -51.51 -45.16 62.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.233 1.013 . . . . 0.0 111.856 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -74.27 -58.27 3.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -30.44 15.04 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 125.9 1.68 . . . . 0.0 113.402 -169.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.52 22.34 5.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.843 1.257 . . . . 0.0 111.566 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.629 0.771 . . . . 0.0 110.054 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.1 -26.09 68.06 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.572 1.149 . . . . 0.0 110.446 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.75 -25.79 65.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.52 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.51 25.59 4.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.43 -1.205 . . . . 0.0 114.077 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -54.41 148.95 10.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.709 1.604 . . . . 0.0 113.646 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m -128.46 -41.51 1.53 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 112.453 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.16 -166.36 39.59 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 156.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.46 138.73 50.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 160.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.95 124.52 65.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.29 121.98 46.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.86 95.87 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 p -78.38 166.04 45.79 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.18 -2.55 12.7 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.225 1.283 . . . . 0.0 112.921 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 p -103.73 -51.05 3.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.595 1.089 . . . . 0.0 109.606 -166.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -157.44 162.97 38.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.758 2.023 . . . . 0.0 107.757 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.1 m -73.11 139.69 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -110.49 144.01 39.95 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.4 mt -135.31 123.41 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.5 101.54 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.5 mt -68.15 123.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 mt -96.5 118.3 32.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.69 -177.92 6.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.689 0.756 . . . . 0.0 111.504 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 p -86.49 -25.36 25.18 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -129.67 78.46 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.68 1.192 . . . . 0.0 107.96 -165.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -40.7 72.81 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.247 1.019 . . . . 0.0 111.346 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -69.51 -22.08 63.62 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.691 -0.631 . . . . 0.0 111.63 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -72.76 -46.43 53.44 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.43 -36.55 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.146 1.378 . . . . 0.0 111.678 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -65.39 -42.67 92.38 Favored 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 120.916 -1.115 . . . . 0.0 109.34 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -179.57 29.42 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-O 122.976 1.32 . . . . 0.0 110.673 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.51 116.81 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.895 2.078 . . . . 0.0 109.156 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt 52.68 8.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.776 2.03 . . . . 0.0 115.305 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 18.72 11.24 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 120.695 1.588 . . . . 0.0 113.493 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -60.77 -57.26 13.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.489 2.145 . . . . 0.0 112.437 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -67.44 -33.61 75.5 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.916 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.6 -44.02 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.151 0.887 . . . . 0.0 110.456 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -69.13 -38.88 79.06 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.113 -0.992 . . . . 0.0 111.228 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.65 -49.12 76.42 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.759 0.709 . . . . 0.0 109.402 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 63' ' ' VAL . 18.0 mt -59.69 -29.09 67.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.647 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 m -60.77 -56.82 16.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.596 1.089 . . . . 0.0 108.922 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.67 73.04 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.763 1.225 . . . . 0.0 111.978 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.3 p -59.17 -51.9 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.539 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.83 -43.88 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.656 1.571 . . . . 0.0 109.778 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -53.05 -44.04 67.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.603 0.761 . . . . 0.0 110.846 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -72.71 -52.75 13.92 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.902 0.774 . . . . 0.0 110.875 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -54.84 -24.17 21.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.667 1.987 . . . . 0.0 112.589 -174.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 96.3 m-85 -128.97 -3.37 5.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.488 1.115 . . . . 0.0 112.961 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.83 7.78 85.26 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.754 1.169 . . . . 0.0 114.924 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -61.22 143.62 92.35 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.389 1.595 . . . . 0.0 111.948 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.44 163.67 23.05 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.472 2.115 . . . . 0.0 110.447 162.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -68.83 141.39 55.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 164.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.44 -40.65 2.42 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.681 1.134 . . . . 0.0 113.661 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.7 m -67.47 -4.78 12.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.943 1.372 . . . . 0.0 112.922 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.91 141.38 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 163.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.96 130.2 48.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.33 137.89 39.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -130.47 167.49 18.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 127.612 2.365 . . . . 0.0 109.209 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.31 120.19 14.41 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.142 1.777 . . . . 0.0 108.915 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -119.14 148.56 42.94 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.717 1.207 . . . . 0.0 110.502 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -74.7 147.73 41.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.403 0.62 . . . . 0.0 109.839 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.428 0 C-N-CA 125.904 1.682 . . . . 0.0 107.982 172.097 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.6 t80 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.22 -35.58 73.88 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -49.79 14.08 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.178 0.991 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.22 -47.78 65.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.445 0.641 . . . . 0.0 109.801 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.856 -0.527 . . . . 0.0 110.824 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.04 -57.5 12.8 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.821 1.248 . . . . 0.0 110.007 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.03 -34.8 78.5 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 118.754 0.706 . . . . 0.0 111.855 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.7 -64.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.687 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.18 80.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.574 1.55 . . . . 0.0 111.717 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.6 m -49.88 -37.38 30.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.616 1.166 . . . . 0.0 110.935 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.79 -16.63 28.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.61 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.68 -16.47 28.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.428 1.091 . . . . 0.0 112.457 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -136.97 36.63 2.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.38 1.472 . . . . 0.0 112.008 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.89 -61.23 2.51 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.051 -1.031 . . . . 0.0 111.774 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.75 -15.86 60.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.801 0.84 . . . . 0.0 112.081 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.12 -15.14 62.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.067 1.347 . . . . 0.0 112.774 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.88 32.75 28.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.167 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -52.96 144.57 14.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.519 0.66 . . . . 0.0 111.213 168.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' HG11 ' A' ' 82' ' ' VAL . 72.1 m -126.58 -47.78 1.55 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.395 1.478 . . . . 0.0 110.428 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.87 -162.94 29.68 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.55 158.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 121.083 -1.245 . . . . 0.0 107.969 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -128.36 157.69 40.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.652 1.981 . . . . 0.0 109.277 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.07 134.65 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.508 1.123 . . . . 0.0 111.231 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -121.45 161.85 21.48 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.673 1.189 . . . . 0.0 110.124 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.76 133.71 65.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.993 1.717 . . . . 0.0 106.493 164.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 64.8 p -122.37 170.53 7.75 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.325 1.45 . . . . 0.0 109.095 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 73.7 Cg_endo -74.44 4.82 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.593 2.196 . . . . 0.0 112.651 166.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.3 p -108.22 -54.9 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.443 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.01 169.28 24.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.592 1.087 . . . . 0.0 111.689 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.4 m -68.0 151.91 46.35 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -135.39 135.08 40.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.9 124.15 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.68 107.42 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.47 1.108 . . . . 0.0 108.582 -166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.17 142.93 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.65 115.55 30.35 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 163.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.58 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.988 0.813 . . . . 0.0 110.546 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -78.64 -49.02 13.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.656 -1.278 . . . . 0.0 111.283 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -99.71 74.28 1.85 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -51.89 -35.35 44.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.691 -0.631 . . . . 0.0 112.659 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -77.09 -18.61 57.88 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.297 1.408 . . . . 0.0 113.067 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -65.12 -59.94 3.56 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 162.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -53.58 -43.83 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.287 1.035 . . . . 0.0 111.751 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.21 -41.32 77.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.48 -0.762 . . . . 0.0 110.816 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.84 178.76 34.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.465 0.481 . . . . 0.0 112.111 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.85 119.15 7.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.62 0.768 . . . . 0.0 110.204 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.87 32.16 5.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.753 1.621 . . . . 0.0 112.356 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.77 58.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.013 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -51.65 -63.43 1.14 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.164 1.482 . . . . 0.0 113.024 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -39.63 94.71 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.732 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.73 -43.53 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.265 1.393 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -68.3 -38.27 81.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.03 -1.044 . . . . 0.0 111.476 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.15 -51.77 66.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.9 mt -62.71 -26.47 68.69 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.277 -1.344 . . . . 0.0 111.752 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -60.82 -50.45 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.117 1.326 . . . . 0.0 108.408 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.26 85.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.689 0.796 . . . . 0.0 112.286 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 60' ' ' LEU . 2.9 p -68.45 -39.07 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.336 -1.316 . . . . 0.0 110.142 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.32 -43.6 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 121.532 1.969 . . . . 0.0 109.961 173.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.64 -40.36 68.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.927 0.891 . . . . 0.0 111.073 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -67.62 -65.53 0.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.494 1.043 . . . . 0.0 108.849 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -38.89 69.0 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.28 2.232 . . . . 0.0 111.754 -167.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.64 -4.4 17.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.623 1.169 . . . . 0.0 111.185 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.26 51.38 57.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.638 1.108 . . . . 0.0 110.908 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -79.12 153.8 77.25 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.638 0.375 . . . . 0.0 110.577 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -72.42 117.03 4.94 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.703 2.268 . . . . 0.0 108.319 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.3 pm0 -57.37 143.42 40.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 110.075 172.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.77 -46.43 3.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.948 1.261 . . . . 0.0 111.085 -168.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m -83.56 17.28 2.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.366 1.466 . . . . 0.0 114.279 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.45 136.07 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.81 135.07 47.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 128.156 2.582 . . . . 0.0 108.155 174.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.3 134.55 52.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.37 177.29 6.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.245 2.218 . . . . 0.0 108.838 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 158.84 43.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.93 153.24 46.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.759 2.424 . . . . 0.0 106.353 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -95.5 135.97 36.48 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' CB ' ' A' ' 26' ' ' SER . 21.2 m . . . . . 0 C--O 1.24 0.602 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 76.9 t80 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.711 0.291 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.94 -38.1 81.45 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.909 -169.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 -55.01 31.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.241 0.616 . . . . 0.0 110.622 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.49 -42.85 78.98 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.315 0.507 . . . . 0.0 111.578 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.5 tp -71.37 -38.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.548 0.339 . . . . 0.0 110.636 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -59.93 -51.53 69.28 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.057 0.943 . . . . 0.0 108.634 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.19 -37.8 81.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 112.371 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.15 -57.01 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.188 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.05 -30.35 71.43 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.686 1.195 . . . . 0.0 111.939 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.9 m -49.67 -40.22 39.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.185 1.394 . . . . 0.0 111.118 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -91.18 -45.87 8.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.448 0.699 . . . . 0.0 110.424 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -55.98 -30.39 61.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.409 0.684 . . . . 0.0 112.613 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.8 mt -125.53 22.45 7.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.015 1.326 . . . . 0.0 110.703 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.18 -63.48 1.14 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.014 0.925 . . . . 0.0 110.222 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.05 -15.51 61.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.521 0.329 . . . . 0.0 111.836 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -35.65 74.94 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.74 28.41 1.42 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.907 -0.94 . . . . 0.0 113.818 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -53.29 153.63 3.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.526 1.163 . . . . 0.0 112.628 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 m -142.42 -34.35 0.45 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.972 1.309 . . . . 0.0 112.405 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.77 -169.57 42.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.064 0.847 . . . . 0.0 111.075 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.4 149.75 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.76 159.67 34.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.867 1.267 . . . . 0.0 108.287 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.1 127.81 18.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.673 1.189 . . . . 0.0 110.904 -163.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -126.03 161.95 26.39 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.796 1.238 . . . . 0.0 108.675 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.46 115.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 51.1 p -92.17 172.44 6.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 123.813 0.845 . . . . 0.0 108.773 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 51.8 Cg_endo -70.94 20.67 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.936 2.424 . . . . 0.0 112.124 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.9 p -128.07 -44.93 1.42 Allowed 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 120.842 -1.161 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.11 172.71 15.41 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.182 0.901 . . . . 0.0 111.122 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 m -71.51 157.43 38.03 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 159.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.81 128.42 34.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.168 1.787 . . . . 0.0 107.195 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.0 mt -117.04 124.09 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.92 104.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.25 133.31 32.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.71 117.03 33.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.047 . . . . 0.0 106.756 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.54 167.49 23.57 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -31.47 65.82 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.909 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -132.35 81.33 1.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.1 p -52.58 -43.73 65.46 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.772 -0.58 . . . . 0.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.45 -30.11 62.47 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.325 1.45 . . . . 0.0 112.734 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -70.14 -52.2 25.46 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.618 0.645 . . . . 0.0 109.478 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.94 -34.19 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.83 1.252 . . . . 0.0 111.073 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -68.86 -35.19 76.62 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.474 -0.766 . . . . 0.0 111.3 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.65 -179.31 26.57 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.835 0.731 . . . . 0.0 111.745 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -54.1 109.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.937 1.695 . . . . 0.0 109.683 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt 46.58 43.34 12.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.783 1.233 . . . . 0.0 111.966 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 11.5 71.67 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.731 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -40.89 -64.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.895 1.678 . . . . 0.0 111.903 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.26 -47.08 68.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.499 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.22 -41.78 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.01 1.277 . . . . 0.0 110.371 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.3 -45.48 80.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.008 0.923 . . . . 0.0 111.463 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.64 -55.14 38.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.173 0.589 . . . . 0.0 109.819 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.77 -33.13 69.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.579 1.551 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.2 m -55.13 -50.49 69.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.686 1.13 . . . . 0.0 109.28 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.65 96.31 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.556 0.617 . . . . 0.0 111.963 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.6 t -58.62 -54.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 t -59.1 -41.31 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.883 2.073 . . . . 0.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -61.47 -22.15 64.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.361 0.982 . . . . 0.0 112.321 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.82 -50.73 5.22 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.503 -0.748 . . . . 0.0 110.859 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.92 62.03 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.231 1.412 . . . . 0.0 110.294 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.73 7.98 28.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.189 1.796 . . . . 0.0 111.041 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.96 23.13 37.48 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 125.352 1.453 . . . . 0.0 114.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -56.6 147.39 51.06 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.349 1.075 . . . . 0.0 111.583 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.2 128.87 30.31 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.627 2.218 . . . . 0.0 110.6 166.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 153.22 28.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 168.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.7 -44.43 0.63 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.837 2.161 . . . . 0.0 114.098 -164.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -91.08 18.24 7.05 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.77 1.628 . . . . 0.0 115.152 -166.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.45 139.89 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.55 150.67 50.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.282 0.492 . . . . 0.0 110.592 163.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.2 126.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -122.42 173.54 7.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.36 1.464 . . . . 0.0 109.807 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.32 109.75 5.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.461 1.105 . . . . 0.0 108.345 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -104.06 142.27 34.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -76.35 149.76 36.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.083 0.953 . . . . 0.0 112.477 168.675 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 45.9 t80 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -61.97 -36.22 80.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -171.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 -60.24 3.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.949 1.299 . . . . 0.0 109.625 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -55.39 -40.66 71.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.084 0.554 . . . . 0.0 111.363 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.466 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.0 tp -69.3 -41.37 76.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.325 0.65 . . . . 0.0 111.031 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.81 -54.45 47.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.226 0.466 . . . . 0.0 109.84 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -57.3 -35.09 69.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.779 0.432 . . . . 0.0 112.145 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -67.22 -58.1 5.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.487 1.115 . . . . 0.0 110.872 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.7 -33.27 73.71 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.43 1.492 . . . . 0.0 111.861 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -47.97 -38.64 17.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.301 1.44 . . . . 0.0 111.321 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -89.09 -40.1 13.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.817 0.735 . . . . 0.0 111.437 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.66 -20.69 63.7 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.5 mt -133.02 24.64 4.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.791 1.636 . . . . 0.0 110.856 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.92 -56.32 20.87 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.88 1.272 . . . . 0.0 111.453 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -61.49 -45.28 94.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.574 1.15 . . . . 0.0 110.47 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.98 -31.28 72.44 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.913 0.885 . . . . 0.0 112.835 -163.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.61 41.05 1.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 119.338 -0.701 . . . . 0.0 113.775 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -49.93 154.85 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.612 0.765 . . . . 0.0 111.33 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.25 -45.43 0.77 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.534 1.534 . . . . 0.0 109.525 172.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.99 -164.89 34.6 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.47 151.64 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 121.457 -1.026 . . . . 0.0 108.646 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -121.99 151.48 40.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.835 0.826 . . . . 0.0 109.27 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.6 p -125.43 148.75 29.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.251 1.42 . . . . 0.0 108.395 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -132.79 153.48 51.2 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.1 t -98.37 135.75 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 155.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -120.89 166.08 16.82 Favored Pre-proline 0 C--O 1.243 0.717 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.7 Cg_endo -72.02 0.91 6.5 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.651 2.234 . . . . 0.0 111.899 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -113.42 -47.33 3.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.486 1.039 . . . . 0.0 111.648 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -162.21 172.97 14.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.062 0.847 . . . . 0.0 110.332 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.7 m -68.96 150.28 47.89 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -124.98 143.65 50.78 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -129.72 122.71 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 99.43 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.97 132.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.63 108.5 20.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.349 1.859 . . . . 0.0 106.38 164.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 172.26 13.02 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 p -83.33 -37.49 23.32 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.873 -0.517 . . . . 0.0 111.43 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -117.11 64.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.634 -1.291 . . . . 0.0 108.035 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -43.83 -48.62 8.27 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.54 2.336 . . . . 0.0 113.169 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.15 -34.2 71.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.136 0.88 . . . . 0.0 111.859 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.58 -32.29 36.58 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.205 -0.934 . . . . 0.0 111.212 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.26 -42.35 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.875 0.87 . . . . 0.0 109.453 169.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 mt -61.26 -44.52 97.11 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.89 45.52 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 124.634 1.111 . . . . 0.0 110.684 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -57.3 114.91 2.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.733 1.213 . . . . 0.0 110.513 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 55.24 32.98 19.66 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.166 0.987 . . . . 0.0 110.897 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.34 22.57 77.35 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.873 -0.959 . . . . 0.0 112.837 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -52.87 63.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.89 1.845 . . . . 0.0 111.636 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -43.91 91.36 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 116.759 -1.591 . . . . 0.0 109.533 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.8 -40.97 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.212 1.369 . . . . 0.0 110.991 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.47 -44.53 82.44 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.914 1.234 . . . . 0.0 112.765 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -54.52 45.96 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.123 0.874 . . . . 0.0 108.799 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' HA ' HG12 ' A' ' 63' ' ' VAL . 57.0 mt -60.12 -27.31 66.93 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.379 1.472 . . . . 0.0 112.491 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.7 m -62.84 -59.53 4.73 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.661 1.119 . . . . 0.0 109.579 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.4 89.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.177 0.991 . . . . 0.0 111.262 -171.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.7 p -57.62 -50.43 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.758 -1.115 . . . . 0.0 108.686 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.81 -49.48 83.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 124.644 1.178 . . . . 0.0 109.495 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -49.56 -46.38 48.75 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.538 1.135 . . . . 0.0 110.623 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -73.06 -53.56 10.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -49.9 -55.52 14.09 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 111.122 -176.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 92.5 m-85 -89.99 2.11 55.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.767 2.027 . . . . 0.0 112.429 -172.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.43 51.11 44.71 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.47 149.99 86.76 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 117.496 0.648 . . . . 0.0 109.433 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.52 124.66 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.697 1.598 . . . . 0.0 109.155 161.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.55 153.62 27.08 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.76 -14.44 3.52 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.598 0.618 . . . . 0.0 113.446 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.8 m -133.04 28.81 4.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.765 1.283 . . . . 0.0 112.236 -161.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.94 145.71 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.091 1.356 . . . . 0.0 107.803 159.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -128.29 148.34 50.65 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.118 1.367 . . . . 0.0 109.266 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.35 137.7 51.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.89 1.276 . . . . 0.0 109.02 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -134.5 168.13 19.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.858 2.463 . . . . 0.0 109.551 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 109.86 6.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.452 1.901 . . . . 0.0 109.018 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -104.13 156.27 18.02 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.616 1.166 . . . . 0.0 109.122 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.69 145.6 27.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.661 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.24 0.595 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 168.332 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -61.2 -34.02 74.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.464 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.98 -59.06 4.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.505 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -55.03 -38.57 68.13 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 118.787 0.721 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.06 -43.81 77.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.456 0.702 . . . . 0.0 110.612 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.15 -43.68 98.3 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 123.97 0.908 . . . . 0.0 109.932 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.17 -25.41 63.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.799 1.24 . . . . 0.0 112.57 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 19' ' ' GLU . 37.0 t80 -72.64 -64.66 0.91 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.393 1.477 . . . . 0.0 108.647 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.92 -43.7 60.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.297 2.239 . . . . 0.0 111.883 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -52.77 -34.04 51.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.071 0.851 . . . . 0.0 111.411 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -91.01 -41.25 11.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.35 -0.834 . . . . 0.0 110.103 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 15' ' ' PHE . 6.6 mm-40 -56.97 -42.92 81.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.749 1.22 . . . . 0.0 112.724 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -115.68 26.63 9.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.514 1.526 . . . . 0.0 109.731 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.38 61.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.125 1.37 . . . . 0.0 111.905 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -79.68 -14.56 58.68 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.262 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.99 -23.04 17.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -159.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 35.85 3.76 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 119.072 0.851 . . . . 0.0 112.687 -168.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.74 162.49 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.185 0.993 . . . . 0.0 109.361 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 m -136.73 -60.84 0.69 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.67 -167.85 29.9 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.91 155.16 17.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -125.67 164.12 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.011 0.91 . . . . 0.0 109.141 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.26 139.58 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.102 1.761 . . . . 0.0 107.357 -170.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -132.82 138.62 47.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 106.96 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.2 t -136.16 116.53 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 36.5 p -120.9 176.69 1.75 Allowed Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.56 0.744 . . . . 0.0 110.361 -164.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 61.3 Cg_endo -73.12 3.75 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 121.727 1.618 . . . . 0.0 112.452 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.9 p -113.44 -52.1 2.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.268 1.395 . . . . 0.0 111.145 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -160.61 174.71 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.364 1.465 . . . . 0.0 111.198 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -82.04 151.59 27.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.505 -0.747 . . . . 0.0 109.062 163.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.14 142.79 34.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.594 1.958 . . . . 0.0 108.018 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.2 mt -141.13 126.03 18.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.4 105.07 15.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -173.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -70.43 130.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.87 115.76 28.73 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.6 169.87 16.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.047 0.84 . . . . 0.0 111.015 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.8 p -70.5 -31.81 69.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.257 -0.902 . . . . 0.0 111.7 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -134.32 85.39 2.19 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 p -53.36 -38.56 63.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.106 0.962 . . . . 0.0 111.454 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -57.97 -44.31 87.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.616 1.167 . . . . 0.0 111.984 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -68.83 -40.62 79.36 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.046 0.538 . . . . 0.0 109.578 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -46.59 93.77 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 C-N-CA 122.978 0.511 . . . . 0.0 109.683 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.53 -36.22 70.94 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.994 -1.066 . . . . 0.0 111.086 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 179.88 50.98 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 109.52 0.5 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.032 1.333 . . . . 0.0 109.277 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 mttm 40.22 46.16 1.87 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.439 1.496 . . . . 0.0 112.765 -173.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.99 9.3 82.72 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.17 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -46.08 78.43 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.57 2.185 . . . . 0.0 113.008 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -45.21 90.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.626 1.103 . . . . 0.0 110.678 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tt -67.55 -34.99 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.456 1.026 . . . . 0.0 111.111 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -57.36 -50.96 71.29 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.575 -0.703 . . . . 0.0 109.889 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -61.07 2.53 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.346 1.058 . . . . 0.0 109.705 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.0 mt -57.74 -34.97 70.08 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.525 -174.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 m -57.64 -48.08 80.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.437 1.017 . . . . 0.0 109.484 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.77 -42.76 73.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.059 0.944 . . . . 0.0 112.005 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.3 p -66.75 -45.75 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.647 1.112 . . . . 0.0 109.736 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -55.67 -45.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.084 1.311 . . . . 0.0 109.511 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.71 -46.42 67.35 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.123 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -71.9 -50.66 27.3 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.075 0.852 . . . . 0.0 111.666 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -39.79 86.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.415 1.086 . . . . 0.0 110.787 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.72 3.77 24.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 111.737 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.91 26.75 71.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.072 0.844 . . . . 0.0 112.823 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -67.77 145.51 98.05 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 118.35 1.075 . . . . 0.0 109.595 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.22 165.66 16.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.795 2.33 . . . . 0.0 110.737 160.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -88.38 147.98 24.47 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.98 -45.99 2.59 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.403 1.478 . . . . 0.0 112.454 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 m -72.04 8.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.257 1.823 . . . . 0.0 112.501 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.87 126.0 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 162.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 146.61 38.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -120.55 140.71 51.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -132.93 165.32 24.94 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.47 1.908 . . . . 0.0 108.569 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.59 109.08 5.59 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -111.38 155.01 23.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.554 1.541 . . . . 0.0 110.371 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.97 141.01 29.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.517 0.675 . . . . 0.0 112.348 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 C--O 1.241 0.613 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.112 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 t80 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -62.11 -29.65 70.47 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.426 -1.273 . . . . 0.0 110.625 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.02 4.46 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.5 1.5 . . . . 0.0 110.387 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.53 -45.16 73.33 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.915 0.486 . . . . 0.0 110.555 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.83 -43.3 84.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.671 0.388 . . . . 0.0 110.455 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -57.26 -51.52 69.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 109.447 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.18 -52.94 62.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.404 0.682 . . . . 0.0 111.028 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -53.27 -48.52 68.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.412 1.085 . . . . 0.0 111.145 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.41 -38.68 81.48 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.58 1.552 . . . . 0.0 111.615 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -51.71 -47.29 64.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -66.97 -47.17 72.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 111.821 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.66 -12.83 60.86 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.999 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.17 15.45 8.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 113.499 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.53 27.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.324 1.05 . . . . 0.0 112.064 -172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -87.81 -26.86 22.62 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.53 -34.74 76.04 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.738 0.699 . . . . 0.0 110.31 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 65.25 0.53 Allowed Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -67.84 174.2 3.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.915 1.34 . . . . 0.0 110.266 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -164.4 -23.99 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.06 1.344 . . . . 0.0 112.046 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.15 -161.78 29.82 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -161.3 155.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -125.94 160.22 30.56 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 108.631 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.91 135.4 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 126.053 1.741 . . . . 0.0 108.287 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -132.62 122.74 25.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.13 92.76 2.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 43.7 p -84.07 176.83 3.39 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.702 1.601 . . . . 0.0 109.433 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 85.6 Cg_endo -76.38 6.08 4.23 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.052 1.835 . . . . 0.0 113.21 165.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -116.6 -57.97 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.68 1.582 . . . . 0.0 112.169 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -161.67 149.58 15.0 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.056 1.342 . . . . 0.0 108.055 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -70.93 138.64 50.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -110.42 137.37 48.22 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.97 122.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.87 103.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.01 145.51 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -115.22 112.04 21.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.47 165.75 26.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.399 0.679 . . . . 0.0 111.522 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.9 p -85.59 -21.55 28.44 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.866 -1.146 . . . . 0.0 113.503 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -131.64 59.17 1.7 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.853 0.751 . . . . 0.0 109.28 -166.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -56.8 -37.37 71.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -63.8 -37.08 86.03 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 120.101 1.319 . . . . 0.0 110.072 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.6 -49.28 78.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.861 1.264 . . . . 0.0 109.014 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.29 -44.83 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.751 2.02 . . . . 0.0 110.904 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.04 -39.12 93.8 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.365 -0.834 . . . . 0.0 110.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 -179.27 48.85 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 122.278 0.932 . . . . 0.0 112.008 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.23 109.1 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.357 2.263 . . . . 0.0 110.937 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt 43.43 50.65 6.16 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.67 1.588 . . . . 0.0 110.673 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 37.67 69.2 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.866 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -67.38 0.42 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.042 1.421 . . . . 0.0 112.351 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -36.74 84.75 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.361 -172.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.78 -44.88 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 119.129 0.877 . . . . 0.0 111.964 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -63.11 -49.5 74.19 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.996 -1.065 . . . . 0.0 110.949 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -51.58 66.31 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.164 0.585 . . . . 0.0 110.046 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 88.8 mt -67.95 -30.16 69.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.613 -1.185 . . . . 0.0 112.096 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.0 m -56.99 -37.28 71.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.736 1.153 . . . . 0.0 110.32 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.51 17.4 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.845 1.202 . . . . 0.0 111.337 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 60' ' ' LEU 0.261 2.0 p -61.46 -42.47 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.124 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.36 -47.72 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 121.249 1.84 . . . . 0.0 109.814 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.417 HE22 ' HG2' ' A' ' 72' ' ' GLU . 9.0 mt-30 -53.43 -37.34 62.47 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.26 0.482 . . . . 0.0 111.845 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 -38.93 18.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.209 0.913 . . . . 0.0 111.138 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.53 -36.78 83.66 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.838 1.255 . . . . 0.0 110.505 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 94.1 m-85 -114.66 -21.33 10.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 112.74 -168.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.03 50.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.052 1.311 . . . . 0.0 114.442 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -53.29 145.65 25.35 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.169 1.484 . . . . 0.0 113.355 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -68.84 156.69 64.59 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.786 2.99 . . . . 0.0 111.578 163.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' HE22 ' A' ' 65' ' ' GLN . 12.3 mt-10 -71.95 139.98 48.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.72 -21.17 1.27 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.897 -1.502 . . . . 0.0 115.026 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m -80.9 -8.69 59.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 120.048 1.924 . . . . 0.0 112.703 168.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.63 126.81 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -113.04 139.54 48.59 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 163.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.32 134.45 54.88 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 72.0 m-85 -132.72 171.76 13.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.747 2.019 . . . . 0.0 109.262 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.91 148.96 52.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 167.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.87 52.09 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.659 1.584 . . . . 0.0 107.517 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -82.96 151.23 25.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.74 178.63 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.5 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -57.35 -43.19 83.27 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.34 -55.39 24.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 117.477 -1.249 . . . . 0.0 108.517 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -47.77 -41.36 23.11 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.496 1.118 . . . . 0.0 111.062 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.27 -45.95 21.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.298 1.439 . . . . 0.0 111.687 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -58.29 -53.84 53.77 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.283 1.033 . . . . 0.0 110.009 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.16 -43.98 96.78 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.855 0.862 . . . . 0.0 111.039 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -48.02 -61.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.59 1.556 . . . . 0.0 110.254 168.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.77 -35.68 78.83 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.566 0.746 . . . . 0.0 112.105 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.5 m -60.75 -29.1 69.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.403 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -90.58 -30.23 17.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.674 1.19 . . . . 0.0 112.59 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.32 -22.33 52.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.49 23.88 3.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.281 1.032 . . . . 0.0 111.755 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.42 34.38 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.953 1.301 . . . . 0.0 112.187 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -71.56 -31.77 67.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.491 0.716 . . . . 0.0 110.503 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.93 -44.2 94.49 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.176 0.99 . . . . 0.0 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.47 28.37 0.52 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.801 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.34 148.53 41.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.367 1.584 . . . . 0.0 112.226 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 -30.5 1.32 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.519 1.128 . . . . 0.0 113.054 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.89 -170.46 43.42 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 120.11 1.323 . . . . 0.0 110.806 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.06 152.25 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -126.68 108.89 11.49 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.831 1.253 . . . . 0.0 107.911 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.5 146.53 6.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.467 1.507 . . . . 0.0 108.44 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -131.9 150.28 52.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.87 1.268 . . . . 0.0 107.755 167.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.41 121.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 48.5 p -120.81 176.75 1.71 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.517 1.527 . . . . 0.0 109.423 -165.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.4 Cg_endo -79.47 4.02 6.99 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.183 1.922 . . . . 0.0 113.833 165.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -121.48 -58.53 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.095 1.316 . . . . 0.0 111.907 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -161.57 138.19 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.664 1.586 . . . . 0.0 110.315 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 m -58.5 143.92 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.74 146.42 39.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 172.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.74 117.4 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.28 113.45 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.76 117.81 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.761 1.224 . . . . 0.0 108.86 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 mt -89.72 110.49 21.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.256 1.822 . . . . 0.0 108.49 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 168.17 20.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.345 0.658 . . . . 0.0 110.865 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -66.73 -35.97 81.35 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.927 -1.108 . . . . 0.0 111.299 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -120.61 79.23 1.46 Allowed 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.555 0.742 . . . . 0.0 109.555 -165.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.59 -48.52 14.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.628 1.571 . . . . 0.0 111.365 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -65.46 -27.41 68.49 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.258 -0.901 . . . . 0.0 112.258 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -70.59 -44.05 68.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.893 1.224 . . . . 0.0 108.938 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.29 -35.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.491 1.116 . . . . 0.0 110.592 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.3 -44.53 71.58 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.662 -1.273 . . . . 0.0 108.871 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.45 45.01 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.5 1.048 . . . . 0.0 111.919 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.72 123.76 14.29 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.247 1.019 . . . . 0.0 108.46 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt 46.79 39.67 7.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.865 0.866 . . . . 0.0 111.959 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.77 30.16 72.65 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.98 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -67.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.398 2.099 . . . . 0.0 112.815 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -37.41 87.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.68 -169.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 tt -57.64 -56.93 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.948 0.794 . . . . 0.0 109.757 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -56.31 -43.57 79.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.224 1.409 . . . . 0.0 112.34 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.14 -58.71 7.46 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.411 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.37 -25.05 66.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.855 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.6 m -57.79 -55.1 39.29 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.378 1.444 . . . . 0.0 109.724 167.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.63 89.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.455 0.702 . . . . 0.0 111.203 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 59' ' ' GLU . 38.1 t -53.78 -59.12 2.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 t -61.26 -39.78 83.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.059 0.944 . . . . 0.0 111.016 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.44 -37.7 70.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.733 0.697 . . . . 0.0 111.067 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.69 -55.27 4.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.734 0.697 . . . . 0.0 109.995 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -39.41 60.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.368 1.867 . . . . 0.0 111.898 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.49 -1.29 13.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.1 1.36 . . . . 0.0 111.546 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.18 78.91 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 120.85 -1.156 . . . . 0.0 114.702 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.31 147.67 75.1 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.819 1.31 . . . . 0.0 112.648 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.53 141.29 79.73 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.747 2.965 . . . . 0.0 111.979 168.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -66.41 141.42 57.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.83 -16.76 6.41 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.214 -0.77 . . . . 0.0 114.294 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -121.48 9.95 10.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 112.916 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.01 155.28 26.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 159.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -139.33 156.44 47.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.753 1.221 . . . . 0.0 108.433 164.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -131.71 134.83 46.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -132.47 160.98 34.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.433 1.893 . . . . 0.0 108.386 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 142.11 46.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.616 0.767 . . . . 0.0 108.961 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -141.7 153.81 44.91 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 108.769 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.66 146.86 27.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 122.38 1.086 . . . . 0.0 108.188 175.077 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.5 t80 . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -53.22 -41.95 65.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.312 1.045 . . . . 0.0 112.009 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.78 25.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.78 1.232 . . . . 0.0 109.588 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.7 -40.33 62.86 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.446 0.566 . . . . 0.0 111.448 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 tp -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.972 1.309 . . . . 0.0 110.826 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -63.0 -43.71 98.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.185 0.594 . . . . 0.0 110.335 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.28 -30.7 71.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.452 1.101 . . . . 0.0 112.853 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -67.51 -63.97 0.95 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.5 mt -56.45 -33.14 65.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.605 1.162 . . . . 0.0 111.96 -168.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -46.2 -46.53 17.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.162 0.985 . . . . 0.0 111.783 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.48 -56.69 4.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.69 -26.51 45.33 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 113.521 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.62 18.9 9.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.774 1.229 . . . . 0.0 111.359 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.94 -64.31 0.87 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.908 0.883 . . . . 0.0 111.023 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.85 -22.12 62.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.474 -0.766 . . . . 0.0 111.309 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.7 -24.29 67.53 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.545 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.06 25.29 3.05 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.459 1.027 . . . . 0.0 114.763 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.757 ' HE1' HG23 ' A' ' 41' ' ' ILE . 40.6 t80 -63.65 165.2 8.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 112.42 -168.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.97 -52.93 0.22 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.729 1.212 . . . . 0.0 110.46 171.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.09 -172.02 38.3 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 118.927 0.785 . . . . 0.0 111.429 -171.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.46 134.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.53 161.91 13.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 164.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.14 144.91 23.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -120.1 160.47 22.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.39 115.71 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 4.3 p -121.01 176.85 1.68 Allowed Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -169.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 81.3 Cg_endo -78.84 12.17 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.281 1.988 . . . . 0.0 111.448 166.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.9 p -127.7 -50.04 1.37 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 0.0 112.579 -170.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -162.6 173.6 13.72 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.142 1.777 . . . . 0.0 110.156 -169.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.1 m -98.23 149.17 22.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -125.32 142.57 51.42 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.764 2.026 . . . . 0.0 105.757 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -129.0 125.93 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -123.73 97.56 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.757 HG23 ' HE1' ' A' ' 25' ' ' TYR . 4.9 mp -76.87 125.95 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.4 108.09 20.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.064 2.146 . . . . 0.0 107.131 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.95 168.09 20.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.852 1.31 . . . . 0.0 110.354 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 p -79.12 -26.84 42.85 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.955 -1.091 . . . . 0.0 111.769 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -129.01 79.93 1.94 Allowed 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.76 1.624 . . . . 0.0 107.904 -167.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 p -48.98 -39.2 25.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.334 1.053 . . . . 0.0 111.334 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.89 -39.95 95.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.215 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -59.87 -48.82 80.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.742 1.155 . . . . 0.0 109.183 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.06 -43.65 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.908 1.283 . . . . 0.0 110.786 -174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.84 -36.67 84.12 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.643 -0.66 . . . . 0.0 109.878 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.57 175.68 41.18 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.058 1.313 . . . . 0.0 110.554 -167.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 55' ' ' ARG . 4.2 tt0 -55.5 128.18 33.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 167.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp 50.33 38.86 18.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.649 0.779 . . . . 0.0 112.839 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.84 10.01 67.01 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.795 0.712 . . . . 0.0 113.907 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 52' ' ' GLU . 17.0 mtm180 -52.31 -53.34 45.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 113.244 -175.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.88 74.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 116.176 -1.868 . . . . 0.0 109.954 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -60.73 -38.05 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 121.562 1.983 . . . . 0.0 111.224 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -52.73 64.31 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.304 -0.873 . . . . 0.0 110.854 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -28.12 63.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.434 1.094 . . . . 0.0 112.108 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 63' ' ' VAL . 31.6 mt -80.03 -24.82 40.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.139 1.376 . . . . 0.0 110.467 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -66.28 -55.38 16.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.19 70.35 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.457 1.103 . . . . 0.0 111.965 -174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 60' ' ' LEU . 12.8 p -58.65 -47.91 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.702 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.36 -39.83 82.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-N 119.649 1.113 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -53.84 -44.94 70.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.799 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.83 -58.45 3.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.819 0.736 . . . . 0.0 109.659 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -45.77 54.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.549 1.54 . . . . 0.0 111.848 -168.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.12 -1.8 25.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.46 47.62 89.67 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 125.244 1.402 . . . . 0.0 112.177 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -80.05 145.62 61.46 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.202 1.001 . . . . 0.0 111.32 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.49 137.52 51.06 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.484 2.123 . . . . 0.0 109.713 166.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.36 143.04 58.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.353 1.061 . . . . 0.0 109.512 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 -6.49 6.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.397 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -117.05 8.37 13.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.128 1.771 . . . . 0.0 112.17 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -113.71 140.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 154.19 51.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 168.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -121.65 136.45 54.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -125.17 163.21 22.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.885 1.674 . . . . 0.0 107.461 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.68 109.12 9.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.163 0.585 . . . . 0.0 109.796 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -119.88 145.8 46.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.439 0.638 . . . . 0.0 110.385 -168.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.75 140.16 36.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 -167.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.141 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.5 t80 . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -54.3 -29.43 47.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.19 1.396 . . . . 0.0 113.499 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -58.12 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.395 2.278 . . . . 0.0 111.007 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -56.05 -40.63 73.81 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.633 1.106 . . . . 0.0 111.2 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.11 -36.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 110.593 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.19 -51.5 67.55 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.585 0.754 . . . . 0.0 109.587 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.34 -27.46 67.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.148 0.979 . . . . 0.0 111.864 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.05 -63.37 1.09 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.429 1.092 . . . . 0.0 109.104 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.05 -31.55 71.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.49 1.116 . . . . 0.0 112.234 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.4 m -55.91 -35.68 66.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.102 1.361 . . . . 0.0 111.157 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -90.54 -44.64 9.43 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.932 -0.48 . . . . 0.0 110.112 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.86 -42.25 93.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.953 0.342 . . . . 0.0 111.902 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.56 20.64 16.42 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.032 1.733 . . . . 0.0 110.554 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.52 -58.87 4.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.398 1.479 . . . . 0.0 110.141 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 -19.74 55.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.632 0.773 . . . . 0.0 111.995 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -71.09 -32.58 69.24 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.282 0.633 . . . . 0.0 110.386 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.07 47.02 1.11 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.399 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.72 171.24 0.49 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.698 1.599 . . . . 0.0 112.967 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.77 -42.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.812 1.645 . . . . 0.0 111.479 170.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.2 -170.29 43.33 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.79 153.99 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -119.94 158.0 27.62 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.437 1.495 . . . . 0.0 109.055 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.41 129.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.34 1.056 . . . . 0.0 110.265 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -125.81 122.93 37.59 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.247 1.019 . . . . 0.0 108.93 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.26 130.09 38.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 163.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 27.1 p -121.76 170.66 7.28 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.612 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 71.6 Cg_endo -74.08 19.37 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.906 2.404 . . . . 0.0 112.809 165.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 p -127.25 -58.1 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -154.44 173.44 16.25 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.285 1.834 . . . . 0.0 109.494 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.2 m -86.54 148.54 25.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 162.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.94 131.69 33.38 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.678 1.591 . . . . 0.0 106.881 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.81 123.65 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.62 1.568 . . . . 0.0 107.799 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.7 112.51 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -73.09 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -99.94 118.09 35.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.079 165.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.62 167.05 25.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.301 0.5 . . . . 0.0 111.258 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -67.13 -45.56 76.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.874 0.47 . . . . 0.0 110.798 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -122.93 82.43 1.99 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.045 1.738 . . . . 0.0 108.144 -167.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 p -46.58 -42.92 16.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.457 1.103 . . . . 0.0 110.552 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -45.15 74.25 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.644 1.111 . . . . 0.0 112.339 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -68.59 -42.26 78.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.71 -31.44 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.062 1.745 . . . . 0.0 110.837 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -76.77 -42.32 41.37 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.29 1.036 . . . . 0.0 110.185 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.19 176.12 27.02 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.165 0.888 . . . . 0.0 111.294 -171.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.88 116.91 4.09 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.366 0.666 . . . . 0.0 110.484 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.1 mttt 42.31 44.63 3.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.238 1.415 . . . . 0.0 111.648 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.5 73.77 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.506 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.29 -56.67 11.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.558 1.679 . . . . 0.0 112.658 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.27 -48.41 81.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.273 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -60.44 -44.47 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.077 0.853 . . . . 0.0 109.879 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -38.19 82.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.362 0.983 . . . . 0.0 112.891 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -62.18 1.85 Allowed 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.01 -24.88 68.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.009 -1.472 . . . . 0.0 111.767 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.0 m -55.55 -51.87 65.63 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 120.683 1.583 . . . . 0.0 108.946 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.24 82.69 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.833 0.742 . . . . 0.0 110.669 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.44 -50.01 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 118.691 0.678 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.86 -51.23 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.372 1.469 . . . . 0.0 109.871 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -54.76 -28.35 47.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -93.48 -44.93 8.0 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.364 0.983 . . . . 0.0 110.213 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -55.04 -39.52 69.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.01 1.324 . . . . 0.0 111.188 174.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 91.9 m-85 -115.07 5.99 15.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.69 1.196 . . . . 0.0 111.417 -171.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.78 41.62 66.86 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.896 2.189 . . . . 0.0 114.576 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -81.9 145.51 53.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.576 1.188 . . . . 0.0 111.488 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.49 153.8 73.06 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.109 1.873 . . . . 0.0 110.888 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.21 122.56 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.759 1.224 . . . . 0.0 109.359 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 -14.76 4.95 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.318 0.961 . . . . 0.0 114.467 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -74.74 -6.88 51.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.192 0.997 . . . . 0.0 111.522 161.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.18 149.46 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 162.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -137.29 149.68 47.25 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 165.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.96 122.64 46.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -118.3 165.62 13.62 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 127.71 2.404 . . . . 0.0 108.997 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.68 113.52 7.88 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.191 1.396 . . . . 0.0 109.202 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.04 154.93 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.86 1.664 . . . . 0.0 109.18 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -90.9 156.12 18.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 C--O 1.237 0.439 0 CA-C-O 122.227 1.013 . . . . 0.0 109.665 -179.819 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 t80 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 29' ' ' GLU . 79.5 tttt -57.47 -31.9 66.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.778 -0.629 . . . . 0.0 111.247 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -39.8 47.39 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.234 0.925 . . . . 0.0 111.766 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.29 -43.85 96.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.358 0.981 . . . . 0.0 109.365 171.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.58 -39.22 93.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.392 0.677 . . . . 0.0 110.54 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.18 -56.33 22.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.161 1.384 . . . . 0.0 109.772 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.2 -28.43 68.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.35 -64.76 0.79 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.567 1.147 . . . . 0.0 109.006 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.28 -37.28 74.7 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 112.646 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.5 m -51.14 -48.32 61.85 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.817 0.847 . . . . 0.0 110.367 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -75.45 -42.22 53.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.134 -0.46 . . . . 0.0 109.919 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -31.57 72.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.836 0.744 . . . . 0.0 111.881 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.7 mt -119.01 15.84 13.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.314 -165.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.83 -63.1 0.92 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.033 1.333 . . . . 0.0 112.331 -173.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -15.46 59.56 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -71.66 -12.1 61.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.678 1.126 . . . . 0.0 111.06 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.5 47.73 4.21 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.699 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -56.96 166.32 1.04 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.933 1.349 . . . . 0.0 110.519 168.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 2.0 m -156.76 -37.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.792 2.037 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.23 -169.32 42.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 124.21 0.909 . . . . 0.0 110.853 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.69 154.13 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -116.55 162.57 17.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.659 1.984 . . . . 0.0 110.124 164.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.36 137.47 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.853 1.261 . . . . 0.0 108.342 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -127.61 127.48 43.9 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.5 91.78 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 12.7 p -90.36 169.64 11.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 54.4 Cg_endo -73.35 4.04 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.832 2.355 . . . . 0.0 112.922 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 p -113.34 -54.89 2.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.354 0.979 . . . . 0.0 110.922 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -155.47 157.82 37.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.61 1.564 . . . . 0.0 108.614 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 m -68.22 139.33 56.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 161.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.33 139.97 44.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.94 124.65 65.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.93 93.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -172.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.16 122.25 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' SER . 63.9 mt -98.39 73.02 2.11 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.633 1.173 . . . . 0.0 109.446 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.7 160.41 15.73 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.423 1.465 . . . . 0.0 111.352 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -72.32 -25.1 61.43 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.676 -1.265 . . . . 0.0 111.527 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -131.81 72.17 1.49 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.541 1.136 . . . . 0.0 108.733 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -56.74 -40.25 75.43 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.45 -0.781 . . . . 0.0 111.808 -174.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -53.33 -39.31 63.99 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.811 1.244 . . . . 0.0 112.634 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.01 -45.34 67.44 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.442 0.697 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.4 -39.73 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.396 0.678 . . . . 0.0 109.302 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.6 -39.09 93.49 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.289 -0.882 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 172.79 28.44 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -165.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -54.87 126.25 23.52 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.706 -0.879 . . . . 0.0 109.67 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.279 58.9 pttt 39.96 42.3 1.05 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.206 1.802 . . . . 0.0 113.507 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.75 20.99 77.62 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.489 -0.757 . . . . 0.0 113.27 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -44.56 -67.26 0.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.407 1.483 . . . . 0.0 111.689 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -32.87 67.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.637 -169.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 tt -61.86 -40.89 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.144 1.338 . . . . 0.0 111.655 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.32 -45.31 88.46 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.027 1.285 . . . . 0.0 110.625 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.25 -48.02 79.91 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.01 0.524 . . . . 0.0 110.518 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 63' ' ' VAL . 10.5 mt -63.93 -36.13 82.95 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 117.975 -1.012 . . . . 0.0 111.524 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.2 m -59.6 -48.99 79.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 120.425 1.466 . . . . 0.0 109.364 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.15 79.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 60' ' ' LEU . 8.0 p -60.66 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.515 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -58.36 -41.75 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.697 1.589 . . . . 0.0 109.54 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -32.79 63.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.063 0.545 . . . . 0.0 111.915 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -96.83 -19.51 18.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.788 2.035 . . . . 0.0 112.842 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -20.63 27.12 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.286 -1.509 . . . . 0.0 110.231 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.69 1.34 4.93 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.665 1.186 . . . . 0.0 112.05 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.77 10.03 66.84 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.574 1.079 . . . . 0.0 114.299 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -57.32 151.98 34.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.915 0.857 . . . . 0.0 111.982 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 58.4 Cg_endo -69.66 174.24 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.988 3.792 . . . . 0.0 109.561 166.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 153.99 22.07 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.72 -46.25 0.55 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.41 1.957 . . . . 0.0 112.569 -166.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 56.1 m -77.86 8.64 4.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.549 1.94 . . . . 0.0 113.194 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.82 131.41 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 160.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -122.08 148.84 44.37 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.356 1.062 . . . . 0.0 108.251 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.81 145.14 42.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.42 162.75 31.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.811 2.044 . . . . 0.0 107.317 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.1 145.35 43.11 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -139.96 141.43 36.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 139.68 36.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.239 0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.706 177.224 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.2 -29.13 68.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.769 0.828 . . . . 0.0 111.879 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.44 -63.66 1.01 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 109.08 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.67 -45.6 19.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.911 1.285 . . . . 0.0 111.581 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 8.7 tp -74.41 -35.81 63.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.219 0.608 . . . . 0.0 111.771 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -66.96 -45.01 79.07 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 109.69 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.59 -55.63 20.94 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.949 0.9 . . . . 0.0 110.147 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.5 -63.53 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.755 1.622 . . . . 0.0 110.033 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.9 mt -59.78 -30.96 69.24 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.814 0.846 . . . . 0.0 113.197 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -55.58 -36.14 66.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.245 0.618 . . . . 0.0 111.237 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -88.35 -52.37 5.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.8 -20.41 49.84 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.59 25.54 4.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.344 1.458 . . . . 0.0 112.015 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.5 -63.17 1.07 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.091 1.757 . . . . 0.0 111.92 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -73.07 -29.83 63.25 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 122.037 -0.414 . . . . 0.0 110.6 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -64.73 -29.87 70.86 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.4 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.24 34.35 0.89 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-O 118.824 -0.986 . . . . 0.0 114.325 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -57.02 171.43 0.36 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.109 1.764 . . . . 0.0 113.705 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -141.29 -60.77 0.48 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.432 1.493 . . . . 0.0 109.215 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.12 41.89 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.53 145.5 16.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.251 -1.146 . . . . 0.0 108.8 -170.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.06 150.83 26.11 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.439 1.496 . . . . 0.0 107.857 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.38 143.29 41.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.125 1.77 . . . . 0.0 107.011 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -133.65 153.31 51.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.8 t -140.1 118.84 11.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 17.5 p -119.68 170.53 6.7 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.0 Cg_endo -69.82 8.65 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.961 1.774 . . . . 0.0 112.589 175.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 p -121.9 -56.31 1.85 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.769 1.168 . . . . 0.0 110.204 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -140.44 170.62 15.45 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.188 0.904 . . . . 0.0 111.589 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 m -87.21 151.07 23.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.75 134.36 45.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -126.0 120.85 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.19 99.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -69.38 139.7 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt -108.96 112.11 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -145.31 171.13 15.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 110.422 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 p -84.26 -28.98 26.83 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.15 -0.969 . . . . 0.0 112.525 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -131.46 73.11 1.52 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -167.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -54.0 -27.81 34.04 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.435 1.094 . . . . 0.0 112.878 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -57.46 -44.39 84.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.828 0.851 . . . . 0.0 111.098 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.92 -38.91 79.84 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.437 1.095 . . . . 0.0 111.538 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 43' ' ' ALA . 61.5 t -65.4 -39.09 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.704 0.802 . . . . 0.0 110.062 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -74.98 -43.66 52.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.69 -172.03 33.0 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -59.66 106.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.798 1.639 . . . . 0.0 110.831 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt 42.69 47.73 4.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.513 1.525 . . . . 0.0 111.202 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.3 11.16 81.12 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.749 -2.139 . . . . 0.0 114.026 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -45.51 -60.13 2.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.244 2.522 . . . . 0.0 112.058 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -50.54 73.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.473 1.033 . . . . 0.0 109.327 -174.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -65.22 -34.33 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.974 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -64.67 -61.09 2.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.694 1.198 . . . . 0.0 110.085 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -50.21 -50.9 48.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 125.709 1.604 . . . . 0.0 111.235 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.1 -21.29 64.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.002 -1.475 . . . . 0.0 112.197 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -56.88 -46.18 82.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 121.53 1.968 . . . . 0.0 108.382 167.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.02 76.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.692 0.678 . . . . 0.0 111.528 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.57 -54.39 35.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.22 -47.37 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 124.611 1.164 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -53.94 -42.11 68.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.535 0.607 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -80.74 -50.69 9.55 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 109.409 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -46.84 68.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.414 1.086 . . . . 0.0 110.682 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 73.9 m-85 -96.19 -14.4 22.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.76 0.824 . . . . 0.0 112.267 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.89 51.86 13.61 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.18 154.25 49.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.097 0.959 . . . . 0.0 110.117 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 167.21 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.3 2.666 . . . . 0.0 111.485 159.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -77.77 161.45 27.68 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 163.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.84 -1.52 4.5 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.93 1.252 . . . . 0.0 114.586 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -132.33 14.73 4.58 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.474 1.51 . . . . 0.0 111.823 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.9 125.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 165.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.75 146.58 43.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.47 134.06 55.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -130.5 165.71 22.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.647 2.379 . . . . 0.0 108.645 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.62 6.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.268 1.027 . . . . 0.0 108.654 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 152.82 21.37 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.494 1.518 . . . . 0.0 108.045 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -97.0 143.78 27.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.323 -0.583 0 C-N-CA 123.785 0.834 . . . . 0.0 108.759 178.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 t80 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.861 0.362 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -61.6 -36.94 82.13 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.051 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.03 -53.88 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.456 1.502 . . . . 0.0 111.379 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -57.94 -43.73 86.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.383 0.538 . . . . 0.0 110.598 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.51 -42.42 92.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.904 0.481 . . . . 0.0 110.219 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.95 -50.45 73.36 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 123.871 0.868 . . . . 0.0 109.991 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -59.49 -37.95 79.6 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -59.52 -60.42 3.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.461 1.028 . . . . 0.0 110.228 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 41' ' ' ILE . 66.8 mt -59.05 -35.48 73.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.649 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 m -53.43 -31.2 44.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.921 1.289 . . . . 0.0 112.709 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -90.51 -54.09 4.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.992 0.814 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.87 -39.96 63.04 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.619 0.767 . . . . 0.0 111.518 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -106.94 18.89 21.23 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.737 1.215 . . . . 0.0 112.295 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.08 -50.09 73.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.266 -0.896 . . . . 0.0 112.746 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.49 -15.09 58.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.74 0.7 . . . . 0.0 111.479 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.24 -41.3 70.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 109.532 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.77 45.46 0.47 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 119.111 -0.827 . . . . 0.0 114.861 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.622 ' HE1' HG23 ' A' ' 41' ' ' ILE . 66.3 t80 -60.56 167.16 2.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.422 1.111 . . . . 0.0 112.277 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -158.96 -27.06 0.07 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.62 -169.74 40.8 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.59 149.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.74 158.51 21.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.722 1.249 . . . . 0.0 109.045 161.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.43 125.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -167.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -133.07 125.53 29.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.012 1.325 . . . . 0.0 108.291 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -116.47 127.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 47.5 p -121.66 174.98 2.74 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 124.797 1.239 . . . . 0.0 109.276 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 49.2 Cg_endo -69.64 3.72 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.942 1.761 . . . . 0.0 113.513 167.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.8 p -113.3 -59.75 1.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.923 1.238 . . . . 0.0 110.511 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -158.75 157.2 31.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.663 1.574 . . . . 0.0 112.933 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.0 m -62.97 147.57 50.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.235 1.014 . . . . 0.0 108.668 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.79 134.93 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.242 2.217 . . . . 0.0 107.381 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -124.94 123.12 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.37 94.01 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.622 HG23 ' HE1' ' A' ' 25' ' ' TYR . 3.4 mp -68.49 139.74 20.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt -107.2 115.3 29.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 127.989 2.516 . . . . 0.0 105.922 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.73 175.83 10.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.758 0.708 . . . . 0.0 112.847 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.32 -21.65 21.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.333 -1.479 . . . . 0.0 114.22 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -137.09 70.9 1.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.476 1.11 . . . . 0.0 108.828 -162.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -57.54 -33.63 68.3 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.527 -0.733 . . . . 0.0 112.109 -173.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -60.16 -36.94 78.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.654 1.116 . . . . 0.0 112.416 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -71.83 -43.68 65.15 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.175 0.99 . . . . 0.0 109.273 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.5 t -57.79 -50.62 77.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 125.898 1.679 . . . . 0.0 108.835 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.63 -31.45 72.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.679 0.792 . . . . 0.0 111.342 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.64 178.84 44.05 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -169.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.86 125.51 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 51.87 21.96 1.61 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.9 63.07 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.672 1.124 . . . . 0.0 113.985 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -55.14 -54.76 39.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 112.56 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -39.08 85.26 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.625 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 tt -63.03 -38.36 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 120.331 1.423 . . . . 0.0 110.97 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -41.21 97.39 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.614 -1.304 . . . . 0.0 111.85 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.89 -58.53 7.59 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 63' ' ' VAL . 61.7 mt -55.44 -40.88 72.11 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.878 1.671 . . . . 0.0 111.961 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.3 m -55.21 -50.87 68.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.261 1.392 . . . . 0.0 111.266 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.38 84.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.049 0.84 . . . . 0.0 112.174 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' LEU . 3.7 p -61.75 -49.73 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.801 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.77 -47.35 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 119.696 1.135 . . . . 0.0 110.337 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -54.17 -47.02 72.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.75 . . . . 0.0 110.607 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -73.78 -41.77 61.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.073 0.851 . . . . 0.0 110.085 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -51.61 63.7 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 109.845 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.59 1.89 46.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.264 1.426 . . . . 0.0 111.28 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 18.73 75.48 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.885 1.231 . . . . 0.0 114.072 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -63.18 149.47 90.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 118.545 1.173 . . . . 0.0 112.028 -174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.44 132.73 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.862 2.374 . . . . 0.0 110.102 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -57.51 141.83 46.37 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.223 1.009 . . . . 0.0 110.939 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 -12.78 1.06 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.195 1.379 . . . . 0.0 113.454 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.9 m -115.27 14.59 16.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.909 1.684 . . . . 0.0 111.333 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.84 144.34 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.741 1.617 . . . . 0.0 107.134 154.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.97 151.62 49.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.37 1.468 . . . . 0.0 108.911 172.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -124.7 128.62 49.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -112.29 168.74 9.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.057 2.143 . . . . 0.0 107.339 175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 108.72 6.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -104.85 166.32 10.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.558 1.143 . . . . 0.0 109.166 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -112.98 143.21 44.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.944 -0.473 . . . . 0.0 110.823 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.24 0.595 0 C-N-CA 124.201 1.0 . . . . 0.0 111.345 171.635 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.7 t80 . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -59.66 -33.75 71.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.287 -1.339 . . . . 0.0 111.345 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.21 13.44 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.471 -1.252 . . . . 0.0 110.038 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.14 -46.77 65.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.483 1.038 . . . . 0.0 109.888 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.52 -40.86 96.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.008 0.923 . . . . 0.0 111.087 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -62.36 -51.75 66.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.798 1.239 . . . . 0.0 109.695 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.32 -27.18 65.15 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 111.29 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.05 -63.26 1.1 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.848 1.659 . . . . 0.0 108.973 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.31 -35.77 72.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.244 1.018 . . . . 0.0 112.093 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.7 m -50.53 -43.35 55.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.338 0.655 . . . . 0.0 111.148 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -42.75 18.03 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.143 0.429 . . . . 0.0 110.215 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -21.74 61.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.975 -172.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.07 30.81 6.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.14 2.176 . . . . 0.0 110.43 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.91 82.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.57 -8.2 58.42 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.983 0.81 . . . . 0.0 111.4 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -16.98 58.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.005 0.922 . . . . 0.0 113.14 -169.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.37 47.8 7.21 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 118.722 -1.704 . . . . 0.0 109.576 -163.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -64.0 142.26 58.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.2 -28.68 3.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.117 0.967 . . . . 0.0 112.209 -174.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.02 -168.83 35.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -153.4 145.82 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -118.29 165.38 13.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.816 1.646 . . . . 0.0 108.442 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 141.53 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.649 1.179 . . . . 0.0 107.872 -171.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -125.32 167.41 14.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.239 1.018 . . . . 0.0 110.269 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.72 118.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 19.7 p -121.69 170.73 7.14 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.719 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 89.8 Cg_endo -78.37 15.66 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 165.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.9 p -127.24 -52.19 1.4 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.125 1.33 . . . . 0.0 111.577 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -154.64 160.91 41.72 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.285 1.034 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.0 m -72.01 151.79 42.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.81 133.15 31.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.39 123.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 125.873 1.669 . . . . 0.0 106.775 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.17 95.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.56 133.16 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.557 1.143 . . . . 0.0 108.496 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.18 114.51 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.91 175.46 10.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.013 0.525 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 HG21 ' A' ' 82' ' ' VAL . 1.6 p -99.76 -49.3 4.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.11 1.323 . . . . 0.0 111.912 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -90.6 61.48 4.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.667 2.387 . . . . 0.0 108.957 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 p -56.07 -28.56 58.1 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.53 -1.356 . . . . 0.0 113.48 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -57.7 -37.96 74.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.384 1.074 . . . . 0.0 113.62 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.88 -46.65 74.27 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.864 0.866 . . . . 0.0 108.905 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.09 -39.21 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.429 1.092 . . . . 0.0 110.108 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.14 -44.62 83.65 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.699 -0.626 . . . . 0.0 110.7 174.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.77 175.92 47.02 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 124.795 1.188 . . . . 0.0 112.151 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -55.44 116.66 2.99 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.355 1.062 . . . . 0.0 109.814 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 53.78 23.44 3.76 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.661 0.784 . . . . 0.0 112.729 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.67 59.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.403 -0.811 . . . . 0.0 112.549 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -59.29 -57.8 11.43 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.052 1.426 . . . . 0.0 110.246 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.06 -41.36 98.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.287 -169.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.4 tp -57.88 -42.83 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 120.091 1.314 . . . . 0.0 111.256 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -70.17 -42.11 72.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 110.794 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -56.32 23.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.1 mt -62.26 -24.26 67.16 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.885 1.274 . . . . 0.0 112.587 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -61.16 -48.76 80.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.348 1.431 . . . . 0.0 109.659 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.98 -40.18 95.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.293 0.497 . . . . 0.0 110.997 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.0 -53.26 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -63.55 -43.69 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 124.995 1.318 . . . . 0.0 110.241 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -54.48 -37.31 65.11 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.358 0.663 . . . . 0.0 110.568 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -73.9 -58.13 3.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.005 0.82 . . . . 0.0 110.081 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -57.38 -30.05 64.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.996 1.318 . . . . 0.0 112.379 -170.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 98.1 m-85 -121.59 2.24 10.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.416 1.486 . . . . 0.0 111.774 -171.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.98 22.9 65.27 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.037 0.835 . . . . 0.0 114.156 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -63.66 146.24 96.89 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.2 0.6 . . . . 0.0 111.267 -172.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.52 129.38 27.81 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.542 2.161 . . . . 0.0 110.581 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.65 143.53 46.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.73 61.11 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.873 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -136.61 21.48 3.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.156 1.478 . . . . 0.0 113.113 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.07 138.8 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 154.94 42.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.899 0.88 . . . . 0.0 110.567 165.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -132.94 114.08 13.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.36 2.264 . . . . 0.0 107.551 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.81 176.29 5.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.623 1.169 . . . . 0.0 110.524 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.18 114.76 8.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.594 0.633 . . . . 0.0 109.635 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -114.56 141.41 47.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.982 2.113 . . . . 0.0 109.598 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.8 156.22 19.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 44' ' ' THR . 29.7 m . . . . . 0 C--O 1.235 0.303 0 C-N-CA 125.192 1.397 . . . . 0.0 110.493 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 67.6 t80 . . . . . 0 N--CA 1.46 0.072 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -70.89 -13.26 61.96 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.471 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.46 -50.55 7.66 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.977 1.262 . . . . 0.0 109.999 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.51 -46.75 80.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.866 0.757 . . . . 0.0 111.687 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 11.1 tp -67.7 -33.99 75.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.787 1.235 . . . . 0.0 110.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -66.59 -51.14 59.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 109.94 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.6 -52.41 59.9 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.122 0.969 . . . . 0.0 110.557 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -52.22 -60.16 3.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.163 1.385 . . . . 0.0 110.498 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.0 mt -62.66 -36.74 83.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -51.79 -47.34 64.27 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.732 0.813 . . . . 0.0 109.237 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -76.68 -41.1 46.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.862 0.465 . . . . 0.0 110.117 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -17.88 62.15 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.718 -1.134 . . . . 0.0 113.677 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -130.54 24.48 5.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.14 1.776 . . . . 0.0 112.631 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.24 66.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.15 -36.21 83.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.803 0.811 . . . . 0.0 109.127 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -38.87 86.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.508 1.123 . . . . 0.0 110.651 -168.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.52 37.88 0.88 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 119.96 1.255 . . . . 0.0 114.386 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.79 165.74 2.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.319 1.047 . . . . 0.0 112.923 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 m -159.03 -31.02 0.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.41 -171.72 43.74 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.51 137.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.86 158.8 15.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.64 117.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 124.767 1.227 . . . . 0.0 107.872 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.85 122.05 46.63 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.7 131.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 161.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 30.9 p -120.51 166.53 15.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 48.6 Cg_endo -67.47 -12.68 36.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.329 1.353 . . . . 0.0 111.511 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.79 -50.59 5.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.307 1.443 . . . . 0.0 110.266 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 76' ' ' GLU . 5.6 ptp180 -162.08 173.7 14.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.386 1.448 . . . . 0.0 111.496 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.15 152.99 39.72 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.933 -1.104 . . . . 0.0 108.084 162.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -135.05 138.78 44.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.475 2.31 . . . . 0.0 105.108 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.9 mt -129.18 124.17 59.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.86 98.01 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.24 127.27 29.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.0 mt -97.1 110.06 22.69 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.171 1.388 . . . . 0.0 107.544 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.13 170.43 19.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.443 0.697 . . . . 0.0 109.48 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.29 -48.67 15.17 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.31 -1.493 . . . . 0.0 112.505 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -94.97 69.49 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.828 1.651 . . . . 0.0 108.795 -165.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -52.75 -34.85 54.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.21 -47.15 85.71 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 120.918 -1.114 . . . . 0.0 111.939 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.65 -43.78 97.93 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.02 -51.79 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 126.414 1.885 . . . . 0.0 109.461 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.4 -32.46 68.65 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 121.879 -0.513 . . . . 0.0 110.204 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 179.07 46.57 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.97 107.28 0.28 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.247 1.419 . . . . 0.0 110.508 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 48.25 50.53 16.25 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.023 0.916 . . . . 0.0 112.173 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.96 58.98 9.82 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -93.57 -68.39 0.8 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.301 1.04 . . . . 0.0 110.565 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -61.82 -38.15 87.09 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.356 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tp -55.64 -43.04 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.269 0.94 . . . . 0.0 111.355 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -72.5 -36.24 68.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.783 -1.198 . . . . 0.0 111.097 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -56.93 15.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.26 -22.73 64.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.552 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.5 m -58.15 -57.41 12.96 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 120.494 1.497 . . . . 0.0 109.054 166.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -27.53 69.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.278 0.944 . . . . 0.0 112.237 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.11 -63.45 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.61 -43.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.329 1.851 . . . . 0.0 110.86 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -53.91 -45.32 71.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.154 0.982 . . . . 0.0 110.784 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -71.68 -57.92 3.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 109.631 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -47.36 27.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.526 1.93 . . . . 0.0 111.918 -173.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.04 -7.57 22.21 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.336 1.454 . . . . 0.0 111.411 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.15 44.68 95.35 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.053 0.835 . . . . 0.0 111.198 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -69.73 141.59 90.29 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 117.55 0.675 . . . . 0.0 109.619 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.15 128.03 27.18 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 108.38 -1.431 . . . . 0.0 108.38 161.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.72 99.94 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.425 1.49 . . . . 0.0 111.643 -175.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.98 -8.75 33.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.532 1.539 . . . . 0.0 112.028 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 m -85.18 21.72 1.62 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.621 1.21 . . . . 0.0 111.111 162.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 154.73 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.59 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.488 ' HG3' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.93 150.95 33.79 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.886 2.075 . . . . 0.0 107.335 174.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -123.86 131.28 53.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.532 1.133 . . . . 0.0 108.862 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -126.16 161.53 27.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.54 2.336 . . . . 0.0 109.314 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.36 109.21 9.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.366 1.066 . . . . 0.0 108.821 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 158.09 16.59 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.155 1.382 . . . . 0.0 108.46 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -83.28 152.22 25.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.63 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.104 160.695 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 63.3 t80 . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.62 -31.02 69.11 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.764 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.0 -59.0 5.42 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.766 1.166 . . . . 0.0 110.705 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.78 -45.01 82.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.473 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.4 tp -66.42 -39.29 88.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.681 0.613 . . . . 0.0 110.513 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.28 -53.0 62.37 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.019 0.827 . . . . 0.0 108.959 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 -30.44 71.47 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.3 0.5 . . . . 0.0 111.569 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -65.78 -52.1 53.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.308 1.443 . . . . 0.0 110.215 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.86 -32.73 72.61 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.577 1.151 . . . . 0.0 112.161 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -50.98 -49.75 59.6 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.229 1.012 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -61.5 -57.69 11.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.735 1.214 . . . . 0.0 110.285 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.21 -14.34 62.92 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -134.48 18.94 3.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.969 0.908 . . . . 0.0 112.157 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -58.15 7.92 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 110.937 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.41 -27.6 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.646 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -15.89 62.77 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.0 1.32 . . . . 0.0 112.158 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.89 42.03 6.14 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.523 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -53.21 167.3 0.19 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.806 1.242 . . . . 0.0 111.616 167.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 m -153.93 -43.21 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.731 1.212 . . . . 0.0 110.928 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.23 34.43 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.86 159.39 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 121.456 -1.026 . . . . 0.0 108.33 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -127.84 164.3 22.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.242 1.017 . . . . 0.0 109.475 158.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.13 148.52 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 127.147 2.179 . . . . 0.0 108.701 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -122.85 129.61 51.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.97 116.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 154.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.1 p -120.74 165.09 19.69 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 165.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.8 -12.85 29.13 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.376 2.051 . . . . 0.0 111.959 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 p -96.37 -47.08 6.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.206 0.912 . . . . 0.0 109.77 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.3 169.59 20.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.81 1.644 . . . . 0.0 108.789 164.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.9 m -72.87 145.13 47.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 162.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.68 140.65 52.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 171.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.38 120.05 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.13 111.71 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.71 132.35 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.5 105.29 17.41 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 163.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -134.22 166.62 22.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -71.3 -35.88 71.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.796 -0.565 . . . . 0.0 111.259 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -127.29 74.89 1.54 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.178 0.899 . . . . 0.0 110.84 -163.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 p -50.61 -40.54 53.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -58.19 -34.69 70.64 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -77.57 -37.33 50.84 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 43' ' ' ALA . 70.2 t -66.26 -37.36 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 118.528 0.604 . . . . 0.0 110.03 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.76 -41.95 97.91 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.151 -0.968 . . . . 0.0 109.164 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.06 179.59 43.68 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.53 115.97 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.969 0.907 . . . . 0.0 109.934 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt 51.33 32.68 8.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.422 1.489 . . . . 0.0 111.633 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 33.7 37.42 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.033 -1.426 . . . . 0.0 112.727 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -65.61 0.64 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.732 1.766 . . . . 0.0 112.274 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -60.59 -42.12 96.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -167.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.27 -42.21 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 123.888 0.743 . . . . 0.0 110.425 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -46.84 83.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.258 1.39 . . . . 0.0 111.303 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -59.88 4.32 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.64 -25.16 66.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 117.303 -1.332 . . . . 0.0 112.185 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -56.23 -52.58 63.93 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 120.324 1.42 . . . . 0.0 108.673 169.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.11 79.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.494 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.28 -60.09 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.81 -44.46 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 127.258 2.223 . . . . 0.0 110.624 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.24 -45.9 76.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.933 0.893 . . . . 0.0 110.467 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -70.17 -50.78 36.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.547 1.067 . . . . 0.0 111.488 170.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -29.24 49.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.796 1.638 . . . . 0.0 112.566 -172.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.71 4.22 7.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.324 1.45 . . . . 0.0 112.133 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.54 79.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.405 1.003 . . . . 0.0 114.625 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -70.25 142.0 89.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.137 . . . . 0.0 112.366 -172.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.74 121.51 8.58 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.496 2.797 . . . . 0.0 110.921 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.94 146.44 26.8 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.593 1.557 . . . . 0.0 110.256 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.42 -22.71 3.09 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 120.87 -1.144 . . . . 0.0 112.462 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.7 m -109.85 10.35 24.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.457 2.303 . . . . 0.0 110.862 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.86 140.22 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 162.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.18 154.76 46.45 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 124.002 0.921 . . . . 0.0 109.083 166.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -119.84 138.7 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -132.83 168.24 18.74 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.942 1.697 . . . . 0.0 109.949 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.79 108.58 9.97 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.168 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.71 147.44 28.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 111.14 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -81.83 150.98 27.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.238 0.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.935 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -63.63 -12.15 31.11 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.317 -0.849 . . . . 0.0 113.159 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.49 1.14 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 121.165 1.802 . . . . 0.0 108.854 166.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -50.32 -45.41 54.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.48 1.512 . . . . 0.0 111.443 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.22 -40.76 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.839 0.456 . . . . 0.0 110.472 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -64.0 -48.13 77.58 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.12 -48.55 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.046 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -53.36 -56.53 15.99 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.091 0.859 . . . . 0.0 110.597 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.2 -37.41 85.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 111.16 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.8 m -53.84 -47.91 70.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.905 0.882 . . . . 0.0 110.618 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -58.37 5.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.01 0.924 . . . . 0.0 109.813 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.01 -27.62 63.69 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.23 18.03 12.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.837 1.655 . . . . 0.0 111.92 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.96 -35.82 47.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.268 1.027 . . . . 0.0 113.361 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -90.82 -19.59 23.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.906 0.775 . . . . 0.0 112.665 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.74 -26.34 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.593 1.157 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 50.58 2.81 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -169.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -57.43 168.42 0.8 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 110.417 166.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -154.24 -43.44 0.09 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 110.184 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.53 -165.9 33.86 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.7 157.47 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -124.96 138.45 54.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 108.212 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.61 116.48 35.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.207 1.803 . . . . 0.0 108.842 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -113.96 122.0 45.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -107.71 111.92 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 p -120.46 167.02 13.66 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.35 22.89 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.878 2.385 . . . . 0.0 111.445 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -127.61 -53.03 1.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.397 -1.439 . . . . 0.0 110.937 -168.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -162.09 171.71 17.06 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.459 2.304 . . . . 0.0 107.56 160.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -87.62 138.05 31.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.75 151.64 27.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.74 122.36 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 mt -123.57 108.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 mt -71.01 122.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.83 110.53 20.57 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.59 168.08 21.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 111.321 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -78.43 -26.37 46.29 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 120.458 -1.401 . . . . 0.0 112.854 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -128.89 67.02 1.41 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.964 0.906 . . . . 0.0 110.562 -164.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -45.32 26.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.697 1.999 . . . . 0.0 113.42 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -70.78 -28.61 64.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.223 -0.923 . . . . 0.0 111.744 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.59 -42.26 64.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 0.56 . . . . 0.0 109.689 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.76 -47.44 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.1 mt -61.82 -38.66 88.99 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.441 -0.787 . . . . 0.0 111.024 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.0 174.05 29.67 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.52 117.21 3.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.273 1.029 . . . . 0.0 109.488 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 47.62 41.11 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.507 1.123 . . . . 0.0 112.925 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.93 13.74 83.34 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.114 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -48.61 -60.16 2.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.132 1.466 . . . . 0.0 113.046 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -43.25 99.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 117.025 -1.465 . . . . 0.0 110.363 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 tt -61.06 -39.02 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 120.185 1.357 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -63.51 -47.7 80.6 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 120.747 -1.221 . . . . 0.0 112.361 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.25 -58.88 6.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.257 1.023 . . . . 0.0 109.303 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.84 -26.23 67.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.624 -173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.4 m -58.32 -47.58 83.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.06 1.3 . . . . 0.0 109.803 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.84 88.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.624 1.102 . . . . 0.0 111.796 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.98 -58.82 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.283 -0.885 . . . . 0.0 108.64 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.2 t -52.12 -45.72 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 126.378 1.871 . . . . 0.0 110.197 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -52.6 -49.29 65.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.534 0.733 . . . . 0.0 110.732 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.87 32.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.734 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -40.92 65.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.011 0.823 . . . . 0.0 111.965 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.15 8.24 27.93 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.055 1.742 . . . . 0.0 111.227 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 33.21 63.38 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.495 1.521 . . . . 0.0 113.695 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -72.32 151.41 92.08 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.782 0.833 . . . . 0.0 112.291 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.0 119.67 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.393 2.062 . . . . 0.0 109.241 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.09 137.16 56.16 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.758 0.823 . . . . 0.0 109.034 166.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.35 56.05 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.75 1.643 . . . . 0.0 113.152 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.3 m -133.51 17.7 3.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.076 1.438 . . . . 0.0 112.993 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.53 139.58 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 151.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -128.49 145.11 51.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.63 140.96 48.39 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -131.6 167.73 18.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 128.136 2.574 . . . . 0.0 108.871 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.33 119.47 15.54 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -121.49 171.78 8.55 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.375 1.47 . . . . 0.0 111.886 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -115.25 131.55 56.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.569 -164.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -173.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 53.7 t80 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.243 0.068 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -52.59 -38.23 59.67 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.698 0.799 . . . . 0.0 110.757 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.26 -49.65 40.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.117 -0.944 . . . . 0.0 112.241 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -55.95 -46.95 78.41 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.516 1.053 . . . . 0.0 109.787 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 14.0 tp -62.4 -39.78 94.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.694 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -61.26 -51.78 67.51 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.003 0.921 . . . . 0.0 109.792 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -59.66 -40.08 86.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.928 0.785 . . . . 0.0 111.579 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.02 -57.92 10.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.934 0.893 . . . . 0.0 109.315 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -61.26 -38.39 86.53 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.856 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -53.61 -31.14 45.89 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.484 1.493 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.86 -47.69 7.46 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 110.526 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -60.63 -33.76 73.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.791 0.723 . . . . 0.0 112.41 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -113.55 23.58 13.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.293 2.237 . . . . 0.0 110.37 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.87 -59.69 4.04 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.593 1.157 . . . . 0.0 110.143 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.03 -39.94 79.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.695 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -43.51 92.66 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.699 1.6 . . . . 0.0 112.21 -164.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.63 48.73 0.78 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.868 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.51 169.79 5.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.163 1.385 . . . . 0.0 111.095 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -157.16 -26.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.14 -169.54 36.75 Favored Glycine 0 C--O 1.227 -0.311 0 O-C-N 121.632 -0.667 . . . . 0.0 111.689 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.59 142.52 11.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.21 158.37 16.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.335 1.054 . . . . 0.0 109.506 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.79 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.093 1.357 . . . . 0.0 107.471 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.7 129.07 57.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.8 p -121.83 177.06 1.67 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.634 1.574 . . . . 0.0 110.407 -172.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.1 Cg_endo -78.75 0.0 10.36 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 121.424 1.416 . . . . 0.0 113.182 165.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -119.64 -53.14 2.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.766 1.621 . . . . 0.0 112.971 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -153.73 161.38 42.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.649 1.18 . . . . 0.0 110.66 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.1 m -71.63 148.06 46.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.08 130.99 53.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.336 1.854 . . . . 0.0 106.769 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.9 mt -124.03 121.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.94 97.14 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -69.61 141.74 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -115.39 120.8 40.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 127.923 2.489 . . . . 0.0 107.76 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.91 169.71 22.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.101 1.361 . . . . 0.0 109.643 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -80.41 -35.43 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.406 -0.809 . . . . 0.0 112.342 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -125.55 83.47 2.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.306 1.442 . . . . 0.0 108.32 -165.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -49.92 -45.15 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.049 1.34 . . . . 0.0 112.387 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -56.85 -38.47 72.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.49 -43.73 80.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.485 1.039 . . . . 0.0 109.877 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.05 -42.32 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.079 0.552 . . . . 0.0 109.768 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.15 -30.78 71.73 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.979 -1.076 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.16 -174.38 9.42 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.06 111.6 1.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 110.228 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp 56.41 3.13 0.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.251 1.82 . . . . 0.0 115.14 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.72 -2.14 9.35 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 120.422 1.464 . . . . 0.0 114.112 -169.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -44.06 -57.44 3.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.057 1.929 . . . . 0.0 113.941 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.87 -45.02 79.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.122 0.874 . . . . 0.0 110.621 -173.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.29 -34.33 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.374 0.988 . . . . 0.0 109.827 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -71.84 -37.42 70.28 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 113.753 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.28 -55.27 16.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.2 mt -56.09 -36.1 67.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.136 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -49.32 -52.56 27.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.18 0.9 . . . . 0.0 110.729 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.61 -44.63 56.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.2 1.0 . . . . 0.0 111.36 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -60.28 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 t -54.85 -46.49 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 120.417 1.462 . . . . 0.0 110.614 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -49.95 -42.51 48.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.272 1.029 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -83.77 -41.06 18.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.002 0.921 . . . . 0.0 111.709 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -29.64 70.88 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.98 0.912 . . . . 0.0 111.474 -173.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.3 -8.76 11.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.983 0.913 . . . . 0.0 110.464 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.5 51.07 45.12 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -78.18 150.4 77.39 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.011 0.524 . . . . 0.0 110.018 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.54 119.51 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.773 1.649 . . . . 0.0 109.712 162.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.86 145.59 15.81 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.93 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.601 -1.111 . . . . 0.0 114.296 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -134.46 40.16 3.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.462 2.131 . . . . 0.0 111.882 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.2 139.57 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 164.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 138.34 50.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.092 1.357 . . . . 0.0 108.729 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.44 129.23 47.44 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -117.04 160.3 21.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.421 1.488 . . . . 0.0 109.554 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.67 109.36 10.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 108.463 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.12 156.48 17.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.376 1.47 . . . . 0.0 108.475 173.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -107.06 148.83 28.27 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.633 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -154.32 157.43 38.62 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.312 -1.11 . . . . 0.0 110.649 -172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.3 t -74.67 150.72 39.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.599 1.16 . . . . 0.0 110.721 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.73 -161.81 31.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.1 m -55.36 143.88 27.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.369 0.668 . . . . 0.0 110.011 164.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m 174.35 -8.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.919 1.688 . . . . 0.0 114.6 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.97 -91.23 0.7 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.705 1.139 . . . . 0.0 112.041 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.421 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 44.9 t80 -45.42 -49.82 12.97 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 126.437 1.895 . . . . 0.0 112.659 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -57.94 -31.72 67.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -42.33 58.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.407 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -62.73 -46.41 88.21 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.144 0.577 . . . . 0.0 110.807 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.6 tp -65.75 -38.82 90.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.651 0.781 . . . . 0.0 110.166 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.45 -42.18 83.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.352 0.524 . . . . 0.0 111.14 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.95 -46.26 78.6 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.588 0.755 . . . . 0.0 110.876 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.57 -61.59 2.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.001 0.92 . . . . 0.0 109.439 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.51 -32.23 72.26 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.737 1.215 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.3 m -54.56 -45.42 73.48 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.885 0.766 . . . . 0.0 110.497 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -49.97 65.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.689 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -55.88 -35.53 66.6 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.104 0.561 . . . . 0.0 112.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -121.15 24.77 9.93 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.09 1.356 . . . . 0.0 110.524 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.03 -63.04 1.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.42 1.488 . . . . 0.0 110.595 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.23 -24.94 51.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.905 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.7 -35.54 72.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.341 0.973 . . . . 0.0 111.418 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.68 35.73 0.83 Allowed Glycine 0 C--N 1.338 0.65 0 O-C-N 123.553 0.533 . . . . 0.0 113.018 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 41' ' ' ILE . 29.9 t80 -59.38 167.46 1.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.174 0.987 . . . . 0.0 112.509 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -44.88 0.16 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.406 1.482 . . . . 0.0 110.042 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.32 -169.53 42.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.77 156.34 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.39 158.96 22.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.576 1.951 . . . . 0.0 107.857 163.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.02 150.07 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -132.88 156.79 46.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 163.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.52 124.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.0 p -120.41 176.83 1.64 Allowed Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -167.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 67.6 Cg_endo -72.12 8.07 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.509 1.473 . . . . 0.0 112.591 167.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -125.78 -45.08 1.77 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.376 0.989 . . . . 0.0 110.637 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -161.73 173.22 14.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.92 1.236 . . . . 0.0 110.865 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.6 m -88.94 149.47 23.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 160.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.2 138.41 52.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.176 1.79 . . . . 0.0 106.613 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -132.16 120.7 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.41 95.03 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.484 HG23 ' CE1' ' A' ' 25' ' ' TYR . 2.5 mp -64.26 153.24 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -118.8 108.14 14.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.827 2.451 . . . . 0.0 105.972 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.93 157.93 45.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.556 0.693 . . . . 0.0 112.29 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.8 p -64.08 -34.24 77.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.549 1.14 . . . . 0.0 111.018 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -134.88 82.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.479 1.512 . . . . 0.0 109.821 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 p -53.4 -35.37 60.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.732 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -60.79 -36.57 79.35 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.448 1.477 . . . . 0.0 112.456 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.03 -45.28 77.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.814 0.733 . . . . 0.0 109.066 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -30.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.049 0.939 . . . . 0.0 111.105 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.21 -40.22 52.72 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.524 -0.735 . . . . 0.0 110.519 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.3 179.7 47.06 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.501 1.048 . . . . 0.0 111.487 -171.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -57.06 114.93 2.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.545 0.738 . . . . 0.0 109.447 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 mttp 39.46 46.82 1.47 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.181 1.792 . . . . 0.0 112.464 -174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.88 9.54 77.43 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.118 -0.824 . . . . 0.0 113.751 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -43.86 -62.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.253 1.526 . . . . 0.0 112.738 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.02 -40.77 78.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.368 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.04 -41.27 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.306 0.957 . . . . 0.0 111.186 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -52.61 64.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.972 -1.08 . . . . 0.0 109.649 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -58.54 -47.06 85.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.795 0.725 . . . . 0.0 111.732 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 63' ' ' VAL . 40.0 mt -62.0 -30.24 70.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.715 0.806 . . . . 0.0 110.898 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -61.17 -51.7 67.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.436 1.016 . . . . 0.0 109.413 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.71 78.79 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.857 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 60' ' ' LEU . 11.4 p -59.87 -46.17 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.722 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 t -60.45 -45.69 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 120.234 1.379 . . . . 0.0 110.152 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -51.9 -44.25 63.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.785 1.234 . . . . 0.0 110.426 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -70.75 -50.78 32.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.2 1.0 . . . . 0.0 110.139 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -44.87 90.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.282 1.433 . . . . 0.0 111.016 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -103.57 -13.67 16.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.81 1.244 . . . . 0.0 111.503 -171.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 20.36 54.91 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 121.324 -0.86 . . . . 0.0 113.943 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -62.32 138.38 96.23 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.063 0.932 . . . . 0.0 112.456 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.96 141.6 49.03 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.275 1.983 . . . . 0.0 110.24 165.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.47 147.35 39.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.735 0.814 . . . . 0.0 110.03 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.97 -7.44 7.57 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.435 -0.791 . . . . 0.0 113.197 -169.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.0 m -122.02 7.21 9.78 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.138 1.775 . . . . 0.0 111.201 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.07 136.84 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 156.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -127.65 140.77 51.88 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.54 126.67 50.92 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.205 1.402 . . . . 0.0 107.629 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 63.5 m-85 -129.89 168.23 16.95 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.847 2.459 . . . . 0.0 109.22 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.62 122.07 17.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.37 155.28 18.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -101.23 149.49 23.95 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.79 144.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 122.517 1.151 . . . . 0.0 108.134 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.57 139.46 5.53 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.488 1.515 . . . . 0.0 108.804 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.4 t -70.2 148.15 48.96 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -65.94 155.3 36.93 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.26 -174.79 23.32 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m 60.12 173.13 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.616 1.967 . . . . 0.0 113.507 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -101.13 178.74 28.25 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.158 0.885 . . . . 0.0 111.63 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.11 -69.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.488 2.125 . . . . 0.0 107.98 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -142.92 -32.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.21 1.804 . . . . 0.0 109.561 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m 70.78 6.73 5.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.019 1.328 . . . . 0.0 112.626 -174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 C-N-CA 128.227 2.822 . . . . 0.0 107.245 171.319 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.277 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t 38.82 83.27 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.181 2.592 . . . . 0.0 113.271 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -145.04 177.18 8.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.68 125.85 1.78 Allowed Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 105.682 -2.967 . . . . 0.0 105.682 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.4 m 30.32 74.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.438 2.295 . . . . 0.0 112.668 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -163.15 142.2 8.5 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.155 1.382 . . . . 0.0 107.404 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.37 94.04 1.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -32.85 -51.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.515 3.126 . . . . 0.0 114.085 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.31 -36.19 60.99 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 118.547 -0.739 . . . . 0.0 112.177 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.37 -51.52 51.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.951 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.91 -46.0 74.82 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.427 1.091 . . . . 0.0 109.932 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.21 -43.26 82.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.737 0.815 . . . . 0.0 110.625 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -64.12 -47.19 80.93 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.324 0.65 . . . . 0.0 109.942 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.73 -44.29 85.89 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.186 1.394 . . . . 0.0 111.739 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -56.54 -60.07 4.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.5 -38.89 78.61 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.476 1.11 . . . . 0.0 112.487 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -51.91 -37.05 51.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.552 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -90.79 -39.01 12.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.293 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.09 -25.46 65.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 113.071 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.38 22.6 12.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.2 1.8 . . . . 0.0 110.758 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.23 64.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.872 1.269 . . . . 0.0 111.683 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.77 -26.65 59.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.673 0.215 . . . . 0.0 111.071 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 -34.99 79.41 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.639 0.775 . . . . 0.0 112.12 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.57 33.63 2.23 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.49 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HE1' HG23 ' A' ' 41' ' ' ILE . 38.5 t80 -51.67 157.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.862 0.865 . . . . 0.0 112.478 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.436 ' CB ' HG21 ' A' ' 82' ' ' VAL . 22.9 m -128.96 -57.06 1.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.472 1.509 . . . . 0.0 108.96 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.12 -166.45 32.9 Favored Glycine 0 C--O 1.227 -0.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.23 154.56 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -124.27 152.17 43.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 165.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.75 137.28 54.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -115.3 152.28 33.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.99 96.23 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 -171.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -120.69 163.89 26.45 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 123.768 0.827 . . . . 0.0 108.914 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.85 13.7 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.84 2.36 . . . . 0.0 112.011 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 p -120.64 -45.52 2.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.33 1.452 . . . . 0.0 110.324 -163.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -162.05 173.22 14.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.95 2.1 . . . . 0.0 106.989 162.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -75.71 147.37 39.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 158.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.77 129.7 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -126.9 132.51 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.99 100.53 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' A' ' 25' ' ' TYR . 59.8 mt -69.55 131.75 33.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 82' ' ' VAL . 51.0 mt -106.92 114.63 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.643 1.977 . . . . 0.0 106.22 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.81 169.63 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.801 0.441 . . . . 0.0 110.081 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -68.61 -46.45 69.27 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.408 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -115.8 89.6 3.14 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 127.519 2.328 . . . . 0.0 107.605 -164.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -45.27 66.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 111.324 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -65.76 -19.43 65.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -74.35 -49.06 24.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.67 -39.29 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.998 1.319 . . . . 0.0 110.844 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.16 -40.73 90.76 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.599 -0.688 . . . . 0.0 110.858 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 -175.29 40.0 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.54 113.67 2.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.889 1.275 . . . . 0.0 110.467 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.1 pttt 46.25 30.07 0.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.635 1.174 . . . . 0.0 113.867 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.62 5.74 59.97 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.992 0.806 . . . . 0.0 114.374 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -45.72 -55.91 5.91 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 112.855 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -72.27 -46.48 55.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.25 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.0 tt -59.08 -35.93 59.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.848 1.658 . . . . 0.0 111.134 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.94 -36.67 72.71 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 120.699 -1.251 . . . . 0.0 112.559 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.91 -49.27 71.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.265 0.484 . . . . 0.0 109.997 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 63' ' ' VAL . 83.1 mt -59.87 -29.09 68.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.937 1.295 . . . . 0.0 110.507 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -63.32 -56.67 14.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.815 . . . . 0.0 109.067 169.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.6 88.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.863 1.265 . . . . 0.0 112.097 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 60' ' ' LEU . 7.4 p -62.88 -52.4 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.115 -1.422 . . . . 0.0 108.101 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.81 -46.38 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.187 1.358 . . . . 0.0 109.976 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.99 -44.89 64.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 0.0 109.517 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -83.89 -37.51 22.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.707 0.685 . . . . 0.0 112.646 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.98 -55.3 32.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.528 1.131 . . . . 0.0 109.088 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 97.2 m-85 -93.8 -11.18 31.85 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.486 1.114 . . . . 0.0 110.51 -169.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.98 23.11 59.96 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.424 1.011 . . . . 0.0 111.811 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.65 139.98 97.71 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 118.263 1.031 . . . . 0.0 111.508 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.17 130.74 35.54 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.934 2.423 . . . . 0.0 109.449 165.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.07 122.67 15.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.433 0.693 . . . . 0.0 109.301 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.58 -12.47 56.03 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.985 0.802 . . . . 0.0 114.368 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -89.2 15.18 9.31 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.779 1.232 . . . . 0.0 111.582 165.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.57 156.4 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 159.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 145.31 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 170.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 113.16 19.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -112.36 164.67 12.98 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.064 2.145 . . . . 0.0 108.609 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.84 114.37 10.39 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.43 153.68 20.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.088 0.946 . . . . 0.0 109.194 172.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -83.28 148.3 27.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 26' ' ' SER . 91.5 t -85.09 146.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.794 0.837 . . . . 0.0 109.339 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 83.81 84.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 129.765 3.226 . . . . 0.0 109.71 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 p -76.03 95.2 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.712 1.605 . . . . 0.0 110.289 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -130.38 141.23 50.56 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.499 -1.375 . . . . 0.0 107.612 163.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.67 -107.33 0.33 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 51.42 74.98 0.22 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.039 1.336 . . . . 0.0 110.103 -169.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.06 95.09 0.6 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 107.29 -2.324 . . . . 0.0 107.29 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.76 -23.5 19.18 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 CA-C-N 119.882 1.841 . . . . 0.0 112.934 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 m 39.95 81.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.265 1.826 . . . . 0.0 112.303 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.1 m 58.67 89.32 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 159.317 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 m -125.45 104.59 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.631 1.572 . . . . 0.0 108.802 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 t -146.97 97.49 2.9 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.551 1.94 . . . . 0.0 106.338 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.86 -39.0 3.0 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.682 1.134 . . . . 0.0 111.934 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.0 m -81.93 142.85 32.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.619 1.709 . . . . 0.0 108.852 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.1 m -141.48 164.94 28.87 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.885 1.274 . . . . 0.0 108.043 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.68 -152.13 48.76 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -46.86 -49.88 19.5 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 125.682 1.593 . . . . 0.0 112.004 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.55 -38.52 74.89 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.544 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.83 65.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.782 0.719 . . . . 0.0 111.759 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -58.13 -48.73 79.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.911 0.778 . . . . 0.0 109.48 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.62 -41.86 92.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.344 1.457 . . . . 0.0 111.39 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.02 -50.16 73.59 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 123.764 0.826 . . . . 0.0 109.51 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.72 -42.68 97.88 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.11 -52.12 65.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.681 0.793 . . . . 0.0 109.419 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.18 -38.66 85.77 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.242 1.017 . . . . 0.0 111.787 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -54.6 -42.53 71.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.907 0.883 . . . . 0.0 109.9 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.51 -61.44 1.89 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.369 0.668 . . . . 0.0 110.061 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -21.97 64.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -170.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -122.65 21.58 10.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.138 1.775 . . . . 0.0 111.104 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.56 -55.07 17.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.309 1.044 . . . . 0.0 112.228 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -71.11 -16.08 62.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.554 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.48 -16.1 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.544 1.066 . . . . 0.0 113.39 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.73 40.26 6.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.58 158.85 4.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.834 -0.804 . . . . 0.0 110.89 170.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -147.35 -29.86 0.34 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.115 0.966 . . . . 0.0 112.564 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.64 -167.02 40.04 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.74 149.27 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.43 119.48 28.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -82.67 135.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -109.39 120.58 42.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.37 121.92 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 157.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 p -120.29 164.75 20.95 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 92.9 Cg_endo -74.29 2.85 5.77 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.678 2.252 . . . . 0.0 111.877 173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -112.82 -41.75 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -161.83 173.37 14.67 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.077 1.351 . . . . 0.0 109.965 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.4 m -74.79 146.38 42.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 154.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -127.45 143.55 51.18 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.435 2.294 . . . . 0.0 105.114 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -132.46 117.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.84 95.98 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.49 125.42 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.36 113.97 25.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.274 1.83 . . . . 0.0 106.299 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.42 171.07 14.57 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 109.209 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -81.87 -17.99 45.38 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.388 -1.445 . . . . 0.0 112.886 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -133.05 61.65 1.67 Allowed 'General case' 0 CA--C 1.523 -0.066 0 C-N-CA 124.74 1.216 . . . . 0.0 110.214 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -48.86 -41.69 34.05 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.894 0.877 . . . . 0.0 112.112 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.2 83.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.625 0.37 . . . . 0.0 111.431 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -72.27 -43.48 64.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.302 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.37 -31.58 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 110.976 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.96 -32.37 70.58 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.069 -1.019 . . . . 0.0 111.767 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.9 169.74 7.57 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.224 1.392 . . . . 0.0 111.665 -166.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.19 125.68 24.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.519 1.528 . . . . 0.0 108.679 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt 42.63 43.63 3.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.153 1.781 . . . . 0.0 111.767 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.0 66.57 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.886 -0.952 . . . . 0.0 114.948 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -52.93 -51.46 61.25 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.753 1.776 . . . . 0.0 111.175 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -34.65 62.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.881 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -65.82 -36.71 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.194 1.361 . . . . 0.0 111.24 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -65.15 -41.16 94.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 120.756 -1.215 . . . . 0.0 111.42 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -56.68 -60.11 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.057 0.943 . . . . 0.0 109.017 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.8 mt -57.27 -35.9 70.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.349 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -55.58 -52.38 63.93 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.594 1.088 . . . . 0.0 109.933 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.91 85.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.688 0.676 . . . . 0.0 111.294 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -64.13 -46.3 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 117.633 -1.175 . . . . 0.0 109.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.92 -46.29 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 120.568 1.531 . . . . 0.0 109.365 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -53.55 -39.91 65.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.085 0.554 . . . . 0.0 110.922 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -85.22 -36.65 20.82 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 118.964 0.802 . . . . 0.0 111.459 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.65 -45.42 94.09 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.807 0.843 . . . . 0.0 109.16 178.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 96.6 m-85 -106.77 -2.77 21.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.905 1.282 . . . . 0.0 112.69 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.27 35.57 63.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.687 1.137 . . . . 0.0 113.573 172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.13 133.7 68.51 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 118.371 1.086 . . . . 0.0 111.453 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.41 138.96 87.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.121 2.548 . . . . 0.0 111.185 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 111.07 9.84 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.169 0.987 . . . . 0.0 110.16 -173.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.76 -2.18 55.65 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.277 -0.735 . . . . 0.0 112.694 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 m -109.66 6.5 23.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.519 1.128 . . . . 0.0 112.081 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.68 163.71 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.749 1.219 . . . . 0.0 107.836 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.66 157.26 43.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.37 1.468 . . . . 0.0 107.43 159.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.39 135.49 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.07 165.25 19.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.016 1.726 . . . . 0.0 108.241 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.77 111.16 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -116.53 154.15 30.93 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.045 1.338 . . . . 0.0 109.009 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -110.69 135.36 51.41 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.633 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.84 130.4 36.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.2 92.48 0.41 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 t -63.29 142.65 58.31 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.962 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -174.27 142.54 0.81 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.657 1.983 . . . . 0.0 107.985 162.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.27 95.04 0.17 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -150.44 152.94 35.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.916 1.358 . . . . 0.0 112.077 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.14 97.82 0.17 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.52 168.31 25.08 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 120.069 1.934 . . . . 0.0 109.444 165.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -140.49 152.58 45.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 162.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.36 -3.92 2.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.97 2.108 . . . . 0.0 112.082 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.526 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 176.229 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.385 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -137.05 125.22 23.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.887 2.075 . . . . 0.0 106.097 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.98 140.58 1.58 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.16 148.66 2.45 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 -172.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.11 25.47 5.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 112.942 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -88.92 121.88 31.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.181 0.992 . . . . 0.0 113.491 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.4 -161.97 41.45 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 124.635 1.112 . . . . 0.0 112.908 158.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.496 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 35.6 t80 -50.59 -48.9 57.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.779 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -54.68 -47.36 73.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.411 -0.805 . . . . 0.0 109.768 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.89 -53.44 50.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.464 1.105 . . . . 0.0 111.917 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.83 -45.77 59.69 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.202 0.601 . . . . 0.0 110.439 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.9 tp -69.23 -41.04 77.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.746 1.219 . . . . 0.0 110.868 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -50.37 74.25 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.983 1.313 . . . . 0.0 108.758 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -66.38 -31.99 73.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.506 1.922 . . . . 0.0 112.127 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.97 -62.6 1.35 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.592 1.157 . . . . 0.0 108.533 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -55.8 -29.6 59.98 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.383 1.473 . . . . 0.0 112.389 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -51.51 -45.16 62.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.233 1.013 . . . . 0.0 111.856 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -74.27 -58.27 3.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -30.44 15.04 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 125.9 1.68 . . . . 0.0 113.402 -169.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.52 22.34 5.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.843 1.257 . . . . 0.0 111.566 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.629 0.771 . . . . 0.0 110.054 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.1 -26.09 68.06 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.572 1.149 . . . . 0.0 110.446 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.75 -25.79 65.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.52 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.51 25.59 4.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.43 -1.205 . . . . 0.0 114.077 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -54.41 148.95 10.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.709 1.604 . . . . 0.0 113.646 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m -128.46 -41.51 1.53 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 112.453 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.16 -166.36 39.59 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 156.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.46 138.73 50.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 160.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.95 124.52 65.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.29 121.98 46.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.86 95.87 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 p -78.38 166.04 45.79 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.18 -2.55 12.7 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.225 1.283 . . . . 0.0 112.921 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 p -103.73 -51.05 3.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.595 1.089 . . . . 0.0 109.606 -166.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -157.44 162.97 38.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.758 2.023 . . . . 0.0 107.757 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.1 m -73.11 139.69 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -110.49 144.01 39.95 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.4 mt -135.31 123.41 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.5 101.54 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.5 mt -68.15 123.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 mt -96.5 118.3 32.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.69 -177.92 6.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.689 0.756 . . . . 0.0 111.504 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 p -86.49 -25.36 25.18 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -129.67 78.46 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.68 1.192 . . . . 0.0 107.96 -165.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -40.7 72.81 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.247 1.019 . . . . 0.0 111.346 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -69.51 -22.08 63.62 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.691 -0.631 . . . . 0.0 111.63 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -72.76 -46.43 53.44 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.43 -36.55 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.146 1.378 . . . . 0.0 111.678 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -65.39 -42.67 92.38 Favored 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 120.916 -1.115 . . . . 0.0 109.34 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -179.57 29.42 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-O 122.976 1.32 . . . . 0.0 110.673 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.51 116.81 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.895 2.078 . . . . 0.0 109.156 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt 52.68 8.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.776 2.03 . . . . 0.0 115.305 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 18.72 11.24 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 120.695 1.588 . . . . 0.0 113.493 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -60.77 -57.26 13.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.489 2.145 . . . . 0.0 112.437 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -67.44 -33.61 75.5 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.916 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.6 -44.02 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.151 0.887 . . . . 0.0 110.456 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -69.13 -38.88 79.06 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.113 -0.992 . . . . 0.0 111.228 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.65 -49.12 76.42 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.759 0.709 . . . . 0.0 109.402 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 63' ' ' VAL . 18.0 mt -59.69 -29.09 67.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.647 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 m -60.77 -56.82 16.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.596 1.089 . . . . 0.0 108.922 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.67 73.04 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.763 1.225 . . . . 0.0 111.978 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.3 p -59.17 -51.9 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.539 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.83 -43.88 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.656 1.571 . . . . 0.0 109.778 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -53.05 -44.04 67.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.603 0.761 . . . . 0.0 110.846 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -72.71 -52.75 13.92 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.902 0.774 . . . . 0.0 110.875 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -54.84 -24.17 21.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.667 1.987 . . . . 0.0 112.589 -174.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 96.3 m-85 -128.97 -3.37 5.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.488 1.115 . . . . 0.0 112.961 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.83 7.78 85.26 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.754 1.169 . . . . 0.0 114.924 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -61.22 143.62 92.35 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.389 1.595 . . . . 0.0 111.948 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.44 163.67 23.05 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.472 2.115 . . . . 0.0 110.447 162.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -68.83 141.39 55.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 164.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.44 -40.65 2.42 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.681 1.134 . . . . 0.0 113.661 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.7 m -67.47 -4.78 12.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.943 1.372 . . . . 0.0 112.922 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.91 141.38 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 163.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.96 130.2 48.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.33 137.89 39.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -130.47 167.49 18.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 127.612 2.365 . . . . 0.0 109.209 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.31 120.19 14.41 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.142 1.777 . . . . 0.0 108.915 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -119.14 148.56 42.94 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.717 1.207 . . . . 0.0 110.502 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -74.7 147.73 41.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.403 0.62 . . . . 0.0 109.839 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.94 159.65 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.904 1.682 . . . . 0.0 107.982 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.7 167.88 12.97 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.844 1.257 . . . . 0.0 111.587 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 85' ' ' ARG . 2.6 m 59.58 -177.47 0.09 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.352 1.061 . . . . 0.0 110.282 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' H ' HG22 ' A' ' 84' ' ' THR . 25.0 ttm180 42.73 67.25 0.64 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.685 1.994 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.68 97.82 1.98 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -104.83 -70.07 0.79 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.761 0.825 . . . . 0.0 109.138 170.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.74 169.87 28.92 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.0 122.72 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.984 2.456 . . . . 0.0 107.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.2 m -135.3 90.46 2.62 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.67 156.84 32.46 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.974 0.91 . . . . 0.0 109.402 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.568 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.827 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -57.24 136.49 56.49 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.481 1.112 . . . . 0.0 109.949 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.57 144.78 50.86 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.97 151.62 19.88 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.008 0.813 . . . . 0.0 111.629 -167.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 m -68.49 106.93 2.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.091 0.956 . . . . 0.0 110.031 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -69.18 163.19 25.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.441 0.296 . . . . 0.0 110.772 162.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.16 -87.23 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 126.277 1.894 . . . . 0.0 110.934 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -33.04 -51.54 0.32 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.13 2.972 . . . . 0.0 113.784 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.22 -35.58 73.88 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -49.79 14.08 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.178 0.991 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.22 -47.78 65.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.445 0.641 . . . . 0.0 109.801 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.856 -0.527 . . . . 0.0 110.824 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.04 -57.5 12.8 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.821 1.248 . . . . 0.0 110.007 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.03 -34.8 78.5 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 118.754 0.706 . . . . 0.0 111.855 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.7 -64.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.687 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.18 80.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.574 1.55 . . . . 0.0 111.717 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.6 m -49.88 -37.38 30.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.616 1.166 . . . . 0.0 110.935 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.79 -16.63 28.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.61 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.68 -16.47 28.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.428 1.091 . . . . 0.0 112.457 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -136.97 36.63 2.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.38 1.472 . . . . 0.0 112.008 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.89 -61.23 2.51 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.051 -1.031 . . . . 0.0 111.774 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.75 -15.86 60.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.801 0.84 . . . . 0.0 112.081 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.12 -15.14 62.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.067 1.347 . . . . 0.0 112.774 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.88 32.75 28.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.167 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -52.96 144.57 14.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.519 0.66 . . . . 0.0 111.213 168.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' HG11 ' A' ' 82' ' ' VAL . 72.1 m -126.58 -47.78 1.55 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.395 1.478 . . . . 0.0 110.428 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.87 -162.94 29.68 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.55 158.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 121.083 -1.245 . . . . 0.0 107.969 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -128.36 157.69 40.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.652 1.981 . . . . 0.0 109.277 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.07 134.65 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.508 1.123 . . . . 0.0 111.231 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -121.45 161.85 21.48 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.673 1.189 . . . . 0.0 110.124 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.76 133.71 65.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.993 1.717 . . . . 0.0 106.493 164.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 64.8 p -122.37 170.53 7.75 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.325 1.45 . . . . 0.0 109.095 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 73.7 Cg_endo -74.44 4.82 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.593 2.196 . . . . 0.0 112.651 166.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.3 p -108.22 -54.9 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.443 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.01 169.28 24.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.592 1.087 . . . . 0.0 111.689 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.4 m -68.0 151.91 46.35 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -135.39 135.08 40.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.9 124.15 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.68 107.42 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.47 1.108 . . . . 0.0 108.582 -166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.17 142.93 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.65 115.55 30.35 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 163.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.58 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.988 0.813 . . . . 0.0 110.546 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -78.64 -49.02 13.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.656 -1.278 . . . . 0.0 111.283 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -99.71 74.28 1.85 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -51.89 -35.35 44.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.691 -0.631 . . . . 0.0 112.659 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -77.09 -18.61 57.88 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.297 1.408 . . . . 0.0 113.067 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -65.12 -59.94 3.56 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 162.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -53.58 -43.83 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.287 1.035 . . . . 0.0 111.751 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.21 -41.32 77.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.48 -0.762 . . . . 0.0 110.816 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.84 178.76 34.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.465 0.481 . . . . 0.0 112.111 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.85 119.15 7.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.62 0.768 . . . . 0.0 110.204 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.87 32.16 5.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.753 1.621 . . . . 0.0 112.356 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.77 58.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.013 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -51.65 -63.43 1.14 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.164 1.482 . . . . 0.0 113.024 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -39.63 94.71 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.732 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.73 -43.53 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.265 1.393 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -68.3 -38.27 81.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.03 -1.044 . . . . 0.0 111.476 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.15 -51.77 66.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.9 mt -62.71 -26.47 68.69 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.277 -1.344 . . . . 0.0 111.752 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -60.82 -50.45 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.117 1.326 . . . . 0.0 108.408 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.26 85.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.689 0.796 . . . . 0.0 112.286 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 60' ' ' LEU . 2.9 p -68.45 -39.07 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.336 -1.316 . . . . 0.0 110.142 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.32 -43.6 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 121.532 1.969 . . . . 0.0 109.961 173.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.64 -40.36 68.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.927 0.891 . . . . 0.0 111.073 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -67.62 -65.53 0.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.494 1.043 . . . . 0.0 108.849 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -38.89 69.0 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.28 2.232 . . . . 0.0 111.754 -167.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.64 -4.4 17.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.623 1.169 . . . . 0.0 111.185 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.26 51.38 57.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.638 1.108 . . . . 0.0 110.908 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -79.12 153.8 77.25 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.638 0.375 . . . . 0.0 110.577 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -72.42 117.03 4.94 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.703 2.268 . . . . 0.0 108.319 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.3 pm0 -57.37 143.42 40.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 110.075 172.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.77 -46.43 3.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.948 1.261 . . . . 0.0 111.085 -168.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m -83.56 17.28 2.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.366 1.466 . . . . 0.0 114.279 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.45 136.07 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.81 135.07 47.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 128.156 2.582 . . . . 0.0 108.155 174.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.3 134.55 52.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.37 177.29 6.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.245 2.218 . . . . 0.0 108.838 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 158.84 43.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.93 153.24 46.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.759 2.424 . . . . 0.0 106.353 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -95.5 135.97 36.48 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' CB ' ' A' ' 26' ' ' SER . 21.2 m -77.76 144.11 11.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -168.85 -168.67 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.41 1.484 . . . . 0.0 107.984 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -17.13 6.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 113.0 2.03 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 124.273 1.029 . . . . 0.0 109.514 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.51 150.26 44.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 142.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.8 m -128.58 168.37 15.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.856 2.462 . . . . 0.0 108.177 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.23 -153.92 7.22 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 118.855 0.752 . . . . 0.0 114.213 -160.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.36 96.08 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.731 2.954 . . . . 0.0 110.202 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.7 t -94.58 -66.33 0.92 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.561 1.944 . . . . 0.0 107.344 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m 55.87 -175.87 0.05 OUTLIER 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.894 0.878 . . . . 0.0 110.569 -151.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 179.057 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.556 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -62.79 -28.26 69.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.692 -166.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m 38.67 55.69 1.92 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.52 1.928 . . . . 0.0 111.862 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.25 -173.58 36.34 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.546 -165.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.6 m 69.83 100.62 0.06 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.694 1.997 . . . . 0.0 108.593 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -42.35 136.24 2.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.887 2.475 . . . . 0.0 109.792 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.31 -170.69 38.82 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -166.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 76.9 t80 -55.56 -53.23 59.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.244 0.618 . . . . 0.0 110.805 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.94 -38.1 81.45 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.909 -169.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 -55.01 31.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.241 0.616 . . . . 0.0 110.622 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.49 -42.85 78.98 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.315 0.507 . . . . 0.0 111.578 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.5 tp -71.37 -38.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.548 0.339 . . . . 0.0 110.636 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -59.93 -51.53 69.28 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.057 0.943 . . . . 0.0 108.634 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.19 -37.8 81.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 112.371 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.15 -57.01 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.188 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.05 -30.35 71.43 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.686 1.195 . . . . 0.0 111.939 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.9 m -49.67 -40.22 39.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.185 1.394 . . . . 0.0 111.118 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -91.18 -45.87 8.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.448 0.699 . . . . 0.0 110.424 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -55.98 -30.39 61.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.409 0.684 . . . . 0.0 112.613 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.8 mt -125.53 22.45 7.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.015 1.326 . . . . 0.0 110.703 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.18 -63.48 1.14 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.014 0.925 . . . . 0.0 110.222 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.05 -15.51 61.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.521 0.329 . . . . 0.0 111.836 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -35.65 74.94 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.74 28.41 1.42 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.907 -0.94 . . . . 0.0 113.818 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -53.29 153.63 3.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.526 1.163 . . . . 0.0 112.628 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 m -142.42 -34.35 0.45 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.972 1.309 . . . . 0.0 112.405 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.77 -169.57 42.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.064 0.847 . . . . 0.0 111.075 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.4 149.75 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.76 159.67 34.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.867 1.267 . . . . 0.0 108.287 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.1 127.81 18.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.673 1.189 . . . . 0.0 110.904 -163.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -126.03 161.95 26.39 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.796 1.238 . . . . 0.0 108.675 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.46 115.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 51.1 p -92.17 172.44 6.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 123.813 0.845 . . . . 0.0 108.773 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 51.8 Cg_endo -70.94 20.67 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.936 2.424 . . . . 0.0 112.124 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.9 p -128.07 -44.93 1.42 Allowed 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 120.842 -1.161 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.11 172.71 15.41 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.182 0.901 . . . . 0.0 111.122 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 m -71.51 157.43 38.03 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 159.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.81 128.42 34.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.168 1.787 . . . . 0.0 107.195 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.0 mt -117.04 124.09 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.92 104.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.25 133.31 32.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.71 117.03 33.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.047 . . . . 0.0 106.756 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.54 167.49 23.57 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -31.47 65.82 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.909 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -132.35 81.33 1.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.1 p -52.58 -43.73 65.46 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.772 -0.58 . . . . 0.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.45 -30.11 62.47 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.325 1.45 . . . . 0.0 112.734 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -70.14 -52.2 25.46 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.618 0.645 . . . . 0.0 109.478 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.94 -34.19 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.83 1.252 . . . . 0.0 111.073 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -68.86 -35.19 76.62 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.474 -0.766 . . . . 0.0 111.3 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.65 -179.31 26.57 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.835 0.731 . . . . 0.0 111.745 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -54.1 109.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.937 1.695 . . . . 0.0 109.683 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt 46.58 43.34 12.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.783 1.233 . . . . 0.0 111.966 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 11.5 71.67 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.731 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -40.89 -64.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.895 1.678 . . . . 0.0 111.903 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.26 -47.08 68.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.499 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.22 -41.78 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.01 1.277 . . . . 0.0 110.371 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.3 -45.48 80.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.008 0.923 . . . . 0.0 111.463 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.64 -55.14 38.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.173 0.589 . . . . 0.0 109.819 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.77 -33.13 69.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.579 1.551 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.2 m -55.13 -50.49 69.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.686 1.13 . . . . 0.0 109.28 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.65 96.31 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.556 0.617 . . . . 0.0 111.963 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.6 t -58.62 -54.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 t -59.1 -41.31 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.883 2.073 . . . . 0.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -61.47 -22.15 64.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.361 0.982 . . . . 0.0 112.321 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.82 -50.73 5.22 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.503 -0.748 . . . . 0.0 110.859 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.92 62.03 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.231 1.412 . . . . 0.0 110.294 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.73 7.98 28.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.189 1.796 . . . . 0.0 111.041 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.96 23.13 37.48 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 125.352 1.453 . . . . 0.0 114.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -56.6 147.39 51.06 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.349 1.075 . . . . 0.0 111.583 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.2 128.87 30.31 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.627 2.218 . . . . 0.0 110.6 166.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 153.22 28.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 168.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.7 -44.43 0.63 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.837 2.161 . . . . 0.0 114.098 -164.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -91.08 18.24 7.05 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.77 1.628 . . . . 0.0 115.152 -166.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.45 139.89 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.55 150.67 50.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.282 0.492 . . . . 0.0 110.592 163.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.2 126.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -122.42 173.54 7.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.36 1.464 . . . . 0.0 109.807 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.32 109.75 5.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.461 1.105 . . . . 0.0 108.345 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -104.06 142.27 34.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -76.35 149.76 36.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 t -70.61 -10.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.083 0.953 . . . . 0.0 112.477 168.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 54.89 -131.42 1.95 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.282 1.433 . . . . 0.0 110.943 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -129.88 46.05 2.71 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.106 1.321 . . . . 0.0 109.555 -170.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 154.68 6.33 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.47 -0.769 . . . . 0.0 111.373 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.94 77.76 1.13 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.501 1.048 . . . . 0.0 110.999 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m 56.81 174.53 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.539 1.535 . . . . 0.0 113.218 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 133.58 179.47 16.4 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.11 142.59 38.4 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.177 2.584 . . . . 0.0 111.026 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m 59.91 169.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.127 2.571 . . . . 0.0 113.792 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.9 m -141.2 172.61 12.44 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.647 1.579 . . . . 0.0 109.83 -171.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.808 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 166.754 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 m -117.71 -60.05 1.85 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.949 0.874 . . . . 0.0 108.693 164.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t 64.92 -71.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.134 1.774 . . . . 0.0 109.818 -170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.41 164.65 22.38 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.031 2.729 . . . . 0.0 107.5 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -154.3 140.96 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.031 1.332 . . . . 0.0 108.12 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -62.0 153.71 28.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.508 1.147 . . . . 0.0 108.893 167.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.89 161.05 30.39 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 106.031 -2.828 . . . . 0.0 106.031 -173.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 45.9 t80 -51.64 -46.06 63.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -61.97 -36.22 80.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -171.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 -60.24 3.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.949 1.299 . . . . 0.0 109.625 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -55.39 -40.66 71.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.084 0.554 . . . . 0.0 111.363 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.466 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.0 tp -69.3 -41.37 76.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.325 0.65 . . . . 0.0 111.031 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.81 -54.45 47.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.226 0.466 . . . . 0.0 109.84 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -57.3 -35.09 69.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.779 0.432 . . . . 0.0 112.145 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -67.22 -58.1 5.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.487 1.115 . . . . 0.0 110.872 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.7 -33.27 73.71 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.43 1.492 . . . . 0.0 111.861 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -47.97 -38.64 17.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.301 1.44 . . . . 0.0 111.321 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -89.09 -40.1 13.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.817 0.735 . . . . 0.0 111.437 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.66 -20.69 63.7 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.5 mt -133.02 24.64 4.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.791 1.636 . . . . 0.0 110.856 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.92 -56.32 20.87 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.88 1.272 . . . . 0.0 111.453 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -61.49 -45.28 94.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.574 1.15 . . . . 0.0 110.47 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.98 -31.28 72.44 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.913 0.885 . . . . 0.0 112.835 -163.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.61 41.05 1.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 119.338 -0.701 . . . . 0.0 113.775 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -49.93 154.85 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.612 0.765 . . . . 0.0 111.33 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.25 -45.43 0.77 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.534 1.534 . . . . 0.0 109.525 172.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.99 -164.89 34.6 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.47 151.64 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 121.457 -1.026 . . . . 0.0 108.646 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -121.99 151.48 40.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.835 0.826 . . . . 0.0 109.27 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.6 p -125.43 148.75 29.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.251 1.42 . . . . 0.0 108.395 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -132.79 153.48 51.2 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.1 t -98.37 135.75 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 155.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -120.89 166.08 16.82 Favored Pre-proline 0 C--O 1.243 0.717 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.7 Cg_endo -72.02 0.91 6.5 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.651 2.234 . . . . 0.0 111.899 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -113.42 -47.33 3.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.486 1.039 . . . . 0.0 111.648 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -162.21 172.97 14.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.062 0.847 . . . . 0.0 110.332 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.7 m -68.96 150.28 47.89 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -124.98 143.65 50.78 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -129.72 122.71 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 99.43 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.97 132.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.63 108.5 20.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.349 1.859 . . . . 0.0 106.38 164.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 172.26 13.02 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 p -83.33 -37.49 23.32 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.873 -0.517 . . . . 0.0 111.43 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -117.11 64.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.634 -1.291 . . . . 0.0 108.035 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -43.83 -48.62 8.27 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.54 2.336 . . . . 0.0 113.169 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.15 -34.2 71.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.136 0.88 . . . . 0.0 111.859 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.58 -32.29 36.58 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.205 -0.934 . . . . 0.0 111.212 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.26 -42.35 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.875 0.87 . . . . 0.0 109.453 169.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 mt -61.26 -44.52 97.11 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.89 45.52 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 124.634 1.111 . . . . 0.0 110.684 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -57.3 114.91 2.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.733 1.213 . . . . 0.0 110.513 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 55.24 32.98 19.66 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.166 0.987 . . . . 0.0 110.897 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.34 22.57 77.35 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.873 -0.959 . . . . 0.0 112.837 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -52.87 63.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.89 1.845 . . . . 0.0 111.636 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -43.91 91.36 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 116.759 -1.591 . . . . 0.0 109.533 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.8 -40.97 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.212 1.369 . . . . 0.0 110.991 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.47 -44.53 82.44 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.914 1.234 . . . . 0.0 112.765 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -54.52 45.96 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.123 0.874 . . . . 0.0 108.799 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' HA ' HG12 ' A' ' 63' ' ' VAL . 57.0 mt -60.12 -27.31 66.93 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.379 1.472 . . . . 0.0 112.491 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.7 m -62.84 -59.53 4.73 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.661 1.119 . . . . 0.0 109.579 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.4 89.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.177 0.991 . . . . 0.0 111.262 -171.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.7 p -57.62 -50.43 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.758 -1.115 . . . . 0.0 108.686 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.81 -49.48 83.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 124.644 1.178 . . . . 0.0 109.495 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -49.56 -46.38 48.75 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.538 1.135 . . . . 0.0 110.623 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -73.06 -53.56 10.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -49.9 -55.52 14.09 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 111.122 -176.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 92.5 m-85 -89.99 2.11 55.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.767 2.027 . . . . 0.0 112.429 -172.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.43 51.11 44.71 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.47 149.99 86.76 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 117.496 0.648 . . . . 0.0 109.433 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.52 124.66 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.697 1.598 . . . . 0.0 109.155 161.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.55 153.62 27.08 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.76 -14.44 3.52 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.598 0.618 . . . . 0.0 113.446 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.8 m -133.04 28.81 4.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.765 1.283 . . . . 0.0 112.236 -161.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.94 145.71 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.091 1.356 . . . . 0.0 107.803 159.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -128.29 148.34 50.65 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.118 1.367 . . . . 0.0 109.266 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.35 137.7 51.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.89 1.276 . . . . 0.0 109.02 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -134.5 168.13 19.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.858 2.463 . . . . 0.0 109.551 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 109.86 6.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.452 1.901 . . . . 0.0 109.018 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -104.13 156.27 18.02 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.616 1.166 . . . . 0.0 109.122 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.69 145.6 27.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.661 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.07 156.51 7.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.26 -170.75 0.76 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.182 1.393 . . . . 0.0 108.824 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.8 -23.63 0.85 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 165.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -164.97 161.66 20.07 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.983 1.265 . . . . 0.0 108.668 161.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.15 164.66 25.84 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.515 1.531 . . . . 0.0 109.571 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 t -160.24 145.51 14.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.96 80.91 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.84 141.98 24.89 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.788 1.659 . . . . 0.0 110.42 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m 87.29 161.47 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.793 2.837 . . . . 0.0 110.61 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 p -143.87 95.11 2.68 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.208 0 N-CA-C 104.852 -3.299 . . . . 0.0 104.852 -179.514 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.786 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -85.16 156.9 20.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 166.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m -153.89 170.12 21.79 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.494 1.118 . . . . 0.0 109.292 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.27 109.61 0.29 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 t -70.82 -61.16 1.87 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -143.81 85.14 1.81 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 118.543 0.611 . . . . 0.0 111.51 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.84 135.98 7.3 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -52.44 -53.91 39.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.211 0.505 . . . . 0.0 110.56 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -61.2 -34.02 74.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.464 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.98 -59.06 4.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.505 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -55.03 -38.57 68.13 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 118.787 0.721 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.06 -43.81 77.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.456 0.702 . . . . 0.0 110.612 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.15 -43.68 98.3 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 123.97 0.908 . . . . 0.0 109.932 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.17 -25.41 63.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.799 1.24 . . . . 0.0 112.57 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 19' ' ' GLU . 37.0 t80 -72.64 -64.66 0.91 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.393 1.477 . . . . 0.0 108.647 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.92 -43.7 60.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.297 2.239 . . . . 0.0 111.883 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -52.77 -34.04 51.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.071 0.851 . . . . 0.0 111.411 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -91.01 -41.25 11.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.35 -0.834 . . . . 0.0 110.103 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 15' ' ' PHE . 6.6 mm-40 -56.97 -42.92 81.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.749 1.22 . . . . 0.0 112.724 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -115.68 26.63 9.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.514 1.526 . . . . 0.0 109.731 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.38 61.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.125 1.37 . . . . 0.0 111.905 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -79.68 -14.56 58.68 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.262 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.99 -23.04 17.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -159.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 35.85 3.76 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 119.072 0.851 . . . . 0.0 112.687 -168.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.74 162.49 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.185 0.993 . . . . 0.0 109.361 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 m -136.73 -60.84 0.69 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.67 -167.85 29.9 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.91 155.16 17.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -125.67 164.12 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.011 0.91 . . . . 0.0 109.141 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.26 139.58 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.102 1.761 . . . . 0.0 107.357 -170.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -132.82 138.62 47.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 106.96 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.2 t -136.16 116.53 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 36.5 p -120.9 176.69 1.75 Allowed Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.56 0.744 . . . . 0.0 110.361 -164.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 61.3 Cg_endo -73.12 3.75 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 121.727 1.618 . . . . 0.0 112.452 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.9 p -113.44 -52.1 2.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.268 1.395 . . . . 0.0 111.145 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -160.61 174.71 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.364 1.465 . . . . 0.0 111.198 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -82.04 151.59 27.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.505 -0.747 . . . . 0.0 109.062 163.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.14 142.79 34.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.594 1.958 . . . . 0.0 108.018 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.2 mt -141.13 126.03 18.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.4 105.07 15.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -173.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -70.43 130.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.87 115.76 28.73 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.6 169.87 16.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.047 0.84 . . . . 0.0 111.015 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.8 p -70.5 -31.81 69.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.257 -0.902 . . . . 0.0 111.7 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -134.32 85.39 2.19 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 p -53.36 -38.56 63.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.106 0.962 . . . . 0.0 111.454 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -57.97 -44.31 87.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.616 1.167 . . . . 0.0 111.984 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -68.83 -40.62 79.36 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.046 0.538 . . . . 0.0 109.578 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -46.59 93.77 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 C-N-CA 122.978 0.511 . . . . 0.0 109.683 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.53 -36.22 70.94 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.994 -1.066 . . . . 0.0 111.086 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 179.88 50.98 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 109.52 0.5 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.032 1.333 . . . . 0.0 109.277 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 mttm 40.22 46.16 1.87 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.439 1.496 . . . . 0.0 112.765 -173.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.99 9.3 82.72 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.17 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -46.08 78.43 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.57 2.185 . . . . 0.0 113.008 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -45.21 90.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.626 1.103 . . . . 0.0 110.678 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tt -67.55 -34.99 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.456 1.026 . . . . 0.0 111.111 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -57.36 -50.96 71.29 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.575 -0.703 . . . . 0.0 109.889 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -61.07 2.53 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.346 1.058 . . . . 0.0 109.705 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.0 mt -57.74 -34.97 70.08 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.525 -174.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 m -57.64 -48.08 80.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.437 1.017 . . . . 0.0 109.484 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.77 -42.76 73.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.059 0.944 . . . . 0.0 112.005 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.3 p -66.75 -45.75 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.647 1.112 . . . . 0.0 109.736 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -55.67 -45.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.084 1.311 . . . . 0.0 109.511 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.71 -46.42 67.35 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.123 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -71.9 -50.66 27.3 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.075 0.852 . . . . 0.0 111.666 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -39.79 86.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.415 1.086 . . . . 0.0 110.787 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.72 3.77 24.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 111.737 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.91 26.75 71.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.072 0.844 . . . . 0.0 112.823 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -67.77 145.51 98.05 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 118.35 1.075 . . . . 0.0 109.595 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.22 165.66 16.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.795 2.33 . . . . 0.0 110.737 160.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -88.38 147.98 24.47 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.98 -45.99 2.59 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.403 1.478 . . . . 0.0 112.454 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 m -72.04 8.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.257 1.823 . . . . 0.0 112.501 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.87 126.0 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 162.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 146.61 38.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -120.55 140.71 51.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -132.93 165.32 24.94 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.47 1.908 . . . . 0.0 108.569 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.59 109.08 5.59 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -111.38 155.01 23.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.554 1.541 . . . . 0.0 110.371 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.97 141.01 29.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.517 0.675 . . . . 0.0 112.348 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.43 154.45 8.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 52.3 38.69 25.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.09 1.756 . . . . 0.0 112.099 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.8 m -64.76 136.47 56.96 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.652 1.181 . . . . 0.0 108.941 169.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -159.05 29.98 0.21 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.679 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.13 -123.81 7.97 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 125.78 1.657 . . . . 0.0 109.565 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 39.76 30.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.411 1.084 . . . . 0.0 113.734 169.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -108.63 85.19 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.321 -1.266 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.13 97.66 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.321 2.681 . . . . 0.0 108.579 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -132.64 119.98 21.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -143.2 98.63 3.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.601 1.56 . . . . 0.0 106.859 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 105.323 -3.111 . . . . 0.0 105.323 -154.498 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.474 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.35 77.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.995 1.718 . . . . 0.0 110.407 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -74.72 174.31 9.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.839 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.35 -110.26 0.65 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.804 1.669 . . . . 0.0 112.685 170.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.7 m -124.9 140.12 53.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.393 1.477 . . . . 0.0 108.39 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 t -152.73 147.38 26.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.84 164.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.29 147.79 18.69 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 125.411 1.481 . . . . 0.0 111.405 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -53.58 -49.32 67.98 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.12 1.368 . . . . 0.0 109.8 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -62.11 -29.65 70.47 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.426 -1.273 . . . . 0.0 110.625 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.02 4.46 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.5 1.5 . . . . 0.0 110.387 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.53 -45.16 73.33 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.915 0.486 . . . . 0.0 110.555 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.83 -43.3 84.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.671 0.388 . . . . 0.0 110.455 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -57.26 -51.52 69.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 109.447 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.18 -52.94 62.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.404 0.682 . . . . 0.0 111.028 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -53.27 -48.52 68.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.412 1.085 . . . . 0.0 111.145 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.41 -38.68 81.48 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.58 1.552 . . . . 0.0 111.615 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -51.71 -47.29 64.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -66.97 -47.17 72.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 111.821 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.66 -12.83 60.86 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.999 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.17 15.45 8.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 113.499 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.53 27.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.324 1.05 . . . . 0.0 112.064 -172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -87.81 -26.86 22.62 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.53 -34.74 76.04 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.738 0.699 . . . . 0.0 110.31 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 65.25 0.53 Allowed Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -67.84 174.2 3.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.915 1.34 . . . . 0.0 110.266 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -164.4 -23.99 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.06 1.344 . . . . 0.0 112.046 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.15 -161.78 29.82 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -161.3 155.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -125.94 160.22 30.56 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 108.631 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.91 135.4 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 126.053 1.741 . . . . 0.0 108.287 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -132.62 122.74 25.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.13 92.76 2.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 43.7 p -84.07 176.83 3.39 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.702 1.601 . . . . 0.0 109.433 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 85.6 Cg_endo -76.38 6.08 4.23 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.052 1.835 . . . . 0.0 113.21 165.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -116.6 -57.97 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.68 1.582 . . . . 0.0 112.169 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -161.67 149.58 15.0 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.056 1.342 . . . . 0.0 108.055 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -70.93 138.64 50.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -110.42 137.37 48.22 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.97 122.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.87 103.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.01 145.51 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -115.22 112.04 21.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.47 165.75 26.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.399 0.679 . . . . 0.0 111.522 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.9 p -85.59 -21.55 28.44 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.866 -1.146 . . . . 0.0 113.503 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -131.64 59.17 1.7 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.853 0.751 . . . . 0.0 109.28 -166.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -56.8 -37.37 71.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -63.8 -37.08 86.03 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 120.101 1.319 . . . . 0.0 110.072 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.6 -49.28 78.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.861 1.264 . . . . 0.0 109.014 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.29 -44.83 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.751 2.02 . . . . 0.0 110.904 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.04 -39.12 93.8 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.365 -0.834 . . . . 0.0 110.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 -179.27 48.85 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 122.278 0.932 . . . . 0.0 112.008 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.23 109.1 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.357 2.263 . . . . 0.0 110.937 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt 43.43 50.65 6.16 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.67 1.588 . . . . 0.0 110.673 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 37.67 69.2 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.866 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -67.38 0.42 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.042 1.421 . . . . 0.0 112.351 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -36.74 84.75 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.361 -172.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.78 -44.88 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 119.129 0.877 . . . . 0.0 111.964 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -63.11 -49.5 74.19 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.996 -1.065 . . . . 0.0 110.949 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -51.58 66.31 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.164 0.585 . . . . 0.0 110.046 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 88.8 mt -67.95 -30.16 69.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.613 -1.185 . . . . 0.0 112.096 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.0 m -56.99 -37.28 71.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.736 1.153 . . . . 0.0 110.32 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.51 17.4 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.845 1.202 . . . . 0.0 111.337 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 60' ' ' LEU 0.261 2.0 p -61.46 -42.47 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.124 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.36 -47.72 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 121.249 1.84 . . . . 0.0 109.814 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.417 HE22 ' HG2' ' A' ' 72' ' ' GLU . 9.0 mt-30 -53.43 -37.34 62.47 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.26 0.482 . . . . 0.0 111.845 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 -38.93 18.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.209 0.913 . . . . 0.0 111.138 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.53 -36.78 83.66 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.838 1.255 . . . . 0.0 110.505 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 94.1 m-85 -114.66 -21.33 10.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 112.74 -168.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.03 50.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.052 1.311 . . . . 0.0 114.442 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -53.29 145.65 25.35 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.169 1.484 . . . . 0.0 113.355 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -68.84 156.69 64.59 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.786 2.99 . . . . 0.0 111.578 163.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' HE22 ' A' ' 65' ' ' GLN . 12.3 mt-10 -71.95 139.98 48.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.72 -21.17 1.27 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.897 -1.502 . . . . 0.0 115.026 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m -80.9 -8.69 59.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 120.048 1.924 . . . . 0.0 112.703 168.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.63 126.81 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -113.04 139.54 48.59 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 163.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.32 134.45 54.88 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 72.0 m-85 -132.72 171.76 13.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.747 2.019 . . . . 0.0 109.262 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.91 148.96 52.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 167.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.87 52.09 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.659 1.584 . . . . 0.0 107.517 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -82.96 151.23 25.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.21 162.39 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.74 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 166.47 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 130.646 3.578 . . . . 0.0 107.372 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p -53.51 -46.97 70.27 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.12 2.168 . . . . 0.0 112.996 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ttm105 -144.92 -82.21 0.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 156.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.79 -176.7 16.19 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.983 1.278 . . . . 0.0 110.182 -170.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m 68.58 128.03 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.423 3.089 . . . . 0.0 115.277 167.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.15 131.6 50.11 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.79 -43.57 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 CA-C-N 119.921 1.861 . . . . 0.0 112.878 -165.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 m -60.99 107.06 0.66 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -149.88 -9.9 0.29 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.502 0.721 . . . . 0.0 112.692 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.983 1.754 . . . . 0.0 109.087 174.725 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.983 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 t 56.7 44.18 24.08 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.996 1.719 . . . . 0.0 112.554 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 p -100.91 145.61 28.4 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.364 -0.835 . . . . 0.0 110.441 169.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.23 -134.18 6.71 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 106.101 -2.8 . . . . 0.0 106.101 160.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -49.64 114.94 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.036 1.335 . . . . 0.0 110.087 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 m -67.47 179.62 1.27 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.921 -0.487 . . . . 0.0 109.912 168.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.13 -108.11 0.76 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -40.14 -42.13 1.4 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.875 2.47 . . . . 0.0 113.443 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -57.35 -43.19 83.27 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.34 -55.39 24.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 117.477 -1.249 . . . . 0.0 108.517 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -47.77 -41.36 23.11 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.496 1.118 . . . . 0.0 111.062 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.27 -45.95 21.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.298 1.439 . . . . 0.0 111.687 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -58.29 -53.84 53.77 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.283 1.033 . . . . 0.0 110.009 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.16 -43.98 96.78 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.855 0.862 . . . . 0.0 111.039 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -48.02 -61.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.59 1.556 . . . . 0.0 110.254 168.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.77 -35.68 78.83 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.566 0.746 . . . . 0.0 112.105 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.5 m -60.75 -29.1 69.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.403 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -90.58 -30.23 17.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.674 1.19 . . . . 0.0 112.59 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.32 -22.33 52.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.49 23.88 3.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.281 1.032 . . . . 0.0 111.755 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.42 34.38 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.953 1.301 . . . . 0.0 112.187 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -71.56 -31.77 67.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.491 0.716 . . . . 0.0 110.503 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.93 -44.2 94.49 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.176 0.99 . . . . 0.0 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.47 28.37 0.52 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.801 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.34 148.53 41.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.367 1.584 . . . . 0.0 112.226 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 -30.5 1.32 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.519 1.128 . . . . 0.0 113.054 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.89 -170.46 43.42 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 120.11 1.323 . . . . 0.0 110.806 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.06 152.25 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -126.68 108.89 11.49 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.831 1.253 . . . . 0.0 107.911 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.5 146.53 6.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.467 1.507 . . . . 0.0 108.44 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -131.9 150.28 52.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.87 1.268 . . . . 0.0 107.755 167.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.41 121.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 48.5 p -120.81 176.75 1.71 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.517 1.527 . . . . 0.0 109.423 -165.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.4 Cg_endo -79.47 4.02 6.99 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.183 1.922 . . . . 0.0 113.833 165.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -121.48 -58.53 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.095 1.316 . . . . 0.0 111.907 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -161.57 138.19 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.664 1.586 . . . . 0.0 110.315 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 m -58.5 143.92 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.74 146.42 39.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 172.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.74 117.4 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.28 113.45 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.76 117.81 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.761 1.224 . . . . 0.0 108.86 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 mt -89.72 110.49 21.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.256 1.822 . . . . 0.0 108.49 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 168.17 20.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.345 0.658 . . . . 0.0 110.865 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -66.73 -35.97 81.35 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.927 -1.108 . . . . 0.0 111.299 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -120.61 79.23 1.46 Allowed 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.555 0.742 . . . . 0.0 109.555 -165.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.59 -48.52 14.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.628 1.571 . . . . 0.0 111.365 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -65.46 -27.41 68.49 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.258 -0.901 . . . . 0.0 112.258 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -70.59 -44.05 68.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.893 1.224 . . . . 0.0 108.938 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.29 -35.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.491 1.116 . . . . 0.0 110.592 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.3 -44.53 71.58 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.662 -1.273 . . . . 0.0 108.871 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.45 45.01 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.5 1.048 . . . . 0.0 111.919 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.72 123.76 14.29 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.247 1.019 . . . . 0.0 108.46 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt 46.79 39.67 7.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.865 0.866 . . . . 0.0 111.959 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.77 30.16 72.65 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.98 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -67.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.398 2.099 . . . . 0.0 112.815 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -37.41 87.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.68 -169.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 tt -57.64 -56.93 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.948 0.794 . . . . 0.0 109.757 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -56.31 -43.57 79.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.224 1.409 . . . . 0.0 112.34 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.14 -58.71 7.46 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.37 -25.05 66.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.855 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.6 m -57.79 -55.1 39.29 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.378 1.444 . . . . 0.0 109.724 167.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.63 89.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.455 0.702 . . . . 0.0 111.203 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 59' ' ' GLU . 38.1 t -53.78 -59.12 2.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 t -61.26 -39.78 83.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.059 0.944 . . . . 0.0 111.016 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.44 -37.7 70.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.733 0.697 . . . . 0.0 111.067 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.69 -55.27 4.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.734 0.697 . . . . 0.0 109.995 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -39.41 60.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.368 1.867 . . . . 0.0 111.898 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.49 -1.29 13.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.1 1.36 . . . . 0.0 111.546 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.18 78.91 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 120.85 -1.156 . . . . 0.0 114.702 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.31 147.67 75.1 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.819 1.31 . . . . 0.0 112.648 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.53 141.29 79.73 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.747 2.965 . . . . 0.0 111.979 168.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -66.41 141.42 57.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.83 -16.76 6.41 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.214 -0.77 . . . . 0.0 114.294 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -121.48 9.95 10.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 112.916 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.01 155.28 26.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 159.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -139.33 156.44 47.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.753 1.221 . . . . 0.0 108.433 164.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -131.71 134.83 46.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -132.47 160.98 34.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.433 1.893 . . . . 0.0 108.386 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 142.11 46.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.616 0.767 . . . . 0.0 108.961 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -141.7 153.81 44.91 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 108.769 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.66 146.86 27.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.87 151.05 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 122.38 1.086 . . . . 0.0 108.188 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.58 166.96 31.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.028 2.131 . . . . 0.0 107.086 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 m -70.78 119.39 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -125.49 -103.68 0.36 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.928 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.57 -176.7 24.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.785 1.175 . . . . 0.0 110.511 -171.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -57.54 -55.3 36.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.702 0.801 . . . . 0.0 112.149 -162.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 45.9 70.82 0.58 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.094 -1.948 . . . . 0.0 111.558 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.49 75.03 0.28 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 125.248 3.965 . . . . 0.0 113.09 -172.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 134.03 54.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.642 1.577 . . . . 0.0 108.334 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.9 m -156.37 167.25 31.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.672 1.189 . . . . 0.0 110.259 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.68 0 N-CA-C 105.877 -2.889 . . . . 0.0 105.877 -164.106 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.9 m -72.8 74.27 1.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.989 1.894 . . . . 0.0 107.759 161.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -164.47 162.6 22.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 130.289 3.436 . . . . 0.0 105.204 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.29 77.69 1.35 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.6 m 61.09 96.47 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.582 1.553 . . . . 0.0 112.478 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -56.68 160.77 3.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.967 . . . . 0.0 108.646 154.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.63 -139.39 14.48 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.385 -2.286 . . . . 0.0 107.385 -157.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -36.79 -54.25 0.91 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.839 1.656 . . . . 0.0 113.983 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -53.22 -41.95 65.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.312 1.045 . . . . 0.0 112.009 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.78 25.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.78 1.232 . . . . 0.0 109.588 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.7 -40.33 62.86 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.446 0.566 . . . . 0.0 111.448 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 tp -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.972 1.309 . . . . 0.0 110.826 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -63.0 -43.71 98.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.185 0.594 . . . . 0.0 110.335 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.28 -30.7 71.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.452 1.101 . . . . 0.0 112.853 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -67.51 -63.97 0.95 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.5 mt -56.45 -33.14 65.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.605 1.162 . . . . 0.0 111.96 -168.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -46.2 -46.53 17.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.162 0.985 . . . . 0.0 111.783 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.48 -56.69 4.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.69 -26.51 45.33 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 113.521 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.62 18.9 9.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.774 1.229 . . . . 0.0 111.359 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.94 -64.31 0.87 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.908 0.883 . . . . 0.0 111.023 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.85 -22.12 62.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.474 -0.766 . . . . 0.0 111.309 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.7 -24.29 67.53 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.545 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.06 25.29 3.05 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.459 1.027 . . . . 0.0 114.763 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.757 ' HE1' HG23 ' A' ' 41' ' ' ILE . 40.6 t80 -63.65 165.2 8.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 112.42 -168.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.97 -52.93 0.22 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.729 1.212 . . . . 0.0 110.46 171.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.09 -172.02 38.3 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 118.927 0.785 . . . . 0.0 111.429 -171.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.46 134.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.53 161.91 13.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 164.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.14 144.91 23.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -120.1 160.47 22.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.39 115.71 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 4.3 p -121.01 176.85 1.68 Allowed Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -169.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 81.3 Cg_endo -78.84 12.17 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.281 1.988 . . . . 0.0 111.448 166.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.9 p -127.7 -50.04 1.37 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 0.0 112.579 -170.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -162.6 173.6 13.72 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.142 1.777 . . . . 0.0 110.156 -169.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.1 m -98.23 149.17 22.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -125.32 142.57 51.42 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.764 2.026 . . . . 0.0 105.757 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -129.0 125.93 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -123.73 97.56 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.757 HG23 ' HE1' ' A' ' 25' ' ' TYR . 4.9 mp -76.87 125.95 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.4 108.09 20.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.064 2.146 . . . . 0.0 107.131 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.95 168.09 20.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.852 1.31 . . . . 0.0 110.354 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 p -79.12 -26.84 42.85 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.955 -1.091 . . . . 0.0 111.769 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -129.01 79.93 1.94 Allowed 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.76 1.624 . . . . 0.0 107.904 -167.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 p -48.98 -39.2 25.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.334 1.053 . . . . 0.0 111.334 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.89 -39.95 95.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.215 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -59.87 -48.82 80.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.742 1.155 . . . . 0.0 109.183 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.06 -43.65 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.908 1.283 . . . . 0.0 110.786 -174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.84 -36.67 84.12 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.643 -0.66 . . . . 0.0 109.878 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.57 175.68 41.18 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.058 1.313 . . . . 0.0 110.554 -167.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 55' ' ' ARG . 4.2 tt0 -55.5 128.18 33.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 167.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp 50.33 38.86 18.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.649 0.779 . . . . 0.0 112.839 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.84 10.01 67.01 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.795 0.712 . . . . 0.0 113.907 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 52' ' ' GLU . 17.0 mtm180 -52.31 -53.34 45.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 113.244 -175.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.88 74.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 116.176 -1.868 . . . . 0.0 109.954 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -60.73 -38.05 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 121.562 1.983 . . . . 0.0 111.224 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -52.73 64.31 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.304 -0.873 . . . . 0.0 110.854 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -28.12 63.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.434 1.094 . . . . 0.0 112.108 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 63' ' ' VAL . 31.6 mt -80.03 -24.82 40.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.139 1.376 . . . . 0.0 110.467 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -66.28 -55.38 16.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.19 70.35 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.457 1.103 . . . . 0.0 111.965 -174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 60' ' ' LEU . 12.8 p -58.65 -47.91 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.702 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.36 -39.83 82.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-N 119.649 1.113 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -53.84 -44.94 70.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.799 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.83 -58.45 3.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.819 0.736 . . . . 0.0 109.659 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -45.77 54.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.549 1.54 . . . . 0.0 111.848 -168.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.12 -1.8 25.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.46 47.62 89.67 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 125.244 1.402 . . . . 0.0 112.177 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -80.05 145.62 61.46 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.202 1.001 . . . . 0.0 111.32 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.49 137.52 51.06 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.484 2.123 . . . . 0.0 109.713 166.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.36 143.04 58.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.353 1.061 . . . . 0.0 109.512 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 -6.49 6.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.397 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -117.05 8.37 13.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.128 1.771 . . . . 0.0 112.17 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -113.71 140.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 154.19 51.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 168.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -121.65 136.45 54.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -125.17 163.21 22.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.885 1.674 . . . . 0.0 107.461 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.68 109.12 9.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.163 0.585 . . . . 0.0 109.796 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -119.88 145.8 46.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.439 0.638 . . . . 0.0 110.385 -168.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.75 140.16 36.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 -167.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.0 160.08 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -140.05 98.48 3.46 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.487 -1.383 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 m -66.23 -65.36 0.69 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.067 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -114.57 154.51 28.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.555 1.525 . . . . 0.0 109.775 -175.331 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' H ' ' HD3' ' A' ' 85' ' ' ARG . . . -169.16 -133.54 1.6 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.029 2.252 . . . . 0.0 108.753 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.0 m 60.11 89.97 0.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.094 2.158 . . . . 0.0 111.24 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.28 172.3 44.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 123.48 0.562 . . . . 0.0 112.827 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.78 67.85 8.48 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.868 3.712 . . . . 0.0 112.346 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 t -61.86 115.41 4.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 162.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.8 m -146.84 118.0 7.79 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.607 1.563 . . . . 0.0 109.578 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 117.514 -1.715 . . . . 0.0 111.451 171.533 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m 40.69 61.58 1.62 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.602 1.561 . . . . 0.0 111.51 -176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -57.33 148.5 22.74 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.2 -121.72 3.49 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -60.19 118.23 6.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.916 1.287 . . . . 0.0 109.181 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -90.22 113.63 25.47 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.368 1.867 . . . . 0.0 108.13 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.84 143.39 14.59 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -32.31 -46.88 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.334 3.453 . . . . 0.0 114.841 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -54.3 -29.43 47.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.19 1.396 . . . . 0.0 113.499 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -58.12 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.395 2.278 . . . . 0.0 111.007 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -56.05 -40.63 73.81 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.633 1.106 . . . . 0.0 111.2 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.11 -36.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 110.593 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.19 -51.5 67.55 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.585 0.754 . . . . 0.0 109.587 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.34 -27.46 67.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.148 0.979 . . . . 0.0 111.864 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.05 -63.37 1.09 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.429 1.092 . . . . 0.0 109.104 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.05 -31.55 71.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.49 1.116 . . . . 0.0 112.234 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.4 m -55.91 -35.68 66.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.102 1.361 . . . . 0.0 111.157 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -90.54 -44.64 9.43 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.932 -0.48 . . . . 0.0 110.112 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.86 -42.25 93.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.953 0.342 . . . . 0.0 111.902 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.56 20.64 16.42 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.032 1.733 . . . . 0.0 110.554 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.52 -58.87 4.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.398 1.479 . . . . 0.0 110.141 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 -19.74 55.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.632 0.773 . . . . 0.0 111.995 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -71.09 -32.58 69.24 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.282 0.633 . . . . 0.0 110.386 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.07 47.02 1.11 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.399 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.72 171.24 0.49 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.698 1.599 . . . . 0.0 112.967 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.77 -42.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.812 1.645 . . . . 0.0 111.479 170.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.2 -170.29 43.33 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.79 153.99 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -119.94 158.0 27.62 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.437 1.495 . . . . 0.0 109.055 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.41 129.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.34 1.056 . . . . 0.0 110.265 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -125.81 122.93 37.59 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.247 1.019 . . . . 0.0 108.93 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.26 130.09 38.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 163.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 27.1 p -121.76 170.66 7.28 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.612 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 71.6 Cg_endo -74.08 19.37 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.906 2.404 . . . . 0.0 112.809 165.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 p -127.25 -58.1 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -154.44 173.44 16.25 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.285 1.834 . . . . 0.0 109.494 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.2 m -86.54 148.54 25.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 162.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.94 131.69 33.38 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.678 1.591 . . . . 0.0 106.881 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.81 123.65 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.62 1.568 . . . . 0.0 107.799 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.7 112.51 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -73.09 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -99.94 118.09 35.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.079 165.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.62 167.05 25.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.301 0.5 . . . . 0.0 111.258 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -67.13 -45.56 76.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.874 0.47 . . . . 0.0 110.798 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -122.93 82.43 1.99 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.045 1.738 . . . . 0.0 108.144 -167.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 p -46.58 -42.92 16.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.457 1.103 . . . . 0.0 110.552 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -45.15 74.25 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.644 1.111 . . . . 0.0 112.339 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -68.59 -42.26 78.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.71 -31.44 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.062 1.745 . . . . 0.0 110.837 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -76.77 -42.32 41.37 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.29 1.036 . . . . 0.0 110.185 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.19 176.12 27.02 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.165 0.888 . . . . 0.0 111.294 -171.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.88 116.91 4.09 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.366 0.666 . . . . 0.0 110.484 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.1 mttt 42.31 44.63 3.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.238 1.415 . . . . 0.0 111.648 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.5 73.77 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.506 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.29 -56.67 11.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.558 1.679 . . . . 0.0 112.658 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.27 -48.41 81.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.273 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -60.44 -44.47 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.077 0.853 . . . . 0.0 109.879 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -38.19 82.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.362 0.983 . . . . 0.0 112.891 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -62.18 1.85 Allowed 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.01 -24.88 68.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.009 -1.472 . . . . 0.0 111.767 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.0 m -55.55 -51.87 65.63 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 120.683 1.583 . . . . 0.0 108.946 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.24 82.69 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.833 0.742 . . . . 0.0 110.669 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.44 -50.01 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 118.691 0.678 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.86 -51.23 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.372 1.469 . . . . 0.0 109.871 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -54.76 -28.35 47.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -93.48 -44.93 8.0 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.364 0.983 . . . . 0.0 110.213 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -55.04 -39.52 69.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.01 1.324 . . . . 0.0 111.188 174.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 91.9 m-85 -115.07 5.99 15.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.69 1.196 . . . . 0.0 111.417 -171.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.78 41.62 66.86 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.896 2.189 . . . . 0.0 114.576 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -81.9 145.51 53.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.576 1.188 . . . . 0.0 111.488 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.49 153.8 73.06 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.109 1.873 . . . . 0.0 110.888 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.21 122.56 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.759 1.224 . . . . 0.0 109.359 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 -14.76 4.95 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.318 0.961 . . . . 0.0 114.467 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -74.74 -6.88 51.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.192 0.997 . . . . 0.0 111.522 161.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.18 149.46 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 162.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -137.29 149.68 47.25 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 165.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.96 122.64 46.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -118.3 165.62 13.62 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 127.71 2.404 . . . . 0.0 108.997 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.68 113.52 7.88 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.191 1.396 . . . . 0.0 109.202 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.04 154.93 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.86 1.664 . . . . 0.0 109.18 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -90.9 156.12 18.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -85.43 150.21 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 122.227 1.013 . . . . 0.0 109.665 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.92 35.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.479 1.912 . . . . 0.0 108.583 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.6 t -81.47 164.87 21.71 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 108.642 168.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.4 mtt-85 -102.79 143.62 32.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 156.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.04 106.39 0.19 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 105.984 -2.847 . . . . 0.0 105.984 170.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 m -64.45 160.13 19.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.857 0.863 . . . . 0.0 110.091 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.05 111.07 0.5 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.37 -34.09 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 120.48 2.14 . . . . 0.0 111.034 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.0 m 51.05 83.13 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.916 1.686 . . . . 0.0 112.033 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.85 -172.95 0.12 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.214 2.206 . . . . 0.0 109.518 -164.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.481 0 C-N-CA 127.749 2.595 . . . . 0.0 106.826 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -134.57 160.88 36.69 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.746 1.219 . . . . 0.0 108.706 168.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -152.49 156.14 38.84 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 107.766 155.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.71 -170.61 31.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -156.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 m -71.67 -86.1 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.358 1.079 . . . . 0.0 108.248 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.2 m -80.05 175.75 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 156.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.22 113.49 3.86 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -53.15 -53.88 43.93 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.863 0.831 . . . . 0.0 110.249 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 29' ' ' GLU . 79.5 tttt -57.47 -31.9 66.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.778 -0.629 . . . . 0.0 111.247 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -39.8 47.39 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.234 0.925 . . . . 0.0 111.766 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.29 -43.85 96.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.358 0.981 . . . . 0.0 109.365 171.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.58 -39.22 93.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.392 0.677 . . . . 0.0 110.54 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.18 -56.33 22.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.161 1.384 . . . . 0.0 109.772 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.2 -28.43 68.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.35 -64.76 0.79 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.567 1.147 . . . . 0.0 109.006 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.28 -37.28 74.7 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 112.646 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.5 m -51.14 -48.32 61.85 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.817 0.847 . . . . 0.0 110.367 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -75.45 -42.22 53.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.134 -0.46 . . . . 0.0 109.919 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -31.57 72.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.836 0.744 . . . . 0.0 111.881 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.7 mt -119.01 15.84 13.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.314 -165.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.83 -63.1 0.92 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.033 1.333 . . . . 0.0 112.331 -173.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -15.46 59.56 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -71.66 -12.1 61.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.678 1.126 . . . . 0.0 111.06 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.5 47.73 4.21 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.699 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -56.96 166.32 1.04 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.933 1.349 . . . . 0.0 110.519 168.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 2.0 m -156.76 -37.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.792 2.037 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.23 -169.32 42.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 124.21 0.909 . . . . 0.0 110.853 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.69 154.13 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -116.55 162.57 17.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.659 1.984 . . . . 0.0 110.124 164.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.36 137.47 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.853 1.261 . . . . 0.0 108.342 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -127.61 127.48 43.9 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.5 91.78 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 12.7 p -90.36 169.64 11.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 54.4 Cg_endo -73.35 4.04 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.832 2.355 . . . . 0.0 112.922 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 p -113.34 -54.89 2.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.354 0.979 . . . . 0.0 110.922 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -155.47 157.82 37.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.61 1.564 . . . . 0.0 108.614 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 m -68.22 139.33 56.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 161.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.33 139.97 44.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.94 124.65 65.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.93 93.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -172.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.16 122.25 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' SER . 63.9 mt -98.39 73.02 2.11 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.633 1.173 . . . . 0.0 109.446 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.7 160.41 15.73 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.423 1.465 . . . . 0.0 111.352 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -72.32 -25.1 61.43 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.676 -1.265 . . . . 0.0 111.527 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -131.81 72.17 1.49 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.541 1.136 . . . . 0.0 108.733 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -56.74 -40.25 75.43 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.45 -0.781 . . . . 0.0 111.808 -174.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -53.33 -39.31 63.99 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.811 1.244 . . . . 0.0 112.634 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.01 -45.34 67.44 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.442 0.697 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.4 -39.73 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.396 0.678 . . . . 0.0 109.302 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.6 -39.09 93.49 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.289 -0.882 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 172.79 28.44 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -165.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -54.87 126.25 23.52 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.706 -0.879 . . . . 0.0 109.67 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.279 58.9 pttt 39.96 42.3 1.05 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.206 1.802 . . . . 0.0 113.507 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.75 20.99 77.62 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.489 -0.757 . . . . 0.0 113.27 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -44.56 -67.26 0.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.407 1.483 . . . . 0.0 111.689 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -32.87 67.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.637 -169.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 tt -61.86 -40.89 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.144 1.338 . . . . 0.0 111.655 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.32 -45.31 88.46 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.027 1.285 . . . . 0.0 110.625 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.25 -48.02 79.91 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.01 0.524 . . . . 0.0 110.518 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 63' ' ' VAL . 10.5 mt -63.93 -36.13 82.95 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 117.975 -1.012 . . . . 0.0 111.524 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.2 m -59.6 -48.99 79.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 120.425 1.466 . . . . 0.0 109.364 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.15 79.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 60' ' ' LEU . 8.0 p -60.66 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.515 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -58.36 -41.75 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.697 1.589 . . . . 0.0 109.54 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -32.79 63.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.063 0.545 . . . . 0.0 111.915 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -96.83 -19.51 18.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.788 2.035 . . . . 0.0 112.842 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -20.63 27.12 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.286 -1.509 . . . . 0.0 110.231 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.69 1.34 4.93 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.665 1.186 . . . . 0.0 112.05 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.77 10.03 66.84 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.574 1.079 . . . . 0.0 114.299 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -57.32 151.98 34.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.915 0.857 . . . . 0.0 111.982 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 58.4 Cg_endo -69.66 174.24 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.988 3.792 . . . . 0.0 109.561 166.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 153.99 22.07 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.72 -46.25 0.55 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.41 1.957 . . . . 0.0 112.569 -166.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 56.1 m -77.86 8.64 4.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.549 1.94 . . . . 0.0 113.194 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.82 131.41 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 160.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -122.08 148.84 44.37 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.356 1.062 . . . . 0.0 108.251 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.81 145.14 42.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.42 162.75 31.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.811 2.044 . . . . 0.0 107.317 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.1 145.35 43.11 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -139.96 141.43 36.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 139.68 36.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.2 160.32 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.706 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.97 -64.89 0.19 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 128.869 2.868 . . . . 0.0 113.168 164.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -67.83 162.87 23.1 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 161.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -140.38 175.26 9.74 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.884 -0.51 . . . . 0.0 110.464 -171.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.63 75.1 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 126.031 1.777 . . . . 0.0 109.657 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -61.57 -166.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.917 0.887 . . . . 0.0 109.365 154.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.84 78.71 1.03 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.74 154.51 74.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.84 1.693 . . . . 0.0 109.916 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.04 150.28 20.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 167.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 m -170.34 144.86 2.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.48 2.712 . . . . 0.0 105.613 163.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.713 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 175.592 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.523 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -147.2 -58.8 0.27 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.111 0.956 . . . . 0.0 110.544 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.88 144.31 50.71 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.756 1.162 . . . . 0.0 111.196 173.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.63 148.19 39.81 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 156.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.83 159.46 39.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -75.85 120.82 21.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.191 0.596 . . . . 0.0 111.188 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.03 146.42 4.45 Favored Glycine 0 C--O 1.223 -0.539 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.423 152.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -33.47 -51.19 0.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.293 2.637 . . . . 0.0 115.882 -170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.2 -29.13 68.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.769 0.828 . . . . 0.0 111.879 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.44 -63.66 1.01 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 109.08 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.67 -45.6 19.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.911 1.285 . . . . 0.0 111.581 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 8.7 tp -74.41 -35.81 63.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.219 0.608 . . . . 0.0 111.771 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -66.96 -45.01 79.07 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 109.69 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.59 -55.63 20.94 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.949 0.9 . . . . 0.0 110.147 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.5 -63.53 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.755 1.622 . . . . 0.0 110.033 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.9 mt -59.78 -30.96 69.24 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.814 0.846 . . . . 0.0 113.197 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -55.58 -36.14 66.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.245 0.618 . . . . 0.0 111.237 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -88.35 -52.37 5.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.8 -20.41 49.84 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.59 25.54 4.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.344 1.458 . . . . 0.0 112.015 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.5 -63.17 1.07 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.091 1.757 . . . . 0.0 111.92 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -73.07 -29.83 63.25 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 122.037 -0.414 . . . . 0.0 110.6 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -64.73 -29.87 70.86 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.4 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.24 34.35 0.89 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-O 118.824 -0.986 . . . . 0.0 114.325 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -57.02 171.43 0.36 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.109 1.764 . . . . 0.0 113.705 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -141.29 -60.77 0.48 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.432 1.493 . . . . 0.0 109.215 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.12 41.89 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.53 145.5 16.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.251 -1.146 . . . . 0.0 108.8 -170.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.06 150.83 26.11 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.439 1.496 . . . . 0.0 107.857 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.38 143.29 41.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.125 1.77 . . . . 0.0 107.011 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -133.65 153.31 51.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.8 t -140.1 118.84 11.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 17.5 p -119.68 170.53 6.7 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.0 Cg_endo -69.82 8.65 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.961 1.774 . . . . 0.0 112.589 175.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 p -121.9 -56.31 1.85 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.769 1.168 . . . . 0.0 110.204 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -140.44 170.62 15.45 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.188 0.904 . . . . 0.0 111.589 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 m -87.21 151.07 23.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.75 134.36 45.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -126.0 120.85 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.19 99.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -69.38 139.7 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt -108.96 112.11 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -145.31 171.13 15.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 110.422 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 p -84.26 -28.98 26.83 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.15 -0.969 . . . . 0.0 112.525 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -131.46 73.11 1.52 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -167.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -54.0 -27.81 34.04 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.435 1.094 . . . . 0.0 112.878 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -57.46 -44.39 84.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.828 0.851 . . . . 0.0 111.098 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.92 -38.91 79.84 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.437 1.095 . . . . 0.0 111.538 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 43' ' ' ALA . 61.5 t -65.4 -39.09 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.704 0.802 . . . . 0.0 110.062 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -74.98 -43.66 52.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.69 -172.03 33.0 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -59.66 106.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.798 1.639 . . . . 0.0 110.831 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt 42.69 47.73 4.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.513 1.525 . . . . 0.0 111.202 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.3 11.16 81.12 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.749 -2.139 . . . . 0.0 114.026 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -45.51 -60.13 2.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.244 2.522 . . . . 0.0 112.058 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -50.54 73.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.473 1.033 . . . . 0.0 109.327 -174.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -65.22 -34.33 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.974 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -64.67 -61.09 2.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.694 1.198 . . . . 0.0 110.085 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -50.21 -50.9 48.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 125.709 1.604 . . . . 0.0 111.235 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.1 -21.29 64.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.002 -1.475 . . . . 0.0 112.197 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -56.88 -46.18 82.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 121.53 1.968 . . . . 0.0 108.382 167.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.02 76.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.692 0.678 . . . . 0.0 111.528 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.57 -54.39 35.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.22 -47.37 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 124.611 1.164 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -53.94 -42.11 68.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.535 0.607 . . . . 0.0 110.876 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -80.74 -50.69 9.55 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 109.409 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -46.84 68.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.414 1.086 . . . . 0.0 110.682 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 73.9 m-85 -96.19 -14.4 22.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.76 0.824 . . . . 0.0 112.267 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.89 51.86 13.61 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.18 154.25 49.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.097 0.959 . . . . 0.0 110.117 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 167.21 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.3 2.666 . . . . 0.0 111.485 159.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -77.77 161.45 27.68 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 163.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.84 -1.52 4.5 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.93 1.252 . . . . 0.0 114.586 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -132.33 14.73 4.58 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.474 1.51 . . . . 0.0 111.823 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.9 125.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 165.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.75 146.58 43.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.47 134.06 55.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -130.5 165.71 22.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.647 2.379 . . . . 0.0 108.645 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.62 6.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.268 1.027 . . . . 0.0 108.654 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 152.82 21.37 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.494 1.518 . . . . 0.0 108.045 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -97.0 143.78 27.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -86.16 145.35 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 123.785 0.834 . . . . 0.0 108.759 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.43 171.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.554 2.342 . . . . 0.0 107.576 167.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.4 p -141.11 124.15 16.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -151.63 136.87 17.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.4 77.43 0.25 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 p -173.91 115.55 0.22 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.72 121.25 6.66 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 108.319 -1.913 . . . . 0.0 108.319 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.01 169.8 21.39 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.367 2.045 . . . . 0.0 110.076 170.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 p -117.92 -167.16 1.29 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.978 2.111 . . . . 0.0 107.149 163.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -144.21 158.81 43.52 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 159.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 -163.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -63.2 140.96 58.93 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.905 1.353 . . . . 0.0 108.364 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 p -153.1 70.65 0.88 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.655 0.741 . . . . 0.0 109.58 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.625 ' HA2' ' HB1' ' A' ' 10' ' ' ALA . . . -135.98 -157.72 7.93 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.973 1.273 . . . . 0.0 110.961 169.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 m 123.58 -159.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 133.049 4.54 . . . . 0.0 106.861 -168.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -51.28 161.04 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.097 0.951 . . . . 0.0 112.725 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 132.94 7.74 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -173.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -54.24 -47.72 71.9 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.404 -0.468 . . . . 0.0 111.298 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -61.6 -36.94 82.13 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.051 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.625 ' HB1' ' HA2' ' A' ' 4' ' ' GLY . . . -63.03 -53.88 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.456 1.502 . . . . 0.0 111.379 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -57.94 -43.73 86.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.383 0.538 . . . . 0.0 110.598 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.51 -42.42 92.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.904 0.481 . . . . 0.0 110.219 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.95 -50.45 73.36 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 123.871 0.868 . . . . 0.0 109.991 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -59.49 -37.95 79.6 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -59.52 -60.42 3.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.461 1.028 . . . . 0.0 110.228 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 41' ' ' ILE . 66.8 mt -59.05 -35.48 73.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.649 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 m -53.43 -31.2 44.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.921 1.289 . . . . 0.0 112.709 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -90.51 -54.09 4.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.992 0.814 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.87 -39.96 63.04 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.619 0.767 . . . . 0.0 111.518 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -106.94 18.89 21.23 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.737 1.215 . . . . 0.0 112.295 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.08 -50.09 73.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.266 -0.896 . . . . 0.0 112.746 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.49 -15.09 58.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.74 0.7 . . . . 0.0 111.479 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.24 -41.3 70.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 109.532 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.77 45.46 0.47 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 119.111 -0.827 . . . . 0.0 114.861 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.622 ' HE1' HG23 ' A' ' 41' ' ' ILE . 66.3 t80 -60.56 167.16 2.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.422 1.111 . . . . 0.0 112.277 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -158.96 -27.06 0.07 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.62 -169.74 40.8 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.59 149.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.74 158.51 21.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.722 1.249 . . . . 0.0 109.045 161.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.43 125.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -167.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -133.07 125.53 29.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.012 1.325 . . . . 0.0 108.291 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -116.47 127.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 47.5 p -121.66 174.98 2.74 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 124.797 1.239 . . . . 0.0 109.276 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 49.2 Cg_endo -69.64 3.72 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.942 1.761 . . . . 0.0 113.513 167.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.8 p -113.3 -59.75 1.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.923 1.238 . . . . 0.0 110.511 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -158.75 157.2 31.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.663 1.574 . . . . 0.0 112.933 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.0 m -62.97 147.57 50.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.235 1.014 . . . . 0.0 108.668 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.79 134.93 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.242 2.217 . . . . 0.0 107.381 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -124.94 123.12 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.37 94.01 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.622 HG23 ' HE1' ' A' ' 25' ' ' TYR . 3.4 mp -68.49 139.74 20.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt -107.2 115.3 29.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 127.989 2.516 . . . . 0.0 105.922 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.73 175.83 10.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.758 0.708 . . . . 0.0 112.847 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.32 -21.65 21.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.333 -1.479 . . . . 0.0 114.22 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -137.09 70.9 1.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.476 1.11 . . . . 0.0 108.828 -162.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -57.54 -33.63 68.3 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.527 -0.733 . . . . 0.0 112.109 -173.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -60.16 -36.94 78.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.654 1.116 . . . . 0.0 112.416 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -71.83 -43.68 65.15 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.175 0.99 . . . . 0.0 109.273 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.5 t -57.79 -50.62 77.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 125.898 1.679 . . . . 0.0 108.835 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.63 -31.45 72.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.679 0.792 . . . . 0.0 111.342 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.64 178.84 44.05 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -169.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.86 125.51 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 51.87 21.96 1.61 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.9 63.07 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.672 1.124 . . . . 0.0 113.985 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -55.14 -54.76 39.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 112.56 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -39.08 85.26 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.625 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 tt -63.03 -38.36 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 120.331 1.423 . . . . 0.0 110.97 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -41.21 97.39 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.614 -1.304 . . . . 0.0 111.85 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.89 -58.53 7.59 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 63' ' ' VAL . 61.7 mt -55.44 -40.88 72.11 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.878 1.671 . . . . 0.0 111.961 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.3 m -55.21 -50.87 68.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.261 1.392 . . . . 0.0 111.266 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.38 84.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.049 0.84 . . . . 0.0 112.174 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' LEU . 3.7 p -61.75 -49.73 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.801 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.77 -47.35 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 119.696 1.135 . . . . 0.0 110.337 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -54.17 -47.02 72.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.75 . . . . 0.0 110.607 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -73.78 -41.77 61.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.073 0.851 . . . . 0.0 110.085 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -51.61 63.7 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 109.845 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.59 1.89 46.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.264 1.426 . . . . 0.0 111.28 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 18.73 75.48 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.885 1.231 . . . . 0.0 114.072 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -63.18 149.47 90.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 118.545 1.173 . . . . 0.0 112.028 -174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.44 132.73 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.862 2.374 . . . . 0.0 110.102 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -57.51 141.83 46.37 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.223 1.009 . . . . 0.0 110.939 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 -12.78 1.06 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.195 1.379 . . . . 0.0 113.454 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.9 m -115.27 14.59 16.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.909 1.684 . . . . 0.0 111.333 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.84 144.34 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.741 1.617 . . . . 0.0 107.134 154.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.97 151.62 49.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.37 1.468 . . . . 0.0 108.911 172.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -124.7 128.62 49.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -112.29 168.74 9.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.057 2.143 . . . . 0.0 107.339 175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 108.72 6.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -104.85 166.32 10.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.558 1.143 . . . . 0.0 109.166 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -112.98 143.21 44.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.944 -0.473 . . . . 0.0 110.823 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.09 162.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.201 1.0 . . . . 0.0 111.345 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.79 -3.94 0.84 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.782 2.033 . . . . 0.0 115.277 163.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.7 m 16.67 75.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 131.459 3.903 . . . . 0.0 113.61 167.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 157.44 40.81 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.652 -0.655 . . . . 0.0 109.816 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.6 164.04 14.03 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -172.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.74 114.57 10.62 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.36 164.26 54.62 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.87 -0.406 . . . . 0.0 112.462 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.16 123.67 14.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 124.055 3.17 . . . . 0.0 111.755 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.2 t -137.5 47.34 2.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.695 1.198 . . . . 0.0 108.521 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 t 79.81 129.96 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.254 2.222 . . . . 0.0 106.73 -159.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 105.124 -3.19 . . . . 0.0 105.124 -158.562 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t 90.82 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 128.386 2.674 . . . . 0.0 107.801 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -69.96 108.53 4.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.56 9.03 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.11 1.338 . . . . 0.0 113.043 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.1 m -142.46 157.66 44.52 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.154 1.382 . . . . 0.0 109.023 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.0 m -170.2 171.01 7.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.609 2.364 . . . . 0.0 107.831 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.78 -142.58 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 166.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -38.11 -48.95 1.28 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.342 1.457 . . . . 0.0 112.935 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -59.66 -33.75 71.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.287 -1.339 . . . . 0.0 111.345 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.21 13.44 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.471 -1.252 . . . . 0.0 110.038 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.14 -46.77 65.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.483 1.038 . . . . 0.0 109.888 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.52 -40.86 96.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.008 0.923 . . . . 0.0 111.087 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -62.36 -51.75 66.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.798 1.239 . . . . 0.0 109.695 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.32 -27.18 65.15 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 111.29 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.05 -63.26 1.1 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.848 1.659 . . . . 0.0 108.973 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.31 -35.77 72.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.244 1.018 . . . . 0.0 112.093 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.7 m -50.53 -43.35 55.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.338 0.655 . . . . 0.0 111.148 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -42.75 18.03 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.143 0.429 . . . . 0.0 110.215 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -21.74 61.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.975 -172.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.07 30.81 6.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.14 2.176 . . . . 0.0 110.43 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.91 82.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.57 -8.2 58.42 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.983 0.81 . . . . 0.0 111.4 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -16.98 58.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.005 0.922 . . . . 0.0 113.14 -169.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.37 47.8 7.21 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 118.722 -1.704 . . . . 0.0 109.576 -163.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -64.0 142.26 58.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.2 -28.68 3.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.117 0.967 . . . . 0.0 112.209 -174.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.02 -168.83 35.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -153.4 145.82 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -118.29 165.38 13.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.816 1.646 . . . . 0.0 108.442 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 141.53 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.649 1.179 . . . . 0.0 107.872 -171.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -125.32 167.41 14.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.239 1.018 . . . . 0.0 110.269 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.72 118.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 19.7 p -121.69 170.73 7.14 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.719 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 89.8 Cg_endo -78.37 15.66 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 165.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.9 p -127.24 -52.19 1.4 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.125 1.33 . . . . 0.0 111.577 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -154.64 160.91 41.72 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.285 1.034 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.0 m -72.01 151.79 42.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.81 133.15 31.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.39 123.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 125.873 1.669 . . . . 0.0 106.775 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.17 95.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.56 133.16 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.557 1.143 . . . . 0.0 108.496 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.18 114.51 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.91 175.46 10.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.013 0.525 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 HG21 ' A' ' 82' ' ' VAL . 1.6 p -99.76 -49.3 4.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.11 1.323 . . . . 0.0 111.912 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -90.6 61.48 4.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.667 2.387 . . . . 0.0 108.957 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 p -56.07 -28.56 58.1 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.53 -1.356 . . . . 0.0 113.48 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -57.7 -37.96 74.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.384 1.074 . . . . 0.0 113.62 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.88 -46.65 74.27 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.864 0.866 . . . . 0.0 108.905 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.09 -39.21 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.429 1.092 . . . . 0.0 110.108 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.14 -44.62 83.65 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.699 -0.626 . . . . 0.0 110.7 174.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.77 175.92 47.02 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 124.795 1.188 . . . . 0.0 112.151 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -55.44 116.66 2.99 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.355 1.062 . . . . 0.0 109.814 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 53.78 23.44 3.76 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.661 0.784 . . . . 0.0 112.729 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.67 59.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.403 -0.811 . . . . 0.0 112.549 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -59.29 -57.8 11.43 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.052 1.426 . . . . 0.0 110.246 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.06 -41.36 98.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.287 -169.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.4 tp -57.88 -42.83 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 120.091 1.314 . . . . 0.0 111.256 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -70.17 -42.11 72.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 110.794 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -56.32 23.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.1 mt -62.26 -24.26 67.16 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.885 1.274 . . . . 0.0 112.587 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -61.16 -48.76 80.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.348 1.431 . . . . 0.0 109.659 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.98 -40.18 95.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.293 0.497 . . . . 0.0 110.997 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.0 -53.26 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -63.55 -43.69 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 124.995 1.318 . . . . 0.0 110.241 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -54.48 -37.31 65.11 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.358 0.663 . . . . 0.0 110.568 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -73.9 -58.13 3.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.005 0.82 . . . . 0.0 110.081 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -57.38 -30.05 64.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.996 1.318 . . . . 0.0 112.379 -170.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 98.1 m-85 -121.59 2.24 10.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.416 1.486 . . . . 0.0 111.774 -171.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.98 22.9 65.27 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.037 0.835 . . . . 0.0 114.156 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -63.66 146.24 96.89 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.2 0.6 . . . . 0.0 111.267 -172.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.52 129.38 27.81 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.542 2.161 . . . . 0.0 110.581 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.65 143.53 46.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.73 61.11 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.873 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -136.61 21.48 3.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.156 1.478 . . . . 0.0 113.113 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.07 138.8 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 154.94 42.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.899 0.88 . . . . 0.0 110.567 165.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -132.94 114.08 13.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.36 2.264 . . . . 0.0 107.551 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.81 176.29 5.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.623 1.169 . . . . 0.0 110.524 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.18 114.76 8.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.594 0.633 . . . . 0.0 109.635 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -114.56 141.41 47.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.982 2.113 . . . . 0.0 109.598 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.8 156.22 19.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 44' ' ' THR . 29.7 m -95.43 158.43 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 125.192 1.397 . . . . 0.0 110.493 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.37 -47.83 0.66 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.938 2.895 . . . . 0.0 114.3 169.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 m 62.74 169.65 0.13 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.517 1.927 . . . . 0.0 112.325 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -153.35 174.74 13.95 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 119.662 -1.899 . . . . 0.0 110.365 167.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.43 -90.79 1.58 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 t 65.2 -173.79 0.18 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.906 0.882 . . . . 0.0 110.242 -161.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.71 101.01 0.43 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 117.671 -1.627 . . . . 0.0 109.242 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.5 163.83 37.46 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 120.27 2.035 . . . . 0.0 110.664 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 71.04 170.61 0.32 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.359 2.663 . . . . 0.0 113.679 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.2 m -161.77 85.66 0.63 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.258 1.823 . . . . 0.0 108.893 -177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 N-CA-C 103.547 -3.821 . . . . 0.0 103.547 -160.082 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -177.77 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 129.607 3.163 . . . . 0.0 109.847 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -136.88 166.64 23.15 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.04 -1.037 . . . . 0.0 109.009 157.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.5 -170.95 44.11 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 p -63.49 167.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 112.162 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 m -74.89 151.94 38.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 154.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.35 171.46 12.69 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.249 -0.907 . . . . 0.0 112.604 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 67.6 t80 -52.58 -50.74 62.4 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.229 1.012 . . . . 0.0 111.834 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -70.89 -13.26 61.96 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.471 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.46 -50.55 7.66 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.977 1.262 . . . . 0.0 109.999 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.51 -46.75 80.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.866 0.757 . . . . 0.0 111.687 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 11.1 tp -67.7 -33.99 75.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.787 1.235 . . . . 0.0 110.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -66.59 -51.14 59.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 109.94 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.6 -52.41 59.9 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.122 0.969 . . . . 0.0 110.557 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -52.22 -60.16 3.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.163 1.385 . . . . 0.0 110.498 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.0 mt -62.66 -36.74 83.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -51.79 -47.34 64.27 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.732 0.813 . . . . 0.0 109.237 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -76.68 -41.1 46.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.862 0.465 . . . . 0.0 110.117 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -17.88 62.15 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.718 -1.134 . . . . 0.0 113.677 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -130.54 24.48 5.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.14 1.776 . . . . 0.0 112.631 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.24 66.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.15 -36.21 83.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.803 0.811 . . . . 0.0 109.127 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -38.87 86.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.508 1.123 . . . . 0.0 110.651 -168.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.52 37.88 0.88 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 119.96 1.255 . . . . 0.0 114.386 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.79 165.74 2.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.319 1.047 . . . . 0.0 112.923 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 m -159.03 -31.02 0.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.41 -171.72 43.74 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.51 137.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.86 158.8 15.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.64 117.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 124.767 1.227 . . . . 0.0 107.872 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.85 122.05 46.63 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.7 131.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 161.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 30.9 p -120.51 166.53 15.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 48.6 Cg_endo -67.47 -12.68 36.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.329 1.353 . . . . 0.0 111.511 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.79 -50.59 5.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.307 1.443 . . . . 0.0 110.266 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 76' ' ' GLU . 5.6 ptp180 -162.08 173.7 14.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.386 1.448 . . . . 0.0 111.496 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.15 152.99 39.72 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.933 -1.104 . . . . 0.0 108.084 162.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -135.05 138.78 44.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.475 2.31 . . . . 0.0 105.108 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.9 mt -129.18 124.17 59.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.86 98.01 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.24 127.27 29.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.0 mt -97.1 110.06 22.69 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.171 1.388 . . . . 0.0 107.544 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.13 170.43 19.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.443 0.697 . . . . 0.0 109.48 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.29 -48.67 15.17 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.31 -1.493 . . . . 0.0 112.505 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -94.97 69.49 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.828 1.651 . . . . 0.0 108.795 -165.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -52.75 -34.85 54.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.21 -47.15 85.71 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 120.918 -1.114 . . . . 0.0 111.939 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.65 -43.78 97.93 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.02 -51.79 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 126.414 1.885 . . . . 0.0 109.461 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.4 -32.46 68.65 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 121.879 -0.513 . . . . 0.0 110.204 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 179.07 46.57 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.97 107.28 0.28 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.247 1.419 . . . . 0.0 110.508 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 48.25 50.53 16.25 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.023 0.916 . . . . 0.0 112.173 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.96 58.98 9.82 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -93.57 -68.39 0.8 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.301 1.04 . . . . 0.0 110.565 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -61.82 -38.15 87.09 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.356 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tp -55.64 -43.04 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.269 0.94 . . . . 0.0 111.355 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -72.5 -36.24 68.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.783 -1.198 . . . . 0.0 111.097 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -56.93 15.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.26 -22.73 64.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.552 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.5 m -58.15 -57.41 12.96 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 120.494 1.497 . . . . 0.0 109.054 166.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -27.53 69.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.278 0.944 . . . . 0.0 112.237 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.11 -63.45 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.61 -43.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.329 1.851 . . . . 0.0 110.86 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -53.91 -45.32 71.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.154 0.982 . . . . 0.0 110.784 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -71.68 -57.92 3.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 109.631 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -47.36 27.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.526 1.93 . . . . 0.0 111.918 -173.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.04 -7.57 22.21 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.336 1.454 . . . . 0.0 111.411 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.15 44.68 95.35 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.053 0.835 . . . . 0.0 111.198 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -69.73 141.59 90.29 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 117.55 0.675 . . . . 0.0 109.619 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.15 128.03 27.18 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 108.38 -1.431 . . . . 0.0 108.38 161.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.72 99.94 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.425 1.49 . . . . 0.0 111.643 -175.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.98 -8.75 33.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.532 1.539 . . . . 0.0 112.028 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 m -85.18 21.72 1.62 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.621 1.21 . . . . 0.0 111.111 162.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 154.73 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.59 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.488 ' HG3' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.93 150.95 33.79 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.886 2.075 . . . . 0.0 107.335 174.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -123.86 131.28 53.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.532 1.133 . . . . 0.0 108.862 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -126.16 161.53 27.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.54 2.336 . . . . 0.0 109.314 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.36 109.21 9.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.366 1.066 . . . . 0.0 108.821 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 158.09 16.59 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.155 1.382 . . . . 0.0 108.46 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -83.28 152.22 25.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.63 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.1 177.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.104 160.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 140.36 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 131.518 3.927 . . . . 0.0 108.351 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.272 18.3 p 58.38 -148.21 0.48 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.717 1.607 . . . . 0.0 111.739 168.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -161.76 -60.77 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.517 1.508 . . . . 0.0 111.327 155.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.9 -98.31 2.12 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.899 1.238 . . . . 0.0 110.012 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -132.96 -103.4 0.25 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 156.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.4 170.96 12.85 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -161.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.76 152.98 53.52 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.634 2.223 . . . . 0.0 111.165 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.1 m -100.26 -12.13 19.78 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 111.962 161.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 m -154.57 165.09 37.59 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.123 1.369 . . . . 0.0 108.352 167.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.55 0 C-N-CA 127.795 2.617 . . . . 0.0 106.964 178.647 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -148.41 92.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.433 -1.039 . . . . 0.0 109.298 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 m -148.17 81.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.77 100.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 O-C-N 121.497 -0.752 . . . . 0.0 111.953 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -126.17 -98.65 0.4 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 136.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -108.9 154.9 21.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.497 0.719 . . . . 0.0 110.167 -163.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.34 153.5 6.39 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 126.276 1.893 . . . . 0.0 108.622 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 63.3 t80 -48.96 -50.47 35.45 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -168.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.62 -31.02 69.11 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.764 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.0 -59.0 5.42 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.766 1.166 . . . . 0.0 110.705 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.78 -45.01 82.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.473 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.4 tp -66.42 -39.29 88.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.681 0.613 . . . . 0.0 110.513 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.28 -53.0 62.37 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.019 0.827 . . . . 0.0 108.959 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 -30.44 71.47 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.3 0.5 . . . . 0.0 111.569 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -65.78 -52.1 53.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.308 1.443 . . . . 0.0 110.215 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.86 -32.73 72.61 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.577 1.151 . . . . 0.0 112.161 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -50.98 -49.75 59.6 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.229 1.012 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -61.5 -57.69 11.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.735 1.214 . . . . 0.0 110.285 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.21 -14.34 62.92 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -134.48 18.94 3.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.969 0.908 . . . . 0.0 112.157 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -58.15 7.92 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 110.937 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.41 -27.6 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.646 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -15.89 62.77 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.0 1.32 . . . . 0.0 112.158 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.89 42.03 6.14 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.523 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -53.21 167.3 0.19 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.806 1.242 . . . . 0.0 111.616 167.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 m -153.93 -43.21 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.731 1.212 . . . . 0.0 110.928 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.23 34.43 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.86 159.39 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 121.456 -1.026 . . . . 0.0 108.33 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -127.84 164.3 22.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.242 1.017 . . . . 0.0 109.475 158.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.13 148.52 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 127.147 2.179 . . . . 0.0 108.701 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -122.85 129.61 51.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.97 116.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 154.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.1 p -120.74 165.09 19.69 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 165.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.8 -12.85 29.13 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.376 2.051 . . . . 0.0 111.959 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 p -96.37 -47.08 6.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.206 0.912 . . . . 0.0 109.77 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.3 169.59 20.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.81 1.644 . . . . 0.0 108.789 164.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.9 m -72.87 145.13 47.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 162.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.68 140.65 52.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 171.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.38 120.05 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.13 111.71 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.71 132.35 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.5 105.29 17.41 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 163.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -134.22 166.62 22.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -71.3 -35.88 71.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.796 -0.565 . . . . 0.0 111.259 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -127.29 74.89 1.54 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.178 0.899 . . . . 0.0 110.84 -163.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 p -50.61 -40.54 53.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -58.19 -34.69 70.64 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -77.57 -37.33 50.84 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 43' ' ' ALA . 70.2 t -66.26 -37.36 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 118.528 0.604 . . . . 0.0 110.03 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.76 -41.95 97.91 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.151 -0.968 . . . . 0.0 109.164 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.06 179.59 43.68 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.53 115.97 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.969 0.907 . . . . 0.0 109.934 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt 51.33 32.68 8.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.422 1.489 . . . . 0.0 111.633 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 33.7 37.42 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.033 -1.426 . . . . 0.0 112.727 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -65.61 0.64 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.732 1.766 . . . . 0.0 112.274 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -60.59 -42.12 96.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -167.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.27 -42.21 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 123.888 0.743 . . . . 0.0 110.425 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -46.84 83.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.258 1.39 . . . . 0.0 111.303 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -59.88 4.32 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.64 -25.16 66.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 117.303 -1.332 . . . . 0.0 112.185 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -56.23 -52.58 63.93 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 120.324 1.42 . . . . 0.0 108.673 169.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.11 79.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.494 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.28 -60.09 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.81 -44.46 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 127.258 2.223 . . . . 0.0 110.624 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.24 -45.9 76.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.933 0.893 . . . . 0.0 110.467 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -70.17 -50.78 36.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.547 1.067 . . . . 0.0 111.488 170.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -29.24 49.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.796 1.638 . . . . 0.0 112.566 -172.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.71 4.22 7.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.324 1.45 . . . . 0.0 112.133 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.54 79.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.405 1.003 . . . . 0.0 114.625 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -70.25 142.0 89.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.137 . . . . 0.0 112.366 -172.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.74 121.51 8.58 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.496 2.797 . . . . 0.0 110.921 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.94 146.44 26.8 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.593 1.557 . . . . 0.0 110.256 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.42 -22.71 3.09 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 120.87 -1.144 . . . . 0.0 112.462 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.7 m -109.85 10.35 24.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.457 2.303 . . . . 0.0 110.862 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.86 140.22 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 162.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.18 154.76 46.45 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 124.002 0.921 . . . . 0.0 109.083 166.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -119.84 138.7 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -132.83 168.24 18.74 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.942 1.697 . . . . 0.0 109.949 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.79 108.58 9.97 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.168 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.71 147.44 28.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 111.14 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -81.83 150.98 27.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.8 157.07 6.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.21 113.5 3.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.425 1.49 . . . . 0.0 107.092 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -75.82 -85.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -144.84 80.43 1.62 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.759 2.023 . . . . 0.0 105.64 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.09 112.25 0.49 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m 60.68 174.96 0.1 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.829 1.651 . . . . 0.0 112.705 -167.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.41 149.04 5.71 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.91 142.39 75.25 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 CA-C-N 119.14 1.47 . . . . 0.0 110.221 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -144.32 -13.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.4 1.08 . . . . 0.0 112.106 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 p -135.43 100.19 4.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.138 0.975 . . . . 0.0 108.507 163.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 -175.611 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -169.77 163.32 9.83 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.269 2.227 . . . . 0.0 107.514 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -71.85 -23.71 61.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -170.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.46 -164.61 12.4 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -161.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m 73.06 107.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.719 2.408 . . . . 0.0 115.007 168.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m 49.31 78.62 0.09 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.664 2.386 . . . . 0.0 112.944 162.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.03 151.39 16.65 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.0 -49.67 76.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -63.63 -12.15 31.11 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.317 -0.849 . . . . 0.0 113.159 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.49 1.14 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 121.165 1.802 . . . . 0.0 108.854 166.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -50.32 -45.41 54.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.48 1.512 . . . . 0.0 111.443 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.22 -40.76 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.839 0.456 . . . . 0.0 110.472 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -64.0 -48.13 77.58 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.12 -48.55 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.046 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -53.36 -56.53 15.99 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.091 0.859 . . . . 0.0 110.597 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.2 -37.41 85.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 111.16 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.8 m -53.84 -47.91 70.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.905 0.882 . . . . 0.0 110.618 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -58.37 5.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.01 0.924 . . . . 0.0 109.813 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.01 -27.62 63.69 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.23 18.03 12.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.837 1.655 . . . . 0.0 111.92 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.96 -35.82 47.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.268 1.027 . . . . 0.0 113.361 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -90.82 -19.59 23.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.906 0.775 . . . . 0.0 112.665 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.74 -26.34 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.593 1.157 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 50.58 2.81 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -169.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -57.43 168.42 0.8 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 110.417 166.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -154.24 -43.44 0.09 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 110.184 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.53 -165.9 33.86 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.7 157.47 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -124.96 138.45 54.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 108.212 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.61 116.48 35.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.207 1.803 . . . . 0.0 108.842 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -113.96 122.0 45.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -107.71 111.92 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 p -120.46 167.02 13.66 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.35 22.89 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.878 2.385 . . . . 0.0 111.445 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -127.61 -53.03 1.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.397 -1.439 . . . . 0.0 110.937 -168.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -162.09 171.71 17.06 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.459 2.304 . . . . 0.0 107.56 160.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -87.62 138.05 31.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.75 151.64 27.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.74 122.36 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 mt -123.57 108.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 mt -71.01 122.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.83 110.53 20.57 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.59 168.08 21.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 111.321 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -78.43 -26.37 46.29 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 120.458 -1.401 . . . . 0.0 112.854 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -128.89 67.02 1.41 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.964 0.906 . . . . 0.0 110.562 -164.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -45.32 26.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.697 1.999 . . . . 0.0 113.42 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -70.78 -28.61 64.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.223 -0.923 . . . . 0.0 111.744 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.59 -42.26 64.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 0.56 . . . . 0.0 109.689 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.76 -47.44 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.1 mt -61.82 -38.66 88.99 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.441 -0.787 . . . . 0.0 111.024 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.0 174.05 29.67 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.52 117.21 3.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.273 1.029 . . . . 0.0 109.488 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 47.62 41.11 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.507 1.123 . . . . 0.0 112.925 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.93 13.74 83.34 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.114 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -48.61 -60.16 2.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.132 1.466 . . . . 0.0 113.046 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -43.25 99.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 117.025 -1.465 . . . . 0.0 110.363 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 tt -61.06 -39.02 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 120.185 1.357 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -63.51 -47.7 80.6 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 120.747 -1.221 . . . . 0.0 112.361 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.25 -58.88 6.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.257 1.023 . . . . 0.0 109.303 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.84 -26.23 67.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.624 -173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.4 m -58.32 -47.58 83.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.06 1.3 . . . . 0.0 109.803 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.84 88.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.624 1.102 . . . . 0.0 111.796 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.98 -58.82 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.283 -0.885 . . . . 0.0 108.64 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.2 t -52.12 -45.72 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 126.378 1.871 . . . . 0.0 110.197 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -52.6 -49.29 65.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.534 0.733 . . . . 0.0 110.732 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.87 32.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.734 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -40.92 65.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.011 0.823 . . . . 0.0 111.965 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.15 8.24 27.93 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.055 1.742 . . . . 0.0 111.227 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 33.21 63.38 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.495 1.521 . . . . 0.0 113.695 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -72.32 151.41 92.08 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.782 0.833 . . . . 0.0 112.291 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.0 119.67 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.393 2.062 . . . . 0.0 109.241 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.09 137.16 56.16 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.758 0.823 . . . . 0.0 109.034 166.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.35 56.05 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.75 1.643 . . . . 0.0 113.152 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.3 m -133.51 17.7 3.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.076 1.438 . . . . 0.0 112.993 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.53 139.58 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 151.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -128.49 145.11 51.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.63 140.96 48.39 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -131.6 167.73 18.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 128.136 2.574 . . . . 0.0 108.871 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.33 119.47 15.54 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -121.49 171.78 8.55 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.375 1.47 . . . . 0.0 111.886 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -115.25 131.55 56.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.569 -164.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.24 148.08 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 74.16 99.76 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.424 2.289 . . . . 0.0 110.653 -175.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.2 m -63.8 120.75 12.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.467 2.307 . . . . 0.0 108.546 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 -23.12 0.12 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.105 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.78 -149.63 5.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.305 0.955 . . . . 0.0 112.113 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 m -146.22 -177.39 5.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.144 1.778 . . . . 0.0 108.562 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.5 171.38 16.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 162.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.34 159.15 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.109 2.54 . . . . 0.0 110.863 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 p -157.25 -20.99 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.681 1.192 . . . . 0.0 112.282 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -156.88 95.73 1.55 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 N-CA-C 106.924 -2.47 . . . . 0.0 106.924 176.031 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -160.99 166.28 28.52 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 117.987 0.893 . . . . 0.0 108.992 163.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 p -163.68 177.85 8.39 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.304 1.442 . . . . 0.0 108.433 159.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.7 159.67 26.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 168.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.4 m -106.42 -63.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.968 1.307 . . . . 0.0 109.195 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -145.82 -44.39 0.21 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.99 0.916 . . . . 0.0 110.768 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.43 -66.68 0.23 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 53.7 t80 -61.61 -56.81 15.82 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.372 1.069 . . . . 0.0 111.153 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -52.59 -38.23 59.67 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.698 0.799 . . . . 0.0 110.757 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.26 -49.65 40.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.117 -0.944 . . . . 0.0 112.241 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -55.95 -46.95 78.41 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.516 1.053 . . . . 0.0 109.787 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 14.0 tp -62.4 -39.78 94.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.694 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -61.26 -51.78 67.51 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.003 0.921 . . . . 0.0 109.792 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -59.66 -40.08 86.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.928 0.785 . . . . 0.0 111.579 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.02 -57.92 10.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.934 0.893 . . . . 0.0 109.315 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -61.26 -38.39 86.53 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.856 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -53.61 -31.14 45.89 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.484 1.493 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.86 -47.69 7.46 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 110.526 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -60.63 -33.76 73.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.791 0.723 . . . . 0.0 112.41 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -113.55 23.58 13.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.293 2.237 . . . . 0.0 110.37 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.87 -59.69 4.04 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.593 1.157 . . . . 0.0 110.143 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.03 -39.94 79.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.695 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -43.51 92.66 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.699 1.6 . . . . 0.0 112.21 -164.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.63 48.73 0.78 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.868 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.51 169.79 5.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.163 1.385 . . . . 0.0 111.095 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -157.16 -26.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.14 -169.54 36.75 Favored Glycine 0 C--O 1.227 -0.311 0 O-C-N 121.632 -0.667 . . . . 0.0 111.689 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.59 142.52 11.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.21 158.37 16.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.335 1.054 . . . . 0.0 109.506 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.79 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.093 1.357 . . . . 0.0 107.471 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.7 129.07 57.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.8 p -121.83 177.06 1.67 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.634 1.574 . . . . 0.0 110.407 -172.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.1 Cg_endo -78.75 0.0 10.36 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 121.424 1.416 . . . . 0.0 113.182 165.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -119.64 -53.14 2.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.766 1.621 . . . . 0.0 112.971 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -153.73 161.38 42.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.649 1.18 . . . . 0.0 110.66 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.1 m -71.63 148.06 46.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.08 130.99 53.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.336 1.854 . . . . 0.0 106.769 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.9 mt -124.03 121.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.94 97.14 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -69.61 141.74 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -115.39 120.8 40.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 127.923 2.489 . . . . 0.0 107.76 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.91 169.71 22.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.101 1.361 . . . . 0.0 109.643 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -80.41 -35.43 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.406 -0.809 . . . . 0.0 112.342 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -125.55 83.47 2.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.306 1.442 . . . . 0.0 108.32 -165.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -49.92 -45.15 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.049 1.34 . . . . 0.0 112.387 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -56.85 -38.47 72.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.49 -43.73 80.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.485 1.039 . . . . 0.0 109.877 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.05 -42.32 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.079 0.552 . . . . 0.0 109.768 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.15 -30.78 71.73 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.979 -1.076 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.16 -174.38 9.42 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.06 111.6 1.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 110.228 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp 56.41 3.13 0.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.251 1.82 . . . . 0.0 115.14 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.72 -2.14 9.35 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 120.422 1.464 . . . . 0.0 114.112 -169.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -44.06 -57.44 3.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.057 1.929 . . . . 0.0 113.941 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.87 -45.02 79.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.122 0.874 . . . . 0.0 110.621 -173.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.29 -34.33 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.374 0.988 . . . . 0.0 109.827 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -71.84 -37.42 70.28 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 113.753 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.28 -55.27 16.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.2 mt -56.09 -36.1 67.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.136 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -49.32 -52.56 27.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.18 0.9 . . . . 0.0 110.729 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.61 -44.63 56.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.2 1.0 . . . . 0.0 111.36 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -60.28 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 t -54.85 -46.49 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 120.417 1.462 . . . . 0.0 110.614 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -49.95 -42.51 48.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.272 1.029 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -83.77 -41.06 18.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.002 0.921 . . . . 0.0 111.709 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -29.64 70.88 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.98 0.912 . . . . 0.0 111.474 -173.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.3 -8.76 11.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.983 0.913 . . . . 0.0 110.464 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.5 51.07 45.12 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -78.18 150.4 77.39 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.011 0.524 . . . . 0.0 110.018 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.54 119.51 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.773 1.649 . . . . 0.0 109.712 162.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.86 145.59 15.81 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.93 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.601 -1.111 . . . . 0.0 114.296 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -134.46 40.16 3.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.462 2.131 . . . . 0.0 111.882 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.2 139.57 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 164.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 138.34 50.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.092 1.357 . . . . 0.0 108.729 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.44 129.23 47.44 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -117.04 160.3 21.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.421 1.488 . . . . 0.0 109.554 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.67 109.36 10.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 108.463 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.12 156.48 17.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.376 1.47 . . . . 0.0 108.475 173.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -107.06 148.83 28.27 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -100.1 146.54 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.63 -44.85 0.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.09 1.756 . . . . 0.0 111.773 -171.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.2 p 32.67 64.8 0.25 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.865 2.866 . . . . 0.0 113.87 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.07 83.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.816 1.246 . . . . 0.0 109.979 -174.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.91 73.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.0 p -154.53 176.36 12.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.408 0.604 . . . . 0.0 111.144 168.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.95 79.44 0.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.92 170.5 17.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.616 2.211 . . . . 0.0 111.209 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.0 t -141.37 170.35 15.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.213 1.405 . . . . 0.0 108.683 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.1 m -137.36 -78.56 0.39 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.972 1.709 . . . . 0.0 107.751 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -149.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.421 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 44.9 t80 . . . . . 0 CA--C 1.527 0.061 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -57.94 -31.72 67.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -42.33 58.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.407 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -62.73 -46.41 88.21 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.144 0.577 . . . . 0.0 110.807 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.6 tp -65.75 -38.82 90.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.651 0.781 . . . . 0.0 110.166 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.45 -42.18 83.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.352 0.524 . . . . 0.0 111.14 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.95 -46.26 78.6 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.588 0.755 . . . . 0.0 110.876 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.57 -61.59 2.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.001 0.92 . . . . 0.0 109.439 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.51 -32.23 72.26 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.737 1.215 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.3 m -54.56 -45.42 73.48 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.885 0.766 . . . . 0.0 110.497 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -49.97 65.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.689 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -55.88 -35.53 66.6 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.104 0.561 . . . . 0.0 112.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -121.15 24.77 9.93 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.09 1.356 . . . . 0.0 110.524 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.03 -63.04 1.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.42 1.488 . . . . 0.0 110.595 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.23 -24.94 51.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.905 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.7 -35.54 72.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.341 0.973 . . . . 0.0 111.418 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.68 35.73 0.83 Allowed Glycine 0 C--N 1.338 0.65 0 O-C-N 123.553 0.533 . . . . 0.0 113.018 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 41' ' ' ILE . 29.9 t80 -59.38 167.46 1.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.174 0.987 . . . . 0.0 112.509 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -44.88 0.16 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.406 1.482 . . . . 0.0 110.042 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.32 -169.53 42.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.77 156.34 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.39 158.96 22.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.576 1.951 . . . . 0.0 107.857 163.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.02 150.07 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -132.88 156.79 46.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 163.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.52 124.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.0 p -120.41 176.83 1.64 Allowed Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -167.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 67.6 Cg_endo -72.12 8.07 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.509 1.473 . . . . 0.0 112.591 167.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -125.78 -45.08 1.77 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.376 0.989 . . . . 0.0 110.637 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -161.73 173.22 14.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.92 1.236 . . . . 0.0 110.865 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.6 m -88.94 149.47 23.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 160.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.2 138.41 52.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.176 1.79 . . . . 0.0 106.613 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -132.16 120.7 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.41 95.03 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.484 HG23 ' CE1' ' A' ' 25' ' ' TYR . 2.5 mp -64.26 153.24 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -118.8 108.14 14.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.827 2.451 . . . . 0.0 105.972 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.93 157.93 45.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.556 0.693 . . . . 0.0 112.29 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.8 p -64.08 -34.24 77.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.549 1.14 . . . . 0.0 111.018 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -134.88 82.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.479 1.512 . . . . 0.0 109.821 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 p -53.4 -35.37 60.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.732 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -60.79 -36.57 79.35 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.448 1.477 . . . . 0.0 112.456 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -67.03 -45.28 77.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.814 0.733 . . . . 0.0 109.066 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -30.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.049 0.939 . . . . 0.0 111.105 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.21 -40.22 52.72 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.524 -0.735 . . . . 0.0 110.519 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.3 179.7 47.06 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.501 1.048 . . . . 0.0 111.487 -171.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -57.06 114.93 2.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.545 0.738 . . . . 0.0 109.447 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 mttp 39.46 46.82 1.47 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.181 1.792 . . . . 0.0 112.464 -174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.88 9.54 77.43 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.118 -0.824 . . . . 0.0 113.751 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -43.86 -62.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.253 1.526 . . . . 0.0 112.738 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.02 -40.77 78.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.368 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.04 -41.27 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.306 0.957 . . . . 0.0 111.186 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -52.61 64.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.972 -1.08 . . . . 0.0 109.649 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -58.54 -47.06 85.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.795 0.725 . . . . 0.0 111.732 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 63' ' ' VAL . 40.0 mt -62.0 -30.24 70.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.715 0.806 . . . . 0.0 110.898 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -61.17 -51.7 67.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.436 1.016 . . . . 0.0 109.413 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.71 78.79 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.857 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 60' ' ' LEU . 11.4 p -59.87 -46.17 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.722 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 t -60.45 -45.69 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 120.234 1.379 . . . . 0.0 110.152 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -51.9 -44.25 63.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.785 1.234 . . . . 0.0 110.426 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -70.75 -50.78 32.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.2 1.0 . . . . 0.0 110.139 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -44.87 90.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.282 1.433 . . . . 0.0 111.016 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -103.57 -13.67 16.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.81 1.244 . . . . 0.0 111.503 -171.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 20.36 54.91 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 121.324 -0.86 . . . . 0.0 113.943 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -62.32 138.38 96.23 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.063 0.932 . . . . 0.0 112.456 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.96 141.6 49.03 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.275 1.983 . . . . 0.0 110.24 165.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.47 147.35 39.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.735 0.814 . . . . 0.0 110.03 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.97 -7.44 7.57 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.435 -0.791 . . . . 0.0 113.197 -169.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.0 m -122.02 7.21 9.78 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.138 1.775 . . . . 0.0 111.201 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.07 136.84 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 156.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -127.65 140.77 51.88 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.54 126.67 50.92 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.205 1.402 . . . . 0.0 107.629 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 63.5 m-85 -129.89 168.23 16.95 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.847 2.459 . . . . 0.0 109.22 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.62 122.07 17.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.37 155.28 18.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -101.23 149.49 23.95 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 122.517 1.151 . . . . 0.0 108.134 178.479 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 t80 . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.31 -36.19 60.99 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 118.547 -0.739 . . . . 0.0 112.177 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.37 -51.52 51.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.951 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.91 -46.0 74.82 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.427 1.091 . . . . 0.0 109.932 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.21 -43.26 82.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.737 0.815 . . . . 0.0 110.625 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -64.12 -47.19 80.93 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.324 0.65 . . . . 0.0 109.942 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.73 -44.29 85.89 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.186 1.394 . . . . 0.0 111.739 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -56.54 -60.07 4.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.5 -38.89 78.61 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.476 1.11 . . . . 0.0 112.487 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -51.91 -37.05 51.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.552 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -90.79 -39.01 12.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.293 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.09 -25.46 65.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 113.071 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.38 22.6 12.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.2 1.8 . . . . 0.0 110.758 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.23 64.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.872 1.269 . . . . 0.0 111.683 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.77 -26.65 59.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.673 0.215 . . . . 0.0 111.071 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 -34.99 79.41 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.639 0.775 . . . . 0.0 112.12 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.57 33.63 2.23 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.49 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HE1' HG23 ' A' ' 41' ' ' ILE . 38.5 t80 -51.67 157.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.862 0.865 . . . . 0.0 112.478 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.436 ' CB ' HG21 ' A' ' 82' ' ' VAL . 22.9 m -128.96 -57.06 1.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.472 1.509 . . . . 0.0 108.96 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.12 -166.45 32.9 Favored Glycine 0 C--O 1.227 -0.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.23 154.56 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -124.27 152.17 43.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 165.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.75 137.28 54.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -115.3 152.28 33.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.99 96.23 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 -171.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -120.69 163.89 26.45 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 123.768 0.827 . . . . 0.0 108.914 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.85 13.7 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.84 2.36 . . . . 0.0 112.011 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 p -120.64 -45.52 2.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.33 1.452 . . . . 0.0 110.324 -163.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -162.05 173.22 14.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.95 2.1 . . . . 0.0 106.989 162.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -75.71 147.37 39.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 158.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.77 129.7 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -126.9 132.51 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.99 100.53 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' A' ' 25' ' ' TYR . 59.8 mt -69.55 131.75 33.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 82' ' ' VAL . 51.0 mt -106.92 114.63 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.643 1.977 . . . . 0.0 106.22 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.81 169.63 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.801 0.441 . . . . 0.0 110.081 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -68.61 -46.45 69.27 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.408 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -115.8 89.6 3.14 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 127.519 2.328 . . . . 0.0 107.605 -164.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -45.27 66.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 111.324 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -65.76 -19.43 65.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -74.35 -49.06 24.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.67 -39.29 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.998 1.319 . . . . 0.0 110.844 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.16 -40.73 90.76 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.599 -0.688 . . . . 0.0 110.858 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 -175.29 40.0 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.54 113.67 2.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.889 1.275 . . . . 0.0 110.467 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.1 pttt 46.25 30.07 0.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.635 1.174 . . . . 0.0 113.867 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.62 5.74 59.97 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.992 0.806 . . . . 0.0 114.374 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -45.72 -55.91 5.91 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 112.855 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -72.27 -46.48 55.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.25 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.0 tt -59.08 -35.93 59.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.848 1.658 . . . . 0.0 111.134 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.94 -36.67 72.71 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 120.699 -1.251 . . . . 0.0 112.559 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.91 -49.27 71.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.265 0.484 . . . . 0.0 109.997 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 63' ' ' VAL . 83.1 mt -59.87 -29.09 68.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.937 1.295 . . . . 0.0 110.507 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -63.32 -56.67 14.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.815 . . . . 0.0 109.067 169.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.6 88.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.863 1.265 . . . . 0.0 112.097 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 60' ' ' LEU . 7.4 p -62.88 -52.4 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.115 -1.422 . . . . 0.0 108.101 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.81 -46.38 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.187 1.358 . . . . 0.0 109.976 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.99 -44.89 64.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 0.0 109.517 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -83.89 -37.51 22.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.707 0.685 . . . . 0.0 112.646 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.98 -55.3 32.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.528 1.131 . . . . 0.0 109.088 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 97.2 m-85 -93.8 -11.18 31.85 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.486 1.114 . . . . 0.0 110.51 -169.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.98 23.11 59.96 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.424 1.011 . . . . 0.0 111.811 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.65 139.98 97.71 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 118.263 1.031 . . . . 0.0 111.508 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.17 130.74 35.54 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.934 2.423 . . . . 0.0 109.449 165.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.07 122.67 15.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.433 0.693 . . . . 0.0 109.301 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.58 -12.47 56.03 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.985 0.802 . . . . 0.0 114.368 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -89.2 15.18 9.31 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.779 1.232 . . . . 0.0 111.582 165.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.57 156.4 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 159.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 145.31 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 170.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 113.16 19.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -112.36 164.67 12.98 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.064 2.145 . . . . 0.0 108.609 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.84 114.37 10.39 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.43 153.68 20.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.088 0.946 . . . . 0.0 109.194 172.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -83.28 148.3 27.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 26' ' ' SER . 91.5 t . . . . . 0 C--N 1.323 -0.558 0 C-N-CA 123.794 0.837 . . . . 0.0 109.339 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.227 -0.101 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.55 -38.52 74.89 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.544 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.83 65.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.782 0.719 . . . . 0.0 111.759 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -58.13 -48.73 79.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.911 0.778 . . . . 0.0 109.48 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.62 -41.86 92.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.344 1.457 . . . . 0.0 111.39 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.02 -50.16 73.59 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 123.764 0.826 . . . . 0.0 109.51 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.72 -42.68 97.88 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.11 -52.12 65.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.681 0.793 . . . . 0.0 109.419 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.18 -38.66 85.77 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.242 1.017 . . . . 0.0 111.787 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -54.6 -42.53 71.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.907 0.883 . . . . 0.0 109.9 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.51 -61.44 1.89 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.369 0.668 . . . . 0.0 110.061 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -21.97 64.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -170.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -122.65 21.58 10.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.138 1.775 . . . . 0.0 111.104 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.56 -55.07 17.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.309 1.044 . . . . 0.0 112.228 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -71.11 -16.08 62.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.554 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.48 -16.1 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.544 1.066 . . . . 0.0 113.39 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.73 40.26 6.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.58 158.85 4.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.834 -0.804 . . . . 0.0 110.89 170.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -147.35 -29.86 0.34 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.115 0.966 . . . . 0.0 112.564 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.64 -167.02 40.04 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.74 149.27 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.43 119.48 28.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -82.67 135.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -109.39 120.58 42.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.37 121.92 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 157.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 p -120.29 164.75 20.95 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 92.9 Cg_endo -74.29 2.85 5.77 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.678 2.252 . . . . 0.0 111.877 173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -112.82 -41.75 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -161.83 173.37 14.67 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.077 1.351 . . . . 0.0 109.965 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.4 m -74.79 146.38 42.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 154.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -127.45 143.55 51.18 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.435 2.294 . . . . 0.0 105.114 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -132.46 117.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.84 95.98 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.49 125.42 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.36 113.97 25.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.274 1.83 . . . . 0.0 106.299 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.42 171.07 14.57 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 109.209 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -81.87 -17.99 45.38 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.388 -1.445 . . . . 0.0 112.886 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -133.05 61.65 1.67 Allowed 'General case' 0 CA--C 1.523 -0.066 0 C-N-CA 124.74 1.216 . . . . 0.0 110.214 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -48.86 -41.69 34.05 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.894 0.877 . . . . 0.0 112.112 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.2 83.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.625 0.37 . . . . 0.0 111.431 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -72.27 -43.48 64.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.302 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.37 -31.58 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 110.976 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.96 -32.37 70.58 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.069 -1.019 . . . . 0.0 111.767 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.9 169.74 7.57 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.224 1.392 . . . . 0.0 111.665 -166.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.19 125.68 24.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.519 1.528 . . . . 0.0 108.679 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt 42.63 43.63 3.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.153 1.781 . . . . 0.0 111.767 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.0 66.57 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.886 -0.952 . . . . 0.0 114.948 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -52.93 -51.46 61.25 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.753 1.776 . . . . 0.0 111.175 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -34.65 62.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.881 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -65.82 -36.71 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.194 1.361 . . . . 0.0 111.24 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -65.15 -41.16 94.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 120.756 -1.215 . . . . 0.0 111.42 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -56.68 -60.11 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.057 0.943 . . . . 0.0 109.017 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.8 mt -57.27 -35.9 70.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.349 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -55.58 -52.38 63.93 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.594 1.088 . . . . 0.0 109.933 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.91 85.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.688 0.676 . . . . 0.0 111.294 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -64.13 -46.3 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 117.633 -1.175 . . . . 0.0 109.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.92 -46.29 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 120.568 1.531 . . . . 0.0 109.365 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -53.55 -39.91 65.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.085 0.554 . . . . 0.0 110.922 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -85.22 -36.65 20.82 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 118.964 0.802 . . . . 0.0 111.459 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.65 -45.42 94.09 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.807 0.843 . . . . 0.0 109.16 178.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 96.6 m-85 -106.77 -2.77 21.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.905 1.282 . . . . 0.0 112.69 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.27 35.57 63.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.687 1.137 . . . . 0.0 113.573 172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.13 133.7 68.51 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 118.371 1.086 . . . . 0.0 111.453 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.41 138.96 87.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.121 2.548 . . . . 0.0 111.185 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 111.07 9.84 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.169 0.987 . . . . 0.0 110.16 -173.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.76 -2.18 55.65 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.277 -0.735 . . . . 0.0 112.694 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 m -109.66 6.5 23.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.519 1.128 . . . . 0.0 112.081 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.68 163.71 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.749 1.219 . . . . 0.0 107.836 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.66 157.26 43.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.37 1.468 . . . . 0.0 107.43 159.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.39 135.49 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.07 165.25 19.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.016 1.726 . . . . 0.0 108.241 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.77 111.16 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -116.53 154.15 30.93 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.045 1.338 . . . . 0.0 109.009 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -110.69 135.36 51.41 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.633 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 C--O 1.239 0.527 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.496 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 35.6 t80 . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 119.496 -0.288 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -54.68 -47.36 73.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.411 -0.805 . . . . 0.0 109.768 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.89 -53.44 50.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.464 1.105 . . . . 0.0 111.917 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.83 -45.77 59.69 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.202 0.601 . . . . 0.0 110.439 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.9 tp -69.23 -41.04 77.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.746 1.219 . . . . 0.0 110.868 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -50.37 74.25 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.983 1.313 . . . . 0.0 108.758 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -66.38 -31.99 73.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.506 1.922 . . . . 0.0 112.127 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.97 -62.6 1.35 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.592 1.157 . . . . 0.0 108.533 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -55.8 -29.6 59.98 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.383 1.473 . . . . 0.0 112.389 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -51.51 -45.16 62.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.233 1.013 . . . . 0.0 111.856 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -74.27 -58.27 3.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -30.44 15.04 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 125.9 1.68 . . . . 0.0 113.402 -169.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.52 22.34 5.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.843 1.257 . . . . 0.0 111.566 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.629 0.771 . . . . 0.0 110.054 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.1 -26.09 68.06 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.572 1.149 . . . . 0.0 110.446 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.75 -25.79 65.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.52 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.51 25.59 4.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.43 -1.205 . . . . 0.0 114.077 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -54.41 148.95 10.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.709 1.604 . . . . 0.0 113.646 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m -128.46 -41.51 1.53 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 112.453 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.16 -166.36 39.59 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 156.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.46 138.73 50.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 160.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.95 124.52 65.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.29 121.98 46.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.86 95.87 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 p -78.38 166.04 45.79 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.18 -2.55 12.7 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.225 1.283 . . . . 0.0 112.921 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 p -103.73 -51.05 3.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.595 1.089 . . . . 0.0 109.606 -166.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -157.44 162.97 38.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.758 2.023 . . . . 0.0 107.757 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.1 m -73.11 139.69 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -110.49 144.01 39.95 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.4 mt -135.31 123.41 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.5 101.54 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.5 mt -68.15 123.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 mt -96.5 118.3 32.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.69 -177.92 6.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.689 0.756 . . . . 0.0 111.504 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 p -86.49 -25.36 25.18 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -129.67 78.46 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.68 1.192 . . . . 0.0 107.96 -165.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -40.7 72.81 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.247 1.019 . . . . 0.0 111.346 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -69.51 -22.08 63.62 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.691 -0.631 . . . . 0.0 111.63 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -72.76 -46.43 53.44 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.43 -36.55 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.146 1.378 . . . . 0.0 111.678 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -65.39 -42.67 92.38 Favored 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 120.916 -1.115 . . . . 0.0 109.34 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -179.57 29.42 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-O 122.976 1.32 . . . . 0.0 110.673 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.51 116.81 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.895 2.078 . . . . 0.0 109.156 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt 52.68 8.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.776 2.03 . . . . 0.0 115.305 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 18.72 11.24 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 120.695 1.588 . . . . 0.0 113.493 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -60.77 -57.26 13.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.489 2.145 . . . . 0.0 112.437 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -67.44 -33.61 75.5 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.916 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.6 -44.02 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.151 0.887 . . . . 0.0 110.456 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -69.13 -38.88 79.06 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.113 -0.992 . . . . 0.0 111.228 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.65 -49.12 76.42 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.759 0.709 . . . . 0.0 109.402 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 63' ' ' VAL . 18.0 mt -59.69 -29.09 67.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.647 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 m -60.77 -56.82 16.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.596 1.089 . . . . 0.0 108.922 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.67 73.04 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.763 1.225 . . . . 0.0 111.978 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.3 p -59.17 -51.9 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.539 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.83 -43.88 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.656 1.571 . . . . 0.0 109.778 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -53.05 -44.04 67.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.603 0.761 . . . . 0.0 110.846 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -72.71 -52.75 13.92 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.902 0.774 . . . . 0.0 110.875 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -54.84 -24.17 21.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.667 1.987 . . . . 0.0 112.589 -174.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 96.3 m-85 -128.97 -3.37 5.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.488 1.115 . . . . 0.0 112.961 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.83 7.78 85.26 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.754 1.169 . . . . 0.0 114.924 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -61.22 143.62 92.35 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.389 1.595 . . . . 0.0 111.948 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.44 163.67 23.05 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.472 2.115 . . . . 0.0 110.447 162.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -68.83 141.39 55.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 164.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.44 -40.65 2.42 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.681 1.134 . . . . 0.0 113.661 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.7 m -67.47 -4.78 12.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.943 1.372 . . . . 0.0 112.922 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.91 141.38 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 163.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.96 130.2 48.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.33 137.89 39.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -130.47 167.49 18.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 127.612 2.365 . . . . 0.0 109.209 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.31 120.19 14.41 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.142 1.777 . . . . 0.0 108.915 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -119.14 148.56 42.94 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.717 1.207 . . . . 0.0 110.502 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -74.7 147.73 41.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.403 0.62 . . . . 0.0 109.839 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.326 -0.428 0 C-N-CA 125.904 1.682 . . . . 0.0 107.982 172.097 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.6 t80 . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.22 -35.58 73.88 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -49.79 14.08 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.178 0.991 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.22 -47.78 65.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.445 0.641 . . . . 0.0 109.801 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.856 -0.527 . . . . 0.0 110.824 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.04 -57.5 12.8 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.821 1.248 . . . . 0.0 110.007 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.03 -34.8 78.5 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 118.754 0.706 . . . . 0.0 111.855 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.7 -64.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.687 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.18 80.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.574 1.55 . . . . 0.0 111.717 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.6 m -49.88 -37.38 30.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.616 1.166 . . . . 0.0 110.935 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.79 -16.63 28.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.61 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.68 -16.47 28.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.428 1.091 . . . . 0.0 112.457 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -136.97 36.63 2.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.38 1.472 . . . . 0.0 112.008 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.89 -61.23 2.51 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.051 -1.031 . . . . 0.0 111.774 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.75 -15.86 60.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.801 0.84 . . . . 0.0 112.081 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.12 -15.14 62.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.067 1.347 . . . . 0.0 112.774 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.88 32.75 28.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.167 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -52.96 144.57 14.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.519 0.66 . . . . 0.0 111.213 168.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' HG11 ' A' ' 82' ' ' VAL . 72.1 m -126.58 -47.78 1.55 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.395 1.478 . . . . 0.0 110.428 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.87 -162.94 29.68 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.55 158.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 121.083 -1.245 . . . . 0.0 107.969 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -128.36 157.69 40.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.652 1.981 . . . . 0.0 109.277 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.07 134.65 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.508 1.123 . . . . 0.0 111.231 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -121.45 161.85 21.48 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.673 1.189 . . . . 0.0 110.124 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.76 133.71 65.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.993 1.717 . . . . 0.0 106.493 164.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 64.8 p -122.37 170.53 7.75 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.325 1.45 . . . . 0.0 109.095 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 73.7 Cg_endo -74.44 4.82 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.593 2.196 . . . . 0.0 112.651 166.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.3 p -108.22 -54.9 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.443 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.01 169.28 24.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.592 1.087 . . . . 0.0 111.689 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.4 m -68.0 151.91 46.35 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -135.39 135.08 40.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.9 124.15 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.68 107.42 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.47 1.108 . . . . 0.0 108.582 -166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.17 142.93 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.65 115.55 30.35 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 163.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.58 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.988 0.813 . . . . 0.0 110.546 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -78.64 -49.02 13.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.656 -1.278 . . . . 0.0 111.283 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -99.71 74.28 1.85 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -51.89 -35.35 44.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.691 -0.631 . . . . 0.0 112.659 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -77.09 -18.61 57.88 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.297 1.408 . . . . 0.0 113.067 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -65.12 -59.94 3.56 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 162.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -53.58 -43.83 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.287 1.035 . . . . 0.0 111.751 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.21 -41.32 77.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.48 -0.762 . . . . 0.0 110.816 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.84 178.76 34.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.465 0.481 . . . . 0.0 112.111 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.85 119.15 7.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.62 0.768 . . . . 0.0 110.204 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.87 32.16 5.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.753 1.621 . . . . 0.0 112.356 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.77 58.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.013 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -51.65 -63.43 1.14 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.164 1.482 . . . . 0.0 113.024 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -39.63 94.71 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.732 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.73 -43.53 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.265 1.393 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -68.3 -38.27 81.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.03 -1.044 . . . . 0.0 111.476 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.15 -51.77 66.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.9 mt -62.71 -26.47 68.69 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.277 -1.344 . . . . 0.0 111.752 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -60.82 -50.45 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.117 1.326 . . . . 0.0 108.408 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.26 85.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.689 0.796 . . . . 0.0 112.286 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 60' ' ' LEU . 2.9 p -68.45 -39.07 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.336 -1.316 . . . . 0.0 110.142 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.32 -43.6 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 121.532 1.969 . . . . 0.0 109.961 173.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -54.64 -40.36 68.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.927 0.891 . . . . 0.0 111.073 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -67.62 -65.53 0.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.494 1.043 . . . . 0.0 108.849 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -38.89 69.0 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.28 2.232 . . . . 0.0 111.754 -167.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.64 -4.4 17.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.623 1.169 . . . . 0.0 111.185 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.26 51.38 57.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.638 1.108 . . . . 0.0 110.908 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -79.12 153.8 77.25 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.638 0.375 . . . . 0.0 110.577 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -72.42 117.03 4.94 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.703 2.268 . . . . 0.0 108.319 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.3 pm0 -57.37 143.42 40.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 110.075 172.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.77 -46.43 3.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.948 1.261 . . . . 0.0 111.085 -168.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m -83.56 17.28 2.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.366 1.466 . . . . 0.0 114.279 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.45 136.07 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.81 135.07 47.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 128.156 2.582 . . . . 0.0 108.155 174.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.3 134.55 52.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.37 177.29 6.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.245 2.218 . . . . 0.0 108.838 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 158.84 43.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.93 153.24 46.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.759 2.424 . . . . 0.0 106.353 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -95.5 135.97 36.48 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' CB ' ' A' ' 26' ' ' SER . 21.2 m . . . . . 0 C--O 1.24 0.602 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 76.9 t80 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.711 0.291 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.94 -38.1 81.45 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.909 -169.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 -55.01 31.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.241 0.616 . . . . 0.0 110.622 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.49 -42.85 78.98 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.315 0.507 . . . . 0.0 111.578 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.5 tp -71.37 -38.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.548 0.339 . . . . 0.0 110.636 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -59.93 -51.53 69.28 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.057 0.943 . . . . 0.0 108.634 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.19 -37.8 81.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 112.371 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.15 -57.01 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.188 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.05 -30.35 71.43 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.686 1.195 . . . . 0.0 111.939 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.9 m -49.67 -40.22 39.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.185 1.394 . . . . 0.0 111.118 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -91.18 -45.87 8.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.448 0.699 . . . . 0.0 110.424 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -55.98 -30.39 61.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.409 0.684 . . . . 0.0 112.613 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.8 mt -125.53 22.45 7.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.015 1.326 . . . . 0.0 110.703 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.18 -63.48 1.14 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.014 0.925 . . . . 0.0 110.222 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.05 -15.51 61.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.521 0.329 . . . . 0.0 111.836 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -35.65 74.94 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.74 28.41 1.42 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.907 -0.94 . . . . 0.0 113.818 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -53.29 153.63 3.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.526 1.163 . . . . 0.0 112.628 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 m -142.42 -34.35 0.45 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.972 1.309 . . . . 0.0 112.405 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.77 -169.57 42.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.064 0.847 . . . . 0.0 111.075 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.4 149.75 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.76 159.67 34.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.867 1.267 . . . . 0.0 108.287 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.1 127.81 18.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.673 1.189 . . . . 0.0 110.904 -163.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -126.03 161.95 26.39 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.796 1.238 . . . . 0.0 108.675 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.46 115.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 51.1 p -92.17 172.44 6.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 123.813 0.845 . . . . 0.0 108.773 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 51.8 Cg_endo -70.94 20.67 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.936 2.424 . . . . 0.0 112.124 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.9 p -128.07 -44.93 1.42 Allowed 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 120.842 -1.161 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.11 172.71 15.41 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.182 0.901 . . . . 0.0 111.122 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 m -71.51 157.43 38.03 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 159.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.81 128.42 34.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.168 1.787 . . . . 0.0 107.195 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.0 mt -117.04 124.09 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.92 104.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.25 133.31 32.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.71 117.03 33.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.047 . . . . 0.0 106.756 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.54 167.49 23.57 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -31.47 65.82 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.909 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -132.35 81.33 1.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.1 p -52.58 -43.73 65.46 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.772 -0.58 . . . . 0.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.45 -30.11 62.47 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.325 1.45 . . . . 0.0 112.734 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -70.14 -52.2 25.46 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.618 0.645 . . . . 0.0 109.478 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.94 -34.19 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.83 1.252 . . . . 0.0 111.073 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -68.86 -35.19 76.62 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.474 -0.766 . . . . 0.0 111.3 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.65 -179.31 26.57 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.835 0.731 . . . . 0.0 111.745 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -54.1 109.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.937 1.695 . . . . 0.0 109.683 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt 46.58 43.34 12.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.783 1.233 . . . . 0.0 111.966 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 11.5 71.67 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.731 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -40.89 -64.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.895 1.678 . . . . 0.0 111.903 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.26 -47.08 68.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.499 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.22 -41.78 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.01 1.277 . . . . 0.0 110.371 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.3 -45.48 80.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.008 0.923 . . . . 0.0 111.463 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.64 -55.14 38.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.173 0.589 . . . . 0.0 109.819 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.77 -33.13 69.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.579 1.551 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.2 m -55.13 -50.49 69.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.686 1.13 . . . . 0.0 109.28 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.65 96.31 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.556 0.617 . . . . 0.0 111.963 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.6 t -58.62 -54.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 t -59.1 -41.31 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.883 2.073 . . . . 0.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -61.47 -22.15 64.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.361 0.982 . . . . 0.0 112.321 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.82 -50.73 5.22 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.503 -0.748 . . . . 0.0 110.859 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.92 62.03 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.231 1.412 . . . . 0.0 110.294 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.73 7.98 28.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.189 1.796 . . . . 0.0 111.041 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.96 23.13 37.48 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 125.352 1.453 . . . . 0.0 114.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -56.6 147.39 51.06 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.349 1.075 . . . . 0.0 111.583 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.2 128.87 30.31 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.627 2.218 . . . . 0.0 110.6 166.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 153.22 28.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 168.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.7 -44.43 0.63 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.837 2.161 . . . . 0.0 114.098 -164.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -91.08 18.24 7.05 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.77 1.628 . . . . 0.0 115.152 -166.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.45 139.89 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.55 150.67 50.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.282 0.492 . . . . 0.0 110.592 163.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.2 126.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -122.42 173.54 7.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.36 1.464 . . . . 0.0 109.807 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.32 109.75 5.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.461 1.105 . . . . 0.0 108.345 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -104.06 142.27 34.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -76.35 149.76 36.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.083 0.953 . . . . 0.0 112.477 168.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 45.9 t80 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -61.97 -36.22 80.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -171.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 -60.24 3.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.949 1.299 . . . . 0.0 109.625 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -55.39 -40.66 71.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.084 0.554 . . . . 0.0 111.363 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.466 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.0 tp -69.3 -41.37 76.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.325 0.65 . . . . 0.0 111.031 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.81 -54.45 47.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.226 0.466 . . . . 0.0 109.84 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -57.3 -35.09 69.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.779 0.432 . . . . 0.0 112.145 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -67.22 -58.1 5.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.487 1.115 . . . . 0.0 110.872 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.7 -33.27 73.71 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.43 1.492 . . . . 0.0 111.861 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -47.97 -38.64 17.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.301 1.44 . . . . 0.0 111.321 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -89.09 -40.1 13.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.817 0.735 . . . . 0.0 111.437 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.66 -20.69 63.7 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.5 mt -133.02 24.64 4.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.791 1.636 . . . . 0.0 110.856 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.92 -56.32 20.87 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.88 1.272 . . . . 0.0 111.453 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -61.49 -45.28 94.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.574 1.15 . . . . 0.0 110.47 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.98 -31.28 72.44 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.913 0.885 . . . . 0.0 112.835 -163.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.61 41.05 1.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 119.338 -0.701 . . . . 0.0 113.775 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -49.93 154.85 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.612 0.765 . . . . 0.0 111.33 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.25 -45.43 0.77 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.534 1.534 . . . . 0.0 109.525 172.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.99 -164.89 34.6 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.47 151.64 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 121.457 -1.026 . . . . 0.0 108.646 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -121.99 151.48 40.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.835 0.826 . . . . 0.0 109.27 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.6 p -125.43 148.75 29.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.251 1.42 . . . . 0.0 108.395 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -132.79 153.48 51.2 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.1 t -98.37 135.75 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 155.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -120.89 166.08 16.82 Favored Pre-proline 0 C--O 1.243 0.717 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.7 Cg_endo -72.02 0.91 6.5 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.651 2.234 . . . . 0.0 111.899 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -113.42 -47.33 3.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.486 1.039 . . . . 0.0 111.648 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -162.21 172.97 14.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.062 0.847 . . . . 0.0 110.332 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.7 m -68.96 150.28 47.89 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -124.98 143.65 50.78 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -129.72 122.71 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 99.43 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.97 132.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.63 108.5 20.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.349 1.859 . . . . 0.0 106.38 164.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 172.26 13.02 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 p -83.33 -37.49 23.32 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.873 -0.517 . . . . 0.0 111.43 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -117.11 64.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.634 -1.291 . . . . 0.0 108.035 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -43.83 -48.62 8.27 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.54 2.336 . . . . 0.0 113.169 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.15 -34.2 71.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.136 0.88 . . . . 0.0 111.859 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.58 -32.29 36.58 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.205 -0.934 . . . . 0.0 111.212 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.26 -42.35 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.875 0.87 . . . . 0.0 109.453 169.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 mt -61.26 -44.52 97.11 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.89 45.52 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 124.634 1.111 . . . . 0.0 110.684 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -57.3 114.91 2.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.733 1.213 . . . . 0.0 110.513 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 55.24 32.98 19.66 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.166 0.987 . . . . 0.0 110.897 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.34 22.57 77.35 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.873 -0.959 . . . . 0.0 112.837 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -52.87 63.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.89 1.845 . . . . 0.0 111.636 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -43.91 91.36 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 116.759 -1.591 . . . . 0.0 109.533 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.8 -40.97 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.212 1.369 . . . . 0.0 110.991 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.47 -44.53 82.44 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.914 1.234 . . . . 0.0 112.765 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -54.52 45.96 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.123 0.874 . . . . 0.0 108.799 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' HA ' HG12 ' A' ' 63' ' ' VAL . 57.0 mt -60.12 -27.31 66.93 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.379 1.472 . . . . 0.0 112.491 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.7 m -62.84 -59.53 4.73 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.661 1.119 . . . . 0.0 109.579 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.4 89.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.177 0.991 . . . . 0.0 111.262 -171.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.7 p -57.62 -50.43 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.758 -1.115 . . . . 0.0 108.686 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.81 -49.48 83.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 124.644 1.178 . . . . 0.0 109.495 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -49.56 -46.38 48.75 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.538 1.135 . . . . 0.0 110.623 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -73.06 -53.56 10.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -49.9 -55.52 14.09 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 111.122 -176.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 92.5 m-85 -89.99 2.11 55.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.767 2.027 . . . . 0.0 112.429 -172.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.43 51.11 44.71 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.47 149.99 86.76 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 117.496 0.648 . . . . 0.0 109.433 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.52 124.66 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.697 1.598 . . . . 0.0 109.155 161.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.55 153.62 27.08 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.76 -14.44 3.52 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.598 0.618 . . . . 0.0 113.446 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.8 m -133.04 28.81 4.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.765 1.283 . . . . 0.0 112.236 -161.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.94 145.71 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.091 1.356 . . . . 0.0 107.803 159.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -128.29 148.34 50.65 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.118 1.367 . . . . 0.0 109.266 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.35 137.7 51.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.89 1.276 . . . . 0.0 109.02 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -134.5 168.13 19.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.858 2.463 . . . . 0.0 109.551 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 109.86 6.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.452 1.901 . . . . 0.0 109.018 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -104.13 156.27 18.02 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.616 1.166 . . . . 0.0 109.122 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.69 145.6 27.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.661 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.24 0.595 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 168.332 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -61.2 -34.02 74.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.464 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.98 -59.06 4.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.505 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -55.03 -38.57 68.13 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 118.787 0.721 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.06 -43.81 77.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.456 0.702 . . . . 0.0 110.612 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.15 -43.68 98.3 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 123.97 0.908 . . . . 0.0 109.932 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.17 -25.41 63.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.799 1.24 . . . . 0.0 112.57 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 19' ' ' GLU . 37.0 t80 -72.64 -64.66 0.91 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.393 1.477 . . . . 0.0 108.647 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.92 -43.7 60.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.297 2.239 . . . . 0.0 111.883 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -52.77 -34.04 51.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.071 0.851 . . . . 0.0 111.411 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -91.01 -41.25 11.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.35 -0.834 . . . . 0.0 110.103 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 15' ' ' PHE . 6.6 mm-40 -56.97 -42.92 81.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.749 1.22 . . . . 0.0 112.724 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -115.68 26.63 9.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.514 1.526 . . . . 0.0 109.731 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.38 61.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.125 1.37 . . . . 0.0 111.905 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -79.68 -14.56 58.68 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.262 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.99 -23.04 17.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -159.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 35.85 3.76 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 119.072 0.851 . . . . 0.0 112.687 -168.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.74 162.49 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.185 0.993 . . . . 0.0 109.361 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 m -136.73 -60.84 0.69 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.67 -167.85 29.9 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.91 155.16 17.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -125.67 164.12 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.011 0.91 . . . . 0.0 109.141 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.26 139.58 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.102 1.761 . . . . 0.0 107.357 -170.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -132.82 138.62 47.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 106.96 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.2 t -136.16 116.53 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 36.5 p -120.9 176.69 1.75 Allowed Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.56 0.744 . . . . 0.0 110.361 -164.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 61.3 Cg_endo -73.12 3.75 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 121.727 1.618 . . . . 0.0 112.452 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.9 p -113.44 -52.1 2.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.268 1.395 . . . . 0.0 111.145 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -160.61 174.71 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.364 1.465 . . . . 0.0 111.198 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -82.04 151.59 27.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.505 -0.747 . . . . 0.0 109.062 163.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.14 142.79 34.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.594 1.958 . . . . 0.0 108.018 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.2 mt -141.13 126.03 18.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.4 105.07 15.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -173.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -70.43 130.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.87 115.76 28.73 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.6 169.87 16.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.047 0.84 . . . . 0.0 111.015 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.8 p -70.5 -31.81 69.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.257 -0.902 . . . . 0.0 111.7 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -134.32 85.39 2.19 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 p -53.36 -38.56 63.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.106 0.962 . . . . 0.0 111.454 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -57.97 -44.31 87.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.616 1.167 . . . . 0.0 111.984 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -68.83 -40.62 79.36 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.046 0.538 . . . . 0.0 109.578 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -46.59 93.77 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 C-N-CA 122.978 0.511 . . . . 0.0 109.683 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.53 -36.22 70.94 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.994 -1.066 . . . . 0.0 111.086 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 179.88 50.98 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 109.52 0.5 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.032 1.333 . . . . 0.0 109.277 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 mttm 40.22 46.16 1.87 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.439 1.496 . . . . 0.0 112.765 -173.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.99 9.3 82.72 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.17 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -46.08 78.43 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.57 2.185 . . . . 0.0 113.008 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -45.21 90.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.626 1.103 . . . . 0.0 110.678 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tt -67.55 -34.99 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.456 1.026 . . . . 0.0 111.111 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -57.36 -50.96 71.29 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.575 -0.703 . . . . 0.0 109.889 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -61.07 2.53 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.346 1.058 . . . . 0.0 109.705 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.0 mt -57.74 -34.97 70.08 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.525 -174.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 m -57.64 -48.08 80.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.437 1.017 . . . . 0.0 109.484 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.77 -42.76 73.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.059 0.944 . . . . 0.0 112.005 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.3 p -66.75 -45.75 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.647 1.112 . . . . 0.0 109.736 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -55.67 -45.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.084 1.311 . . . . 0.0 109.511 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.71 -46.42 67.35 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.123 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -71.9 -50.66 27.3 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.075 0.852 . . . . 0.0 111.666 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -39.79 86.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.415 1.086 . . . . 0.0 110.787 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.72 3.77 24.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 111.737 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.91 26.75 71.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.072 0.844 . . . . 0.0 112.823 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -67.77 145.51 98.05 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 118.35 1.075 . . . . 0.0 109.595 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.22 165.66 16.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.795 2.33 . . . . 0.0 110.737 160.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -88.38 147.98 24.47 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.98 -45.99 2.59 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.403 1.478 . . . . 0.0 112.454 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 m -72.04 8.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.257 1.823 . . . . 0.0 112.501 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.87 126.0 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 162.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 146.61 38.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -120.55 140.71 51.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -132.93 165.32 24.94 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.47 1.908 . . . . 0.0 108.569 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.59 109.08 5.59 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -111.38 155.01 23.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.554 1.541 . . . . 0.0 110.371 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.97 141.01 29.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.517 0.675 . . . . 0.0 112.348 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 C--O 1.241 0.613 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.112 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 t80 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -62.11 -29.65 70.47 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.426 -1.273 . . . . 0.0 110.625 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.02 4.46 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.5 1.5 . . . . 0.0 110.387 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.53 -45.16 73.33 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.915 0.486 . . . . 0.0 110.555 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.83 -43.3 84.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.671 0.388 . . . . 0.0 110.455 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -57.26 -51.52 69.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 109.447 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.18 -52.94 62.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.404 0.682 . . . . 0.0 111.028 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -53.27 -48.52 68.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.412 1.085 . . . . 0.0 111.145 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.41 -38.68 81.48 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.58 1.552 . . . . 0.0 111.615 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -51.71 -47.29 64.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -66.97 -47.17 72.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 111.821 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.66 -12.83 60.86 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.999 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.17 15.45 8.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 113.499 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.53 27.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.324 1.05 . . . . 0.0 112.064 -172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -87.81 -26.86 22.62 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.53 -34.74 76.04 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.738 0.699 . . . . 0.0 110.31 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 65.25 0.53 Allowed Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -67.84 174.2 3.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.915 1.34 . . . . 0.0 110.266 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -164.4 -23.99 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.06 1.344 . . . . 0.0 112.046 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.15 -161.78 29.82 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -161.3 155.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -125.94 160.22 30.56 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 108.631 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.91 135.4 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 126.053 1.741 . . . . 0.0 108.287 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -132.62 122.74 25.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.13 92.76 2.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 43.7 p -84.07 176.83 3.39 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.702 1.601 . . . . 0.0 109.433 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 85.6 Cg_endo -76.38 6.08 4.23 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.052 1.835 . . . . 0.0 113.21 165.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -116.6 -57.97 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.68 1.582 . . . . 0.0 112.169 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -161.67 149.58 15.0 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.056 1.342 . . . . 0.0 108.055 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -70.93 138.64 50.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -110.42 137.37 48.22 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.97 122.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.87 103.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.01 145.51 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -115.22 112.04 21.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.47 165.75 26.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.399 0.679 . . . . 0.0 111.522 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.9 p -85.59 -21.55 28.44 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.866 -1.146 . . . . 0.0 113.503 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -131.64 59.17 1.7 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.853 0.751 . . . . 0.0 109.28 -166.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -56.8 -37.37 71.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -63.8 -37.08 86.03 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 120.101 1.319 . . . . 0.0 110.072 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.6 -49.28 78.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.861 1.264 . . . . 0.0 109.014 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.29 -44.83 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.751 2.02 . . . . 0.0 110.904 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.04 -39.12 93.8 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.365 -0.834 . . . . 0.0 110.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 -179.27 48.85 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 122.278 0.932 . . . . 0.0 112.008 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.23 109.1 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.357 2.263 . . . . 0.0 110.937 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt 43.43 50.65 6.16 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.67 1.588 . . . . 0.0 110.673 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 37.67 69.2 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.866 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -67.38 0.42 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.042 1.421 . . . . 0.0 112.351 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -36.74 84.75 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.361 -172.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.78 -44.88 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 119.129 0.877 . . . . 0.0 111.964 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -63.11 -49.5 74.19 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.996 -1.065 . . . . 0.0 110.949 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -51.58 66.31 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.164 0.585 . . . . 0.0 110.046 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 88.8 mt -67.95 -30.16 69.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.613 -1.185 . . . . 0.0 112.096 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.0 m -56.99 -37.28 71.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.736 1.153 . . . . 0.0 110.32 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.51 17.4 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.845 1.202 . . . . 0.0 111.337 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 60' ' ' LEU 0.261 2.0 p -61.46 -42.47 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.124 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.36 -47.72 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 121.249 1.84 . . . . 0.0 109.814 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.417 HE22 ' HG2' ' A' ' 72' ' ' GLU . 9.0 mt-30 -53.43 -37.34 62.47 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.26 0.482 . . . . 0.0 111.845 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 -38.93 18.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.209 0.913 . . . . 0.0 111.138 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.53 -36.78 83.66 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.838 1.255 . . . . 0.0 110.505 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 94.1 m-85 -114.66 -21.33 10.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 112.74 -168.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.03 50.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.052 1.311 . . . . 0.0 114.442 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -53.29 145.65 25.35 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.169 1.484 . . . . 0.0 113.355 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -68.84 156.69 64.59 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.786 2.99 . . . . 0.0 111.578 163.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' HE22 ' A' ' 65' ' ' GLN . 12.3 mt-10 -71.95 139.98 48.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.72 -21.17 1.27 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.897 -1.502 . . . . 0.0 115.026 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m -80.9 -8.69 59.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 120.048 1.924 . . . . 0.0 112.703 168.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.63 126.81 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -113.04 139.54 48.59 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 163.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.32 134.45 54.88 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 72.0 m-85 -132.72 171.76 13.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.747 2.019 . . . . 0.0 109.262 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.91 148.96 52.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 167.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.87 52.09 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.659 1.584 . . . . 0.0 107.517 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -82.96 151.23 25.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.74 178.63 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.5 t80 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -57.35 -43.19 83.27 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.34 -55.39 24.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 117.477 -1.249 . . . . 0.0 108.517 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -47.77 -41.36 23.11 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.496 1.118 . . . . 0.0 111.062 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.27 -45.95 21.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.298 1.439 . . . . 0.0 111.687 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -58.29 -53.84 53.77 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.283 1.033 . . . . 0.0 110.009 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.16 -43.98 96.78 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.855 0.862 . . . . 0.0 111.039 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -48.02 -61.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.59 1.556 . . . . 0.0 110.254 168.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.77 -35.68 78.83 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.566 0.746 . . . . 0.0 112.105 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.5 m -60.75 -29.1 69.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.403 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -90.58 -30.23 17.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.674 1.19 . . . . 0.0 112.59 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.32 -22.33 52.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.49 23.88 3.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.281 1.032 . . . . 0.0 111.755 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.42 34.38 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.953 1.301 . . . . 0.0 112.187 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -71.56 -31.77 67.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.491 0.716 . . . . 0.0 110.503 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.93 -44.2 94.49 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.176 0.99 . . . . 0.0 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.47 28.37 0.52 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.801 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.34 148.53 41.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.367 1.584 . . . . 0.0 112.226 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 -30.5 1.32 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.519 1.128 . . . . 0.0 113.054 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.89 -170.46 43.42 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 120.11 1.323 . . . . 0.0 110.806 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.06 152.25 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -126.68 108.89 11.49 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.831 1.253 . . . . 0.0 107.911 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.5 146.53 6.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.467 1.507 . . . . 0.0 108.44 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -131.9 150.28 52.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.87 1.268 . . . . 0.0 107.755 167.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.41 121.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 48.5 p -120.81 176.75 1.71 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.517 1.527 . . . . 0.0 109.423 -165.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.4 Cg_endo -79.47 4.02 6.99 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.183 1.922 . . . . 0.0 113.833 165.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -121.48 -58.53 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.095 1.316 . . . . 0.0 111.907 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -161.57 138.19 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.664 1.586 . . . . 0.0 110.315 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 m -58.5 143.92 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.74 146.42 39.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 172.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.74 117.4 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.28 113.45 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.76 117.81 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.761 1.224 . . . . 0.0 108.86 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 mt -89.72 110.49 21.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.256 1.822 . . . . 0.0 108.49 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 168.17 20.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.345 0.658 . . . . 0.0 110.865 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -66.73 -35.97 81.35 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.927 -1.108 . . . . 0.0 111.299 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -120.61 79.23 1.46 Allowed 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.555 0.742 . . . . 0.0 109.555 -165.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.59 -48.52 14.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.628 1.571 . . . . 0.0 111.365 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -65.46 -27.41 68.49 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.258 -0.901 . . . . 0.0 112.258 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -70.59 -44.05 68.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.893 1.224 . . . . 0.0 108.938 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.29 -35.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.491 1.116 . . . . 0.0 110.592 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.3 -44.53 71.58 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.662 -1.273 . . . . 0.0 108.871 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.45 45.01 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.5 1.048 . . . . 0.0 111.919 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.72 123.76 14.29 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.247 1.019 . . . . 0.0 108.46 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt 46.79 39.67 7.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.865 0.866 . . . . 0.0 111.959 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.77 30.16 72.65 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.98 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -67.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.398 2.099 . . . . 0.0 112.815 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -37.41 87.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.68 -169.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 tt -57.64 -56.93 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.948 0.794 . . . . 0.0 109.757 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -56.31 -43.57 79.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.224 1.409 . . . . 0.0 112.34 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.14 -58.71 7.46 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.37 -25.05 66.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.855 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.6 m -57.79 -55.1 39.29 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.378 1.444 . . . . 0.0 109.724 167.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.63 89.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.455 0.702 . . . . 0.0 111.203 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 59' ' ' GLU . 38.1 t -53.78 -59.12 2.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 t -61.26 -39.78 83.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.059 0.944 . . . . 0.0 111.016 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.44 -37.7 70.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.733 0.697 . . . . 0.0 111.067 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.69 -55.27 4.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.734 0.697 . . . . 0.0 109.995 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -39.41 60.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.368 1.867 . . . . 0.0 111.898 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.49 -1.29 13.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.1 1.36 . . . . 0.0 111.546 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.18 78.91 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 120.85 -1.156 . . . . 0.0 114.702 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.31 147.67 75.1 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.819 1.31 . . . . 0.0 112.648 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.53 141.29 79.73 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.747 2.965 . . . . 0.0 111.979 168.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -66.41 141.42 57.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.83 -16.76 6.41 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.214 -0.77 . . . . 0.0 114.294 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -121.48 9.95 10.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 112.916 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.01 155.28 26.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 159.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -139.33 156.44 47.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.753 1.221 . . . . 0.0 108.433 164.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -131.71 134.83 46.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -132.47 160.98 34.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.433 1.893 . . . . 0.0 108.386 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 142.11 46.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.616 0.767 . . . . 0.0 108.961 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -141.7 153.81 44.91 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 108.769 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.66 146.86 27.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 122.38 1.086 . . . . 0.0 108.188 175.077 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.5 t80 . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -53.22 -41.95 65.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.312 1.045 . . . . 0.0 112.009 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.78 25.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.78 1.232 . . . . 0.0 109.588 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.7 -40.33 62.86 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.446 0.566 . . . . 0.0 111.448 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 tp -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.972 1.309 . . . . 0.0 110.826 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -63.0 -43.71 98.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.185 0.594 . . . . 0.0 110.335 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.28 -30.7 71.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.452 1.101 . . . . 0.0 112.853 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -67.51 -63.97 0.95 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.5 mt -56.45 -33.14 65.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.605 1.162 . . . . 0.0 111.96 -168.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -46.2 -46.53 17.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.162 0.985 . . . . 0.0 111.783 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.48 -56.69 4.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.69 -26.51 45.33 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 113.521 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.62 18.9 9.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.774 1.229 . . . . 0.0 111.359 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.94 -64.31 0.87 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.908 0.883 . . . . 0.0 111.023 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.85 -22.12 62.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.474 -0.766 . . . . 0.0 111.309 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.7 -24.29 67.53 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.545 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.06 25.29 3.05 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.459 1.027 . . . . 0.0 114.763 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.757 ' HE1' HG23 ' A' ' 41' ' ' ILE . 40.6 t80 -63.65 165.2 8.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 112.42 -168.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.97 -52.93 0.22 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.729 1.212 . . . . 0.0 110.46 171.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.09 -172.02 38.3 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 118.927 0.785 . . . . 0.0 111.429 -171.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.46 134.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.53 161.91 13.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 164.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.14 144.91 23.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -120.1 160.47 22.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.39 115.71 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 4.3 p -121.01 176.85 1.68 Allowed Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -169.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 81.3 Cg_endo -78.84 12.17 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.281 1.988 . . . . 0.0 111.448 166.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.9 p -127.7 -50.04 1.37 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 0.0 112.579 -170.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -162.6 173.6 13.72 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.142 1.777 . . . . 0.0 110.156 -169.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.1 m -98.23 149.17 22.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -125.32 142.57 51.42 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.764 2.026 . . . . 0.0 105.757 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -129.0 125.93 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -123.73 97.56 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.757 HG23 ' HE1' ' A' ' 25' ' ' TYR . 4.9 mp -76.87 125.95 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.4 108.09 20.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.064 2.146 . . . . 0.0 107.131 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.95 168.09 20.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.852 1.31 . . . . 0.0 110.354 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 p -79.12 -26.84 42.85 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.955 -1.091 . . . . 0.0 111.769 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -129.01 79.93 1.94 Allowed 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.76 1.624 . . . . 0.0 107.904 -167.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 p -48.98 -39.2 25.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.334 1.053 . . . . 0.0 111.334 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.89 -39.95 95.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.215 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -59.87 -48.82 80.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.742 1.155 . . . . 0.0 109.183 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.06 -43.65 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.908 1.283 . . . . 0.0 110.786 -174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.84 -36.67 84.12 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.643 -0.66 . . . . 0.0 109.878 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.57 175.68 41.18 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.058 1.313 . . . . 0.0 110.554 -167.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 55' ' ' ARG . 4.2 tt0 -55.5 128.18 33.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 167.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp 50.33 38.86 18.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.649 0.779 . . . . 0.0 112.839 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.84 10.01 67.01 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.795 0.712 . . . . 0.0 113.907 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 52' ' ' GLU . 17.0 mtm180 -52.31 -53.34 45.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 113.244 -175.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.88 74.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 116.176 -1.868 . . . . 0.0 109.954 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -60.73 -38.05 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 121.562 1.983 . . . . 0.0 111.224 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -52.73 64.31 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.304 -0.873 . . . . 0.0 110.854 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -28.12 63.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.434 1.094 . . . . 0.0 112.108 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 63' ' ' VAL . 31.6 mt -80.03 -24.82 40.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.139 1.376 . . . . 0.0 110.467 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -66.28 -55.38 16.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.19 70.35 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.457 1.103 . . . . 0.0 111.965 -174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 60' ' ' LEU . 12.8 p -58.65 -47.91 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.702 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.36 -39.83 82.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-N 119.649 1.113 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -53.84 -44.94 70.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.799 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.83 -58.45 3.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.819 0.736 . . . . 0.0 109.659 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -45.77 54.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.549 1.54 . . . . 0.0 111.848 -168.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.12 -1.8 25.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.46 47.62 89.67 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 125.244 1.402 . . . . 0.0 112.177 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -80.05 145.62 61.46 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.202 1.001 . . . . 0.0 111.32 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.49 137.52 51.06 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.484 2.123 . . . . 0.0 109.713 166.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.36 143.04 58.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.353 1.061 . . . . 0.0 109.512 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 -6.49 6.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.397 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -117.05 8.37 13.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.128 1.771 . . . . 0.0 112.17 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -113.71 140.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 154.19 51.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 168.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -121.65 136.45 54.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -125.17 163.21 22.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.885 1.674 . . . . 0.0 107.461 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.68 109.12 9.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.163 0.585 . . . . 0.0 109.796 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -119.88 145.8 46.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.439 0.638 . . . . 0.0 110.385 -168.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.75 140.16 36.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 -167.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.141 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.5 t80 . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -54.3 -29.43 47.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.19 1.396 . . . . 0.0 113.499 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -58.12 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.395 2.278 . . . . 0.0 111.007 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -56.05 -40.63 73.81 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.633 1.106 . . . . 0.0 111.2 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.11 -36.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 110.593 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.19 -51.5 67.55 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.585 0.754 . . . . 0.0 109.587 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.34 -27.46 67.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.148 0.979 . . . . 0.0 111.864 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.05 -63.37 1.09 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.429 1.092 . . . . 0.0 109.104 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.05 -31.55 71.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.49 1.116 . . . . 0.0 112.234 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.4 m -55.91 -35.68 66.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.102 1.361 . . . . 0.0 111.157 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -90.54 -44.64 9.43 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.932 -0.48 . . . . 0.0 110.112 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.86 -42.25 93.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.953 0.342 . . . . 0.0 111.902 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.56 20.64 16.42 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.032 1.733 . . . . 0.0 110.554 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.52 -58.87 4.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.398 1.479 . . . . 0.0 110.141 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 -19.74 55.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.632 0.773 . . . . 0.0 111.995 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -71.09 -32.58 69.24 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.282 0.633 . . . . 0.0 110.386 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.07 47.02 1.11 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.399 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.72 171.24 0.49 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.698 1.599 . . . . 0.0 112.967 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.77 -42.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.812 1.645 . . . . 0.0 111.479 170.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.2 -170.29 43.33 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.79 153.99 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -119.94 158.0 27.62 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.437 1.495 . . . . 0.0 109.055 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.41 129.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.34 1.056 . . . . 0.0 110.265 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -125.81 122.93 37.59 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.247 1.019 . . . . 0.0 108.93 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.26 130.09 38.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 163.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 27.1 p -121.76 170.66 7.28 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.612 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 71.6 Cg_endo -74.08 19.37 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.906 2.404 . . . . 0.0 112.809 165.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 p -127.25 -58.1 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -154.44 173.44 16.25 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.285 1.834 . . . . 0.0 109.494 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.2 m -86.54 148.54 25.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 162.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.94 131.69 33.38 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.678 1.591 . . . . 0.0 106.881 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.81 123.65 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.62 1.568 . . . . 0.0 107.799 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.7 112.51 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -73.09 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -99.94 118.09 35.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.079 165.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.62 167.05 25.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.301 0.5 . . . . 0.0 111.258 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -67.13 -45.56 76.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.874 0.47 . . . . 0.0 110.798 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -122.93 82.43 1.99 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.045 1.738 . . . . 0.0 108.144 -167.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 p -46.58 -42.92 16.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.457 1.103 . . . . 0.0 110.552 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -45.15 74.25 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.644 1.111 . . . . 0.0 112.339 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -68.59 -42.26 78.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.71 -31.44 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.062 1.745 . . . . 0.0 110.837 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -76.77 -42.32 41.37 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.29 1.036 . . . . 0.0 110.185 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.19 176.12 27.02 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.165 0.888 . . . . 0.0 111.294 -171.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.88 116.91 4.09 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.366 0.666 . . . . 0.0 110.484 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.1 mttt 42.31 44.63 3.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.238 1.415 . . . . 0.0 111.648 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.5 73.77 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.506 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.29 -56.67 11.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.558 1.679 . . . . 0.0 112.658 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.27 -48.41 81.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.273 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -60.44 -44.47 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.077 0.853 . . . . 0.0 109.879 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -38.19 82.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.362 0.983 . . . . 0.0 112.891 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -62.18 1.85 Allowed 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.01 -24.88 68.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.009 -1.472 . . . . 0.0 111.767 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.0 m -55.55 -51.87 65.63 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 120.683 1.583 . . . . 0.0 108.946 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.24 82.69 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.833 0.742 . . . . 0.0 110.669 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.44 -50.01 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 118.691 0.678 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.86 -51.23 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.372 1.469 . . . . 0.0 109.871 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -54.76 -28.35 47.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -93.48 -44.93 8.0 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.364 0.983 . . . . 0.0 110.213 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -55.04 -39.52 69.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.01 1.324 . . . . 0.0 111.188 174.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 91.9 m-85 -115.07 5.99 15.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.69 1.196 . . . . 0.0 111.417 -171.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.78 41.62 66.86 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.896 2.189 . . . . 0.0 114.576 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -81.9 145.51 53.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.576 1.188 . . . . 0.0 111.488 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.49 153.8 73.06 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.109 1.873 . . . . 0.0 110.888 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.21 122.56 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.759 1.224 . . . . 0.0 109.359 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 -14.76 4.95 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.318 0.961 . . . . 0.0 114.467 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -74.74 -6.88 51.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.192 0.997 . . . . 0.0 111.522 161.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.18 149.46 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 162.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -137.29 149.68 47.25 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 165.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.96 122.64 46.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -118.3 165.62 13.62 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 127.71 2.404 . . . . 0.0 108.997 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.68 113.52 7.88 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.191 1.396 . . . . 0.0 109.202 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.04 154.93 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.86 1.664 . . . . 0.0 109.18 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -90.9 156.12 18.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 C--O 1.237 0.439 0 CA-C-O 122.227 1.013 . . . . 0.0 109.665 -179.819 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 t80 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 29' ' ' GLU . 79.5 tttt -57.47 -31.9 66.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.778 -0.629 . . . . 0.0 111.247 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -39.8 47.39 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.234 0.925 . . . . 0.0 111.766 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.29 -43.85 96.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.358 0.981 . . . . 0.0 109.365 171.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.58 -39.22 93.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.392 0.677 . . . . 0.0 110.54 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.18 -56.33 22.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.161 1.384 . . . . 0.0 109.772 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.2 -28.43 68.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.35 -64.76 0.79 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.567 1.147 . . . . 0.0 109.006 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.28 -37.28 74.7 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 112.646 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.5 m -51.14 -48.32 61.85 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.817 0.847 . . . . 0.0 110.367 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -75.45 -42.22 53.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.134 -0.46 . . . . 0.0 109.919 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -31.57 72.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.836 0.744 . . . . 0.0 111.881 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.7 mt -119.01 15.84 13.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.314 -165.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.83 -63.1 0.92 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.033 1.333 . . . . 0.0 112.331 -173.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -15.46 59.56 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -71.66 -12.1 61.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.678 1.126 . . . . 0.0 111.06 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.5 47.73 4.21 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.699 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -56.96 166.32 1.04 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.933 1.349 . . . . 0.0 110.519 168.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 2.0 m -156.76 -37.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.792 2.037 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.23 -169.32 42.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 124.21 0.909 . . . . 0.0 110.853 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.69 154.13 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -116.55 162.57 17.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.659 1.984 . . . . 0.0 110.124 164.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.36 137.47 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.853 1.261 . . . . 0.0 108.342 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -127.61 127.48 43.9 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.5 91.78 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 12.7 p -90.36 169.64 11.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 54.4 Cg_endo -73.35 4.04 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.832 2.355 . . . . 0.0 112.922 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 p -113.34 -54.89 2.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.354 0.979 . . . . 0.0 110.922 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -155.47 157.82 37.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.61 1.564 . . . . 0.0 108.614 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 m -68.22 139.33 56.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 161.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.33 139.97 44.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.94 124.65 65.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.93 93.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -172.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.16 122.25 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' SER . 63.9 mt -98.39 73.02 2.11 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.633 1.173 . . . . 0.0 109.446 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.7 160.41 15.73 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.423 1.465 . . . . 0.0 111.352 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -72.32 -25.1 61.43 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.676 -1.265 . . . . 0.0 111.527 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -131.81 72.17 1.49 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.541 1.136 . . . . 0.0 108.733 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -56.74 -40.25 75.43 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.45 -0.781 . . . . 0.0 111.808 -174.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -53.33 -39.31 63.99 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.811 1.244 . . . . 0.0 112.634 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.01 -45.34 67.44 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.442 0.697 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.4 -39.73 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.396 0.678 . . . . 0.0 109.302 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.6 -39.09 93.49 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.289 -0.882 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 172.79 28.44 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -165.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -54.87 126.25 23.52 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.706 -0.879 . . . . 0.0 109.67 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.279 58.9 pttt 39.96 42.3 1.05 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.206 1.802 . . . . 0.0 113.507 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.75 20.99 77.62 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.489 -0.757 . . . . 0.0 113.27 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -44.56 -67.26 0.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.407 1.483 . . . . 0.0 111.689 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -32.87 67.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.637 -169.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 tt -61.86 -40.89 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.144 1.338 . . . . 0.0 111.655 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.32 -45.31 88.46 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.027 1.285 . . . . 0.0 110.625 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.25 -48.02 79.91 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.01 0.524 . . . . 0.0 110.518 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 63' ' ' VAL . 10.5 mt -63.93 -36.13 82.95 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 117.975 -1.012 . . . . 0.0 111.524 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.2 m -59.6 -48.99 79.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 120.425 1.466 . . . . 0.0 109.364 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.15 79.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 60' ' ' LEU . 8.0 p -60.66 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.515 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -58.36 -41.75 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.697 1.589 . . . . 0.0 109.54 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -32.79 63.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.063 0.545 . . . . 0.0 111.915 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -96.83 -19.51 18.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.788 2.035 . . . . 0.0 112.842 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -20.63 27.12 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.286 -1.509 . . . . 0.0 110.231 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.69 1.34 4.93 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.665 1.186 . . . . 0.0 112.05 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.77 10.03 66.84 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.574 1.079 . . . . 0.0 114.299 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -57.32 151.98 34.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.915 0.857 . . . . 0.0 111.982 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 58.4 Cg_endo -69.66 174.24 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.988 3.792 . . . . 0.0 109.561 166.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 153.99 22.07 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.72 -46.25 0.55 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.41 1.957 . . . . 0.0 112.569 -166.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 56.1 m -77.86 8.64 4.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.549 1.94 . . . . 0.0 113.194 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.82 131.41 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 160.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -122.08 148.84 44.37 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.356 1.062 . . . . 0.0 108.251 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.81 145.14 42.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.42 162.75 31.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.811 2.044 . . . . 0.0 107.317 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.1 145.35 43.11 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -139.96 141.43 36.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 139.68 36.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.239 0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.706 177.224 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.2 -29.13 68.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.769 0.828 . . . . 0.0 111.879 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.44 -63.66 1.01 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 109.08 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.67 -45.6 19.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.911 1.285 . . . . 0.0 111.581 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 8.7 tp -74.41 -35.81 63.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.219 0.608 . . . . 0.0 111.771 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -66.96 -45.01 79.07 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 109.69 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.59 -55.63 20.94 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.949 0.9 . . . . 0.0 110.147 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.5 -63.53 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.755 1.622 . . . . 0.0 110.033 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.9 mt -59.78 -30.96 69.24 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.814 0.846 . . . . 0.0 113.197 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -55.58 -36.14 66.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.245 0.618 . . . . 0.0 111.237 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -88.35 -52.37 5.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.8 -20.41 49.84 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.59 25.54 4.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.344 1.458 . . . . 0.0 112.015 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.5 -63.17 1.07 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.091 1.757 . . . . 0.0 111.92 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -73.07 -29.83 63.25 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 122.037 -0.414 . . . . 0.0 110.6 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -64.73 -29.87 70.86 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.4 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.24 34.35 0.89 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-O 118.824 -0.986 . . . . 0.0 114.325 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -57.02 171.43 0.36 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.109 1.764 . . . . 0.0 113.705 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -141.29 -60.77 0.48 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.432 1.493 . . . . 0.0 109.215 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.12 41.89 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.53 145.5 16.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.251 -1.146 . . . . 0.0 108.8 -170.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.06 150.83 26.11 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.439 1.496 . . . . 0.0 107.857 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.38 143.29 41.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.125 1.77 . . . . 0.0 107.011 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -133.65 153.31 51.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.8 t -140.1 118.84 11.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 17.5 p -119.68 170.53 6.7 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.0 Cg_endo -69.82 8.65 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.961 1.774 . . . . 0.0 112.589 175.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 p -121.9 -56.31 1.85 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.769 1.168 . . . . 0.0 110.204 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -140.44 170.62 15.45 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.188 0.904 . . . . 0.0 111.589 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 m -87.21 151.07 23.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.75 134.36 45.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -126.0 120.85 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.19 99.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -69.38 139.7 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt -108.96 112.11 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -145.31 171.13 15.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 110.422 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 p -84.26 -28.98 26.83 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.15 -0.969 . . . . 0.0 112.525 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -131.46 73.11 1.52 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -167.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -54.0 -27.81 34.04 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.435 1.094 . . . . 0.0 112.878 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -57.46 -44.39 84.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.828 0.851 . . . . 0.0 111.098 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.92 -38.91 79.84 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.437 1.095 . . . . 0.0 111.538 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 43' ' ' ALA . 61.5 t -65.4 -39.09 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.704 0.802 . . . . 0.0 110.062 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -74.98 -43.66 52.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.69 -172.03 33.0 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -59.66 106.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.798 1.639 . . . . 0.0 110.831 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt 42.69 47.73 4.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.513 1.525 . . . . 0.0 111.202 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.3 11.16 81.12 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.749 -2.139 . . . . 0.0 114.026 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -45.51 -60.13 2.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.244 2.522 . . . . 0.0 112.058 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -50.54 73.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.473 1.033 . . . . 0.0 109.327 -174.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -65.22 -34.33 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.974 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -64.67 -61.09 2.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.694 1.198 . . . . 0.0 110.085 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -50.21 -50.9 48.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 125.709 1.604 . . . . 0.0 111.235 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.1 -21.29 64.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.002 -1.475 . . . . 0.0 112.197 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -56.88 -46.18 82.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 121.53 1.968 . . . . 0.0 108.382 167.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.02 76.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.692 0.678 . . . . 0.0 111.528 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.57 -54.39 35.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.22 -47.37 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 124.611 1.164 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.511 HE22 ' HG2' ' A' ' 72' ' ' GLU . 1.6 mt-30 -53.94 -42.11 68.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.535 0.607 . . . . 0.0 110.876 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -80.74 -50.69 9.55 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 109.409 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -46.84 68.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.414 1.086 . . . . 0.0 110.682 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 73.9 m-85 -96.19 -14.4 22.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.76 0.824 . . . . 0.0 112.267 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.89 51.86 13.61 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.18 154.25 49.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.097 0.959 . . . . 0.0 110.117 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 167.21 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.3 2.666 . . . . 0.0 111.485 159.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' HG2' HE22 ' A' ' 65' ' ' GLN . 50.9 mt-10 -77.77 161.45 27.68 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 163.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.84 -1.52 4.5 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.93 1.252 . . . . 0.0 114.586 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -132.33 14.73 4.58 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.474 1.51 . . . . 0.0 111.823 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.9 125.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 165.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.75 146.58 43.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.47 134.06 55.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -130.5 165.71 22.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.647 2.379 . . . . 0.0 108.645 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.62 6.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.268 1.027 . . . . 0.0 108.654 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 152.82 21.37 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.494 1.518 . . . . 0.0 108.045 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -97.0 143.78 27.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.323 -0.583 0 C-N-CA 123.785 0.834 . . . . 0.0 108.759 178.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 t80 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.861 0.362 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -61.6 -36.94 82.13 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.051 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.03 -53.88 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.456 1.502 . . . . 0.0 111.379 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -57.94 -43.73 86.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.383 0.538 . . . . 0.0 110.598 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.51 -42.42 92.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.904 0.481 . . . . 0.0 110.219 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.95 -50.45 73.36 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 123.871 0.868 . . . . 0.0 109.991 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -59.49 -37.95 79.6 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -59.52 -60.42 3.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.461 1.028 . . . . 0.0 110.228 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 41' ' ' ILE . 66.8 mt -59.05 -35.48 73.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.649 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 m -53.43 -31.2 44.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.921 1.289 . . . . 0.0 112.709 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -90.51 -54.09 4.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.992 0.814 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.87 -39.96 63.04 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.619 0.767 . . . . 0.0 111.518 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -106.94 18.89 21.23 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.737 1.215 . . . . 0.0 112.295 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.08 -50.09 73.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.266 -0.896 . . . . 0.0 112.746 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.49 -15.09 58.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.74 0.7 . . . . 0.0 111.479 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.24 -41.3 70.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 109.532 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.77 45.46 0.47 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 119.111 -0.827 . . . . 0.0 114.861 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.622 ' HE1' HG23 ' A' ' 41' ' ' ILE . 66.3 t80 -60.56 167.16 2.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.422 1.111 . . . . 0.0 112.277 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -158.96 -27.06 0.07 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.62 -169.74 40.8 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.59 149.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.74 158.51 21.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.722 1.249 . . . . 0.0 109.045 161.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.43 125.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -167.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -133.07 125.53 29.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.012 1.325 . . . . 0.0 108.291 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -116.47 127.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 47.5 p -121.66 174.98 2.74 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 124.797 1.239 . . . . 0.0 109.276 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 49.2 Cg_endo -69.64 3.72 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.942 1.761 . . . . 0.0 113.513 167.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.8 p -113.3 -59.75 1.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.923 1.238 . . . . 0.0 110.511 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -158.75 157.2 31.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.663 1.574 . . . . 0.0 112.933 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.0 m -62.97 147.57 50.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.235 1.014 . . . . 0.0 108.668 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.79 134.93 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.242 2.217 . . . . 0.0 107.381 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -124.94 123.12 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.37 94.01 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.622 HG23 ' HE1' ' A' ' 25' ' ' TYR . 3.4 mp -68.49 139.74 20.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt -107.2 115.3 29.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 127.989 2.516 . . . . 0.0 105.922 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.73 175.83 10.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.758 0.708 . . . . 0.0 112.847 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.32 -21.65 21.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.333 -1.479 . . . . 0.0 114.22 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -137.09 70.9 1.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.476 1.11 . . . . 0.0 108.828 -162.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -57.54 -33.63 68.3 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.527 -0.733 . . . . 0.0 112.109 -173.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -60.16 -36.94 78.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.654 1.116 . . . . 0.0 112.416 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -71.83 -43.68 65.15 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.175 0.99 . . . . 0.0 109.273 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.5 t -57.79 -50.62 77.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 125.898 1.679 . . . . 0.0 108.835 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.63 -31.45 72.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.679 0.792 . . . . 0.0 111.342 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.64 178.84 44.05 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -169.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.86 125.51 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 51.87 21.96 1.61 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.9 63.07 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.672 1.124 . . . . 0.0 113.985 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -55.14 -54.76 39.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 112.56 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -39.08 85.26 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.625 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 tt -63.03 -38.36 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 120.331 1.423 . . . . 0.0 110.97 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -41.21 97.39 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.614 -1.304 . . . . 0.0 111.85 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.89 -58.53 7.59 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 63' ' ' VAL . 61.7 mt -55.44 -40.88 72.11 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.878 1.671 . . . . 0.0 111.961 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.3 m -55.21 -50.87 68.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.261 1.392 . . . . 0.0 111.266 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.38 84.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.049 0.84 . . . . 0.0 112.174 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' LEU . 3.7 p -61.75 -49.73 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.801 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.77 -47.35 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 119.696 1.135 . . . . 0.0 110.337 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -54.17 -47.02 72.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.75 . . . . 0.0 110.607 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -73.78 -41.77 61.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.073 0.851 . . . . 0.0 110.085 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -51.61 63.7 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 109.845 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.59 1.89 46.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.264 1.426 . . . . 0.0 111.28 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 18.73 75.48 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.885 1.231 . . . . 0.0 114.072 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -63.18 149.47 90.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 118.545 1.173 . . . . 0.0 112.028 -174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.44 132.73 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.862 2.374 . . . . 0.0 110.102 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -57.51 141.83 46.37 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.223 1.009 . . . . 0.0 110.939 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 -12.78 1.06 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.195 1.379 . . . . 0.0 113.454 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.9 m -115.27 14.59 16.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.909 1.684 . . . . 0.0 111.333 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.84 144.34 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.741 1.617 . . . . 0.0 107.134 154.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.97 151.62 49.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.37 1.468 . . . . 0.0 108.911 172.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -124.7 128.62 49.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -112.29 168.74 9.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.057 2.143 . . . . 0.0 107.339 175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 108.72 6.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -104.85 166.32 10.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.558 1.143 . . . . 0.0 109.166 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -112.98 143.21 44.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.944 -0.473 . . . . 0.0 110.823 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.24 0.595 0 C-N-CA 124.201 1.0 . . . . 0.0 111.345 171.635 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.7 t80 . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -59.66 -33.75 71.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.287 -1.339 . . . . 0.0 111.345 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.21 13.44 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.471 -1.252 . . . . 0.0 110.038 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.14 -46.77 65.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.483 1.038 . . . . 0.0 109.888 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.52 -40.86 96.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.008 0.923 . . . . 0.0 111.087 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -62.36 -51.75 66.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.798 1.239 . . . . 0.0 109.695 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.32 -27.18 65.15 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 111.29 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.05 -63.26 1.1 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.848 1.659 . . . . 0.0 108.973 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.31 -35.77 72.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.244 1.018 . . . . 0.0 112.093 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.7 m -50.53 -43.35 55.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.338 0.655 . . . . 0.0 111.148 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -42.75 18.03 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.143 0.429 . . . . 0.0 110.215 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -21.74 61.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.975 -172.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.07 30.81 6.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.14 2.176 . . . . 0.0 110.43 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.91 82.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.57 -8.2 58.42 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.983 0.81 . . . . 0.0 111.4 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -16.98 58.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.005 0.922 . . . . 0.0 113.14 -169.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.37 47.8 7.21 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 118.722 -1.704 . . . . 0.0 109.576 -163.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -64.0 142.26 58.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.2 -28.68 3.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.117 0.967 . . . . 0.0 112.209 -174.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.02 -168.83 35.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -153.4 145.82 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -118.29 165.38 13.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.816 1.646 . . . . 0.0 108.442 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 141.53 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.649 1.179 . . . . 0.0 107.872 -171.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -125.32 167.41 14.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.239 1.018 . . . . 0.0 110.269 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.72 118.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 19.7 p -121.69 170.73 7.14 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.719 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 89.8 Cg_endo -78.37 15.66 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 165.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.9 p -127.24 -52.19 1.4 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.125 1.33 . . . . 0.0 111.577 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -154.64 160.91 41.72 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.285 1.034 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.0 m -72.01 151.79 42.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.81 133.15 31.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.39 123.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 125.873 1.669 . . . . 0.0 106.775 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.17 95.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.56 133.16 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.557 1.143 . . . . 0.0 108.496 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.18 114.51 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.91 175.46 10.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.013 0.525 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 HG21 ' A' ' 82' ' ' VAL . 1.6 p -99.76 -49.3 4.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.11 1.323 . . . . 0.0 111.912 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -90.6 61.48 4.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.667 2.387 . . . . 0.0 108.957 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 p -56.07 -28.56 58.1 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.53 -1.356 . . . . 0.0 113.48 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -57.7 -37.96 74.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.384 1.074 . . . . 0.0 113.62 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.88 -46.65 74.27 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.864 0.866 . . . . 0.0 108.905 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.09 -39.21 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.429 1.092 . . . . 0.0 110.108 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.14 -44.62 83.65 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.699 -0.626 . . . . 0.0 110.7 174.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.77 175.92 47.02 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 124.795 1.188 . . . . 0.0 112.151 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -55.44 116.66 2.99 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.355 1.062 . . . . 0.0 109.814 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 53.78 23.44 3.76 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.661 0.784 . . . . 0.0 112.729 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.67 59.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.403 -0.811 . . . . 0.0 112.549 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -59.29 -57.8 11.43 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.052 1.426 . . . . 0.0 110.246 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.06 -41.36 98.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.287 -169.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.4 tp -57.88 -42.83 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 120.091 1.314 . . . . 0.0 111.256 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -70.17 -42.11 72.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 110.794 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -56.32 23.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.1 mt -62.26 -24.26 67.16 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.885 1.274 . . . . 0.0 112.587 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -61.16 -48.76 80.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.348 1.431 . . . . 0.0 109.659 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.98 -40.18 95.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.293 0.497 . . . . 0.0 110.997 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.0 -53.26 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -63.55 -43.69 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 124.995 1.318 . . . . 0.0 110.241 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -54.48 -37.31 65.11 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.358 0.663 . . . . 0.0 110.568 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -73.9 -58.13 3.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.005 0.82 . . . . 0.0 110.081 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -57.38 -30.05 64.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.996 1.318 . . . . 0.0 112.379 -170.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 98.1 m-85 -121.59 2.24 10.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.416 1.486 . . . . 0.0 111.774 -171.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.98 22.9 65.27 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.037 0.835 . . . . 0.0 114.156 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -63.66 146.24 96.89 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.2 0.6 . . . . 0.0 111.267 -172.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.52 129.38 27.81 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.542 2.161 . . . . 0.0 110.581 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.65 143.53 46.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.73 61.11 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.873 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -136.61 21.48 3.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.156 1.478 . . . . 0.0 113.113 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.07 138.8 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 154.94 42.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.899 0.88 . . . . 0.0 110.567 165.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -132.94 114.08 13.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.36 2.264 . . . . 0.0 107.551 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.81 176.29 5.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.623 1.169 . . . . 0.0 110.524 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.18 114.76 8.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.594 0.633 . . . . 0.0 109.635 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -114.56 141.41 47.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.982 2.113 . . . . 0.0 109.598 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.8 156.22 19.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 44' ' ' THR . 29.7 m . . . . . 0 C--O 1.235 0.303 0 C-N-CA 125.192 1.397 . . . . 0.0 110.493 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 67.6 t80 . . . . . 0 N--CA 1.46 0.072 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -70.89 -13.26 61.96 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.471 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.46 -50.55 7.66 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.977 1.262 . . . . 0.0 109.999 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.51 -46.75 80.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.866 0.757 . . . . 0.0 111.687 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 11.1 tp -67.7 -33.99 75.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.787 1.235 . . . . 0.0 110.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -66.59 -51.14 59.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 109.94 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.6 -52.41 59.9 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.122 0.969 . . . . 0.0 110.557 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -52.22 -60.16 3.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.163 1.385 . . . . 0.0 110.498 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.0 mt -62.66 -36.74 83.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -51.79 -47.34 64.27 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.732 0.813 . . . . 0.0 109.237 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -76.68 -41.1 46.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.862 0.465 . . . . 0.0 110.117 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -17.88 62.15 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.718 -1.134 . . . . 0.0 113.677 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -130.54 24.48 5.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.14 1.776 . . . . 0.0 112.631 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.24 66.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.15 -36.21 83.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.803 0.811 . . . . 0.0 109.127 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -38.87 86.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.508 1.123 . . . . 0.0 110.651 -168.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.52 37.88 0.88 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 119.96 1.255 . . . . 0.0 114.386 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.79 165.74 2.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.319 1.047 . . . . 0.0 112.923 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 m -159.03 -31.02 0.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.41 -171.72 43.74 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.51 137.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.86 158.8 15.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.64 117.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 124.767 1.227 . . . . 0.0 107.872 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.85 122.05 46.63 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.7 131.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 161.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 30.9 p -120.51 166.53 15.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 48.6 Cg_endo -67.47 -12.68 36.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.329 1.353 . . . . 0.0 111.511 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.79 -50.59 5.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.307 1.443 . . . . 0.0 110.266 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 76' ' ' GLU . 5.6 ptp180 -162.08 173.7 14.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.386 1.448 . . . . 0.0 111.496 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.15 152.99 39.72 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.933 -1.104 . . . . 0.0 108.084 162.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -135.05 138.78 44.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.475 2.31 . . . . 0.0 105.108 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.9 mt -129.18 124.17 59.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.86 98.01 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.24 127.27 29.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.0 mt -97.1 110.06 22.69 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.171 1.388 . . . . 0.0 107.544 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.13 170.43 19.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.443 0.697 . . . . 0.0 109.48 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.29 -48.67 15.17 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.31 -1.493 . . . . 0.0 112.505 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -94.97 69.49 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.828 1.651 . . . . 0.0 108.795 -165.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -52.75 -34.85 54.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.21 -47.15 85.71 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 120.918 -1.114 . . . . 0.0 111.939 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.65 -43.78 97.93 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.02 -51.79 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 126.414 1.885 . . . . 0.0 109.461 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.4 -32.46 68.65 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 121.879 -0.513 . . . . 0.0 110.204 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 179.07 46.57 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.97 107.28 0.28 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.247 1.419 . . . . 0.0 110.508 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 48.25 50.53 16.25 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.023 0.916 . . . . 0.0 112.173 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.96 58.98 9.82 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -93.57 -68.39 0.8 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.301 1.04 . . . . 0.0 110.565 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -61.82 -38.15 87.09 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.356 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tp -55.64 -43.04 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.269 0.94 . . . . 0.0 111.355 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -72.5 -36.24 68.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.783 -1.198 . . . . 0.0 111.097 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -56.93 15.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.26 -22.73 64.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.552 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.5 m -58.15 -57.41 12.96 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 120.494 1.497 . . . . 0.0 109.054 166.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -27.53 69.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.278 0.944 . . . . 0.0 112.237 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.11 -63.45 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.61 -43.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.329 1.851 . . . . 0.0 110.86 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -53.91 -45.32 71.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.154 0.982 . . . . 0.0 110.784 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -71.68 -57.92 3.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 109.631 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -47.36 27.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.526 1.93 . . . . 0.0 111.918 -173.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.04 -7.57 22.21 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.336 1.454 . . . . 0.0 111.411 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.15 44.68 95.35 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.053 0.835 . . . . 0.0 111.198 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -69.73 141.59 90.29 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 117.55 0.675 . . . . 0.0 109.619 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.15 128.03 27.18 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 108.38 -1.431 . . . . 0.0 108.38 161.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.72 99.94 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.425 1.49 . . . . 0.0 111.643 -175.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.98 -8.75 33.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.532 1.539 . . . . 0.0 112.028 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 m -85.18 21.72 1.62 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.621 1.21 . . . . 0.0 111.111 162.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 154.73 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.59 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.488 ' HG3' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.93 150.95 33.79 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.886 2.075 . . . . 0.0 107.335 174.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -123.86 131.28 53.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.532 1.133 . . . . 0.0 108.862 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -126.16 161.53 27.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.54 2.336 . . . . 0.0 109.314 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.36 109.21 9.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.366 1.066 . . . . 0.0 108.821 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 158.09 16.59 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.155 1.382 . . . . 0.0 108.46 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -83.28 152.22 25.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.63 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.104 160.695 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 63.3 t80 . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.62 -31.02 69.11 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.764 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.0 -59.0 5.42 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.766 1.166 . . . . 0.0 110.705 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.78 -45.01 82.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.473 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.4 tp -66.42 -39.29 88.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.681 0.613 . . . . 0.0 110.513 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.28 -53.0 62.37 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.019 0.827 . . . . 0.0 108.959 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 -30.44 71.47 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.3 0.5 . . . . 0.0 111.569 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -65.78 -52.1 53.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.308 1.443 . . . . 0.0 110.215 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.86 -32.73 72.61 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.577 1.151 . . . . 0.0 112.161 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -50.98 -49.75 59.6 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.229 1.012 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -61.5 -57.69 11.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.735 1.214 . . . . 0.0 110.285 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.21 -14.34 62.92 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -134.48 18.94 3.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.969 0.908 . . . . 0.0 112.157 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -58.15 7.92 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 110.937 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.41 -27.6 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.646 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -15.89 62.77 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.0 1.32 . . . . 0.0 112.158 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.89 42.03 6.14 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.523 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -53.21 167.3 0.19 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.806 1.242 . . . . 0.0 111.616 167.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 m -153.93 -43.21 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.731 1.212 . . . . 0.0 110.928 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.23 34.43 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.86 159.39 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 121.456 -1.026 . . . . 0.0 108.33 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -127.84 164.3 22.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.242 1.017 . . . . 0.0 109.475 158.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.13 148.52 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 127.147 2.179 . . . . 0.0 108.701 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -122.85 129.61 51.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.97 116.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 154.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.1 p -120.74 165.09 19.69 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 165.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.8 -12.85 29.13 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.376 2.051 . . . . 0.0 111.959 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 p -96.37 -47.08 6.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.206 0.912 . . . . 0.0 109.77 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.3 169.59 20.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.81 1.644 . . . . 0.0 108.789 164.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.9 m -72.87 145.13 47.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 162.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.68 140.65 52.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 171.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.38 120.05 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.13 111.71 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.71 132.35 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.5 105.29 17.41 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 163.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -134.22 166.62 22.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -71.3 -35.88 71.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.796 -0.565 . . . . 0.0 111.259 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -127.29 74.89 1.54 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.178 0.899 . . . . 0.0 110.84 -163.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 p -50.61 -40.54 53.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -58.19 -34.69 70.64 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -77.57 -37.33 50.84 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 43' ' ' ALA . 70.2 t -66.26 -37.36 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 118.528 0.604 . . . . 0.0 110.03 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.76 -41.95 97.91 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.151 -0.968 . . . . 0.0 109.164 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.06 179.59 43.68 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.53 115.97 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.969 0.907 . . . . 0.0 109.934 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt 51.33 32.68 8.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.422 1.489 . . . . 0.0 111.633 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 33.7 37.42 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.033 -1.426 . . . . 0.0 112.727 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -65.61 0.64 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.732 1.766 . . . . 0.0 112.274 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -60.59 -42.12 96.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -167.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.27 -42.21 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 123.888 0.743 . . . . 0.0 110.425 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -46.84 83.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.258 1.39 . . . . 0.0 111.303 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -59.88 4.32 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.64 -25.16 66.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 117.303 -1.332 . . . . 0.0 112.185 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -56.23 -52.58 63.93 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 120.324 1.42 . . . . 0.0 108.673 169.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.11 79.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.494 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.28 -60.09 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.81 -44.46 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 127.258 2.223 . . . . 0.0 110.624 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.24 -45.9 76.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.933 0.893 . . . . 0.0 110.467 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -70.17 -50.78 36.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.547 1.067 . . . . 0.0 111.488 170.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -29.24 49.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.796 1.638 . . . . 0.0 112.566 -172.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.71 4.22 7.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.324 1.45 . . . . 0.0 112.133 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.54 79.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.405 1.003 . . . . 0.0 114.625 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -70.25 142.0 89.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.137 . . . . 0.0 112.366 -172.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.74 121.51 8.58 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.496 2.797 . . . . 0.0 110.921 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.94 146.44 26.8 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.593 1.557 . . . . 0.0 110.256 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.42 -22.71 3.09 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 120.87 -1.144 . . . . 0.0 112.462 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.7 m -109.85 10.35 24.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.457 2.303 . . . . 0.0 110.862 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.86 140.22 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 162.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.18 154.76 46.45 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 124.002 0.921 . . . . 0.0 109.083 166.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -119.84 138.7 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -132.83 168.24 18.74 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.942 1.697 . . . . 0.0 109.949 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.79 108.58 9.97 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.168 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.71 147.44 28.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 111.14 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -81.83 150.98 27.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.238 0.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -63.63 -12.15 31.11 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.317 -0.849 . . . . 0.0 113.159 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.49 1.14 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 121.165 1.802 . . . . 0.0 108.854 166.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -50.32 -45.41 54.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.48 1.512 . . . . 0.0 111.443 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.22 -40.76 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.839 0.456 . . . . 0.0 110.472 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -64.0 -48.13 77.58 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.12 -48.55 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.046 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -53.36 -56.53 15.99 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.091 0.859 . . . . 0.0 110.597 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.2 -37.41 85.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 111.16 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.8 m -53.84 -47.91 70.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.905 0.882 . . . . 0.0 110.618 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -58.37 5.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.01 0.924 . . . . 0.0 109.813 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.01 -27.62 63.69 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.23 18.03 12.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.837 1.655 . . . . 0.0 111.92 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.96 -35.82 47.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.268 1.027 . . . . 0.0 113.361 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -90.82 -19.59 23.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.906 0.775 . . . . 0.0 112.665 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.74 -26.34 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.593 1.157 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 50.58 2.81 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -169.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -57.43 168.42 0.8 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 110.417 166.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -154.24 -43.44 0.09 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 110.184 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.53 -165.9 33.86 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.7 157.47 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -124.96 138.45 54.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 108.212 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.61 116.48 35.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.207 1.803 . . . . 0.0 108.842 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -113.96 122.0 45.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -107.71 111.92 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 p -120.46 167.02 13.66 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.35 22.89 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.878 2.385 . . . . 0.0 111.445 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -127.61 -53.03 1.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.397 -1.439 . . . . 0.0 110.937 -168.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -162.09 171.71 17.06 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.459 2.304 . . . . 0.0 107.56 160.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -87.62 138.05 31.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.75 151.64 27.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.74 122.36 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 mt -123.57 108.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 mt -71.01 122.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.83 110.53 20.57 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.59 168.08 21.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 111.321 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -78.43 -26.37 46.29 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 120.458 -1.401 . . . . 0.0 112.854 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -128.89 67.02 1.41 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.964 0.906 . . . . 0.0 110.562 -164.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -45.32 26.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.697 1.999 . . . . 0.0 113.42 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -70.78 -28.61 64.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.223 -0.923 . . . . 0.0 111.744 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.59 -42.26 64.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 0.56 . . . . 0.0 109.689 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.76 -47.44 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.1 mt -61.82 -38.66 88.99 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.441 -0.787 . . . . 0.0 111.024 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.0 174.05 29.67 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.52 117.21 3.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.273 1.029 . . . . 0.0 109.488 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 47.62 41.11 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.507 1.123 . . . . 0.0 112.925 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.93 13.74 83.34 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.114 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -48.61 -60.16 2.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.132 1.466 . . . . 0.0 113.046 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -43.25 99.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 117.025 -1.465 . . . . 0.0 110.363 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 tt -61.06 -39.02 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 120.185 1.357 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -63.51 -47.7 80.6 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 120.747 -1.221 . . . . 0.0 112.361 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.25 -58.88 6.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.257 1.023 . . . . 0.0 109.303 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.84 -26.23 67.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.624 -173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.4 m -58.32 -47.58 83.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.06 1.3 . . . . 0.0 109.803 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.84 88.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.624 1.102 . . . . 0.0 111.796 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.98 -58.82 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.283 -0.885 . . . . 0.0 108.64 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.2 t -52.12 -45.72 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 126.378 1.871 . . . . 0.0 110.197 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -52.6 -49.29 65.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.534 0.733 . . . . 0.0 110.732 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.87 32.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.734 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -40.92 65.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.011 0.823 . . . . 0.0 111.965 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.15 8.24 27.93 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.055 1.742 . . . . 0.0 111.227 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 33.21 63.38 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.495 1.521 . . . . 0.0 113.695 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -72.32 151.41 92.08 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.782 0.833 . . . . 0.0 112.291 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.0 119.67 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.393 2.062 . . . . 0.0 109.241 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.09 137.16 56.16 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.758 0.823 . . . . 0.0 109.034 166.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.35 56.05 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.75 1.643 . . . . 0.0 113.152 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.3 m -133.51 17.7 3.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.076 1.438 . . . . 0.0 112.993 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.53 139.58 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 151.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -128.49 145.11 51.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.63 140.96 48.39 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -131.6 167.73 18.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 128.136 2.574 . . . . 0.0 108.871 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.33 119.47 15.54 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -121.49 171.78 8.55 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.375 1.47 . . . . 0.0 111.886 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -115.25 131.55 56.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.569 -164.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -173.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 53.7 t80 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.243 0.068 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -52.59 -38.23 59.67 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.698 0.799 . . . . 0.0 110.757 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.26 -49.65 40.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.117 -0.944 . . . . 0.0 112.241 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -55.95 -46.95 78.41 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.516 1.053 . . . . 0.0 109.787 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 14.0 tp -62.4 -39.78 94.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.694 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -61.26 -51.78 67.51 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.003 0.921 . . . . 0.0 109.792 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -59.66 -40.08 86.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.928 0.785 . . . . 0.0 111.579 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.02 -57.92 10.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.934 0.893 . . . . 0.0 109.315 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -61.26 -38.39 86.53 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.856 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -53.61 -31.14 45.89 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.484 1.493 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.86 -47.69 7.46 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 110.526 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -60.63 -33.76 73.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.791 0.723 . . . . 0.0 112.41 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -113.55 23.58 13.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.293 2.237 . . . . 0.0 110.37 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.87 -59.69 4.04 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.593 1.157 . . . . 0.0 110.143 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.03 -39.94 79.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.695 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -43.51 92.66 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.699 1.6 . . . . 0.0 112.21 -164.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.63 48.73 0.78 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.868 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.51 169.79 5.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.163 1.385 . . . . 0.0 111.095 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -157.16 -26.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.14 -169.54 36.75 Favored Glycine 0 C--O 1.227 -0.311 0 O-C-N 121.632 -0.667 . . . . 0.0 111.689 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.59 142.52 11.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.21 158.37 16.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.335 1.054 . . . . 0.0 109.506 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.79 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.093 1.357 . . . . 0.0 107.471 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.7 129.07 57.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.8 p -121.83 177.06 1.67 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.634 1.574 . . . . 0.0 110.407 -172.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.1 Cg_endo -78.75 0.0 10.36 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 121.424 1.416 . . . . 0.0 113.182 165.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -119.64 -53.14 2.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.766 1.621 . . . . 0.0 112.971 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -153.73 161.38 42.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.649 1.18 . . . . 0.0 110.66 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.1 m -71.63 148.06 46.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.08 130.99 53.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.336 1.854 . . . . 0.0 106.769 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.9 mt -124.03 121.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.94 97.14 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -69.61 141.74 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -115.39 120.8 40.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 127.923 2.489 . . . . 0.0 107.76 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.91 169.71 22.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.101 1.361 . . . . 0.0 109.643 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -80.41 -35.43 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.406 -0.809 . . . . 0.0 112.342 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -125.55 83.47 2.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.306 1.442 . . . . 0.0 108.32 -165.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -49.92 -45.15 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.049 1.34 . . . . 0.0 112.387 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -56.85 -38.47 72.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.49 -43.73 80.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.485 1.039 . . . . 0.0 109.877 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.05 -42.32 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.079 0.552 . . . . 0.0 109.768 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.15 -30.78 71.73 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.979 -1.076 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.16 -174.38 9.42 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.06 111.6 1.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 110.228 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp 56.41 3.13 0.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.251 1.82 . . . . 0.0 115.14 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.72 -2.14 9.35 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 120.422 1.464 . . . . 0.0 114.112 -169.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -44.06 -57.44 3.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.057 1.929 . . . . 0.0 113.941 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.87 -45.02 79.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.122 0.874 . . . . 0.0 110.621 -173.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.29 -34.33 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.374 0.988 . . . . 0.0 109.827 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -71.84 -37.42 70.28 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 113.753 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.28 -55.27 16.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.2 mt -56.09 -36.1 67.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.136 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -49.32 -52.56 27.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.18 0.9 . . . . 0.0 110.729 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.61 -44.63 56.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.2 1.0 . . . . 0.0 111.36 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -60.28 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 t -54.85 -46.49 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 120.417 1.462 . . . . 0.0 110.614 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -49.95 -42.51 48.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.272 1.029 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -83.77 -41.06 18.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.002 0.921 . . . . 0.0 111.709 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -29.64 70.88 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.98 0.912 . . . . 0.0 111.474 -173.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.3 -8.76 11.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.983 0.913 . . . . 0.0 110.464 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.5 51.07 45.12 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -78.18 150.4 77.39 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.011 0.524 . . . . 0.0 110.018 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.54 119.51 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.773 1.649 . . . . 0.0 109.712 162.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.86 145.59 15.81 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.93 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.601 -1.111 . . . . 0.0 114.296 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -134.46 40.16 3.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.462 2.131 . . . . 0.0 111.882 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.2 139.57 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 164.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 138.34 50.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.092 1.357 . . . . 0.0 108.729 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.44 129.23 47.44 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -117.04 160.3 21.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.421 1.488 . . . . 0.0 109.554 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.67 109.36 10.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 108.463 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.12 156.48 17.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.376 1.47 . . . . 0.0 108.475 173.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -107.06 148.83 28.27 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.633 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -154.32 157.43 38.62 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.312 -1.11 . . . . 0.0 110.649 -172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.3 t -74.67 150.72 39.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.599 1.16 . . . . 0.0 110.721 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.73 -161.81 31.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.1 m -55.36 143.88 27.09 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.369 0.668 . . . . 0.0 110.011 164.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m 174.35 -8.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.919 1.688 . . . . 0.0 114.6 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.97 -91.23 0.7 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.705 1.139 . . . . 0.0 112.041 168.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.421 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 44.9 t80 -45.42 -49.82 12.97 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 126.437 1.895 . . . . 0.0 112.659 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -57.94 -31.72 67.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.7 -42.33 58.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.407 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -62.73 -46.41 88.21 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.144 0.577 . . . . 0.0 110.807 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.6 tp -65.75 -38.82 90.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.651 0.781 . . . . 0.0 110.166 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.45 -42.18 83.51 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.352 0.524 . . . . 0.0 111.14 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.95 -46.26 78.6 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.588 0.755 . . . . 0.0 110.876 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.57 -61.59 2.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.001 0.92 . . . . 0.0 109.439 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.51 -32.23 72.26 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.737 1.215 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.3 m -54.56 -45.42 73.48 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.885 0.766 . . . . 0.0 110.497 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -49.97 65.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.689 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -55.88 -35.53 66.6 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.104 0.561 . . . . 0.0 112.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -121.15 24.77 9.93 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.09 1.356 . . . . 0.0 110.524 -167.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.03 -63.04 1.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.42 1.488 . . . . 0.0 110.595 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.23 -24.94 51.17 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.905 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.7 -35.54 72.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.341 0.973 . . . . 0.0 111.418 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.68 35.73 0.83 Allowed Glycine 0 C--N 1.338 0.65 0 O-C-N 123.553 0.533 . . . . 0.0 113.018 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 41' ' ' ILE . 29.9 t80 -59.38 167.46 1.87 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.174 0.987 . . . . 0.0 112.509 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -44.88 0.16 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.406 1.482 . . . . 0.0 110.042 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.32 -169.53 42.1 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.77 156.34 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.39 158.96 22.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.576 1.951 . . . . 0.0 107.857 163.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.02 150.07 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -132.88 156.79 46.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 163.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.52 124.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.0 p -120.41 176.83 1.64 Allowed Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -167.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 67.6 Cg_endo -72.12 8.07 1.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.509 1.473 . . . . 0.0 112.591 167.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 p -125.78 -45.08 1.77 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.376 0.989 . . . . 0.0 110.637 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -161.73 173.22 14.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.92 1.236 . . . . 0.0 110.865 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.6 m -88.94 149.47 23.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 160.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.2 138.41 52.46 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.176 1.79 . . . . 0.0 106.613 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -132.16 120.7 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.41 95.03 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.484 HG23 ' CE1' ' A' ' 25' ' ' TYR . 2.5 mp -64.26 153.24 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -118.8 108.14 14.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.827 2.451 . . . . 0.0 105.972 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.93 157.93 45.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.556 0.693 . . . . 0.0 112.29 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.8 p -64.08 -34.24 77.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.549 1.14 . . . . 0.0 111.018 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.2 mtt-85 -134.88 82.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.479 1.512 . . . . 0.0 109.821 -169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.6 p -53.4 -35.37 60.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.732 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -60.79 -36.57 79.35 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.448 1.477 . . . . 0.0 112.456 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -67.03 -45.28 77.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.814 0.733 . . . . 0.0 109.066 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -30.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.049 0.939 . . . . 0.0 111.105 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.21 -40.22 52.72 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.524 -0.735 . . . . 0.0 110.519 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.3 179.7 47.06 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.501 1.048 . . . . 0.0 111.487 -171.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -57.06 114.93 2.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.545 0.738 . . . . 0.0 109.447 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 mttp 39.46 46.82 1.47 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.181 1.792 . . . . 0.0 112.464 -174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.88 9.54 77.43 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.118 -0.824 . . . . 0.0 113.751 171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -43.86 -62.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.253 1.526 . . . . 0.0 112.738 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.02 -40.77 78.46 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.368 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.04 -41.27 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.306 0.957 . . . . 0.0 111.186 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -52.61 64.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.972 -1.08 . . . . 0.0 109.649 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -58.54 -47.06 85.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.795 0.725 . . . . 0.0 111.732 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 63' ' ' VAL . 40.0 mt -62.0 -30.24 70.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.715 0.806 . . . . 0.0 110.898 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -61.17 -51.7 67.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.436 1.016 . . . . 0.0 109.413 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.71 78.79 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.857 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 60' ' ' LEU . 11.4 p -59.87 -46.17 94.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.722 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 t -60.45 -45.69 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 120.234 1.379 . . . . 0.0 110.152 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -51.9 -44.25 63.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.785 1.234 . . . . 0.0 110.426 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -70.75 -50.78 32.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.2 1.0 . . . . 0.0 110.139 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -44.87 90.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.282 1.433 . . . . 0.0 111.016 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -103.57 -13.67 16.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.81 1.244 . . . . 0.0 111.503 -171.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 20.36 54.91 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 121.324 -0.86 . . . . 0.0 113.943 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -62.32 138.38 96.23 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.063 0.932 . . . . 0.0 112.456 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.96 141.6 49.03 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.275 1.983 . . . . 0.0 110.24 165.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.47 147.35 39.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.735 0.814 . . . . 0.0 110.03 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.97 -7.44 7.57 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.435 -0.791 . . . . 0.0 113.197 -169.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.0 m -122.02 7.21 9.78 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.138 1.775 . . . . 0.0 111.201 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.07 136.84 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 156.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -127.65 140.77 51.88 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.54 126.67 50.92 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.205 1.402 . . . . 0.0 107.629 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 63.5 m-85 -129.89 168.23 16.95 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.847 2.459 . . . . 0.0 109.22 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.62 122.07 17.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.37 155.28 18.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -101.23 149.49 23.95 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.79 144.15 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 122.517 1.151 . . . . 0.0 108.134 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.57 139.46 5.53 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.488 1.515 . . . . 0.0 108.804 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.4 t -70.2 148.15 48.96 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -65.94 155.3 36.93 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.26 -174.79 23.32 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m 60.12 173.13 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.616 1.967 . . . . 0.0 113.507 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -101.13 178.74 28.25 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.158 0.885 . . . . 0.0 111.63 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.11 -69.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.488 2.125 . . . . 0.0 107.98 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -142.92 -32.39 0.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.21 1.804 . . . . 0.0 109.561 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m 70.78 6.73 5.96 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.019 1.328 . . . . 0.0 112.626 -174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 C-N-CA 128.227 2.822 . . . . 0.0 107.245 171.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.277 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t 38.82 83.27 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.181 2.592 . . . . 0.0 113.271 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -145.04 177.18 8.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.68 125.85 1.78 Allowed Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 105.682 -2.967 . . . . 0.0 105.682 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.4 m 30.32 74.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.438 2.295 . . . . 0.0 112.668 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -163.15 142.2 8.5 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.155 1.382 . . . . 0.0 107.404 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.37 94.04 1.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -32.85 -51.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 129.515 3.126 . . . . 0.0 114.085 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.31 -36.19 60.99 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 118.547 -0.739 . . . . 0.0 112.177 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.37 -51.52 51.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.951 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.91 -46.0 74.82 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.427 1.091 . . . . 0.0 109.932 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.21 -43.26 82.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.737 0.815 . . . . 0.0 110.625 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -64.12 -47.19 80.93 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.324 0.65 . . . . 0.0 109.942 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -57.73 -44.29 85.89 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.186 1.394 . . . . 0.0 111.739 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -56.54 -60.07 4.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -58.5 -38.89 78.61 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.476 1.11 . . . . 0.0 112.487 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -51.91 -37.05 51.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.552 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -90.79 -39.01 12.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.293 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.09 -25.46 65.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.063 0.847 . . . . 0.0 113.071 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.38 22.6 12.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.2 1.8 . . . . 0.0 110.758 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -52.23 64.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.872 1.269 . . . . 0.0 111.683 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -74.77 -26.65 59.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.673 0.215 . . . . 0.0 111.071 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 -34.99 79.41 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.639 0.775 . . . . 0.0 112.12 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.57 33.63 2.23 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.49 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HE1' HG23 ' A' ' 41' ' ' ILE . 38.5 t80 -51.67 157.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.862 0.865 . . . . 0.0 112.478 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.436 ' CB ' HG21 ' A' ' 82' ' ' VAL . 22.9 m -128.96 -57.06 1.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.472 1.509 . . . . 0.0 108.96 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.12 -166.45 32.9 Favored Glycine 0 C--O 1.227 -0.325 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.23 154.56 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -124.27 152.17 43.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 165.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.75 137.28 54.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -115.3 152.28 33.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.99 96.23 3.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 -171.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.8 p -120.69 163.89 26.45 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 123.768 0.827 . . . . 0.0 108.914 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.85 13.7 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.84 2.36 . . . . 0.0 112.011 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 p -120.64 -45.52 2.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.33 1.452 . . . . 0.0 110.324 -163.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -162.05 173.22 14.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.95 2.1 . . . . 0.0 106.989 162.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -75.71 147.37 39.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 158.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.77 129.7 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.6 mt -126.9 132.51 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.99 100.53 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' A' ' 25' ' ' TYR . 59.8 mt -69.55 131.75 33.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 82' ' ' VAL . 51.0 mt -106.92 114.63 28.83 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.643 1.977 . . . . 0.0 106.22 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.81 169.63 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.801 0.441 . . . . 0.0 110.081 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 p -68.61 -46.45 69.27 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.408 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -115.8 89.6 3.14 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 127.519 2.328 . . . . 0.0 107.605 -164.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -45.27 66.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 111.324 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -65.76 -19.43 65.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -74.35 -49.06 24.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -59.67 -39.29 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.998 1.319 . . . . 0.0 110.844 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.16 -40.73 90.76 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.599 -0.688 . . . . 0.0 110.858 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 -175.29 40.0 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.54 113.67 2.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.889 1.275 . . . . 0.0 110.467 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.1 pttt 46.25 30.07 0.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.635 1.174 . . . . 0.0 113.867 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.62 5.74 59.97 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.992 0.806 . . . . 0.0 114.374 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -45.72 -55.91 5.91 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.341 1.456 . . . . 0.0 112.855 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -72.27 -46.48 55.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.25 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.0 tt -59.08 -35.93 59.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.848 1.658 . . . . 0.0 111.134 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.94 -36.67 72.71 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 120.699 -1.251 . . . . 0.0 112.559 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -64.91 -49.27 71.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.265 0.484 . . . . 0.0 109.997 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 63' ' ' VAL . 83.1 mt -59.87 -29.09 68.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.937 1.295 . . . . 0.0 110.507 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -63.32 -56.67 14.54 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.815 . . . . 0.0 109.067 169.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.6 88.09 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.863 1.265 . . . . 0.0 112.097 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 60' ' ' LEU . 7.4 p -62.88 -52.4 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.115 -1.422 . . . . 0.0 108.101 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 t -54.81 -46.38 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.187 1.358 . . . . 0.0 109.976 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.99 -44.89 64.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 0.0 109.517 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -83.89 -37.51 22.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.707 0.685 . . . . 0.0 112.646 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -54.98 -55.3 32.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.528 1.131 . . . . 0.0 109.088 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 97.2 m-85 -93.8 -11.18 31.85 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.486 1.114 . . . . 0.0 110.51 -169.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.98 23.11 59.96 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.424 1.011 . . . . 0.0 111.811 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.65 139.98 97.71 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 118.263 1.031 . . . . 0.0 111.508 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -60.17 130.74 35.54 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.934 2.423 . . . . 0.0 109.449 165.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.07 122.67 15.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.433 0.693 . . . . 0.0 109.301 -173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.58 -12.47 56.03 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.985 0.802 . . . . 0.0 114.368 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -89.2 15.18 9.31 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.779 1.232 . . . . 0.0 111.582 165.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.57 156.4 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 159.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.23 145.31 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 170.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 113.16 19.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -112.36 164.67 12.98 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.064 2.145 . . . . 0.0 108.609 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.84 114.37 10.39 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -104.43 153.68 20.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.088 0.946 . . . . 0.0 109.194 172.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -83.28 148.3 27.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 26' ' ' SER . 91.5 t -85.09 146.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.794 0.837 . . . . 0.0 109.339 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 83.81 84.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 129.765 3.226 . . . . 0.0 109.71 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 p -76.03 95.2 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.712 1.605 . . . . 0.0 110.289 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -130.38 141.23 50.56 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.499 -1.375 . . . . 0.0 107.612 163.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.67 -107.33 0.33 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -167.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 51.42 74.98 0.22 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.039 1.336 . . . . 0.0 110.103 -169.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.06 95.09 0.6 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 107.29 -2.324 . . . . 0.0 107.29 173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.76 -23.5 19.18 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 CA-C-N 119.882 1.841 . . . . 0.0 112.934 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 m 39.95 81.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.265 1.826 . . . . 0.0 112.303 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.1 m 58.67 89.32 0.06 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 159.317 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 m -125.45 104.59 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.631 1.572 . . . . 0.0 108.802 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 t -146.97 97.49 2.9 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.551 1.94 . . . . 0.0 106.338 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.86 -39.0 3.0 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.682 1.134 . . . . 0.0 111.934 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.0 m -81.93 142.85 32.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.619 1.709 . . . . 0.0 108.852 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.1 m -141.48 164.94 28.87 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.885 1.274 . . . . 0.0 108.043 168.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.68 -152.13 48.76 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -46.86 -49.88 19.5 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 125.682 1.593 . . . . 0.0 112.004 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.55 -38.52 74.89 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.544 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.83 65.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.782 0.719 . . . . 0.0 111.759 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -58.13 -48.73 79.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.911 0.778 . . . . 0.0 109.48 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.62 -41.86 92.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.344 1.457 . . . . 0.0 111.39 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.02 -50.16 73.59 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 123.764 0.826 . . . . 0.0 109.51 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.72 -42.68 97.88 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.11 -52.12 65.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.681 0.793 . . . . 0.0 109.419 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.18 -38.66 85.77 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.242 1.017 . . . . 0.0 111.787 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.7 m -54.6 -42.53 71.22 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.907 0.883 . . . . 0.0 109.9 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -67.51 -61.44 1.89 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.369 0.668 . . . . 0.0 110.061 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -21.97 64.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -170.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -122.65 21.58 10.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.138 1.775 . . . . 0.0 111.104 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.56 -55.07 17.81 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.309 1.044 . . . . 0.0 112.228 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -71.11 -16.08 62.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.554 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.48 -16.1 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.544 1.066 . . . . 0.0 113.39 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.73 40.26 6.0 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.58 158.85 4.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.834 -0.804 . . . . 0.0 110.89 170.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -147.35 -29.86 0.34 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.115 0.966 . . . . 0.0 112.564 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.64 -167.02 40.04 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.74 149.27 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.43 119.48 28.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 168.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -82.67 135.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -109.39 120.58 42.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 160.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.37 121.92 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 157.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 p -120.29 164.75 20.95 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 92.9 Cg_endo -74.29 2.85 5.77 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.678 2.252 . . . . 0.0 111.877 173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -112.82 -41.75 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.37 1.468 . . . . 0.0 110.545 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -161.83 173.37 14.67 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.077 1.351 . . . . 0.0 109.965 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.4 m -74.79 146.38 42.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 154.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -127.45 143.55 51.18 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.435 2.294 . . . . 0.0 105.114 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -132.46 117.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.84 95.98 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.49 125.42 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.36 113.97 25.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.274 1.83 . . . . 0.0 106.299 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.42 171.07 14.57 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 109.209 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -81.87 -17.99 45.38 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.388 -1.445 . . . . 0.0 112.886 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -133.05 61.65 1.67 Allowed 'General case' 0 CA--C 1.523 -0.066 0 C-N-CA 124.74 1.216 . . . . 0.0 110.214 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -48.86 -41.69 34.05 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.894 0.877 . . . . 0.0 112.112 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.2 83.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.625 0.37 . . . . 0.0 111.431 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -72.27 -43.48 64.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.302 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.37 -31.58 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.077 0.951 . . . . 0.0 110.976 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.96 -32.37 70.58 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.069 -1.019 . . . . 0.0 111.767 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.9 169.74 7.57 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.224 1.392 . . . . 0.0 111.665 -166.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.19 125.68 24.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.519 1.528 . . . . 0.0 108.679 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt 42.63 43.63 3.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.153 1.781 . . . . 0.0 111.767 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.0 66.57 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.886 -0.952 . . . . 0.0 114.948 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -52.93 -51.46 61.25 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.753 1.776 . . . . 0.0 111.175 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -34.65 62.95 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.881 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -65.82 -36.71 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.194 1.361 . . . . 0.0 111.24 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -65.15 -41.16 94.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 120.756 -1.215 . . . . 0.0 111.42 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -56.68 -60.11 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.057 0.943 . . . . 0.0 109.017 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.8 mt -57.27 -35.9 70.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.349 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -55.58 -52.38 63.93 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.594 1.088 . . . . 0.0 109.933 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.91 85.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.688 0.676 . . . . 0.0 111.294 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -64.13 -46.3 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 117.633 -1.175 . . . . 0.0 109.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.92 -46.29 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 120.568 1.531 . . . . 0.0 109.365 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -53.55 -39.91 65.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.085 0.554 . . . . 0.0 110.922 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -85.22 -36.65 20.82 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 118.964 0.802 . . . . 0.0 111.459 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.65 -45.42 94.09 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.807 0.843 . . . . 0.0 109.16 178.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 96.6 m-85 -106.77 -2.77 21.17 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.905 1.282 . . . . 0.0 112.69 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.27 35.57 63.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.687 1.137 . . . . 0.0 113.573 172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.13 133.7 68.51 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 118.371 1.086 . . . . 0.0 111.453 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.41 138.96 87.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.121 2.548 . . . . 0.0 111.185 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.0 111.07 9.84 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.169 0.987 . . . . 0.0 110.16 -173.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.76 -2.18 55.65 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.277 -0.735 . . . . 0.0 112.694 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 m -109.66 6.5 23.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.519 1.128 . . . . 0.0 112.081 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.68 163.71 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.749 1.219 . . . . 0.0 107.836 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.66 157.26 43.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.37 1.468 . . . . 0.0 107.43 159.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -124.39 135.49 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.07 165.25 19.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.016 1.726 . . . . 0.0 108.241 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.77 111.16 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -116.53 154.15 30.93 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.045 1.338 . . . . 0.0 109.009 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -110.69 135.36 51.41 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.633 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.84 130.4 36.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.2 92.48 0.41 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 t -63.29 142.65 58.31 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.962 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -174.27 142.54 0.81 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.657 1.983 . . . . 0.0 107.985 162.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.27 95.04 0.17 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -150.44 152.94 35.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.916 1.358 . . . . 0.0 112.077 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.14 97.82 0.17 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.52 168.31 25.08 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 120.069 1.934 . . . . 0.0 109.444 165.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -140.49 152.58 45.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 162.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.36 -3.92 2.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.97 2.108 . . . . 0.0 112.082 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.526 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 176.229 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.385 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -137.05 125.22 23.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.887 2.075 . . . . 0.0 106.097 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.98 140.58 1.58 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.16 148.66 2.45 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 -172.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.11 25.47 5.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 112.942 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 m -88.92 121.88 31.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.181 0.992 . . . . 0.0 113.491 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.4 -161.97 41.45 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 124.635 1.112 . . . . 0.0 112.908 158.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.496 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 35.6 t80 -50.59 -48.9 57.54 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.487 1.115 . . . . 0.0 110.779 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -54.68 -47.36 73.73 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.411 -0.805 . . . . 0.0 109.768 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.89 -53.44 50.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.464 1.105 . . . . 0.0 111.917 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.83 -45.77 59.69 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.202 0.601 . . . . 0.0 110.439 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 12.9 tp -69.23 -41.04 77.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.746 1.219 . . . . 0.0 110.868 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -50.37 74.25 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.983 1.313 . . . . 0.0 108.758 176.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -66.38 -31.99 73.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.506 1.922 . . . . 0.0 112.127 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.97 -62.6 1.35 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.592 1.157 . . . . 0.0 108.533 171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -55.8 -29.6 59.98 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.383 1.473 . . . . 0.0 112.389 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -51.51 -45.16 62.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.233 1.013 . . . . 0.0 111.856 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -74.27 -58.27 3.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -30.44 15.04 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 125.9 1.68 . . . . 0.0 113.402 -169.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -128.52 22.34 5.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.843 1.257 . . . . 0.0 111.566 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.629 0.771 . . . . 0.0 110.054 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.1 -26.09 68.06 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.572 1.149 . . . . 0.0 110.446 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.75 -25.79 65.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.52 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.51 25.59 4.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.43 -1.205 . . . . 0.0 114.077 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -54.41 148.95 10.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.709 1.604 . . . . 0.0 113.646 -173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m -128.46 -41.51 1.53 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 112.453 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.16 -166.36 39.59 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 156.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.46 138.73 50.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 160.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.95 124.52 65.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.29 121.98 46.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.86 95.87 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 p -78.38 166.04 45.79 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.18 -2.55 12.7 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.225 1.283 . . . . 0.0 112.921 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 p -103.73 -51.05 3.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.595 1.089 . . . . 0.0 109.606 -166.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -157.44 162.97 38.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.758 2.023 . . . . 0.0 107.757 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.1 m -73.11 139.69 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -110.49 144.01 39.95 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.4 mt -135.31 123.41 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.5 101.54 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.5 mt -68.15 123.23 21.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.4 mt -96.5 118.3 32.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.69 -177.92 6.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.689 0.756 . . . . 0.0 111.504 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 p -86.49 -25.36 25.18 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -129.67 78.46 1.85 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.68 1.192 . . . . 0.0 107.96 -165.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -40.7 72.81 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.247 1.019 . . . . 0.0 111.346 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -69.51 -22.08 63.62 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.691 -0.631 . . . . 0.0 111.63 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -72.76 -46.43 53.44 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.43 -36.55 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.146 1.378 . . . . 0.0 111.678 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.2 mt -65.39 -42.67 92.38 Favored 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 120.916 -1.115 . . . . 0.0 109.34 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -179.57 29.42 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-O 122.976 1.32 . . . . 0.0 110.673 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.51 116.81 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.895 2.078 . . . . 0.0 109.156 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt 52.68 8.1 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.776 2.03 . . . . 0.0 115.305 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 18.72 11.24 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 120.695 1.588 . . . . 0.0 113.493 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -60.77 -57.26 13.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.489 2.145 . . . . 0.0 112.437 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -67.44 -33.61 75.5 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.916 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.6 -44.02 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.151 0.887 . . . . 0.0 110.456 173.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -69.13 -38.88 79.06 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.113 -0.992 . . . . 0.0 111.228 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.65 -49.12 76.42 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.759 0.709 . . . . 0.0 109.402 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 63' ' ' VAL . 18.0 mt -59.69 -29.09 67.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.647 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 m -60.77 -56.82 16.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.596 1.089 . . . . 0.0 108.922 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.67 73.04 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.763 1.225 . . . . 0.0 111.978 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.3 p -59.17 -51.9 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.539 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.83 -43.88 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.656 1.571 . . . . 0.0 109.778 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -53.05 -44.04 67.14 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.603 0.761 . . . . 0.0 110.846 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -72.71 -52.75 13.92 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.902 0.774 . . . . 0.0 110.875 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -54.84 -24.17 21.83 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.667 1.987 . . . . 0.0 112.589 -174.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 96.3 m-85 -128.97 -3.37 5.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.488 1.115 . . . . 0.0 112.961 -175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.83 7.78 85.26 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.754 1.169 . . . . 0.0 114.924 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -61.22 143.62 92.35 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.389 1.595 . . . . 0.0 111.948 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -63.44 163.67 23.05 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.472 2.115 . . . . 0.0 110.447 162.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -68.83 141.39 55.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 164.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.44 -40.65 2.42 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.681 1.134 . . . . 0.0 113.661 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.7 m -67.47 -4.78 12.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.943 1.372 . . . . 0.0 112.922 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.91 141.38 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 163.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.96 130.2 48.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.33 137.89 39.98 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -130.47 167.49 18.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 127.612 2.365 . . . . 0.0 109.209 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.31 120.19 14.41 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.142 1.777 . . . . 0.0 108.915 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -119.14 148.56 42.94 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.717 1.207 . . . . 0.0 110.502 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -74.7 147.73 41.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.403 0.62 . . . . 0.0 109.839 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.94 159.65 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.904 1.682 . . . . 0.0 107.982 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.7 167.88 12.97 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.844 1.257 . . . . 0.0 111.587 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 85' ' ' ARG . 2.6 m 59.58 -177.47 0.09 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.352 1.061 . . . . 0.0 110.282 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' H ' HG22 ' A' ' 84' ' ' THR . 25.0 ttm180 42.73 67.25 0.64 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.685 1.994 . . . . 0.0 111.695 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.68 97.82 1.98 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -104.83 -70.07 0.79 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.761 0.825 . . . . 0.0 109.138 170.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.74 169.87 28.92 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.0 122.72 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.984 2.456 . . . . 0.0 107.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.2 m -135.3 90.46 2.62 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.67 156.84 32.46 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.974 0.91 . . . . 0.0 109.402 -173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.568 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.827 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -57.24 136.49 56.49 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.481 1.112 . . . . 0.0 109.949 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.57 144.78 50.86 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.97 151.62 19.88 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.008 0.813 . . . . 0.0 111.629 -167.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 m -68.49 106.93 2.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.091 0.956 . . . . 0.0 110.031 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -69.18 163.19 25.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.441 0.296 . . . . 0.0 110.772 162.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.16 -87.23 0.02 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 126.277 1.894 . . . . 0.0 110.934 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -33.04 -51.54 0.32 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.13 2.972 . . . . 0.0 113.784 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.22 -35.58 73.88 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.44 -49.79 14.08 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.178 0.991 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.22 -47.78 65.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.445 0.641 . . . . 0.0 109.801 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.856 -0.527 . . . . 0.0 110.824 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.04 -57.5 12.8 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.821 1.248 . . . . 0.0 110.007 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.03 -34.8 78.5 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 118.754 0.706 . . . . 0.0 111.855 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.7 -64.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.687 169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.18 80.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.574 1.55 . . . . 0.0 111.717 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.6 m -49.88 -37.38 30.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.616 1.166 . . . . 0.0 110.935 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.79 -16.63 28.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.61 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.68 -16.47 28.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.428 1.091 . . . . 0.0 112.457 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.3 mt -136.97 36.63 2.58 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.38 1.472 . . . . 0.0 112.008 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.89 -61.23 2.51 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.051 -1.031 . . . . 0.0 111.774 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.75 -15.86 60.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.801 0.84 . . . . 0.0 112.081 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.12 -15.14 62.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.067 1.347 . . . . 0.0 112.774 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.88 32.75 28.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.167 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -52.96 144.57 14.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.519 0.66 . . . . 0.0 111.213 168.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' HG11 ' A' ' 82' ' ' VAL . 72.1 m -126.58 -47.78 1.55 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.395 1.478 . . . . 0.0 110.428 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.87 -162.94 29.68 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.55 158.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 121.083 -1.245 . . . . 0.0 107.969 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -128.36 157.69 40.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.652 1.981 . . . . 0.0 109.277 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.07 134.65 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.508 1.123 . . . . 0.0 111.231 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -121.45 161.85 21.48 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.673 1.189 . . . . 0.0 110.124 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.76 133.71 65.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.993 1.717 . . . . 0.0 106.493 164.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 64.8 p -122.37 170.53 7.75 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.325 1.45 . . . . 0.0 109.095 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 73.7 Cg_endo -74.44 4.82 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.593 2.196 . . . . 0.0 112.651 166.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.3 p -108.22 -54.9 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.443 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -159.01 169.28 24.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.592 1.087 . . . . 0.0 111.689 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.4 m -68.0 151.91 46.35 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -135.39 135.08 40.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.9 124.15 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.68 107.42 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.47 1.108 . . . . 0.0 108.582 -166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.17 142.93 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.65 115.55 30.35 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 163.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.58 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.988 0.813 . . . . 0.0 110.546 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.7 p -78.64 -49.02 13.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 120.656 -1.278 . . . . 0.0 111.283 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -99.71 74.28 1.85 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -51.89 -35.35 44.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.691 -0.631 . . . . 0.0 112.659 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -77.09 -18.61 57.88 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.297 1.408 . . . . 0.0 113.067 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -65.12 -59.94 3.56 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 162.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -53.58 -43.83 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.287 1.035 . . . . 0.0 111.751 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.21 -41.32 77.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.48 -0.762 . . . . 0.0 110.816 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.84 178.76 34.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.465 0.481 . . . . 0.0 112.111 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.85 119.15 7.16 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.62 0.768 . . . . 0.0 110.204 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.87 32.16 5.22 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.753 1.621 . . . . 0.0 112.356 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.77 58.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.013 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -51.65 -63.43 1.14 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.164 1.482 . . . . 0.0 113.024 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -39.63 94.71 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 117.525 -1.226 . . . . 0.0 109.732 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.73 -43.53 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.265 1.393 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -68.3 -38.27 81.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.03 -1.044 . . . . 0.0 111.476 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.15 -51.77 66.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.9 mt -62.71 -26.47 68.69 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.277 -1.344 . . . . 0.0 111.752 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -60.82 -50.45 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 120.117 1.326 . . . . 0.0 108.408 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.26 85.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.689 0.796 . . . . 0.0 112.286 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 60' ' ' LEU . 2.9 p -68.45 -39.07 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 117.336 -1.316 . . . . 0.0 110.142 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.32 -43.6 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 121.532 1.969 . . . . 0.0 109.961 173.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -54.64 -40.36 68.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.927 0.891 . . . . 0.0 111.073 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -67.62 -65.53 0.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.494 1.043 . . . . 0.0 108.849 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -38.89 69.0 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.28 2.232 . . . . 0.0 111.754 -167.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.64 -4.4 17.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.623 1.169 . . . . 0.0 111.185 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.26 51.38 57.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.638 1.108 . . . . 0.0 110.908 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -79.12 153.8 77.25 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.638 0.375 . . . . 0.0 110.577 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -72.42 117.03 4.94 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.703 2.268 . . . . 0.0 108.319 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 1.3 pm0 -57.37 143.42 40.1 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.582 1.153 . . . . 0.0 110.075 172.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.77 -46.43 3.65 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.948 1.261 . . . . 0.0 111.085 -168.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m -83.56 17.28 2.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.366 1.466 . . . . 0.0 114.279 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.45 136.07 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 169.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.81 135.07 47.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 128.156 2.582 . . . . 0.0 108.155 174.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.3 134.55 52.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.37 177.29 6.82 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.245 2.218 . . . . 0.0 108.838 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 158.84 43.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.93 153.24 46.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.759 2.424 . . . . 0.0 106.353 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -95.5 135.97 36.48 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' CB ' ' A' ' 26' ' ' SER . 21.2 m -77.76 144.11 11.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -168.85 -168.67 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.41 1.484 . . . . 0.0 107.984 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -17.13 6.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 113.0 2.03 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 124.273 1.029 . . . . 0.0 109.514 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.51 150.26 44.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 142.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.8 m -128.58 168.37 15.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.856 2.462 . . . . 0.0 108.177 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.23 -153.92 7.22 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 118.855 0.752 . . . . 0.0 114.213 -160.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -67.36 96.08 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.731 2.954 . . . . 0.0 110.202 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.7 t -94.58 -66.33 0.92 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.561 1.944 . . . . 0.0 107.344 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m 55.87 -175.87 0.05 OUTLIER 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.894 0.878 . . . . 0.0 110.569 -151.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 179.057 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.556 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -62.79 -28.26 69.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.692 -166.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m 38.67 55.69 1.92 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.52 1.928 . . . . 0.0 111.862 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.25 -173.58 36.34 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.546 -165.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.6 m 69.83 100.62 0.06 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.694 1.997 . . . . 0.0 108.593 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -42.35 136.24 2.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.887 2.475 . . . . 0.0 109.792 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.31 -170.69 38.82 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -166.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 76.9 t80 -55.56 -53.23 59.04 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.244 0.618 . . . . 0.0 110.805 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.94 -38.1 81.45 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.909 -169.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 -55.01 31.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.241 0.616 . . . . 0.0 110.622 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.49 -42.85 78.98 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.315 0.507 . . . . 0.0 111.578 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.5 tp -71.37 -38.5 71.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.548 0.339 . . . . 0.0 110.636 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -59.93 -51.53 69.28 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.057 0.943 . . . . 0.0 108.634 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.19 -37.8 81.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.877 1.271 . . . . 0.0 112.371 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -62.15 -57.01 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.188 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.05 -30.35 71.43 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.686 1.195 . . . . 0.0 111.939 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.9 m -49.67 -40.22 39.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.185 1.394 . . . . 0.0 111.118 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -91.18 -45.87 8.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.448 0.699 . . . . 0.0 110.424 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -55.98 -30.39 61.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.409 0.684 . . . . 0.0 112.613 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.8 mt -125.53 22.45 7.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.015 1.326 . . . . 0.0 110.703 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.18 -63.48 1.14 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.014 0.925 . . . . 0.0 110.222 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.05 -15.51 61.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.521 0.329 . . . . 0.0 111.836 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -35.65 74.94 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.74 28.41 1.42 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.907 -0.94 . . . . 0.0 113.818 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -53.29 153.63 3.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.526 1.163 . . . . 0.0 112.628 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 m -142.42 -34.35 0.45 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.972 1.309 . . . . 0.0 112.405 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.77 -169.57 42.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.064 0.847 . . . . 0.0 111.075 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.4 149.75 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.76 159.67 34.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.867 1.267 . . . . 0.0 108.287 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.1 127.81 18.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.673 1.189 . . . . 0.0 110.904 -163.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -126.03 161.95 26.39 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.796 1.238 . . . . 0.0 108.675 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.46 115.92 7.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 51.1 p -92.17 172.44 6.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 123.813 0.845 . . . . 0.0 108.773 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 51.8 Cg_endo -70.94 20.67 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.936 2.424 . . . . 0.0 112.124 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.9 p -128.07 -44.93 1.42 Allowed 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 120.842 -1.161 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -162.11 172.71 15.41 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.182 0.901 . . . . 0.0 111.122 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 m -71.51 157.43 38.03 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 159.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.81 128.42 34.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.168 1.787 . . . . 0.0 107.195 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.0 mt -117.04 124.09 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.92 104.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.25 133.31 32.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.71 117.03 33.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.047 . . . . 0.0 106.756 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.54 167.49 23.57 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -31.47 65.82 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.909 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -132.35 81.33 1.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -167.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.1 p -52.58 -43.73 65.46 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.772 -0.58 . . . . 0.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.45 -30.11 62.47 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.325 1.45 . . . . 0.0 112.734 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -70.14 -52.2 25.46 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.618 0.645 . . . . 0.0 109.478 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.94 -34.19 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.83 1.252 . . . . 0.0 111.073 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 mt -68.86 -35.19 76.62 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.474 -0.766 . . . . 0.0 111.3 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.65 -179.31 26.57 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.835 0.731 . . . . 0.0 111.745 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -54.1 109.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.937 1.695 . . . . 0.0 109.683 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt 46.58 43.34 12.35 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.783 1.233 . . . . 0.0 111.966 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 11.5 71.67 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.731 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -40.89 -64.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.895 1.678 . . . . 0.0 111.903 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.26 -47.08 68.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.499 -172.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.3 tt -59.22 -41.78 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.01 1.277 . . . . 0.0 110.371 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.3 -45.48 80.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.008 0.923 . . . . 0.0 111.463 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.64 -55.14 38.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.173 0.589 . . . . 0.0 109.819 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.77 -33.13 69.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.579 1.551 . . . . 0.0 111.328 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.2 m -55.13 -50.49 69.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.686 1.13 . . . . 0.0 109.28 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.65 96.31 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.556 0.617 . . . . 0.0 111.963 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.6 t -58.62 -54.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 t -59.1 -41.31 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.883 2.073 . . . . 0.0 110.672 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -61.47 -22.15 64.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.361 0.982 . . . . 0.0 112.321 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.82 -50.73 5.22 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.503 -0.748 . . . . 0.0 110.859 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.92 62.03 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.231 1.412 . . . . 0.0 110.294 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.73 7.98 28.66 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.189 1.796 . . . . 0.0 111.041 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.96 23.13 37.48 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 125.352 1.453 . . . . 0.0 114.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -56.6 147.39 51.06 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.349 1.075 . . . . 0.0 111.583 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.2 128.87 30.31 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.627 2.218 . . . . 0.0 110.6 166.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 153.22 28.43 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 168.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.7 -44.43 0.63 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.837 2.161 . . . . 0.0 114.098 -164.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -91.08 18.24 7.05 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.77 1.628 . . . . 0.0 115.152 -166.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.45 139.89 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.55 150.67 50.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.282 0.492 . . . . 0.0 110.592 163.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.2 126.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -122.42 173.54 7.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.36 1.464 . . . . 0.0 109.807 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.32 109.75 5.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.461 1.105 . . . . 0.0 108.345 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -104.06 142.27 34.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -76.35 149.76 36.96 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 t -70.61 -10.08 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.083 0.953 . . . . 0.0 112.477 168.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 54.89 -131.42 1.95 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.282 1.433 . . . . 0.0 110.943 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 m -129.88 46.05 2.71 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.106 1.321 . . . . 0.0 109.555 -170.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 154.68 6.33 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.47 -0.769 . . . . 0.0 111.373 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.94 77.76 1.13 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.501 1.048 . . . . 0.0 110.999 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.8 m 56.81 174.53 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.539 1.535 . . . . 0.0 113.218 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 133.58 179.47 16.4 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.11 142.59 38.4 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.177 2.584 . . . . 0.0 111.026 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m 59.91 169.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.127 2.571 . . . . 0.0 113.792 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.9 m -141.2 172.61 12.44 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.647 1.579 . . . . 0.0 109.83 -171.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.808 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 166.754 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 m -117.71 -60.05 1.85 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.949 0.874 . . . . 0.0 108.693 164.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t 64.92 -71.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.134 1.774 . . . . 0.0 109.818 -170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.41 164.65 22.38 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.031 2.729 . . . . 0.0 107.5 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 m -154.3 140.96 18.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.031 1.332 . . . . 0.0 108.12 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -62.0 153.71 28.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.508 1.147 . . . . 0.0 108.893 167.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.89 161.05 30.39 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 106.031 -2.828 . . . . 0.0 106.031 -173.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 45.9 t80 -51.64 -46.06 63.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -61.97 -36.22 80.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -171.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.81 -60.24 3.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.949 1.299 . . . . 0.0 109.625 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -55.39 -40.66 71.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.084 0.554 . . . . 0.0 111.363 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.466 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.0 tp -69.3 -41.37 76.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.325 0.65 . . . . 0.0 111.031 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.81 -54.45 47.0 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.226 0.466 . . . . 0.0 109.84 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -57.3 -35.09 69.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.779 0.432 . . . . 0.0 112.145 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -67.22 -58.1 5.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.487 1.115 . . . . 0.0 110.872 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -61.7 -33.27 73.71 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.43 1.492 . . . . 0.0 111.861 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -47.97 -38.64 17.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.301 1.44 . . . . 0.0 111.321 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -89.09 -40.1 13.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.817 0.735 . . . . 0.0 111.437 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -61.66 -20.69 63.7 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.5 mt -133.02 24.64 4.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.791 1.636 . . . . 0.0 110.856 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.92 -56.32 20.87 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.88 1.272 . . . . 0.0 111.453 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -61.49 -45.28 94.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.574 1.15 . . . . 0.0 110.47 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.98 -31.28 72.44 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.913 0.885 . . . . 0.0 112.835 -163.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.61 41.05 1.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 119.338 -0.701 . . . . 0.0 113.775 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -49.93 154.85 1.0 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.612 0.765 . . . . 0.0 111.33 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.25 -45.43 0.77 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.534 1.534 . . . . 0.0 109.525 172.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 176.99 -164.89 34.6 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.47 151.64 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 121.457 -1.026 . . . . 0.0 108.646 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -121.99 151.48 40.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.835 0.826 . . . . 0.0 109.27 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.6 p -125.43 148.75 29.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.251 1.42 . . . . 0.0 108.395 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -132.79 153.48 51.2 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.1 t -98.37 135.75 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 155.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -120.89 166.08 16.82 Favored Pre-proline 0 C--O 1.243 0.717 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.7 Cg_endo -72.02 0.91 6.5 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.651 2.234 . . . . 0.0 111.899 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -113.42 -47.33 3.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.486 1.039 . . . . 0.0 111.648 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -162.21 172.97 14.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.062 0.847 . . . . 0.0 110.332 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.7 m -68.96 150.28 47.89 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 163.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -124.98 143.65 50.78 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.4 mt -129.72 122.71 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 99.43 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.97 132.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.63 108.5 20.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.349 1.859 . . . . 0.0 106.38 164.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 172.26 13.02 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 p -83.33 -37.49 23.32 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.873 -0.517 . . . . 0.0 111.43 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -117.11 64.71 0.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.634 -1.291 . . . . 0.0 108.035 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -43.83 -48.62 8.27 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.54 2.336 . . . . 0.0 113.169 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -59.15 -34.2 71.8 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.136 0.88 . . . . 0.0 111.859 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.58 -32.29 36.58 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.205 -0.934 . . . . 0.0 111.212 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.26 -42.35 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.875 0.87 . . . . 0.0 109.453 169.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 mt -61.26 -44.52 97.11 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.89 45.52 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 124.634 1.111 . . . . 0.0 110.684 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -57.3 114.91 2.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.733 1.213 . . . . 0.0 110.513 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 55.24 32.98 19.66 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.166 0.987 . . . . 0.0 110.897 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.34 22.57 77.35 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.873 -0.959 . . . . 0.0 112.837 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -52.87 63.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.89 1.845 . . . . 0.0 111.636 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -43.91 91.36 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 116.759 -1.591 . . . . 0.0 109.533 -175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.8 -40.97 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.212 1.369 . . . . 0.0 110.991 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.47 -44.53 82.44 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.914 1.234 . . . . 0.0 112.765 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -54.52 45.96 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.123 0.874 . . . . 0.0 108.799 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' HA ' HG12 ' A' ' 63' ' ' VAL . 57.0 mt -60.12 -27.31 66.93 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.379 1.472 . . . . 0.0 112.491 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.7 m -62.84 -59.53 4.73 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.661 1.119 . . . . 0.0 109.579 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.4 89.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.177 0.991 . . . . 0.0 111.262 -171.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 60' ' ' LEU . 14.7 p -57.62 -50.43 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 117.758 -1.115 . . . . 0.0 108.686 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.81 -49.48 83.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 124.644 1.178 . . . . 0.0 109.495 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -49.56 -46.38 48.75 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.538 1.135 . . . . 0.0 110.623 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -73.06 -53.56 10.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -49.9 -55.52 14.09 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 111.122 -176.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CE2' ' HD2' ' A' ' 67' ' ' ARG . 92.5 m-85 -89.99 2.11 55.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.767 2.027 . . . . 0.0 112.429 -172.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.43 51.11 44.71 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -74.47 149.99 86.76 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 117.496 0.648 . . . . 0.0 109.433 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.52 124.66 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.697 1.598 . . . . 0.0 109.155 161.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.55 153.62 27.08 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.76 -14.44 3.52 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.598 0.618 . . . . 0.0 113.446 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.8 m -133.04 28.81 4.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.765 1.283 . . . . 0.0 112.236 -161.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.94 145.71 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.091 1.356 . . . . 0.0 107.803 159.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -128.29 148.34 50.65 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.118 1.367 . . . . 0.0 109.266 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.35 137.7 51.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.89 1.276 . . . . 0.0 109.02 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -134.5 168.13 19.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.858 2.463 . . . . 0.0 109.551 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 109.86 6.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.452 1.901 . . . . 0.0 109.018 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -104.13 156.27 18.02 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.616 1.166 . . . . 0.0 109.122 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.69 145.6 27.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.661 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.07 156.51 7.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.26 -170.75 0.76 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.182 1.393 . . . . 0.0 108.824 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.8 -23.63 0.85 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 165.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -164.97 161.66 20.07 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.983 1.265 . . . . 0.0 108.668 161.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.15 164.66 25.84 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.515 1.531 . . . . 0.0 109.571 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 t -160.24 145.51 14.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.96 80.91 0.36 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.84 141.98 24.89 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.788 1.659 . . . . 0.0 110.42 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 m 87.29 161.47 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.793 2.837 . . . . 0.0 110.61 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 p -143.87 95.11 2.68 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.208 0 N-CA-C 104.852 -3.299 . . . . 0.0 104.852 -179.514 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.786 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -85.16 156.9 20.82 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 166.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m -153.89 170.12 21.79 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.494 1.118 . . . . 0.0 109.292 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.27 109.61 0.29 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 t -70.82 -61.16 1.87 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -143.81 85.14 1.81 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 118.543 0.611 . . . . 0.0 111.51 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.84 135.98 7.3 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -52.44 -53.91 39.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.211 0.505 . . . . 0.0 110.56 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -61.2 -34.02 74.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.464 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.98 -59.06 4.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.505 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -55.03 -38.57 68.13 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 118.787 0.721 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.06 -43.81 77.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.456 0.702 . . . . 0.0 110.612 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.15 -43.68 98.3 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 123.97 0.908 . . . . 0.0 109.932 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.17 -25.41 63.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.799 1.24 . . . . 0.0 112.57 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 19' ' ' GLU . 37.0 t80 -72.64 -64.66 0.91 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.393 1.477 . . . . 0.0 108.647 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.92 -43.7 60.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.297 2.239 . . . . 0.0 111.883 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -52.77 -34.04 51.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.071 0.851 . . . . 0.0 111.411 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -91.01 -41.25 11.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.35 -0.834 . . . . 0.0 110.103 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 15' ' ' PHE . 6.6 mm-40 -56.97 -42.92 81.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.749 1.22 . . . . 0.0 112.724 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -115.68 26.63 9.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.514 1.526 . . . . 0.0 109.731 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.38 61.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.125 1.37 . . . . 0.0 111.905 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -79.68 -14.56 58.68 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.262 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.99 -23.04 17.02 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -159.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 35.85 3.76 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 119.072 0.851 . . . . 0.0 112.687 -168.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.74 162.49 6.61 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 118.185 0.993 . . . . 0.0 109.361 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 m -136.73 -60.84 0.69 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.67 -167.85 29.9 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.91 155.16 17.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -125.67 164.12 21.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.011 0.91 . . . . 0.0 109.141 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.26 139.58 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.102 1.761 . . . . 0.0 107.357 -170.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -132.82 138.62 47.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 106.96 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.2 t -136.16 116.53 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 36.5 p -120.9 176.69 1.75 Allowed Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.56 0.744 . . . . 0.0 110.361 -164.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 61.3 Cg_endo -73.12 3.75 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 121.727 1.618 . . . . 0.0 112.452 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.9 p -113.44 -52.1 2.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.268 1.395 . . . . 0.0 111.145 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -160.61 174.71 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.364 1.465 . . . . 0.0 111.198 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -82.04 151.59 27.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.505 -0.747 . . . . 0.0 109.062 163.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.14 142.79 34.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.594 1.958 . . . . 0.0 108.018 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.2 mt -141.13 126.03 18.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.4 105.07 15.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -173.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -70.43 130.17 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.8 mt -97.87 115.76 28.73 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.6 169.87 16.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.047 0.84 . . . . 0.0 111.015 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.8 p -70.5 -31.81 69.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.257 -0.902 . . . . 0.0 111.7 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -134.32 85.39 2.19 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 p -53.36 -38.56 63.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.106 0.962 . . . . 0.0 111.454 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -57.97 -44.31 87.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.616 1.167 . . . . 0.0 111.984 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -68.83 -40.62 79.36 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.046 0.538 . . . . 0.0 109.578 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -46.59 93.77 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 C-N-CA 122.978 0.511 . . . . 0.0 109.683 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.53 -36.22 70.94 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.994 -1.066 . . . . 0.0 111.086 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 179.88 50.98 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.45 109.52 0.5 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.032 1.333 . . . . 0.0 109.277 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.6 mttm 40.22 46.16 1.87 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.439 1.496 . . . . 0.0 112.765 -173.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.99 9.3 82.72 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.17 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -46.08 78.43 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.57 2.185 . . . . 0.0 113.008 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -45.21 90.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.626 1.103 . . . . 0.0 110.678 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tt -67.55 -34.99 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.456 1.026 . . . . 0.0 111.111 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -57.36 -50.96 71.29 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.575 -0.703 . . . . 0.0 109.889 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -61.07 2.53 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.346 1.058 . . . . 0.0 109.705 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.0 mt -57.74 -34.97 70.08 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.525 -174.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 m -57.64 -48.08 80.44 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.437 1.017 . . . . 0.0 109.484 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.77 -42.76 73.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.059 0.944 . . . . 0.0 112.005 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.3 p -66.75 -45.75 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.647 1.112 . . . . 0.0 109.736 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -55.67 -45.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.084 1.311 . . . . 0.0 109.511 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.71 -46.42 67.35 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.123 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -71.9 -50.66 27.3 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.075 0.852 . . . . 0.0 111.666 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -39.79 86.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.415 1.086 . . . . 0.0 110.787 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.72 3.77 24.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 111.737 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.91 26.75 71.46 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.072 0.844 . . . . 0.0 112.823 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -67.77 145.51 98.05 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 118.35 1.075 . . . . 0.0 109.595 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.22 165.66 16.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.795 2.33 . . . . 0.0 110.737 160.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -88.38 147.98 24.47 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.98 -45.99 2.59 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.403 1.478 . . . . 0.0 112.454 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 m -72.04 8.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.257 1.823 . . . . 0.0 112.501 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.87 126.0 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 162.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 146.61 38.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 169.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -120.55 140.71 51.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -132.93 165.32 24.94 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.47 1.908 . . . . 0.0 108.569 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.59 109.08 5.59 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -111.38 155.01 23.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.554 1.541 . . . . 0.0 110.371 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.97 141.01 29.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.517 0.675 . . . . 0.0 112.348 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.43 154.45 8.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 52.3 38.69 25.56 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.09 1.756 . . . . 0.0 112.099 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.8 m -64.76 136.47 56.96 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.652 1.181 . . . . 0.0 108.941 169.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.9 ptt85 -159.05 29.98 0.21 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.679 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.13 -123.81 7.97 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 125.78 1.657 . . . . 0.0 109.565 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 39.76 30.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.411 1.084 . . . . 0.0 113.734 169.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -108.63 85.19 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.321 -1.266 . . . . 0.0 110.631 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -65.13 97.66 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.321 2.681 . . . . 0.0 108.579 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -132.64 119.98 21.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -143.2 98.63 3.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.601 1.56 . . . . 0.0 106.859 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 105.323 -3.111 . . . . 0.0 105.323 -154.498 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.474 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.35 77.76 0.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.995 1.718 . . . . 0.0 110.407 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -74.72 174.31 9.3 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.839 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.35 -110.26 0.65 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.804 1.669 . . . . 0.0 112.685 170.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.7 m -124.9 140.12 53.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.393 1.477 . . . . 0.0 108.39 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 t -152.73 147.38 26.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.84 164.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.29 147.79 18.69 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 125.411 1.481 . . . . 0.0 111.405 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -53.58 -49.32 67.98 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.12 1.368 . . . . 0.0 109.8 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -62.11 -29.65 70.47 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.426 -1.273 . . . . 0.0 110.625 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.61 -58.02 4.46 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 120.5 1.5 . . . . 0.0 110.387 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.53 -45.16 73.33 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.915 0.486 . . . . 0.0 110.555 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.83 -43.3 84.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.671 0.388 . . . . 0.0 110.455 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -57.26 -51.52 69.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.607 0.763 . . . . 0.0 109.447 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.18 -52.94 62.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.404 0.682 . . . . 0.0 111.028 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -53.27 -48.52 68.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.412 1.085 . . . . 0.0 111.145 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.41 -38.68 81.48 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.58 1.552 . . . . 0.0 111.615 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -51.71 -47.29 64.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -66.97 -47.17 72.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.533 1.133 . . . . 0.0 111.821 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -73.66 -12.83 60.86 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.999 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.17 15.45 8.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.393 1.477 . . . . 0.0 113.499 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.53 27.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.324 1.05 . . . . 0.0 112.064 -172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -87.81 -26.86 22.62 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.53 -34.74 76.04 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.738 0.699 . . . . 0.0 110.31 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 65.25 0.53 Allowed Glycine 0 CA--C 1.505 -0.583 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -67.84 174.2 3.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.915 1.34 . . . . 0.0 110.266 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -164.4 -23.99 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.06 1.344 . . . . 0.0 112.046 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.15 -161.78 29.82 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -161.3 155.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -125.94 160.22 30.56 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.675 1.59 . . . . 0.0 108.631 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.91 135.4 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 126.053 1.741 . . . . 0.0 108.287 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -132.62 122.74 25.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.13 92.76 2.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 43.7 p -84.07 176.83 3.39 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.702 1.601 . . . . 0.0 109.433 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 85.6 Cg_endo -76.38 6.08 4.23 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.052 1.835 . . . . 0.0 113.21 165.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -116.6 -57.97 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.68 1.582 . . . . 0.0 112.169 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -161.67 149.58 15.0 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.056 1.342 . . . . 0.0 108.055 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -70.93 138.64 50.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -110.42 137.37 48.22 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.97 122.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.87 103.81 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.01 145.51 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -115.22 112.04 21.87 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.47 165.75 26.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.399 0.679 . . . . 0.0 111.522 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.9 p -85.59 -21.55 28.44 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.866 -1.146 . . . . 0.0 113.503 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -131.64 59.17 1.7 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.853 0.751 . . . . 0.0 109.28 -166.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -56.8 -37.37 71.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -63.8 -37.08 86.03 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 120.101 1.319 . . . . 0.0 110.072 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.6 -49.28 78.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.861 1.264 . . . . 0.0 109.014 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.29 -44.83 99.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.751 2.02 . . . . 0.0 110.904 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.04 -39.12 93.8 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.365 -0.834 . . . . 0.0 110.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 -179.27 48.85 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 122.278 0.932 . . . . 0.0 112.008 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.23 109.1 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 127.357 2.263 . . . . 0.0 110.937 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt 43.43 50.65 6.16 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.67 1.588 . . . . 0.0 110.673 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.49 37.67 69.2 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.866 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -67.38 0.42 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.042 1.421 . . . . 0.0 112.351 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -36.74 84.75 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.361 -172.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.78 -44.88 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 119.129 0.877 . . . . 0.0 111.964 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -63.11 -49.5 74.19 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.996 -1.065 . . . . 0.0 110.949 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -51.58 66.31 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.164 0.585 . . . . 0.0 110.046 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 88.8 mt -67.95 -30.16 69.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.613 -1.185 . . . . 0.0 112.096 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.0 m -56.99 -37.28 71.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.736 1.153 . . . . 0.0 110.32 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.51 17.4 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.845 1.202 . . . . 0.0 111.337 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 60' ' ' LEU 0.261 2.0 p -61.46 -42.47 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.124 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.36 -47.72 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 121.249 1.84 . . . . 0.0 109.814 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.417 HE22 ' HG2' ' A' ' 72' ' ' GLU . 9.0 mt-30 -53.43 -37.34 62.47 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.26 0.482 . . . . 0.0 111.845 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 -38.93 18.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.209 0.913 . . . . 0.0 111.138 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.53 -36.78 83.66 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.838 1.255 . . . . 0.0 110.505 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 94.1 m-85 -114.66 -21.33 10.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 112.74 -168.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.03 50.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.052 1.311 . . . . 0.0 114.442 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -53.29 145.65 25.35 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.169 1.484 . . . . 0.0 113.355 -171.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -68.84 156.69 64.59 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.786 2.99 . . . . 0.0 111.578 163.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' HE22 ' A' ' 65' ' ' GLN . 12.3 mt-10 -71.95 139.98 48.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 172.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.72 -21.17 1.27 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.897 -1.502 . . . . 0.0 115.026 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m -80.9 -8.69 59.8 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 120.048 1.924 . . . . 0.0 112.703 168.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.63 126.81 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -113.04 139.54 48.59 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 163.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.32 134.45 54.88 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 76' ' ' GLU . 72.0 m-85 -132.72 171.76 13.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.747 2.019 . . . . 0.0 109.262 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.91 148.96 52.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 167.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.58 150.87 52.09 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.659 1.584 . . . . 0.0 107.517 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -82.96 151.23 25.97 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.21 162.39 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.74 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 166.47 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 130.646 3.578 . . . . 0.0 107.372 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 p -53.51 -46.97 70.27 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.12 2.168 . . . . 0.0 112.996 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ttm105 -144.92 -82.21 0.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 156.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.79 -176.7 16.19 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.983 1.278 . . . . 0.0 110.182 -170.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m 68.58 128.03 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.423 3.089 . . . . 0.0 115.277 167.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.15 131.6 50.11 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.79 -43.57 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 CA-C-N 119.921 1.861 . . . . 0.0 112.878 -165.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 m -60.99 107.06 0.66 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 p -149.88 -9.9 0.29 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.502 0.721 . . . . 0.0 112.692 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.983 1.754 . . . . 0.0 109.087 174.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.983 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 t 56.7 44.18 24.08 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.996 1.719 . . . . 0.0 112.554 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 p -100.91 145.61 28.4 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.364 -0.835 . . . . 0.0 110.441 169.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.23 -134.18 6.71 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 106.101 -2.8 . . . . 0.0 106.101 160.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -49.64 114.94 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.036 1.335 . . . . 0.0 110.087 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 m -67.47 179.62 1.27 Allowed 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.921 -0.487 . . . . 0.0 109.912 168.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.13 -108.11 0.76 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -40.14 -42.13 1.4 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.875 2.47 . . . . 0.0 113.443 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -57.35 -43.19 83.27 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.34 -55.39 24.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 117.477 -1.249 . . . . 0.0 108.517 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -47.77 -41.36 23.11 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.496 1.118 . . . . 0.0 111.062 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.27 -45.95 21.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.298 1.439 . . . . 0.0 111.687 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -58.29 -53.84 53.77 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.283 1.033 . . . . 0.0 110.009 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.16 -43.98 96.78 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.855 0.862 . . . . 0.0 111.039 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -48.02 -61.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.59 1.556 . . . . 0.0 110.254 168.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.77 -35.68 78.83 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.566 0.746 . . . . 0.0 112.105 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.5 m -60.75 -29.1 69.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.403 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -90.58 -30.23 17.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.674 1.19 . . . . 0.0 112.59 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.32 -22.33 52.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.3 mt -134.49 23.88 3.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.281 1.032 . . . . 0.0 111.755 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.42 34.38 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.953 1.301 . . . . 0.0 112.187 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -71.56 -31.77 67.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.491 0.716 . . . . 0.0 110.503 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.93 -44.2 94.49 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.176 0.99 . . . . 0.0 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.47 28.37 0.52 Allowed Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.747 -1.029 . . . . 0.0 114.801 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -61.34 148.53 41.09 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.367 1.584 . . . . 0.0 112.226 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 -30.5 1.32 Allowed 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.519 1.128 . . . . 0.0 113.054 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.89 -170.46 43.42 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 120.11 1.323 . . . . 0.0 110.806 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.06 152.25 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -126.68 108.89 11.49 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.831 1.253 . . . . 0.0 107.911 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.5 146.53 6.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.467 1.507 . . . . 0.0 108.44 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.5 mtt-85 -131.9 150.28 52.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.87 1.268 . . . . 0.0 107.755 167.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.41 121.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 48.5 p -120.81 176.75 1.71 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.517 1.527 . . . . 0.0 109.423 -165.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.4 Cg_endo -79.47 4.02 6.99 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.183 1.922 . . . . 0.0 113.833 165.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -121.48 -58.53 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.095 1.316 . . . . 0.0 111.907 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -161.57 138.19 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.664 1.586 . . . . 0.0 110.315 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 m -58.5 143.92 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.74 146.42 39.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 172.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.74 117.4 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.28 113.45 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.76 117.81 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.761 1.224 . . . . 0.0 108.86 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.4 mt -89.72 110.49 21.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.256 1.822 . . . . 0.0 108.49 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.94 168.17 20.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.345 0.658 . . . . 0.0 110.865 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -66.73 -35.97 81.35 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.927 -1.108 . . . . 0.0 111.299 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -120.61 79.23 1.46 Allowed 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.555 0.742 . . . . 0.0 109.555 -165.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.59 -48.52 14.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.628 1.571 . . . . 0.0 111.365 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -65.46 -27.41 68.49 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.258 -0.901 . . . . 0.0 112.258 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -70.59 -44.05 68.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.893 1.224 . . . . 0.0 108.938 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.29 -35.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.491 1.116 . . . . 0.0 110.592 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.3 -44.53 71.58 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.662 -1.273 . . . . 0.0 108.871 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.97 -177.45 45.01 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.5 1.048 . . . . 0.0 111.919 -169.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.72 123.76 14.29 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.247 1.019 . . . . 0.0 108.46 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt 46.79 39.67 7.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.865 0.866 . . . . 0.0 111.959 172.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.77 30.16 72.65 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.636 -1.091 . . . . 0.0 113.98 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -67.14 0.34 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.398 2.099 . . . . 0.0 112.815 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -37.41 87.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.68 -169.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 tt -57.64 -56.93 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.948 0.794 . . . . 0.0 109.757 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -56.31 -43.57 79.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.224 1.409 . . . . 0.0 112.34 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.14 -58.71 7.46 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.37 -25.05 66.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.855 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 37.6 m -57.79 -55.1 39.29 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 120.378 1.444 . . . . 0.0 109.724 167.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.63 89.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.455 0.702 . . . . 0.0 111.203 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 59' ' ' GLU . 38.1 t -53.78 -59.12 2.16 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 t -61.26 -39.78 83.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.059 0.944 . . . . 0.0 111.016 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.44 -37.7 70.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.733 0.697 . . . . 0.0 111.067 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -80.69 -55.27 4.95 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.734 0.697 . . . . 0.0 109.995 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.17 -39.41 60.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.368 1.867 . . . . 0.0 111.898 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.49 -1.29 13.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.1 1.36 . . . . 0.0 111.546 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.18 78.91 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 120.85 -1.156 . . . . 0.0 114.702 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.31 147.67 75.1 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.819 1.31 . . . . 0.0 112.648 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.53 141.29 79.73 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.747 2.965 . . . . 0.0 111.979 168.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -66.41 141.42 57.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.83 -16.76 6.41 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.214 -0.77 . . . . 0.0 114.294 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 57.4 m -121.48 9.95 10.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 112.916 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.01 155.28 26.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 159.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -139.33 156.44 47.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.753 1.221 . . . . 0.0 108.433 164.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -131.71 134.83 46.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -132.47 160.98 34.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.433 1.893 . . . . 0.0 108.386 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 142.11 46.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.616 0.767 . . . . 0.0 108.961 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -141.7 153.81 44.91 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 108.769 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -101.66 146.86 27.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.87 151.05 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 122.38 1.086 . . . . 0.0 108.188 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.58 166.96 31.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.028 2.131 . . . . 0.0 107.086 162.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 m -70.78 119.39 14.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -125.49 -103.68 0.36 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.928 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.57 -176.7 24.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 119.785 1.175 . . . . 0.0 110.511 -171.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -57.54 -55.3 36.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.702 0.801 . . . . 0.0 112.149 -162.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 45.9 70.82 0.58 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.094 -1.948 . . . . 0.0 111.558 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.49 75.03 0.28 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 125.248 3.965 . . . . 0.0 113.09 -172.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 134.03 54.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.642 1.577 . . . . 0.0 108.334 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.9 m -156.37 167.25 31.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.672 1.189 . . . . 0.0 110.259 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.68 0 N-CA-C 105.877 -2.889 . . . . 0.0 105.877 -164.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.9 m -72.8 74.27 1.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.989 1.894 . . . . 0.0 107.759 161.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -164.47 162.6 22.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 130.289 3.436 . . . . 0.0 105.204 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.29 77.69 1.35 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.6 m 61.09 96.47 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.582 1.553 . . . . 0.0 112.478 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -56.68 160.77 3.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.152 -0.967 . . . . 0.0 108.646 154.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.63 -139.39 14.48 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.385 -2.286 . . . . 0.0 107.385 -157.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -36.79 -54.25 0.91 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.839 1.656 . . . . 0.0 113.983 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -53.22 -41.95 65.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.312 1.045 . . . . 0.0 112.009 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.78 25.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.78 1.232 . . . . 0.0 109.588 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.7 -40.33 62.86 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.446 0.566 . . . . 0.0 111.448 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.9 tp -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.972 1.309 . . . . 0.0 110.826 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -63.0 -43.71 98.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.185 0.594 . . . . 0.0 110.335 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.28 -30.7 71.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.452 1.101 . . . . 0.0 112.853 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -67.51 -63.97 0.95 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.5 mt -56.45 -33.14 65.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.605 1.162 . . . . 0.0 111.96 -168.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.6 m -46.2 -46.53 17.58 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.162 0.985 . . . . 0.0 111.783 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.48 -56.69 4.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.69 -26.51 45.33 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 113.521 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.62 18.9 9.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.774 1.229 . . . . 0.0 111.359 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.94 -64.31 0.87 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.908 0.883 . . . . 0.0 111.023 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.85 -22.12 62.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.474 -0.766 . . . . 0.0 111.309 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.7 -24.29 67.53 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.545 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.06 25.29 3.05 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.459 1.027 . . . . 0.0 114.763 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.757 ' HE1' HG23 ' A' ' 41' ' ' ILE . 40.6 t80 -63.65 165.2 8.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 112.42 -168.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.97 -52.93 0.22 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.729 1.212 . . . . 0.0 110.46 171.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.09 -172.02 38.3 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 118.927 0.785 . . . . 0.0 111.429 -171.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.46 134.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.53 161.91 13.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 164.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.14 144.91 23.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -120.1 160.47 22.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.39 115.71 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 4.3 p -121.01 176.85 1.68 Allowed Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.194 -0.941 . . . . 0.0 109.842 -169.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 81.3 Cg_endo -78.84 12.17 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.281 1.988 . . . . 0.0 111.448 166.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.9 p -127.7 -50.04 1.37 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 0.0 112.579 -170.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -162.6 173.6 13.72 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.142 1.777 . . . . 0.0 110.156 -169.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.1 m -98.23 149.17 22.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -125.32 142.57 51.42 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.764 2.026 . . . . 0.0 105.757 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -129.0 125.93 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.4 mp -123.73 97.56 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.757 HG23 ' HE1' ' A' ' 25' ' ' TYR . 4.9 mp -76.87 125.95 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.4 108.09 20.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.064 2.146 . . . . 0.0 107.131 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.95 168.09 20.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.852 1.31 . . . . 0.0 110.354 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.7 p -79.12 -26.84 42.85 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 120.955 -1.091 . . . . 0.0 111.769 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -129.01 79.93 1.94 Allowed 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 125.76 1.624 . . . . 0.0 107.904 -167.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 p -48.98 -39.2 25.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.334 1.053 . . . . 0.0 111.334 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.89 -39.95 95.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.215 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -59.87 -48.82 80.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.742 1.155 . . . . 0.0 109.183 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.06 -43.65 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.908 1.283 . . . . 0.0 110.786 -174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.84 -36.67 84.12 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.643 -0.66 . . . . 0.0 109.878 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.57 175.68 41.18 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.058 1.313 . . . . 0.0 110.554 -167.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 55' ' ' ARG . 4.2 tt0 -55.5 128.18 33.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 167.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp 50.33 38.86 18.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.649 0.779 . . . . 0.0 112.839 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.84 10.01 67.01 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.795 0.712 . . . . 0.0 113.907 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 52' ' ' GLU . 17.0 mtm180 -52.31 -53.34 45.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.896 1.348 . . . . 0.0 113.244 -175.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.88 74.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 116.176 -1.868 . . . . 0.0 109.954 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.9 tt -60.73 -38.05 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 121.562 1.983 . . . . 0.0 111.224 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -52.73 64.31 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.304 -0.873 . . . . 0.0 110.854 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -28.12 63.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.434 1.094 . . . . 0.0 112.108 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 63' ' ' VAL . 31.6 mt -80.03 -24.82 40.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.139 1.376 . . . . 0.0 110.467 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -66.28 -55.38 16.36 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.19 70.35 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.457 1.103 . . . . 0.0 111.965 -174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 60' ' ' LEU . 12.8 p -58.65 -47.91 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.702 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.36 -39.83 82.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-N 119.649 1.113 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -53.84 -44.94 70.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.799 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.83 -58.45 3.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.819 0.736 . . . . 0.0 109.659 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.31 -45.77 54.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.549 1.54 . . . . 0.0 111.848 -168.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.12 -1.8 25.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.46 47.62 89.67 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 125.244 1.402 . . . . 0.0 112.177 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -80.05 145.62 61.46 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.202 1.001 . . . . 0.0 111.32 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.49 137.52 51.06 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.484 2.123 . . . . 0.0 109.713 166.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.36 143.04 58.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.353 1.061 . . . . 0.0 109.512 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 -6.49 6.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.708 -1.051 . . . . 0.0 113.397 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -117.05 8.37 13.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.128 1.771 . . . . 0.0 112.17 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -113.71 140.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 154.19 51.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 168.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -121.65 136.45 54.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -125.17 163.21 22.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.885 1.674 . . . . 0.0 107.461 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.68 109.12 9.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.163 0.585 . . . . 0.0 109.796 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -119.88 145.8 46.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.439 0.638 . . . . 0.0 110.385 -168.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.75 140.16 36.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 -167.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.0 160.08 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -140.05 98.48 3.46 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.487 -1.383 . . . . 0.0 110.282 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 m -66.23 -65.36 0.69 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.067 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -114.57 154.51 28.17 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.555 1.525 . . . . 0.0 109.775 -175.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' H ' ' HD3' ' A' ' 85' ' ' ARG . . . -169.16 -133.54 1.6 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.029 2.252 . . . . 0.0 108.753 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.0 m 60.11 89.97 0.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.094 2.158 . . . . 0.0 111.24 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.28 172.3 44.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 123.48 0.562 . . . . 0.0 112.827 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.78 67.85 8.48 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.868 3.712 . . . . 0.0 112.346 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 t -61.86 115.41 4.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 162.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.8 m -146.84 118.0 7.79 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.607 1.563 . . . . 0.0 109.578 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 117.514 -1.715 . . . . 0.0 111.451 171.533 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m 40.69 61.58 1.62 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.602 1.561 . . . . 0.0 111.51 -176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -57.33 148.5 22.74 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.2 -121.72 3.49 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -60.19 118.23 6.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.916 1.287 . . . . 0.0 109.181 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -90.22 113.63 25.47 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.368 1.867 . . . . 0.0 108.13 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.84 143.39 14.59 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -32.31 -46.88 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.334 3.453 . . . . 0.0 114.841 -169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -54.3 -29.43 47.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.19 1.396 . . . . 0.0 113.499 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -58.12 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.395 2.278 . . . . 0.0 111.007 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -56.05 -40.63 73.81 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.633 1.106 . . . . 0.0 111.2 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.11 -36.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 110.593 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.19 -51.5 67.55 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.585 0.754 . . . . 0.0 109.587 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.34 -27.46 67.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.148 0.979 . . . . 0.0 111.864 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.05 -63.37 1.09 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.429 1.092 . . . . 0.0 109.104 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.05 -31.55 71.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.49 1.116 . . . . 0.0 112.234 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.4 m -55.91 -35.68 66.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.102 1.361 . . . . 0.0 111.157 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -90.54 -44.64 9.43 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.932 -0.48 . . . . 0.0 110.112 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.86 -42.25 93.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.953 0.342 . . . . 0.0 111.902 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.56 20.64 16.42 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.032 1.733 . . . . 0.0 110.554 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.52 -58.87 4.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.398 1.479 . . . . 0.0 110.141 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 -19.74 55.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.632 0.773 . . . . 0.0 111.995 -173.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -71.09 -32.58 69.24 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 123.282 0.633 . . . . 0.0 110.386 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.07 47.02 1.11 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.399 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.72 171.24 0.49 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.698 1.599 . . . . 0.0 112.967 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.77 -42.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.812 1.645 . . . . 0.0 111.479 170.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.2 -170.29 43.33 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.79 153.99 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -119.94 158.0 27.62 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.437 1.495 . . . . 0.0 109.055 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.41 129.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.34 1.056 . . . . 0.0 110.265 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -125.81 122.93 37.59 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.247 1.019 . . . . 0.0 108.93 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.26 130.09 38.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 163.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 27.1 p -121.76 170.66 7.28 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.612 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 71.6 Cg_endo -74.08 19.37 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.906 2.404 . . . . 0.0 112.809 165.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.1 p -127.25 -58.1 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -154.44 173.44 16.25 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.285 1.834 . . . . 0.0 109.494 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.2 m -86.54 148.54 25.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 162.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.94 131.69 33.38 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 125.678 1.591 . . . . 0.0 106.881 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.81 123.65 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.62 1.568 . . . . 0.0 107.799 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.7 112.51 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -73.09 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -99.94 118.09 35.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.079 165.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.62 167.05 25.55 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.301 0.5 . . . . 0.0 111.258 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.8 p -67.13 -45.56 76.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.874 0.47 . . . . 0.0 110.798 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -122.93 82.43 1.99 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.045 1.738 . . . . 0.0 108.144 -167.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 p -46.58 -42.92 16.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.457 1.103 . . . . 0.0 110.552 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -45.15 74.25 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.644 1.111 . . . . 0.0 112.339 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -68.59 -42.26 78.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.71 -31.44 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.062 1.745 . . . . 0.0 110.837 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -76.77 -42.32 41.37 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.29 1.036 . . . . 0.0 110.185 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.19 176.12 27.02 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.165 0.888 . . . . 0.0 111.294 -171.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -58.88 116.91 4.09 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.366 0.666 . . . . 0.0 110.484 -173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.1 mttt 42.31 44.63 3.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.238 1.415 . . . . 0.0 111.648 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.5 73.77 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.506 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -51.29 -56.67 11.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.558 1.679 . . . . 0.0 112.658 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.27 -48.41 81.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.273 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 tt -60.44 -44.47 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.077 0.853 . . . . 0.0 109.879 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -38.19 82.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.362 0.983 . . . . 0.0 112.891 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -62.18 1.85 Allowed 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.01 -24.88 68.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.009 -1.472 . . . . 0.0 111.767 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.0 m -55.55 -51.87 65.63 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 120.683 1.583 . . . . 0.0 108.946 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.24 82.69 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.833 0.742 . . . . 0.0 110.669 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.44 -50.01 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 118.691 0.678 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.86 -51.23 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.372 1.469 . . . . 0.0 109.871 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -54.76 -28.35 47.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.483 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -93.48 -44.93 8.0 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.364 0.983 . . . . 0.0 110.213 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -55.04 -39.52 69.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.01 1.324 . . . . 0.0 111.188 174.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 91.9 m-85 -115.07 5.99 15.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.69 1.196 . . . . 0.0 111.417 -171.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.78 41.62 66.86 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.896 2.189 . . . . 0.0 114.576 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -81.9 145.51 53.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.576 1.188 . . . . 0.0 111.488 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.49 153.8 73.06 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.109 1.873 . . . . 0.0 110.888 168.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.21 122.56 17.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.759 1.224 . . . . 0.0 109.359 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 -14.76 4.95 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.318 0.961 . . . . 0.0 114.467 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 m -74.74 -6.88 51.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.192 0.997 . . . . 0.0 111.522 161.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.18 149.46 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 162.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -137.29 149.68 47.25 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 165.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.96 122.64 46.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -118.3 165.62 13.62 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 127.71 2.404 . . . . 0.0 108.997 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.68 113.52 7.88 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.191 1.396 . . . . 0.0 109.202 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.04 154.93 19.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.86 1.664 . . . . 0.0 109.18 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -90.9 156.12 18.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.6 t -85.43 150.21 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 122.227 1.013 . . . . 0.0 109.665 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.92 35.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.479 1.912 . . . . 0.0 108.583 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.6 t -81.47 164.87 21.71 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 108.642 168.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.4 mtt-85 -102.79 143.62 32.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 156.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.04 106.39 0.19 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 105.984 -2.847 . . . . 0.0 105.984 170.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 m -64.45 160.13 19.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.857 0.863 . . . . 0.0 110.091 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.05 111.07 0.5 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.37 -34.09 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 120.48 2.14 . . . . 0.0 111.034 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.0 m 51.05 83.13 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.916 1.686 . . . . 0.0 112.033 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.85 -172.95 0.12 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.214 2.206 . . . . 0.0 109.518 -164.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.481 0 C-N-CA 127.749 2.595 . . . . 0.0 106.826 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -134.57 160.88 36.69 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.746 1.219 . . . . 0.0 108.706 168.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -152.49 156.14 38.84 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 107.766 155.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.71 -170.61 31.19 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -156.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 m -71.67 -86.1 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.358 1.079 . . . . 0.0 108.248 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.2 m -80.05 175.75 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 156.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.22 113.49 3.86 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -53.15 -53.88 43.93 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.863 0.831 . . . . 0.0 110.249 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 29' ' ' GLU . 79.5 tttt -57.47 -31.9 66.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.778 -0.629 . . . . 0.0 111.247 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -39.8 47.39 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 119.234 0.925 . . . . 0.0 111.766 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.29 -43.85 96.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.358 0.981 . . . . 0.0 109.365 171.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp -64.58 -39.22 93.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.392 0.677 . . . . 0.0 110.54 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.18 -56.33 22.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.161 1.384 . . . . 0.0 109.772 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.2 -28.43 68.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.35 -64.76 0.79 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.567 1.147 . . . . 0.0 109.006 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -58.28 -37.28 74.7 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 112.646 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.5 m -51.14 -48.32 61.85 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.817 0.847 . . . . 0.0 110.367 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -75.45 -42.22 53.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.134 -0.46 . . . . 0.0 109.919 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -31.57 72.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.836 0.744 . . . . 0.0 111.881 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.7 mt -119.01 15.84 13.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.314 -165.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.83 -63.1 0.92 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.033 1.333 . . . . 0.0 112.331 -173.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -15.46 59.56 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -71.66 -12.1 61.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.678 1.126 . . . . 0.0 111.06 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.5 47.73 4.21 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.699 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -56.96 166.32 1.04 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.933 1.349 . . . . 0.0 110.519 168.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 2.0 m -156.76 -37.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.792 2.037 . . . . 0.0 109.958 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.23 -169.32 42.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 124.21 0.909 . . . . 0.0 110.853 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.69 154.13 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -116.55 162.57 17.4 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.659 1.984 . . . . 0.0 110.124 164.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.36 137.47 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.853 1.261 . . . . 0.0 108.342 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -127.61 127.48 43.9 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.5 91.78 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 12.7 p -90.36 169.64 11.73 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 54.4 Cg_endo -73.35 4.04 4.21 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.832 2.355 . . . . 0.0 112.922 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 p -113.34 -54.89 2.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.354 0.979 . . . . 0.0 110.922 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -155.47 157.82 37.56 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.61 1.564 . . . . 0.0 108.614 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 m -68.22 139.33 56.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 161.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.33 139.97 44.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.94 124.65 65.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.93 93.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -172.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.16 122.25 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' SER . 63.9 mt -98.39 73.02 2.11 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.633 1.173 . . . . 0.0 109.446 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.7 160.41 15.73 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.423 1.465 . . . . 0.0 111.352 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -72.32 -25.1 61.43 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.676 -1.265 . . . . 0.0 111.527 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -131.81 72.17 1.49 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.541 1.136 . . . . 0.0 108.733 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -56.74 -40.25 75.43 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.45 -0.781 . . . . 0.0 111.808 -174.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -53.33 -39.31 63.99 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.811 1.244 . . . . 0.0 112.634 174.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.01 -45.34 67.44 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.442 0.697 . . . . 0.0 109.803 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.4 -39.73 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.396 0.678 . . . . 0.0 109.302 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.6 -39.09 93.49 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.289 -0.882 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 172.79 28.44 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -165.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -54.87 126.25 23.52 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.706 -0.879 . . . . 0.0 109.67 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.279 58.9 pttt 39.96 42.3 1.05 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.206 1.802 . . . . 0.0 113.507 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.75 20.99 77.62 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.489 -0.757 . . . . 0.0 113.27 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -44.56 -67.26 0.3 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.407 1.483 . . . . 0.0 111.689 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -32.87 67.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.637 -169.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 tt -61.86 -40.89 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.144 1.338 . . . . 0.0 111.655 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -64.32 -45.31 88.46 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 120.027 1.285 . . . . 0.0 110.625 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.25 -48.02 79.91 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.01 0.524 . . . . 0.0 110.518 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HA ' HG12 ' A' ' 63' ' ' VAL . 10.5 mt -63.93 -36.13 82.95 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 117.975 -1.012 . . . . 0.0 111.524 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.2 m -59.6 -48.99 79.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 120.425 1.466 . . . . 0.0 109.364 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -47.15 79.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 60' ' ' LEU . 8.0 p -60.66 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-O 117.621 -1.181 . . . . 0.0 109.515 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -58.36 -41.75 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.697 1.589 . . . . 0.0 109.54 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -32.79 63.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.063 0.545 . . . . 0.0 111.915 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -96.83 -19.51 18.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.788 2.035 . . . . 0.0 112.842 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -20.63 27.12 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.286 -1.509 . . . . 0.0 110.231 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.69 1.34 4.93 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.665 1.186 . . . . 0.0 112.05 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.77 10.03 66.84 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.574 1.079 . . . . 0.0 114.299 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -57.32 151.98 34.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.915 0.857 . . . . 0.0 111.982 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 58.4 Cg_endo -69.66 174.24 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.988 3.792 . . . . 0.0 109.561 166.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 153.99 22.07 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.72 -46.25 0.55 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.41 1.957 . . . . 0.0 112.569 -166.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 56.1 m -77.86 8.64 4.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.549 1.94 . . . . 0.0 113.194 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.5 p -129.82 131.41 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 160.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -122.08 148.84 44.37 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.356 1.062 . . . . 0.0 108.251 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.81 145.14 42.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -134.42 162.75 31.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.811 2.044 . . . . 0.0 107.317 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.1 145.35 43.11 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -139.96 141.43 36.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.21 139.68 36.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.2 160.32 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.706 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.97 -64.89 0.19 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 128.869 2.868 . . . . 0.0 113.168 164.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -67.83 162.87 23.1 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 161.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -140.38 175.26 9.74 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.884 -0.51 . . . . 0.0 110.464 -171.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.63 75.1 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 126.031 1.777 . . . . 0.0 109.657 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -61.57 -166.7 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.917 0.887 . . . . 0.0 109.365 154.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.84 78.71 1.03 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.74 154.51 74.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.84 1.693 . . . . 0.0 109.916 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.04 150.28 20.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 167.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.1 m -170.34 144.86 2.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.48 2.712 . . . . 0.0 105.613 163.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.713 0 N-CA-C 107.36 -2.296 . . . . 0.0 107.36 175.592 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.523 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -147.2 -58.8 0.27 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.111 0.956 . . . . 0.0 110.544 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.88 144.31 50.71 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.756 1.162 . . . . 0.0 111.196 173.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.63 148.19 39.81 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 156.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.83 159.46 39.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -75.85 120.82 21.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.191 0.596 . . . . 0.0 111.188 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.03 146.42 4.45 Favored Glycine 0 C--O 1.223 -0.539 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.423 152.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -33.47 -51.19 0.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.293 2.637 . . . . 0.0 115.882 -170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.2 -29.13 68.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.769 0.828 . . . . 0.0 111.879 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.44 -63.66 1.01 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.179 1.392 . . . . 0.0 109.08 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.67 -45.6 19.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.911 1.285 . . . . 0.0 111.581 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 8.7 tp -74.41 -35.81 63.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.219 0.608 . . . . 0.0 111.771 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -66.96 -45.01 79.07 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 109.69 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.59 -55.63 20.94 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.949 0.9 . . . . 0.0 110.147 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -50.5 -63.53 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.755 1.622 . . . . 0.0 110.033 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.9 mt -59.78 -30.96 69.24 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.814 0.846 . . . . 0.0 113.197 -173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -55.58 -36.14 66.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.245 0.618 . . . . 0.0 111.237 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -88.35 -52.37 5.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.8 -20.41 49.84 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.59 25.54 4.75 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.344 1.458 . . . . 0.0 112.015 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.5 -63.17 1.07 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.091 1.757 . . . . 0.0 111.92 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -73.07 -29.83 63.25 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 122.037 -0.414 . . . . 0.0 110.6 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -64.73 -29.87 70.86 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.4 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.24 34.35 0.89 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-O 118.824 -0.986 . . . . 0.0 114.325 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -57.02 171.43 0.36 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.109 1.764 . . . . 0.0 113.705 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -141.29 -60.77 0.48 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.432 1.493 . . . . 0.0 109.215 171.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.12 41.89 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.53 145.5 16.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.251 -1.146 . . . . 0.0 108.8 -170.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.06 150.83 26.11 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.439 1.496 . . . . 0.0 107.857 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.38 143.29 41.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.125 1.77 . . . . 0.0 107.011 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -133.65 153.31 51.78 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.8 t -140.1 118.84 11.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 17.5 p -119.68 170.53 6.7 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 57.0 Cg_endo -69.82 8.65 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.961 1.774 . . . . 0.0 112.589 175.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 p -121.9 -56.31 1.85 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.769 1.168 . . . . 0.0 110.204 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -140.44 170.62 15.45 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.188 0.904 . . . . 0.0 111.589 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 m -87.21 151.07 23.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.75 134.36 45.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -126.0 120.85 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.19 99.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -69.38 139.7 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt -108.96 112.11 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -145.31 171.13 15.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 110.422 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 p -84.26 -28.98 26.83 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.15 -0.969 . . . . 0.0 112.525 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -131.46 73.11 1.52 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -167.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -54.0 -27.81 34.04 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.435 1.094 . . . . 0.0 112.878 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -57.46 -44.39 84.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.828 0.851 . . . . 0.0 111.098 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.92 -38.91 79.84 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.437 1.095 . . . . 0.0 111.538 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 43' ' ' ALA . 61.5 t -65.4 -39.09 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 123.704 0.802 . . . . 0.0 110.062 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -74.98 -43.66 52.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.69 -172.03 33.0 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -59.66 106.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.798 1.639 . . . . 0.0 110.831 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt 42.69 47.73 4.66 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.513 1.525 . . . . 0.0 111.202 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.3 11.16 81.12 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.749 -2.139 . . . . 0.0 114.026 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -45.51 -60.13 2.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.244 2.522 . . . . 0.0 112.058 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -50.54 73.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.473 1.033 . . . . 0.0 109.327 -174.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -65.22 -34.33 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.974 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -64.67 -61.09 2.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.694 1.198 . . . . 0.0 110.085 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -50.21 -50.9 48.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 125.709 1.604 . . . . 0.0 111.235 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.1 -21.29 64.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.002 -1.475 . . . . 0.0 112.197 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -56.88 -46.18 82.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 121.53 1.968 . . . . 0.0 108.382 167.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.02 76.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.692 0.678 . . . . 0.0 111.528 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.57 -54.39 35.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.22 -47.37 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 124.611 1.164 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.511 HE22 ' HG2' ' A' ' 72' ' ' GLU . 1.6 mt-30 -53.94 -42.11 68.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.535 0.607 . . . . 0.0 110.876 -176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -80.74 -50.69 9.55 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 109.409 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -46.84 68.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.414 1.086 . . . . 0.0 110.682 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 73.9 m-85 -96.19 -14.4 22.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.76 0.824 . . . . 0.0 112.267 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.89 51.86 13.61 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -89.18 154.25 49.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.097 0.959 . . . . 0.0 110.117 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 167.21 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.3 2.666 . . . . 0.0 111.485 159.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' HG2' HE22 ' A' ' 65' ' ' GLN . 50.9 mt-10 -77.77 161.45 27.68 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 163.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.84 -1.52 4.5 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.93 1.252 . . . . 0.0 114.586 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.4 m -132.33 14.73 4.58 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.474 1.51 . . . . 0.0 111.823 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.9 125.49 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 165.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.75 146.58 43.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.47 134.06 55.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -130.5 165.71 22.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.647 2.379 . . . . 0.0 108.645 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.62 6.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.268 1.027 . . . . 0.0 108.654 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 152.82 21.37 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.494 1.518 . . . . 0.0 108.045 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -97.0 143.78 27.52 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -86.16 145.35 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 123.785 0.834 . . . . 0.0 108.759 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.43 171.89 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.554 2.342 . . . . 0.0 107.576 167.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.4 p -141.11 124.15 16.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -151.63 136.87 17.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.4 77.43 0.25 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 p -173.91 115.55 0.22 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.72 121.25 6.66 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 108.319 -1.913 . . . . 0.0 108.319 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.01 169.8 21.39 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.367 2.045 . . . . 0.0 110.076 170.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 p -117.92 -167.16 1.29 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.978 2.111 . . . . 0.0 107.149 163.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -144.21 158.81 43.52 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 159.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 -163.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -63.2 140.96 58.93 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.905 1.353 . . . . 0.0 108.364 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 p -153.1 70.65 0.88 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.655 0.741 . . . . 0.0 109.58 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.625 ' HA2' ' HB1' ' A' ' 10' ' ' ALA . . . -135.98 -157.72 7.93 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.973 1.273 . . . . 0.0 110.961 169.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.0 m 123.58 -159.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 1 C-N-CA 133.049 4.54 . . . . 0.0 106.861 -168.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -51.28 161.04 0.48 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.097 0.951 . . . . 0.0 112.725 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.99 132.94 7.74 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -173.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -54.24 -47.72 71.9 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.404 -0.468 . . . . 0.0 111.298 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -61.6 -36.94 82.13 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.051 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.625 ' HB1' ' HA2' ' A' ' 4' ' ' GLY . . . -63.03 -53.88 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.456 1.502 . . . . 0.0 111.379 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -57.94 -43.73 86.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.383 0.538 . . . . 0.0 110.598 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.51 -42.42 92.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.904 0.481 . . . . 0.0 110.219 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.95 -50.45 73.36 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 123.871 0.868 . . . . 0.0 109.991 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -59.49 -37.95 79.6 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -59.52 -60.42 3.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.461 1.028 . . . . 0.0 110.228 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 41' ' ' ILE . 66.8 mt -59.05 -35.48 73.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.649 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 m -53.43 -31.2 44.24 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.921 1.289 . . . . 0.0 112.709 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -90.51 -54.09 4.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.992 0.814 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.87 -39.96 63.04 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.619 0.767 . . . . 0.0 111.518 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -106.94 18.89 21.23 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.737 1.215 . . . . 0.0 112.295 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.08 -50.09 73.33 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.266 -0.896 . . . . 0.0 112.746 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.49 -15.09 58.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.74 0.7 . . . . 0.0 111.479 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.24 -41.3 70.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.478 0.711 . . . . 0.0 109.532 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.77 45.46 0.47 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-O 119.111 -0.827 . . . . 0.0 114.861 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.622 ' HE1' HG23 ' A' ' 41' ' ' ILE . 66.3 t80 -60.56 167.16 2.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.422 1.111 . . . . 0.0 112.277 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -158.96 -27.06 0.07 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.62 -169.74 40.8 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.59 149.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.74 158.51 21.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.722 1.249 . . . . 0.0 109.045 161.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.43 125.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -167.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -133.07 125.53 29.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.012 1.325 . . . . 0.0 108.291 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 p -116.47 127.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 47.5 p -121.66 174.98 2.74 Favored Pre-proline 0 C--O 1.241 0.624 0 C-N-CA 124.797 1.239 . . . . 0.0 109.276 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 49.2 Cg_endo -69.64 3.72 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.942 1.761 . . . . 0.0 113.513 167.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.8 p -113.3 -59.75 1.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.923 1.238 . . . . 0.0 110.511 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -158.75 157.2 31.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.663 1.574 . . . . 0.0 112.933 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.0 m -62.97 147.57 50.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.235 1.014 . . . . 0.0 108.668 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -137.79 134.93 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.242 2.217 . . . . 0.0 107.381 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -124.94 123.12 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.37 94.01 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.622 HG23 ' HE1' ' A' ' 25' ' ' TYR . 3.4 mp -68.49 139.74 20.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt -107.2 115.3 29.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 127.989 2.516 . . . . 0.0 105.922 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.73 175.83 10.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.758 0.708 . . . . 0.0 112.847 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.32 -21.65 21.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.333 -1.479 . . . . 0.0 114.22 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -137.09 70.9 1.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.476 1.11 . . . . 0.0 108.828 -162.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -57.54 -33.63 68.3 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.527 -0.733 . . . . 0.0 112.109 -173.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -60.16 -36.94 78.7 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.654 1.116 . . . . 0.0 112.416 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -71.83 -43.68 65.15 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.175 0.99 . . . . 0.0 109.273 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.5 t -57.79 -50.62 77.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 125.898 1.679 . . . . 0.0 108.835 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.63 -31.45 72.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.679 0.792 . . . . 0.0 111.342 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.64 178.84 44.05 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -169.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.86 125.51 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 51.87 21.96 1.61 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.9 63.07 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 119.672 1.124 . . . . 0.0 113.985 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -55.14 -54.76 39.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.524 1.53 . . . . 0.0 112.56 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -39.08 85.26 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.625 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 tt -63.03 -38.36 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 120.331 1.423 . . . . 0.0 110.97 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -41.21 97.39 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.614 -1.304 . . . . 0.0 111.85 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.89 -58.53 7.59 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 63' ' ' VAL . 61.7 mt -55.44 -40.88 72.11 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.878 1.671 . . . . 0.0 111.961 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.3 m -55.21 -50.87 68.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.261 1.392 . . . . 0.0 111.266 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.38 84.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.049 0.84 . . . . 0.0 112.174 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' LEU . 3.7 p -61.75 -49.73 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.801 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.77 -47.35 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 119.696 1.135 . . . . 0.0 110.337 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -54.17 -47.02 72.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.75 . . . . 0.0 110.607 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -73.78 -41.77 61.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.073 0.851 . . . . 0.0 110.085 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -51.61 63.7 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 109.845 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -98.59 1.89 46.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.264 1.426 . . . . 0.0 111.28 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 18.73 75.48 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.885 1.231 . . . . 0.0 114.072 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -63.18 149.47 90.99 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 118.545 1.173 . . . . 0.0 112.028 -174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.44 132.73 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.862 2.374 . . . . 0.0 110.102 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -57.51 141.83 46.37 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.223 1.009 . . . . 0.0 110.939 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 -12.78 1.06 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.195 1.379 . . . . 0.0 113.454 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.9 m -115.27 14.59 16.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.909 1.684 . . . . 0.0 111.333 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.84 144.34 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.741 1.617 . . . . 0.0 107.134 154.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.97 151.62 49.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.37 1.468 . . . . 0.0 108.911 172.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -124.7 128.62 49.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -112.29 168.74 9.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.057 2.143 . . . . 0.0 107.339 175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 108.72 6.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -104.85 166.32 10.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.558 1.143 . . . . 0.0 109.166 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -112.98 143.21 44.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 121.944 -0.473 . . . . 0.0 110.823 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.09 162.42 4.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.201 1.0 . . . . 0.0 111.345 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.79 -3.94 0.84 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.782 2.033 . . . . 0.0 115.277 163.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.7 m 16.67 75.52 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 131.459 3.903 . . . . 0.0 113.61 167.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 157.44 40.81 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.652 -0.655 . . . . 0.0 109.816 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.6 164.04 14.03 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -172.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.74 114.57 10.62 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.36 164.26 54.62 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.87 -0.406 . . . . 0.0 112.462 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.16 123.67 14.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 124.055 3.17 . . . . 0.0 111.755 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.2 t -137.5 47.34 2.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.695 1.198 . . . . 0.0 108.521 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 t 79.81 129.96 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.254 2.222 . . . . 0.0 106.73 -159.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 105.124 -3.19 . . . . 0.0 105.124 -158.562 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 CA-C-O 118.988 -0.896 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t 90.82 96.34 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 128.386 2.674 . . . . 0.0 107.801 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -69.96 108.53 4.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.56 9.03 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.11 1.338 . . . . 0.0 113.043 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.1 m -142.46 157.66 44.52 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.154 1.382 . . . . 0.0 109.023 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.0 m -170.2 171.01 7.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.609 2.364 . . . . 0.0 107.831 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.78 -142.58 45.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 166.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -38.11 -48.95 1.28 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.342 1.457 . . . . 0.0 112.935 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -59.66 -33.75 71.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.287 -1.339 . . . . 0.0 111.345 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.03 -52.21 13.44 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.471 -1.252 . . . . 0.0 110.038 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.14 -46.77 65.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.483 1.038 . . . . 0.0 109.888 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.4 tp -64.52 -40.86 96.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.008 0.923 . . . . 0.0 111.087 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -62.36 -51.75 66.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.798 1.239 . . . . 0.0 109.695 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.32 -27.18 65.15 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 111.29 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.05 -63.26 1.1 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.848 1.659 . . . . 0.0 108.973 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.2 mt -58.31 -35.77 72.35 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.244 1.018 . . . . 0.0 112.093 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.7 m -50.53 -43.35 55.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.338 0.655 . . . . 0.0 111.148 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -42.75 18.03 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.143 0.429 . . . . 0.0 110.215 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -21.74 61.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.975 -172.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.07 30.81 6.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.14 2.176 . . . . 0.0 110.43 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.91 82.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.57 -8.2 58.42 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.983 0.81 . . . . 0.0 111.4 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -16.98 58.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.005 0.922 . . . . 0.0 113.14 -169.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.37 47.8 7.21 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 118.722 -1.704 . . . . 0.0 109.576 -163.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -64.0 142.26 58.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.2 -28.68 3.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.117 0.967 . . . . 0.0 112.209 -174.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.02 -168.83 35.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 p -153.4 145.82 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -118.29 165.38 13.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.816 1.646 . . . . 0.0 108.442 168.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -143.41 141.53 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.649 1.179 . . . . 0.0 107.872 -171.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -125.32 167.41 14.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.239 1.018 . . . . 0.0 110.269 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.72 118.76 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 19.7 p -121.69 170.73 7.14 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.719 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 89.8 Cg_endo -78.37 15.66 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 165.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.9 p -127.24 -52.19 1.4 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.125 1.33 . . . . 0.0 111.577 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -154.64 160.91 41.72 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.285 1.034 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.0 m -72.01 151.79 42.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 164.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -138.81 133.15 31.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.39 123.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 125.873 1.669 . . . . 0.0 106.775 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.17 95.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.56 133.16 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.557 1.143 . . . . 0.0 108.496 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.18 114.51 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.91 175.46 10.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.013 0.525 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 HG21 ' A' ' 82' ' ' VAL . 1.6 p -99.76 -49.3 4.41 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.11 1.323 . . . . 0.0 111.912 -175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -90.6 61.48 4.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.667 2.387 . . . . 0.0 108.957 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 p -56.07 -28.56 58.1 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.53 -1.356 . . . . 0.0 113.48 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -57.7 -37.96 74.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.384 1.074 . . . . 0.0 113.62 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.88 -46.65 74.27 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.864 0.866 . . . . 0.0 108.905 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.09 -39.21 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.429 1.092 . . . . 0.0 110.108 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.14 -44.62 83.65 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.699 -0.626 . . . . 0.0 110.7 174.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.77 175.92 47.02 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 124.795 1.188 . . . . 0.0 112.151 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -55.44 116.66 2.99 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.355 1.062 . . . . 0.0 109.814 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? 53.78 23.44 3.76 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.661 0.784 . . . . 0.0 112.729 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.67 59.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.403 -0.811 . . . . 0.0 112.549 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -59.29 -57.8 11.43 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.052 1.426 . . . . 0.0 110.246 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.06 -41.36 98.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.287 -169.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.4 tp -57.88 -42.83 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 120.091 1.314 . . . . 0.0 111.256 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -70.17 -42.11 72.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.093 0.957 . . . . 0.0 110.794 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -56.32 23.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.1 mt -62.26 -24.26 67.16 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.885 1.274 . . . . 0.0 112.587 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.2 m -61.16 -48.76 80.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.348 1.431 . . . . 0.0 109.659 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.98 -40.18 95.8 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.293 0.497 . . . . 0.0 110.997 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.0 -53.26 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.3 t -63.55 -43.69 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 124.995 1.318 . . . . 0.0 110.241 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -54.48 -37.31 65.11 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.358 0.663 . . . . 0.0 110.568 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -73.9 -58.13 3.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.005 0.82 . . . . 0.0 110.081 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -57.38 -30.05 64.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.996 1.318 . . . . 0.0 112.379 -170.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 67' ' ' ARG . 98.1 m-85 -121.59 2.24 10.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.416 1.486 . . . . 0.0 111.774 -171.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.98 22.9 65.27 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.037 0.835 . . . . 0.0 114.156 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -63.66 146.24 96.89 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.2 0.6 . . . . 0.0 111.267 -172.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.52 129.38 27.81 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.542 2.161 . . . . 0.0 110.581 167.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.65 143.53 46.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.73 61.11 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.881 -0.955 . . . . 0.0 113.873 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -136.61 21.48 3.12 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.156 1.478 . . . . 0.0 113.113 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.07 138.8 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 154.94 42.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.899 0.88 . . . . 0.0 110.567 165.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -132.94 114.08 13.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.36 2.264 . . . . 0.0 107.551 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.81 176.29 5.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.623 1.169 . . . . 0.0 110.524 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.18 114.76 8.9 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.594 0.633 . . . . 0.0 109.635 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -114.56 141.41 47.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.982 2.113 . . . . 0.0 109.598 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.8 156.22 19.09 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 44' ' ' THR . 29.7 m -95.43 158.43 3.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 125.192 1.397 . . . . 0.0 110.493 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 71.37 -47.83 0.66 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.938 2.895 . . . . 0.0 114.3 169.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 m 62.74 169.65 0.13 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.517 1.927 . . . . 0.0 112.325 169.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -153.35 174.74 13.95 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 119.662 -1.899 . . . . 0.0 110.365 167.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.43 -90.79 1.58 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 t 65.2 -173.79 0.18 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.906 0.882 . . . . 0.0 110.242 -161.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.71 101.01 0.43 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 117.671 -1.627 . . . . 0.0 109.242 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.5 163.83 37.46 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 120.27 2.035 . . . . 0.0 110.664 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 71.04 170.61 0.32 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.359 2.663 . . . . 0.0 113.679 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.2 m -161.77 85.66 0.63 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.258 1.823 . . . . 0.0 108.893 -177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 N-CA-C 103.547 -3.821 . . . . 0.0 103.547 -160.082 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -177.77 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 129.607 3.163 . . . . 0.0 109.847 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -136.88 166.64 23.15 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.04 -1.037 . . . . 0.0 109.009 157.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.5 -170.95 44.11 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 p -63.49 167.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 112.162 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 m -74.89 151.94 38.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 154.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.35 171.46 12.69 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.249 -0.907 . . . . 0.0 112.604 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 67.6 t80 -52.58 -50.74 62.4 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.229 1.012 . . . . 0.0 111.834 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -70.89 -13.26 61.96 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.471 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.46 -50.55 7.66 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.977 1.262 . . . . 0.0 109.999 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.51 -46.75 80.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.866 0.757 . . . . 0.0 111.687 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 11.1 tp -67.7 -33.99 75.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.787 1.235 . . . . 0.0 110.931 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -66.59 -51.14 59.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 109.94 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.6 -52.41 59.9 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.122 0.969 . . . . 0.0 110.557 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -52.22 -60.16 3.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.163 1.385 . . . . 0.0 110.498 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.0 mt -62.66 -36.74 83.82 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 m -51.79 -47.34 64.27 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.732 0.813 . . . . 0.0 109.237 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -76.68 -41.1 46.77 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.862 0.465 . . . . 0.0 110.117 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -17.88 62.15 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.718 -1.134 . . . . 0.0 113.677 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -130.54 24.48 5.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.14 1.776 . . . . 0.0 112.631 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.24 66.05 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 111.826 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.15 -36.21 83.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.803 0.811 . . . . 0.0 109.127 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -38.87 86.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.508 1.123 . . . . 0.0 110.651 -168.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.52 37.88 0.88 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 119.96 1.255 . . . . 0.0 114.386 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.79 165.74 2.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.319 1.047 . . . . 0.0 112.923 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 m -159.03 -31.02 0.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.41 -171.72 43.74 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.51 137.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.86 158.8 15.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.64 117.13 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 124.767 1.227 . . . . 0.0 107.872 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.85 122.05 46.63 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.7 131.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 161.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 30.9 p -120.51 166.53 15.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 48.6 Cg_endo -67.47 -12.68 36.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.329 1.353 . . . . 0.0 111.511 174.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.79 -50.59 5.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.307 1.443 . . . . 0.0 110.266 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.488 HH11 ' HG3' ' A' ' 76' ' ' GLU . 5.6 ptp180 -162.08 173.7 14.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.386 1.448 . . . . 0.0 111.496 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.15 152.99 39.72 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.933 -1.104 . . . . 0.0 108.084 162.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -135.05 138.78 44.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.475 2.31 . . . . 0.0 105.108 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.9 mt -129.18 124.17 59.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.86 98.01 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.24 127.27 29.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.0 mt -97.1 110.06 22.69 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.171 1.388 . . . . 0.0 107.544 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.13 170.43 19.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.443 0.697 . . . . 0.0 109.48 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.29 -48.67 15.17 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.31 -1.493 . . . . 0.0 112.505 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -94.97 69.49 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.828 1.651 . . . . 0.0 108.795 -165.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -52.75 -34.85 54.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.21 -47.15 85.71 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 120.918 -1.114 . . . . 0.0 111.939 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.65 -43.78 97.93 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.02 -51.79 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 126.414 1.885 . . . . 0.0 109.461 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.5 mt -58.4 -32.46 68.65 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 121.879 -0.513 . . . . 0.0 110.204 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.44 179.07 46.57 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.97 107.28 0.28 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.247 1.419 . . . . 0.0 110.508 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 48.25 50.53 16.25 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.023 0.916 . . . . 0.0 112.173 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.96 58.98 9.82 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -93.57 -68.39 0.8 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.301 1.04 . . . . 0.0 110.565 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -61.82 -38.15 87.09 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.356 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 tp -55.64 -43.04 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.269 0.94 . . . . 0.0 111.355 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 mtp-105 -72.5 -36.24 68.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 120.783 -1.198 . . . . 0.0 111.097 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -56.93 15.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.26 -22.73 64.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.552 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.5 m -58.15 -57.41 12.96 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 120.494 1.497 . . . . 0.0 109.054 166.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.78 -27.53 69.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.278 0.944 . . . . 0.0 112.237 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.11 -63.45 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.61 -43.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.329 1.851 . . . . 0.0 110.86 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -53.91 -45.32 71.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.154 0.982 . . . . 0.0 110.784 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -71.68 -57.92 3.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 109.631 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -47.36 27.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.526 1.93 . . . . 0.0 111.918 -173.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.04 -7.57 22.21 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.336 1.454 . . . . 0.0 111.411 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.15 44.68 95.35 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.053 0.835 . . . . 0.0 111.198 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -69.73 141.59 90.29 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 117.55 0.675 . . . . 0.0 109.619 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.15 128.03 27.18 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 108.38 -1.431 . . . . 0.0 108.38 161.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.72 99.94 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.425 1.49 . . . . 0.0 111.643 -175.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.98 -8.75 33.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.532 1.539 . . . . 0.0 112.028 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 m -85.18 21.72 1.62 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.621 1.21 . . . . 0.0 111.111 162.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 154.73 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.59 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.488 ' HG3' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -148.93 150.95 33.79 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.886 2.075 . . . . 0.0 107.335 174.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -123.86 131.28 53.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.532 1.133 . . . . 0.0 108.862 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -126.16 161.53 27.46 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.54 2.336 . . . . 0.0 109.314 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.36 109.21 9.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.366 1.066 . . . . 0.0 108.821 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.5 158.09 16.59 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.155 1.382 . . . . 0.0 108.46 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -83.28 152.22 25.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.63 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.1 177.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.104 160.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 140.36 176.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 131.518 3.927 . . . . 0.0 108.351 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.272 18.3 p 58.38 -148.21 0.48 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.717 1.607 . . . . 0.0 111.739 168.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -161.76 -60.77 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.517 1.508 . . . . 0.0 111.327 155.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.9 -98.31 2.12 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.899 1.238 . . . . 0.0 110.012 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -132.96 -103.4 0.25 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 156.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.4 170.96 12.85 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -161.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.76 152.98 53.52 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.634 2.223 . . . . 0.0 111.165 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.1 m -100.26 -12.13 19.78 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 111.962 161.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 m -154.57 165.09 37.59 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.123 1.369 . . . . 0.0 108.352 167.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.55 0 C-N-CA 127.795 2.617 . . . . 0.0 106.964 178.647 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -148.41 92.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.433 -1.039 . . . . 0.0 109.298 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 m -148.17 81.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.77 100.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 O-C-N 121.497 -0.752 . . . . 0.0 111.953 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -126.17 -98.65 0.4 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 136.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -108.9 154.9 21.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.497 0.719 . . . . 0.0 110.167 -163.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.34 153.5 6.39 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 126.276 1.893 . . . . 0.0 108.622 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 63.3 t80 -48.96 -50.47 35.45 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -168.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.62 -31.02 69.11 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.764 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.0 -59.0 5.42 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.766 1.166 . . . . 0.0 110.705 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.78 -45.01 82.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.473 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 13.4 tp -66.42 -39.29 88.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.681 0.613 . . . . 0.0 110.513 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.28 -53.0 62.37 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.019 0.827 . . . . 0.0 108.959 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 -30.44 71.47 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.3 0.5 . . . . 0.0 111.569 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -65.78 -52.1 53.63 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.308 1.443 . . . . 0.0 110.215 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.86 -32.73 72.61 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.577 1.151 . . . . 0.0 112.161 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.4 m -50.98 -49.75 59.6 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.229 1.012 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -61.5 -57.69 11.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.735 1.214 . . . . 0.0 110.285 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.21 -14.34 62.92 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -134.48 18.94 3.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.969 0.908 . . . . 0.0 112.157 -174.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.94 -58.15 7.92 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 110.937 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.41 -27.6 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.646 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -15.89 62.77 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.0 1.32 . . . . 0.0 112.158 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.89 42.03 6.14 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-O 118.257 -1.302 . . . . 0.0 112.523 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -53.21 167.3 0.19 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.806 1.242 . . . . 0.0 111.616 167.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 m -153.93 -43.21 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.731 1.212 . . . . 0.0 110.928 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.6 -166.23 34.43 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.86 159.39 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 121.456 -1.026 . . . . 0.0 108.33 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -127.84 164.3 22.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.242 1.017 . . . . 0.0 109.475 158.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -143.13 148.52 19.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 127.147 2.179 . . . . 0.0 108.701 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -122.85 129.61 51.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 165.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.97 116.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 154.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.1 p -120.74 165.09 19.69 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 165.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.8 -12.85 29.13 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.376 2.051 . . . . 0.0 111.959 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 p -96.37 -47.08 6.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.206 0.912 . . . . 0.0 109.77 -167.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.3 169.59 20.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.81 1.644 . . . . 0.0 108.789 164.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.9 m -72.87 145.13 47.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 162.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.68 140.65 52.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 171.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.38 120.05 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.13 111.71 29.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mp -70.71 132.35 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.5 105.29 17.41 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 163.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HB3' HG21 ' A' ' 49' ' ' VAL . . . -134.22 166.62 22.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 172.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -71.3 -35.88 71.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.796 -0.565 . . . . 0.0 111.259 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -127.29 74.89 1.54 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.178 0.899 . . . . 0.0 110.84 -163.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 p -50.61 -40.54 53.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -58.19 -34.69 70.64 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -77.57 -37.33 50.84 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 43' ' ' ALA . 70.2 t -66.26 -37.36 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 118.528 0.604 . . . . 0.0 110.03 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.76 -41.95 97.91 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.151 -0.968 . . . . 0.0 109.164 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.06 179.59 43.68 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.53 115.97 2.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.969 0.907 . . . . 0.0 109.934 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt 51.33 32.68 8.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.422 1.489 . . . . 0.0 111.633 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 33.7 37.42 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.033 -1.426 . . . . 0.0 112.727 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -65.61 0.64 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.732 1.766 . . . . 0.0 112.274 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -60.59 -42.12 96.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -167.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.27 -42.21 89.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 123.888 0.743 . . . . 0.0 110.425 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -46.84 83.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.258 1.39 . . . . 0.0 111.303 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -59.88 4.32 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.6 mt -66.64 -25.16 66.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 117.303 -1.332 . . . . 0.0 112.185 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.6 m -56.23 -52.58 63.93 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 120.324 1.42 . . . . 0.0 108.673 169.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.11 79.79 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.494 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.28 -60.09 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.81 -44.46 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 127.258 2.223 . . . . 0.0 110.624 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -55.24 -45.9 76.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.933 0.893 . . . . 0.0 110.467 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -70.17 -50.78 36.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.547 1.067 . . . . 0.0 111.488 170.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -29.24 49.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.796 1.638 . . . . 0.0 112.566 -172.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.71 4.22 7.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.324 1.45 . . . . 0.0 112.133 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.54 79.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.405 1.003 . . . . 0.0 114.625 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -70.25 142.0 89.31 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.137 . . . . 0.0 112.366 -172.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.74 121.51 8.58 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.496 2.797 . . . . 0.0 110.921 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.94 146.44 26.8 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.593 1.557 . . . . 0.0 110.256 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.42 -22.71 3.09 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 120.87 -1.144 . . . . 0.0 112.462 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.7 m -109.85 10.35 24.51 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.457 2.303 . . . . 0.0 110.862 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.86 140.22 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 162.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -129.18 154.76 46.45 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 124.002 0.921 . . . . 0.0 109.083 166.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -119.84 138.7 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -132.83 168.24 18.74 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.942 1.697 . . . . 0.0 109.949 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.79 108.58 9.97 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.835 1.254 . . . . 0.0 110.168 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.71 147.44 28.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 111.14 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -81.83 150.98 27.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.8 157.07 6.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.21 113.5 3.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.425 1.49 . . . . 0.0 107.092 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -75.82 -85.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -144.84 80.43 1.62 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.759 2.023 . . . . 0.0 105.64 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.09 112.25 0.49 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 m 60.68 174.96 0.1 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.829 1.651 . . . . 0.0 112.705 -167.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.41 149.04 5.71 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.91 142.39 75.25 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 CA-C-N 119.14 1.47 . . . . 0.0 110.221 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -144.32 -13.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.4 1.08 . . . . 0.0 112.106 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 p -135.43 100.19 4.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.138 0.975 . . . . 0.0 108.507 163.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 -175.611 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.741 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -169.77 163.32 9.83 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.269 2.227 . . . . 0.0 107.514 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -71.85 -23.71 61.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -170.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.46 -164.61 12.4 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -161.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m 73.06 107.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.719 2.408 . . . . 0.0 115.007 168.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 m 49.31 78.62 0.09 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.664 2.386 . . . . 0.0 112.944 162.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.03 151.39 16.65 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -61.0 -49.67 76.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -63.63 -12.15 31.11 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 118.317 -0.849 . . . . 0.0 113.159 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.49 1.14 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 121.165 1.802 . . . . 0.0 108.854 166.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -50.32 -45.41 54.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.48 1.512 . . . . 0.0 111.443 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.22 -40.76 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.839 0.456 . . . . 0.0 110.472 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -64.0 -48.13 77.58 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.12 -48.55 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.046 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -53.36 -56.53 15.99 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.091 0.859 . . . . 0.0 110.597 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.2 -37.41 85.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.369 1.068 . . . . 0.0 111.16 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.8 m -53.84 -47.91 70.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.905 0.882 . . . . 0.0 110.618 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -58.37 5.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.01 0.924 . . . . 0.0 109.813 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -58.01 -27.62 63.69 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.3 mt -120.23 18.03 12.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.837 1.655 . . . . 0.0 111.92 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.96 -35.82 47.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.268 1.027 . . . . 0.0 113.361 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -90.82 -19.59 23.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.906 0.775 . . . . 0.0 112.665 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.74 -26.34 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.593 1.157 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 50.58 2.81 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -169.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -57.43 168.42 0.8 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 110.417 166.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -154.24 -43.44 0.09 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 110.184 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -178.53 -165.9 33.86 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.7 157.47 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -124.96 138.45 54.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 108.212 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.61 116.48 35.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.207 1.803 . . . . 0.0 108.842 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -113.96 122.0 45.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.7 t -107.71 111.92 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 p -120.46 167.02 13.66 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.35 22.89 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.878 2.385 . . . . 0.0 111.445 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -127.61 -53.03 1.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.397 -1.439 . . . . 0.0 110.937 -168.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -162.09 171.71 17.06 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.459 2.304 . . . . 0.0 107.56 160.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -87.62 138.05 31.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.75 151.64 27.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.74 122.36 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 mt -123.57 108.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 mt -71.01 122.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.83 110.53 20.57 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.59 168.08 21.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 111.321 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -78.43 -26.37 46.29 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 120.458 -1.401 . . . . 0.0 112.854 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -128.89 67.02 1.41 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.964 0.906 . . . . 0.0 110.562 -164.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -45.32 26.46 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.697 1.999 . . . . 0.0 113.42 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -70.78 -28.61 64.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.223 -0.923 . . . . 0.0 111.744 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -72.59 -42.26 64.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 0.56 . . . . 0.0 109.689 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.76 -47.44 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.431 1.092 . . . . 0.0 108.89 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.1 mt -61.82 -38.66 88.99 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.441 -0.787 . . . . 0.0 111.024 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.0 174.05 29.67 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.52 117.21 3.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.273 1.029 . . . . 0.0 109.488 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 47.62 41.11 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.507 1.123 . . . . 0.0 112.925 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.93 13.74 83.34 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.114 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -48.61 -60.16 2.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.132 1.466 . . . . 0.0 113.046 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -43.25 99.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 117.025 -1.465 . . . . 0.0 110.363 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 tt -61.06 -39.02 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 120.185 1.357 . . . . 0.0 110.278 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -63.51 -47.7 80.6 Favored 'General case' 0 C--N 1.34 0.156 0 O-C-N 120.747 -1.221 . . . . 0.0 112.361 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.25 -58.88 6.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.257 1.023 . . . . 0.0 109.303 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.84 -26.23 67.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.624 -173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.4 m -58.32 -47.58 83.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.06 1.3 . . . . 0.0 109.803 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.84 88.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.624 1.102 . . . . 0.0 111.796 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.98 -58.82 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.283 -0.885 . . . . 0.0 108.64 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.2 t -52.12 -45.72 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 C-N-CA 126.378 1.871 . . . . 0.0 110.197 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -52.6 -49.29 65.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.534 0.733 . . . . 0.0 110.732 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.87 32.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.734 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -40.92 65.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.011 0.823 . . . . 0.0 111.965 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.15 8.24 27.93 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.055 1.742 . . . . 0.0 111.227 -175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.95 33.21 63.38 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.495 1.521 . . . . 0.0 113.695 172.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -72.32 151.41 92.08 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.782 0.833 . . . . 0.0 112.291 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.0 119.67 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.393 2.062 . . . . 0.0 109.241 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.09 137.16 56.16 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.758 0.823 . . . . 0.0 109.034 166.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.35 56.05 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.75 1.643 . . . . 0.0 113.152 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.3 m -133.51 17.7 3.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.076 1.438 . . . . 0.0 112.993 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.53 139.58 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 151.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -128.49 145.11 51.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.63 140.96 48.39 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -131.6 167.73 18.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 128.136 2.574 . . . . 0.0 108.871 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.33 119.47 15.54 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -121.49 171.78 8.55 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.375 1.47 . . . . 0.0 111.886 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -115.25 131.55 56.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.569 -164.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.24 148.08 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 74.16 99.76 0.07 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.424 2.289 . . . . 0.0 110.653 -175.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.2 m -63.8 120.75 12.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.467 2.307 . . . . 0.0 108.546 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 -23.12 0.12 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.105 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.78 -149.63 5.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.305 0.955 . . . . 0.0 112.113 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 m -146.22 -177.39 5.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.144 1.778 . . . . 0.0 108.562 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.5 171.38 16.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 162.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.34 159.15 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.109 2.54 . . . . 0.0 110.863 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 p -157.25 -20.99 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.681 1.192 . . . . 0.0 112.282 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -156.88 95.73 1.55 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 N-CA-C 106.924 -2.47 . . . . 0.0 106.924 176.031 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -160.99 166.28 28.52 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 117.987 0.893 . . . . 0.0 108.992 163.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 p -163.68 177.85 8.39 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.304 1.442 . . . . 0.0 108.433 159.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.7 159.67 26.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 168.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.4 m -106.42 -63.06 1.31 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.968 1.307 . . . . 0.0 109.195 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -145.82 -44.39 0.21 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.99 0.916 . . . . 0.0 110.768 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.43 -66.68 0.23 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 53.7 t80 -61.61 -56.81 15.82 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.372 1.069 . . . . 0.0 111.153 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -52.59 -38.23 59.67 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.698 0.799 . . . . 0.0 110.757 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.26 -49.65 40.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.117 -0.944 . . . . 0.0 112.241 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -55.95 -46.95 78.41 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.516 1.053 . . . . 0.0 109.787 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' CZ ' ' A' ' 8' ' ' PHE . 14.0 tp -62.4 -39.78 94.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.694 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -61.26 -51.78 67.51 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.003 0.921 . . . . 0.0 109.792 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -59.66 -40.08 86.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.928 0.785 . . . . 0.0 111.579 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.02 -57.92 10.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.934 0.893 . . . . 0.0 109.315 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -61.26 -38.39 86.53 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.856 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -53.61 -31.14 45.89 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.484 1.493 . . . . 0.0 111.25 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.86 -47.69 7.46 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 110.526 178.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -60.63 -33.76 73.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.791 0.723 . . . . 0.0 112.41 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -113.55 23.58 13.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.293 2.237 . . . . 0.0 110.37 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.87 -59.69 4.04 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.593 1.157 . . . . 0.0 110.143 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.03 -39.94 79.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.695 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.31 -43.51 92.66 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.699 1.6 . . . . 0.0 112.21 -164.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.63 48.73 0.78 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.868 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.51 169.79 5.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.163 1.385 . . . . 0.0 111.095 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -157.16 -26.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.14 -169.54 36.75 Favored Glycine 0 C--O 1.227 -0.311 0 O-C-N 121.632 -0.667 . . . . 0.0 111.689 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.59 142.52 11.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.21 158.37 16.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.335 1.054 . . . . 0.0 109.506 171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.79 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.093 1.357 . . . . 0.0 107.471 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.7 129.07 57.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 5.8 p -121.83 177.06 1.67 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.634 1.574 . . . . 0.0 110.407 -172.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 33' ' ' THR . 91.1 Cg_endo -78.75 0.0 10.36 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 121.424 1.416 . . . . 0.0 113.182 165.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -119.64 -53.14 2.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.766 1.621 . . . . 0.0 112.971 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -153.73 161.38 42.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.649 1.18 . . . . 0.0 110.66 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.1 m -71.63 148.06 46.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.08 130.99 53.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.336 1.854 . . . . 0.0 106.769 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.9 mt -124.03 121.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -120.94 97.14 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -69.61 141.74 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -115.39 120.8 40.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 127.923 2.489 . . . . 0.0 107.76 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.91 169.71 22.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.101 1.361 . . . . 0.0 109.643 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -80.41 -35.43 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.406 -0.809 . . . . 0.0 112.342 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -125.55 83.47 2.17 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.306 1.442 . . . . 0.0 108.32 -165.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -49.92 -45.15 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.049 1.34 . . . . 0.0 112.387 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -56.85 -38.47 72.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.49 -43.73 80.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.485 1.039 . . . . 0.0 109.877 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.05 -42.32 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.079 0.552 . . . . 0.0 109.768 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.15 -30.78 71.73 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.979 -1.076 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.16 -174.38 9.42 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.06 111.6 1.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 110.228 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp 56.41 3.13 0.1 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.251 1.82 . . . . 0.0 115.14 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.72 -2.14 9.35 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 120.422 1.464 . . . . 0.0 114.112 -169.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -44.06 -57.44 3.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.057 1.929 . . . . 0.0 113.941 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.87 -45.02 79.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.122 0.874 . . . . 0.0 110.621 -173.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.29 -34.33 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.374 0.988 . . . . 0.0 109.827 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -71.84 -37.42 70.28 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.569 1.148 . . . . 0.0 113.753 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.28 -55.27 16.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 18.2 mt -56.09 -36.1 67.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.136 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.5 m -49.32 -52.56 27.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.18 0.9 . . . . 0.0 110.729 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.61 -44.63 56.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.2 1.0 . . . . 0.0 111.36 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 60' ' ' LEU . 2.5 p -60.28 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 t -54.85 -46.49 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 120.417 1.462 . . . . 0.0 110.614 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -49.95 -42.51 48.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.272 1.029 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -83.77 -41.06 18.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.002 0.921 . . . . 0.0 111.709 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -29.64 70.88 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.98 0.912 . . . . 0.0 111.474 -173.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.3 -8.76 11.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.983 0.913 . . . . 0.0 110.464 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.5 51.07 45.12 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -78.18 150.4 77.39 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.011 0.524 . . . . 0.0 110.018 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.54 119.51 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.773 1.649 . . . . 0.0 109.712 162.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.86 145.59 15.81 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.93 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.601 -1.111 . . . . 0.0 114.296 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -134.46 40.16 3.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.462 2.131 . . . . 0.0 111.882 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -141.2 139.57 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 164.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.28 138.34 50.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.092 1.357 . . . . 0.0 108.729 171.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.44 129.23 47.44 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -117.04 160.3 21.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.421 1.488 . . . . 0.0 109.554 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.67 109.36 10.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.92 1.288 . . . . 0.0 108.463 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.12 156.48 17.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.376 1.47 . . . . 0.0 108.475 173.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -107.06 148.83 28.27 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -100.1 146.54 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.63 -44.85 0.19 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.09 1.756 . . . . 0.0 111.773 -171.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.2 p 32.67 64.8 0.25 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.865 2.866 . . . . 0.0 113.87 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.07 83.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.816 1.246 . . . . 0.0 109.979 -174.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.91 73.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.0 p -154.53 176.36 12.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.408 0.604 . . . . 0.0 111.144 168.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.95 79.44 0.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.92 170.5 17.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.616 2.211 . . . . 0.0 111.209 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.0 t -141.37 170.35 15.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.213 1.405 . . . . 0.0 108.683 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.1 m -137.36 -78.56 0.39 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.972 1.709 . . . . 0.0 107.751 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -149.984 . . . . . . . . 0 0 . 1 stop_ save_